data_2l26_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l26 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.786 0.327 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 154.94 40.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.08 159.74 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.758 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -88.94 168.39 12.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.36 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.79 107.93 11.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.03 136.07 54.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 121.05 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.609 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.76 125.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.03 132.56 50.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -124.22 126.51 46.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.4 p -135.12 122.77 22.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.78 2.94 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.47 27.66 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -119.8 134.56 55.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.59 115.25 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.488 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -109.77 116.27 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.32 121.27 44.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 129.36 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.23 -152.54 20.15 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.57 154.3 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.39 144.74 44.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.5 -19.2 37.68 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.629 2.219 . . . . 0.0 111.873 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.65 -157.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.438 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.02 -26.45 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.389 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.26 98.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.353 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.35 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -58.45 -36.92 74.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.49 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.08 75.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.363 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.89 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.312 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.67 -39.98 93.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.439 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mmt -56.38 -37.16 69.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.478 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -65.98 -42.7 89.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.291 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.69 -22.87 62.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.44 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.03 -44.2 20.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.541 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -45.73 -37.47 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.7 -44.16 40.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' A' ' 114' ' ' LEU . 1.2 tp -43.53 -73.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 161.17 -156.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.698 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.628 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . 175.83 -48.89 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.573 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.666 ' C ' ' H ' ' A' ' 118' ' ' VAL . 86.3 Cg_exo -40.03 -129.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.547 2.831 . . . . 0.0 113.834 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.37 -2.36 0.03 OUTLIER Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.666 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.9 t -95.72 134.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 122.353 -0.498 . . . . 0.0 110.362 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.89 129.38 35.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.532 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 t -129.33 116.7 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.24 140.04 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.259 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -126.36 96.65 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -99.33 61.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.949 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 124' ' ' ILE . 0.8 OUTLIER -105.63 128.71 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.678 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.58 146.59 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.3 t -99.6 119.2 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.63 125.07 20.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.289 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.17 42.88 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.368 2.045 . . . . 0.0 112.16 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.82 -35.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.57 167.34 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.07 159.29 34.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -143.94 155.8 44.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.705 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.11 135.8 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.37 139.46 57.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.73 38.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.81 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -66.6 -58.68 4.66 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.615 0.721 . . . . 0.0 110.988 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 m -109.31 15.51 23.06 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.002 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -96.87 -23.26 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.797 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.8 OUTLIER -55.74 -46.26 99.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 23.2 Cg_exo -59.98 -29.59 89.69 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.805 2.337 . . . . 0.0 111.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.55 -44.96 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.59 -32.4 73.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 39.3 p -65.59 -36.17 82.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.714 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.28 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -97.77 0.71 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.7 t -65.68 -38.78 27.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 72.4 Cg_endo -85.02 20.44 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.692 2.261 . . . . 0.0 112.336 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.57 116.62 22.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.676 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.36 178.61 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.14 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 54.38 20.29 2.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -82.69 139.51 33.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.772 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.08 153.24 24.89 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.6 127.92 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.63 123.25 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.29 136.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.43 79.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.474 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 54.87 -115.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.732 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 158' ' ' ASP . 16.2 t70 -82.98 18.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -125.25 124.63 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.55 117.91 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.137 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -128.29 127.53 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.869 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.16 124.96 48.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.166 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.55 151.71 46.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.48 164.01 24.48 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 123.82 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.48 106.44 40.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.85 -62.52 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.338 2.026 . . . . 0.0 112.046 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.16 121.53 27.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.59 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.534 ' HG ' ' N ' ' A' ' 170' ' ' GLU . 4.9 p -61.67 -30.6 70.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.534 ' N ' ' HG ' ' A' ' 169' ' ' SER . 80.4 tt0 -58.99 -38.6 79.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.48 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -41.94 96.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -64.57 -39.95 94.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.62 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.81 -46.9 71.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.64 86.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.24 -37.8 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -58.34 -44.29 88.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.457 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.44 -37.16 82.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.59 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.86 -41.27 97.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HA ' ' HG1' ' A' ' 182' ' ' THR . . . -62.15 -46.83 87.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 76.3 p -63.81 -40.87 97.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.903 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.7 t -71.37 -29.97 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.154 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 22.8 m -50.71 -63.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.468 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -144.05 79.27 13.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.58 -33.56 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.921 2.414 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -75.82 55.87 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 187' ' ' LYS . 23.3 tpp -176.7 166.12 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.603 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.469 ' HZ2' ' HB3' ' A' ' 187' ' ' LYS . 5.5 mtpm? -86.76 126.24 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.47 137.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.671 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.84 118.66 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -94.38 108.81 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.42 71.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.164 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.58 128.63 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.798 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -111.82 145.73 38.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.295 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.0 m -88.38 129.4 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.59 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.747 -179.87 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 39.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.864 0.364 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -72.12 137.81 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 209' ' ' ALA . 16.0 m-20 37.81 19.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.7 OUTLIER -56.3 -30.81 63.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.523 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 212' ' ' GLN . 0.3 OUTLIER -54.28 -40.89 68.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -69.47 -42.05 75.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.404 0.621 . . . . 0.0 110.989 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.77 -34.69 64.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.079 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 216' ' ' ASN . 2.8 tt -59.03 -37.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.527 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 215' ' ' ILE . 2.6 t-20 -54.16 -32.69 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.213 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.18 -45.7 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.664 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.486 ' CG2' ' HZ1' ' A' ' 246' ' ' LYS . 13.0 t -60.46 -38.85 79.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.532 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 220' ' ' GLY . 20.2 p -78.82 -31.44 45.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 219' ' ' THR . . . 19.57 52.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 219' ' ' THR . . . -153.88 166.32 31.89 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.74 138.93 39.05 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.89 2.394 . . . . 0.0 112.071 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.691 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.798 0.332 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.62 -32.86 73.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.91 -36.96 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.809 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -46.15 87.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -63.29 -35.58 80.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -66.26 -45.25 81.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.499 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.88 86.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.528 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.3 -41.91 76.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.35 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.486 ' HZ1' ' CG2' ' A' ' 218' ' ' VAL . 20.0 mtmt -69.83 -32.41 70.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.452 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -64.45 -31.07 72.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.828 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.25 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -106.01 3.78 28.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.247 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.689 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.7 m -75.41 -27.59 0.7 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.6 Cg_exo -53.58 -14.21 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.466 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 251' ' ' PRO . 40.2 t0 -39.88 -23.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -115.41 -148.82 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.76 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -109.61 139.39 44.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.9 t -118.83 132.15 69.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.894 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 95.5 m -123.4 125.77 45.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -113.81 120.25 63.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.874 0.369 . . . . 0.0 110.493 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.49 149.51 27.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -124.87 123.79 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -100.6 133.93 44.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.7 165.19 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.362 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 -158.85 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 2.7 t-20 -176.34 129.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 35.9 m -150.6 -15.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.676 ' ND2' ' NH1' ' A' ' 315' ' ' ARG . 11.3 m120 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 0.7 OUTLIER -57.43 -51.82 78.89 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 12.4 Cg_endo -59.87 -41.91 49.89 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.947 1.765 . . . . 0.0 112.508 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.457 ' C ' HH22 ' A' ' 319' ' ' ARG . 5.4 tp -68.8 -37.97 79.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.502 ' N ' HH22 ' A' ' 319' ' ' ARG . 1.4 p -64.86 -40.18 94.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.9 -51.99 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.7 -34.59 78.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -60.51 -41.77 95.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.47 91.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -57.26 -40.21 77.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.596 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 11.1 mm -61.05 -40.68 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.589 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.45 -45.99 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.507 ' O ' ' CG2' ' A' ' 286' ' ' VAL . . . -61.93 -43.14 99.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.49 -39.4 87.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.13 -52.09 31.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.65 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 57.2 mt -59.6 -45.46 91.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.543 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 282' ' ' ALA . 59.4 t -58.95 -36.36 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.194 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.8 -25.13 68.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 0.0 OUTLIER -84.16 -2.43 56.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.296 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.47 12.6 26.4 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 90.4 t -77.34 118.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 110.467 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.72 109.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.79 1.81 71.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.41 -15.84 59.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.409 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.41 5.98 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 295' ' ' ILE . 10.4 tt -91.07 133.83 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -130.0 135.98 48.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.41 134.05 51.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 122.13 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.71 106.67 3.39 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.405 ' H ' ' CD1' ' A' ' 300' ' ' LEU . 0.0 OUTLIER -103.49 89.39 3.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.658 ' O ' ' OG ' ' A' ' 302' ' ' SER . . . -91.5 167.82 31.49 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.658 ' OG ' ' O ' ' A' ' 301' ' ' GLY . 89.7 p 69.64 -43.71 0.53 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.312 0.577 . . . . 0.0 110.963 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 301' ' ' GLY . 27.4 m -64.37 166.32 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.468 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 303' ' ' VAL . 10.3 m120 30.18 60.91 0.94 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.526 ' O ' ' C ' ' A' ' 306' ' ' ILE . 37.5 Cg_endo -69.72 67.16 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.784 2.323 . . . . 0.0 112.272 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 305' ' ' PRO . 6.4 mm -30.92 -66.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.391 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.7 160.4 22.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.33 160.27 30.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -100.81 108.55 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.206 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -163.84 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.59 161.32 28.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.69 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -50.23 -33.04 34.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.523 2.149 . . . . 0.0 112.08 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -68.51 -31.87 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.748 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.64 97.63 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.676 ' NH1' ' ND2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -63.44 -45.8 89.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.779 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -62.78 -40.43 97.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.717 HD21 ' N ' ' A' ' 319' ' ' ARG . 0.4 OUTLIER -83.79 -25.11 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.906 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.717 ' N ' HD21 ' A' ' 318' ' ' ASN . 0.7 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -137.22 157.77 45.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 111.048 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.9 t -144.87 152.58 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.73 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.97 142.95 29.17 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.507 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.1 mt -119.03 120.67 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.13 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 256' ' ' THR . 2.7 m -127.76 131.52 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.37 136.1 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.478 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.551 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 1.8 m-20 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.535 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 131' ' ' ARG . 24.2 p -129.3 138.27 51.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.24 159.29 15.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.6 p -97.18 159.67 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.745 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.45 115.77 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.637 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.96 144.09 49.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.81 125.94 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -133.43 115.49 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.347 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 m -137.26 127.37 26.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HE ' HG13 ' A' ' 91' ' ' VAL . 7.9 mtt85 -114.91 126.46 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.302 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 p -134.23 116.71 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 150' ' ' ASP . . . 71.73 -137.14 25.29 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -95.22 15.68 18.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 110.497 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -121.61 125.76 47.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.48 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 5.8 m -107.36 118.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.38 127.72 45.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 94' ' ' ILE . 14.0 tp -133.15 120.41 21.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.284 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -134.13 129.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.614 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.5 -156.21 23.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 154.1 41.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 20.9 m-85 -138.67 146.59 51.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.535 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 24.9 Cg_endo -64.48 -25.47 63.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.676 2.251 . . . . 0.0 112.144 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 98' ' ' PRO . 35.5 m-20 -155.76 119.82 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.611 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -45.23 -21.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.43 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ASP . . . -60.41 -36.82 79.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.64 81.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -36.88 85.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.14 -38.52 79.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.351 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.37 90.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.28 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.54 -43.22 85.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -26.42 61.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -60.56 -42.81 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.799 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.09 67.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.469 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mt -79.74 -21.15 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.61 -30.38 8.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.56 61.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 1.9 tt -88.04 -47.53 8.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.835 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 mt -21.2 116.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.157 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.606 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -142.98 -178.27 0.77 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.35 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 115' ' ' ALA . 71.7 Cg_endo -89.01 153.58 5.8 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.127 2.552 . . . . 0.0 112.594 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.86 -10.04 21.06 Favored Glycine 0 C--O 1.24 0.483 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 115' ' ' ALA . 3.2 m -92.86 130.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.01 -0.7 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.44 HD21 ' N ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -92.26 130.47 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.524 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.44 ' N ' HD21 ' A' ' 119' ' ' ASN . 0.8 OUTLIER -102.3 129.06 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.425 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.0 mm -130.16 110.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.31 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 78.78 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.059 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -85.94 75.98 9.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.9 130.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.736 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.01 146.47 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.054 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.76 111.74 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.654 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -137.54 102.94 8.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.351 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.71 26.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.391 2.061 . . . . 0.0 112.183 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.654 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.3 t -124.46 -4.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.902 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 171.41 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.735 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 78' ' ' SER . 6.2 mmt-85 -117.82 159.27 23.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.678 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -125.22 155.23 40.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.704 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.48 ' CD2' ' CE2' ' A' ' 183' ' ' TRP . 4.4 tp -86.91 134.98 33.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.61 132.41 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.734 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -117.68 27.31 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.302 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.1 m -32.65 -47.2 0.16 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.171 0.51 . . . . 0.0 110.978 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -100.22 -91.49 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.802 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 69.99 -43.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.694 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 137' ' ' SER . 2.8 mm-40 -51.75 -58.86 9.52 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.958 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 20.6 Cg_endo -64.28 -35.13 52.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.514 2.143 . . . . 0.0 112.143 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.447 ' CG2' ' HG1' ' A' ' 182' ' ' THR . 20.9 t -69.92 -48.27 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.84 -42.8 94.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.0 p -65.97 -33.98 77.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.72 -22.03 59.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 p -111.99 5.54 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -63.86 -42.68 72.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.245 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 26.3 Cg_exo -57.92 -10.98 8.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.592 2.195 . . . . 0.0 111.756 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mm -125.03 89.7 52.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.63 16.36 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.666 2.244 . . . . 0.0 112.059 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 88' ' ' GLY . 6.3 m-20 -132.4 61.66 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.616 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 2.7 p90 -125.55 143.17 51.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.54 142.2 15.61 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.6 tp -141.93 127.22 18.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -125.16 128.8 48.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.024 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.28 127.48 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.132 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 157' ' ' ARG . 2.2 tt0 -110.45 176.16 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.12 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 156' ' ' GLU . 25.6 mtt180 -32.26 -43.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.633 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 30.55 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 m -135.82 130.38 33.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.632 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.49 127.2 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 m -131.14 127.22 37.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.608 ' CD1' ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -117.19 121.31 40.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.722 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.9 m -122.76 147.15 46.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.522 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.97 158.47 8.64 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.6 p -96.47 135.3 38.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.05 142.22 26.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.62 -39.19 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.687 2.258 . . . . 0.0 112.272 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.464 ' HB3' ' HD1' ' A' ' 171' ' ' HIS . 44.5 t -123.61 137.66 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.638 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -33.17 75.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -59.01 -48.56 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.464 ' HD1' ' HB3' ' A' ' 168' ' ' SER . 29.9 m80 -58.35 -40.84 83.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.353 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.78 ' HZ2' ' NZ ' ' A' ' 176' ' ' LYS . 8.5 tttm -62.89 -36.18 82.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.6 t70 -63.93 -38.64 91.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.64 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.38 71.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.93 -51.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.78 ' NZ ' ' HZ2' ' A' ' 172' ' ' LYS . 1.5 ptpt -63.52 -36.73 84.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.799 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 176' ' ' LYS . 9.3 ttm180 -59.76 -53.99 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.723 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.576 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -66.8 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.98 77.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.693 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.6 OUTLIER -63.25 -38.59 91.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.716 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 p -70.88 -36.32 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.2 OUTLIER -66.48 -68.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.845 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 133' ' ' LEU . 8.5 m-90 -114.8 90.44 22.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 186' ' ' MET . 72.4 Cg_endo -83.53 22.52 0.91 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 123.017 2.478 . . . . 0.0 111.671 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 186' ' ' MET . 54.2 m-20 -36.56 -20.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.671 ' N ' ' O ' ' A' ' 184' ' ' PRO . 5.4 tpt 91.1 -39.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.564 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.12 53.53 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.44 119.08 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.93 129.68 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -104.41 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -125.13 59.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.291 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.39 129.16 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -121.99 139.63 53.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.232 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -88.28 129.42 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.485 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 250' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -65.32 134.37 53.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.822 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.0 OUTLIER 39.03 16.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.784 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -56.25 -30.85 62.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.077 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -38.2 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.402 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -65.73 -42.48 90.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.521 0.677 . . . . 0.0 110.984 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.83 64.21 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.37 -39.12 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 220' ' ' GLY . 2.6 m120 -59.91 -38.52 82.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.29 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -58.6 -34.9 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 220' ' ' GLY . 3.5 t -105.54 -30.38 9.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 122.95 -37.93 2.66 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.21 -170.04 33.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 143.06 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.794 2.329 . . . . 0.0 111.976 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.738 ' CD1' ' H ' ' A' ' 223' ' ' ILE . 3.1 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.64 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.78 0.324 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.44 -39.52 88.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 58.8 mt -68.89 -36.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.73 -32.74 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.595 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -56.1 -43.08 77.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -45.92 79.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.6 -45.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.25 83.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.35 -50.64 70.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -31.7 71.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.115 0.483 . . . . 0.0 109.757 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -55.07 -30.19 59.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.49 11.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -104.36 -2.92 24.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.469 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.6 m -74.85 -27.17 0.7 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 51.4 Cg_exo -51.91 -13.83 2.02 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.728 1.618 . . . . 0.0 111.857 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.36 -14.65 63.11 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.9 -166.29 1.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.703 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -113.43 138.7 49.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.36 133.13 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.944 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.2 m -117.34 118.85 33.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.051 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.493 HG21 HD12 ' A' ' 257' ' ' ILE . 65.6 mt -101.62 120.2 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -100.21 134.93 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.97 125.63 8.26 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -109.18 112.51 24.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.451 ' CG2' ' OD1' ' A' ' 270' ' ' ASN . 8.8 t -116.67 -158.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.251 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.432 ' N ' ' OG1' ' A' ' 261' ' ' THR . 1.0 OUTLIER -122.81 -151.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -119.7 28.46 8.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.3 m -58.68 -68.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' CG2' ' A' ' 261' ' ' THR . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.714 0.292 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.2 mm -59.96 -51.94 77.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.4 Cg_endo -61.67 -33.25 86.64 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.111 1.874 . . . . 0.0 112.106 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.31 -42.61 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.423 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 p -74.33 -37.8 63.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.635 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.13 -35.8 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 41.7 mtt-85 -63.05 -47.11 84.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.91 70.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.393 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -55.82 -39.1 70.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.469 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.8 -43.62 89.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.328 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.73 -38.19 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.21 93.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.644 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.96 -37.25 86.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.514 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -52.33 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.49 -48.94 79.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.36 -39.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.187 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.7 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.196 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 0.4 47.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.7 12.05 42.01 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.45 133.93 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.563 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.74 102.8 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -85.93 1.71 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.602 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -133.4 6.99 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.2 mt -96.57 133.84 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.327 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.53 147.04 50.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 128.31 40.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.84 140.23 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.722 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -105.38 112.44 3.99 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 299' ' ' GLY . 11.4 mt -46.27 -96.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 302' ' ' SER . . . 132.05 82.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 301' ' ' GLY . 47.0 t 30.21 68.76 0.09 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.017 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.67 -82.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.704 0.288 . . . . 0.0 110.263 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.675 ' C ' ' H ' ' A' ' 306' ' ' ILE . 0.7 OUTLIER -178.45 -51.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 32.1 Cg_exo -57.34 16.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.58 2.187 . . . . 0.0 112.346 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.675 ' H ' ' C ' ' A' ' 304' ' ' ASN . 14.4 pt -77.34 178.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.309 . . . . 0.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.74 171.91 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.726 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 14.5 m -81.18 152.88 27.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.41 31.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.86 -35.13 69.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.631 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.63 154.38 79.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.01 -34.2 97.17 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.89 2.393 . . . . 0.0 111.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.433 ' CG ' ' N ' ' A' ' 314' ' ' GLY . 7.8 pt-20 -65.24 -36.66 84.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.287 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 313' ' ' GLU . . . -59.82 -39.23 95.13 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.528 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -65.57 -44.64 86.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.42 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.418 ' HA ' ' NH2' ' A' ' 319' ' ' ARG . . . -55.45 -40.33 71.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.384 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -65.52 -29.95 70.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.546 ' C ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -76.23 -16.1 59.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.517 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 316' ' ' ALA . 52.9 mtm180 -94.6 95.73 8.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -132.11 146.63 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.261 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.26 147.92 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.88 136.82 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.582 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.19 117.9 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.62 131.64 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.438 HG12 ' SG ' ' A' ' 250' ' ' CYS . 2.3 p -109.69 135.36 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.555 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.549 ' O ' ' OD1' ' A' ' 326' ' ' ASN . 19.2 t-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.612 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.979 0.418 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.81 144.68 8.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 5.8 mt -129.28 159.34 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.795 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.7 p -86.71 167.36 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 123.98 21.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.97 118.04 15.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.272 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 p -127.83 129.25 46.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 1.4 pt -134.53 132.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.472 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -124.81 126.85 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.524 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -113.4 131.2 56.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 90' ' ' THR . 41.2 t -142.8 112.5 6.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.12 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.65 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 27.08 106.04 0.0 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.14 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.7 1.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.65 ' H ' ' C ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -106.99 124.91 50.31 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.476 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.86 125.64 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 78.2 m -123.12 118.59 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.77 127.25 52.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.766 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 mt -135.32 128.19 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.475 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.56 -161.15 33.38 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.76 146.04 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CD2' ' OG ' ' A' ' 132' ' ' SER . 11.4 m-85 -125.32 156.01 70.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.356 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 -20.76 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.779 2.319 . . . . 0.0 112.945 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 18.2 t0 -156.45 157.75 36.06 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.222 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -76.25 -26.99 56.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.062 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.06 79.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.08 86.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.203 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -57.07 -36.7 70.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.59 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.59 -40.42 68.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.98 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -41.34 76.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.301 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 39.3 mtp -58.58 -33.4 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.457 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.2 OUTLIER -61.29 -35.17 76.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.48 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.8 mt -78.36 -20.61 50.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -46.83 -23.02 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.93 -22.43 55.31 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 14.6 tp -98.28 -44.58 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.77 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -24.38 101.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.29 69.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.621 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 118' ' ' VAL . 17.8 Cg_endo -61.91 -79.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.884 2.389 . . . . 0.0 112.217 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -43.9 -10.35 0.01 OUTLIER Glycine 0 N--CA 1.46 0.246 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 116' ' ' PRO . 38.4 t -102.37 120.8 52.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 O-C-N 122.238 -0.566 . . . . 0.0 110.623 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.35 118.7 31.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -118.73 125.95 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.435 ' C ' ' OD1' ' A' ' 122' ' ' ASP . 13.5 pt -123.71 138.22 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.125 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -126.78 90.94 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.296 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.55 68.81 9.69 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.69 119.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.871 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -91.48 145.99 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.02 112.27 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.875 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.74 125.35 22.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.15 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.49 49.27 1.73 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.298 1.999 . . . . 0.0 112.171 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.4 t -154.1 -35.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.23 153.6 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -110.08 159.54 17.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.609 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 1.4 m -120.78 150.55 40.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 29.8 tp -83.24 129.82 35.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -53.3 147.35 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.8 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -125.21 11.75 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.151 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.4 p -39.63 -25.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -140.63 31.05 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.809 -179.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.83 24.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.3 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -51.59 -58.95 9.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.971 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 17.9 Cg_endo -63.39 -31.63 72.51 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.396 2.064 . . . . 0.0 112.042 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.6 t -64.75 -47.74 87.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.75 -37.47 87.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 p -68.08 -33.15 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.693 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.0 -27.41 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -100.54 0.45 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.002 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.729 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -70.76 -36.16 5.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 16.4 Cg_exo -64.04 18.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.945 2.43 . . . . 0.0 112.208 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 150' ' ' ASP . 60.2 mt -139.73 86.65 13.57 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.19 2.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.836 2.357 . . . . 0.0 112.008 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.2 p-10 -130.26 70.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.453 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -127.71 140.66 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.87 133.67 7.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.48 131.65 53.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 0.0 110.714 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 124.76 45.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.374 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.9 124.34 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -136.03 93.79 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.412 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 3.5 mtp180 58.79 -93.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.42 15.38 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -114.15 125.27 53.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.19 117.21 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.619 ' CG2' HD21 ' A' ' 191' ' ' ASN . 9.0 m -134.32 135.78 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.41 124.25 46.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.507 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.55 149.12 45.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 154.7 160.07 9.64 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.532 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 95.9 m -91.28 139.27 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.87 108.48 42.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.12 -27.28 1.78 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.416 2.077 . . . . 0.0 112.147 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -130.05 131.81 45.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -34.35 77.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -36.04 75.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.427 ' HD1' ' HA ' ' A' ' 171' ' ' HIS . 2.2 m-70 -63.67 -35.94 82.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -46.22 91.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.38 -44.43 95.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.38 86.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.75 -41.19 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.314 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 -52.13 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.115 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -57.17 -40.47 77.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -65.65 -36.43 83.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.424 ' HA ' ' HG1' ' A' ' 182' ' ' THR . . . -68.62 -46.21 69.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.3 m -60.58 -41.0 93.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -67.73 -29.16 68.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 2.6 m -68.38 -66.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.491 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.456 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 6.3 m-90 -118.42 67.24 6.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.693 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.67 1.93 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.627 2.218 . . . . 0.0 111.829 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.77 60.71 0.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.54 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 ttt -171.84 -163.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 104.98 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.93 127.75 57.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.488 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.49 121.14 58.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 190' ' ' ASN . 0.9 OUTLIER -97.58 116.95 30.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.742 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.619 HD21 ' CG2' ' A' ' 161' ' ' THR . 12.4 m-80 -117.29 48.53 1.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.219 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.15 125.78 52.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.12 142.96 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.3 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.73 107.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.412 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 179.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.689 ' SG ' ' O ' ' A' ' 246' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.702 0.287 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . 53.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 2.7 m-20 33.46 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.615 ' H ' ' CD2' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -56.24 -46.05 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.123 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.458 ' C ' ' CD ' ' A' ' 212' ' ' GLN . 10.2 tp60 -72.73 -50.38 25.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.249 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -71.17 -44.42 65.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.601 0.36 . . . . 0.0 110.948 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.597 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -71.33 -45.27 63.38 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.028 -0.42 . . . . 0.0 111.943 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 211' ' ' LEU . 1.7 tp -69.48 -36.62 72.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.942 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 216' ' ' ASN . 0.7 OUTLIER -69.92 -43.96 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.662 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.81 95.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.703 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.8 -50.15 80.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 221' ' ' GLY . 57.4 p -69.29 -22.22 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 74.5 -40.18 1.1 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -168.56 174.76 43.27 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.35 141.68 94.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.834 2.356 . . . . 0.0 111.986 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.631 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.564 ' O ' ' OD1' ' A' ' 241' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.915 0.388 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.61 -46.04 73.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 24.5 mt -59.49 -38.06 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 77.6 mt -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 237' ' ' TYR . 11.1 m120 -55.82 -49.03 74.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.903 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -65.03 -45.78 84.03 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.724 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.04 -48.42 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.31 82.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -50.71 70.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.689 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 6.0 mtpm? -69.18 -33.41 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.981 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.441 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.9 OUTLIER -54.81 -31.29 58.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.594 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -62.5 -16.88 58.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.22 22.27 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.34 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 57.8 m -74.98 -28.63 0.81 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.3 Cg_exo -53.63 -14.23 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.327 2.018 . . . . 0.0 112.646 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -52.36 -10.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 251' ' ' PRO . . . -128.98 -157.87 0.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.217 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -100.23 139.1 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 50.7 t -119.41 132.95 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.112 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.512 ' HB ' HG21 ' A' ' 324' ' ' VAL . 95.2 m -121.23 119.43 32.26 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 257' ' ' ILE . 36.4 mt -106.17 121.02 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.79 0.328 . . . . 0.0 110.786 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.68 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -109.45 125.1 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -112.4 166.21 12.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 261' ' ' THR . 1.2 t80 -172.99 109.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.688 ' O ' ' CE1' ' A' ' 260' ' ' TYR . 1.3 t -105.08 -162.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.714 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 261' ' ' THR . 12.6 p-10 -89.75 174.69 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 265' ' ' GLY . 2.4 m-20 -96.6 -86.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 54.2 m 61.09 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.458 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.567 0.222 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.7 mm -68.26 -52.49 21.7 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.8 Cg_endo -61.7 -35.59 79.28 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.085 1.856 . . . . 0.0 112.292 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.26 -47.25 68.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.5 p -73.3 -35.19 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.54 -38.49 71.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.32 -43.79 98.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.658 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -60.15 -39.76 87.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.608 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.34 -31.21 70.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -73.57 -37.5 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.81 -46.52 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.69 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.15 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.123 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -30.83 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -46.69 51.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.712 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.46 ' O ' ' CG2' ' A' ' 290' ' ' VAL . 9.7 mt -59.91 -49.25 78.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.15 -36.21 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.76 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 -2.33 58.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.419 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.4 2.67 38.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 285' ' ' LEU . 22.0 t -68.74 131.91 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.349 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.77 97.66 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.596 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -77.46 12.86 12.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.14 -16.29 38.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -121.31 27.68 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.328 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 295' ' ' ILE . 35.4 mt -117.75 124.85 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.3 135.5 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 124.44 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.99 116.47 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.152 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.8 105.37 2.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.679 ' O ' ' N ' ' A' ' 302' ' ' SER . 27.5 mt -74.29 0.07 15.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 110.42 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.5 -72.18 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 300' ' ' LEU . 89.4 p -174.73 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 120.352 0.12 . . . . 0.0 110.955 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 304' ' ' ASN . 66.2 t -41.89 -84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.63 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 0.1 OUTLIER -86.38 -39.58 0.56 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.14 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 60.4 Cg_endo -82.53 143.64 12.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.667 2.245 . . . . 0.0 112.465 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.24 137.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.92 163.04 30.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 158.72 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -122.07 49.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -106.78 -40.06 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.852 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.91 157.99 67.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -50.04 -30.11 23.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.609 2.206 . . . . 0.0 112.056 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.09 -40.54 89.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.452 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -67.99 -44.13 79.39 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.409 ' HG2' ' NH1' ' A' ' 315' ' ' ARG . 27.1 mtt-85 -66.08 -46.15 78.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.76 80.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.316 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -72.7 -24.38 60.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 260' ' ' TYR . 65.5 m-20 -72.8 -24.27 60.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -91.72 101.68 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.23 139.52 39.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.759 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.32 155.11 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.04 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -145.09 143.17 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 111.018 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 17.8 mt -125.89 112.7 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.054 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.512 HG21 ' HB ' ' A' ' 256' ' ' THR . 2.5 m -122.03 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.169 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.51 135.05 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.465 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 41.5 t30 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.703 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.836 0.35 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 p -92.08 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.113 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 2.5 mt -121.35 159.65 25.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.2 m -81.31 178.91 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.245 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 3.7 pp -83.1 132.71 35.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.662 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.95 138.33 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.09 123.08 39.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.41 115.72 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.394 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -136.5 130.36 32.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 149' ' ' PRO . 42.1 mtt85 -112.22 140.15 47.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.8 p -142.89 114.82 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.623 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 56.66 -161.09 7.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.72 7.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 110.49 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 88' ' ' GLY . 99.7 m -107.58 130.93 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.35 116.93 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.3 m -103.25 121.38 42.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.582 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -123.05 127.62 49.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.31 123.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.386 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . 178.36 -161.39 28.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER -137.33 156.36 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.624 0.249 . . . . 0.0 110.447 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -133.28 150.88 76.5 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.569 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.6 -19.66 31.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.772 2.315 . . . . 0.0 112.132 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.8 173.36 10.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -82.05 -34.8 29.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.89 85.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.9 78.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HZ1' ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -55.86 -36.75 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.717 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -37.5 64.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.536 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -60.56 -38.07 83.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.28 -43.98 69.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.016 0.436 . . . . 0.0 110.3 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.0 mtp -58.0 -26.31 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.531 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -43.97 96.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.79 -21.95 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.415 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.8 mt -99.64 -1.43 38.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -47.79 -34.39 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 -32.13 29.98 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.38 -34.91 69.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.317 . . . . 0.0 110.595 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mt -39.28 116.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.506 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.14 155.15 23.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.672 ' O ' ' N ' ' A' ' 118' ' ' VAL . 26.7 Cg_endo -65.11 -83.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.753 2.302 . . . . 0.0 112.108 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -41.86 -11.71 0.01 OUTLIER Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.672 ' N ' ' O ' ' A' ' 116' ' ' PRO . 27.8 t -92.38 137.51 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 122.416 -0.461 . . . . 0.0 110.743 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -100.44 134.9 42.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.236 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.46 114.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.998 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -124.74 122.59 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.792 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 121' ' ' ILE . 49.5 m-20 -133.56 86.85 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.007 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' LEU . 11.6 mm100 -83.84 55.39 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.033 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.1 128.44 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.47 143.29 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.32 112.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.4 OUTLIER -136.5 134.6 19.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.401 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.69 33.06 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.6 t -136.18 -51.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.14 150.03 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.632 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -104.03 159.04 16.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.406 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.08 151.16 41.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.425 HD23 ' CD1' ' A' ' 183' ' ' TRP . 11.4 tp -80.99 133.12 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.656 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.68 133.42 56.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.457 ' O ' ' C ' ' A' ' 136' ' ' SER . 26.5 p90 -102.35 -22.87 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.584 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.2 m -34.17 -61.8 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.516 0.674 . . . . 0.0 110.988 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.18 20.76 9.8 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.747 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.4 -9.78 7.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.654 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -56.86 -43.85 99.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.803 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.2 Cg_exo -55.05 -36.49 92.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.39 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.404 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 43.4 t -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.39 -42.72 99.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.807 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -71.34 -36.04 71.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.664 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.06 -20.42 61.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.562 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -116.34 12.08 15.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -68.83 -43.28 27.16 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 12.2 Cg_exo -66.21 6.5 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.643 2.228 . . . . 0.0 111.901 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mm -111.91 99.99 47.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.722 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 86' ' ' ARG . 65.4 Cg_endo -79.83 -5.57 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.615 2.21 . . . . 0.0 112.187 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.52 40.49 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.517 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 4.0 t80 -127.65 137.87 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.631 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -142.94 160.46 27.5 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.49 138.55 24.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.756 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -106.15 128.65 54.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.2 t -112.81 138.55 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 158' ' ' ASP . 21.8 tt0 -150.39 102.83 3.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 15.7 mtt180 49.83 -91.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 156' ' ' GLU . 4.4 p30 -121.57 33.98 5.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.92 130.75 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.338 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.4 129.88 62.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.696 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.02 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.67 105.29 12.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 p -118.04 149.72 40.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.29 175.32 14.38 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 66.7 p -100.17 119.27 38.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.48 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -87.09 145.79 38.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.52 -60.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.759 2.306 . . . . 0.0 111.845 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 t -124.47 153.87 41.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.469 ' H ' ' HG ' ' A' ' 169' ' ' SER . 0.0 OUTLIER -66.73 -30.89 71.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.872 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.26 -43.46 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -58.45 -37.08 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.013 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -69.09 -39.03 79.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.001 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -59.28 -47.78 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.877 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.68 77.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.09 -39.12 65.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -64.32 -44.31 91.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -64.95 -44.44 89.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.586 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -31.92 72.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.83 71.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 -47.76 83.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.7 t -70.72 -27.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.556 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 183' ' ' TRP . 0.9 OUTLIER -66.38 -60.92 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.642 ' C ' ' H ' ' A' ' 185' ' ' ASP . 21.7 m95 -120.67 85.14 38.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.139 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.67 ' O ' ' N ' ' A' ' 186' ' ' MET . 17.6 Cg_exo -62.35 20.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.88 2.387 . . . . 0.0 111.73 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.642 ' H ' ' C ' ' A' ' 183' ' ' TRP . 0.8 OUTLIER -35.9 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.67 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.5 ttm 78.08 -8.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -120.05 80.98 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.19 136.71 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.1 t -126.97 121.72 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.761 HD21 ' H ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -87.73 125.99 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.57 40.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.466 . . . . 0.0 110.427 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.48 126.43 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -126.91 148.51 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.03 110.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.716 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 195' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.427 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 31.1 t . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.905 0.383 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 210' ' ' ASP . . . -38.65 160.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.761 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 33.12 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.154 0.502 . . . . 0.0 110.15 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.572 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -56.76 -42.94 80.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.065 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 216' ' ' ASN . 12.7 pt20 -71.96 -49.74 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.191 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 212' ' ' GLN . 72.7 m -71.08 -48.69 51.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' ASP . . . -62.51 -44.84 95.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.426 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.572 ' CG2' ' O ' ' A' ' 211' ' ' LEU . 3.6 tp -69.36 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.6 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 220' ' ' GLY . 3.1 m120 -67.8 -39.77 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.422 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.33 70.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.273 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 214' ' ' ALA . 74.3 t -58.46 -47.03 89.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.189 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 221' ' ' GLY . 68.1 p -87.83 -21.5 25.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.584 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.32 -37.57 0.21 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -160.48 179.75 35.78 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.6 154.22 9.46 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.763 2.308 . . . . 0.0 112.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -66.21 -37.72 86.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.04 -43.42 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.64 -32.35 68.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.374 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -44.73 94.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -63.67 -41.29 98.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.87 -40.91 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.51 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.91 85.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.715 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -56.11 -50.81 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.67 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 0.4 OUTLIER -65.01 -35.54 81.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.531 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 9.0 tp -55.29 -30.2 59.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.368 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 8.5 ptmt -63.63 -36.13 82.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 248' ' ' LYS . . . -107.49 3.24 24.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.714 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 85.7 m -74.63 -28.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 41.1 Cg_exo -55.12 -14.37 8.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.539 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 251' ' ' PRO . 9.0 t70 -40.89 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -119.99 -153.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.082 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -106.83 138.06 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.94 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.1 131.72 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -124.13 124.28 42.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 77.9 mt -113.01 117.44 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 110.715 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.42 131.99 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.383 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -108.07 133.19 11.52 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 318' ' ' ASN . 11.8 m-85 -100.49 107.82 19.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.56 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -143.84 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.282 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 262' ' ' ASP . 36.2 t0 -145.92 -99.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.497 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 0.2 OUTLIER -177.96 44.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.606 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.0 m -45.97 -58.74 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.465 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.439 0.162 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 272' ' ' PRO . 0.4 OUTLIER -73.46 -48.33 7.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.163 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 28.0 Cg_exo -53.53 -39.51 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.993 1.795 . . . . 0.0 111.669 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.21 -44.7 75.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.22 77.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.48 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.551 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.85 -45.18 90.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.439 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -44.51 94.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.335 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -68.19 -45.74 72.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.367 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.27 -45.99 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.529 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.39 -46.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.368 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.28 88.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.39 -32.97 69.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.546 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.6 -48.19 27.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.45 -44.69 92.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.313 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 65.3 t -59.34 -37.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.291 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.32 -20.7 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 288' ' ' ARG . 0.0 OUTLIER -87.94 0.15 56.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.27 18.13 20.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.1 132.79 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -75.98 104.45 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.63 16.74 7.58 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.0 OUTLIER -96.4 -12.2 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.703 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.652 ' N ' ' ND1' ' A' ' 294' ' ' HIS . 0.2 OUTLIER -119.45 23.38 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.633 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 4.9 mt -117.19 134.13 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.39 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.119 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.94 129.16 49.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.867 0.365 . . . . 0.0 110.992 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 12.1 t -133.26 116.69 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 301' ' ' GLY . . . -89.15 105.59 3.21 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 302' ' ' SER . 26.0 mt -56.64 77.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 299' ' ' GLY . . . -47.49 80.6 0.0 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.634 ' N ' ' O ' ' A' ' 300' ' ' LEU . 70.3 m 73.91 -52.89 0.69 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.292 0.567 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.541 ' C ' ' O ' ' A' ' 302' ' ' SER . 2.8 m -27.99 130.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 304' ' ' ASN . 0.1 OUTLIER 58.19 56.82 6.65 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 110.338 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 41.8 Cg_endo -71.69 176.78 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.905 2.403 . . . . 0.0 112.369 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 20.9 mt -132.52 -72.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.28 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.449 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 310' ' ' ALA . 5.3 p -68.02 171.05 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -76.18 24.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -44.29 -52.88 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.365 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.41 161.93 56.27 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -50.37 -41.06 52.57 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.255 1.97 . . . . 0.0 111.738 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.84 -42.26 98.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.04 -47.53 59.1 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.568 ' CZ ' ' NH2' ' A' ' 319' ' ' ARG . 58.2 ttt180 -60.16 -46.26 90.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.339 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.22 78.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.382 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -31.42 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.65 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -79.95 -25.13 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.549 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' A' ' 315' ' ' ARG . 1.5 mtt85 -80.38 82.21 6.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.317 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.3 ttm180 -129.03 141.97 51.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.33 161.12 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.033 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.24 127.9 16.18 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.086 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.47 110.33 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.37 135.65 60.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.76 135.62 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.225 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.525 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 2.0 t30 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.663 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.679 0.276 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.86 121.42 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 5.1 mp -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 p -50.64 134.95 23.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -47.56 124.11 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.61 125.57 38.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.356 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -101.91 131.54 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.892 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.85 120.0 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 92' ' ' THR . 15.5 t -133.34 140.05 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -125.22 150.01 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.421 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 90' ' ' THR . 8.9 t -145.23 95.09 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 46.72 -130.45 12.1 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -69.65 4.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' SER . 30.9 m -115.98 126.05 53.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.535 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -117.48 117.57 55.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 85' ' ' SER . 7.8 m -106.6 126.07 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.825 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.88 121.19 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.486 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.86 141.49 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.07 -157.28 27.72 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -130.98 156.8 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 0.0 110.563 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -141.42 153.35 65.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.3 -29.73 80.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.925 2.417 . . . . 0.0 112.455 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.56 176.1 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.648 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -74.85 -16.03 60.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.524 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.42 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.202 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.41 77.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.129 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 122' ' ' ASP . 2.6 tttp -63.81 -36.45 83.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.375 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.31 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.72 79.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.14 -41.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.603 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.7 mmt -58.35 -39.44 79.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -38.6 89.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.39 -16.12 62.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.86 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -100.77 -13.95 18.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -52.17 -25.6 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -10.81 81.51 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -111.13 -17.25 13.27 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.261 -0.553 . . . . 0.0 110.646 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.74 95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . -151.73 140.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 118' ' ' VAL . 81.8 Cg_exo -41.17 173.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.6 2.2 . . . . 0.0 112.276 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.0 -14.64 0.18 Allowed Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.617 ' H ' ' C ' ' A' ' 116' ' ' PRO . 48.8 t -101.72 139.39 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 122.218 -0.578 . . . . 0.0 110.646 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -108.06 123.55 48.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.619 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.19 114.43 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.463 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.409 HD12 ' HG1' ' A' ' 92' ' ' THR . 0.8 OUTLIER -130.34 139.6 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 103' ' ' LYS . 7.7 p-10 -154.43 110.43 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -95.21 90.16 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.67 129.09 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.009 0.433 . . . . 0.0 111.132 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 148.94 22.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.566 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.02 117.95 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.228 0.537 . . . . 0.0 110.987 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -112.66 141.26 25.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.083 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 127' ' ' ASP . 91.1 Cg_exo -29.3 -62.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.06 2.507 . . . . 0.0 112.856 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 130' ' ' VAL . 6.1 p -164.09 47.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.267 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 129' ' ' VAL . 1.5 m -50.4 -169.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -108.86 158.81 17.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -148.97 155.86 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.458 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -79.04 136.16 37.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.04 129.24 39.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 136' ' ' SER . 0.0 OUTLIER -105.45 -8.32 18.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.579 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.8 t -21.51 -47.74 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.403 0.621 . . . . 0.0 111.002 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.4 t -133.42 65.64 1.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.284 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -123.56 -15.5 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.5 tt0 -48.11 -49.32 61.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.7 Cg_exo -57.97 -30.94 91.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.728 2.285 . . . . 0.0 112.105 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.504 ' O ' ' OG ' ' A' ' 145' ' ' SER . 18.3 t -67.07 -42.98 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.35 -41.7 98.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.245 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 21.3 p -60.88 -37.69 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.081 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.61 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.797 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 141' ' ' VAL . 0.7 OUTLIER -106.44 11.24 31.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.739 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 3.5 t -88.23 -32.24 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 60.3 Cg_endo -85.84 9.6 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.862 2.374 . . . . 0.0 112.357 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.458 HG22 HD13 ' A' ' 148' ' ' ILE . 8.8 mt -126.63 98.56 31.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 173.71 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.6 2.2 . . . . 0.0 112.058 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 52.88 54.19 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.69 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.651 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -127.08 145.8 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.36 149.03 16.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 154' ' ' LYS . 17.3 tp -139.02 126.48 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -126.08 126.7 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.852 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 154' ' ' LYS . 88.8 t -114.82 122.83 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.14 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 158' ' ' ASP . 4.8 tt0 -110.98 163.42 13.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -25.52 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.782 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 156' ' ' GLU . 1.4 p-10 -156.14 29.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.536 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 125.97 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.534 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.54 121.65 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -130.38 136.96 49.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.592 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.19 109.22 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 147.99 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.542 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.81 -169.28 36.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.2 m -107.37 137.44 45.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.464 ' O ' ' CG1' ' A' ' 194' ' ' VAL . . . -124.62 109.65 28.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.43 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.31 -16.11 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.435 2.09 . . . . 0.0 112.417 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.21 129.37 35.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.03 -41.71 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.647 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -35.75 76.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.582 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -63.06 -42.18 99.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -66.84 -39.4 87.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.98 -46.1 90.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.863 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.24 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.59 -37.59 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.804 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -62.38 -49.32 75.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.797 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.89 -39.42 94.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.17 96.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.09 68.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.4 m -58.16 -39.57 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.412 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.416 ' H ' ' HG ' ' A' ' 181' ' ' SER . 3.8 p -65.85 -27.05 67.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.86 -44.07 28.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.466 ' CD2' ' HB ' ' A' ' 182' ' ' THR . 2.3 m-90 -138.21 67.26 46.85 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.627 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.27 -10.75 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.814 2.343 . . . . 0.0 111.973 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.71 58.47 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.433 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -176.57 -170.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.533 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -107.21 110.75 22.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.41 131.41 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.02 121.4 49.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.57 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.46 ' C ' HD21 ' A' ' 191' ' ' ASN . 2.6 m-20 -89.56 110.17 21.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 191' ' ' ASN . 2.1 m120 -104.1 55.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.662 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.41 115.85 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.385 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.545 ' CD ' ' O ' ' A' ' 193' ' ' GLU . 2.9 pp20? -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.683 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 166' ' ' ALA . 3.0 m -93.53 134.99 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.313 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.463 ' SG ' ' HD3' ' A' ' 251' ' ' PRO . 1.9 t . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.686 0.279 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -135.82 -147.89 0.28 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.256 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -70.01 50.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.151 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -31.52 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.402 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 0.0 OUTLIER -54.19 -31.62 53.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 72.8 m -65.94 -48.55 70.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.706 0.765 . . . . 0.0 110.996 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -75.26 -34.55 61.39 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.848 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 0.3 OUTLIER -58.37 -39.5 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 2.2 m-20 -53.63 -34.42 58.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.083 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.88 62.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.53 -43.38 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.643 ' C ' ' H ' ' A' ' 221' ' ' GLY . 6.3 p -93.67 -31.56 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.463 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.96 -35.33 0.1 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -174.56 -173.15 40.26 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.66 154.07 32.98 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.735 2.29 . . . . 0.0 111.895 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.806 0.336 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.47 -32.92 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.292 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -40.94 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.468 ' O ' ' NE ' ' A' ' 288' ' ' ARG . 12.5 mt -58.56 -47.28 84.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.344 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.515 ' OD1' ' C ' ' A' ' 241' ' ' ASN . 8.7 t-20 -63.52 -33.19 75.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.296 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.75 84.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.513 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.06 -42.55 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.59 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 109.897 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.58 -40.14 74.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.4 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 28.9 ttmt -69.6 -31.29 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -33.04 54.24 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.3 OUTLIER -62.0 -12.11 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.496 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -69.04 11.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.879 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.571 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -37.63 -48.8 2.68 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.23 -178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.463 ' HD3' ' SG ' ' A' ' 208' ' ' CYS . 31.3 Cg_exo -56.29 -18.64 24.97 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.904 1.736 . . . . 0.0 111.596 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 254' ' ' ARG . 14.0 m-20 -156.74 39.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.668 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -62.65 62.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.711 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 252' ' ' ASP . 1.6 mtm180 -111.52 134.91 52.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.05 139.5 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.926 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.9 m -122.54 127.05 49.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.1 123.19 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 111.254 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.41 120.1 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.15 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -100.55 139.57 14.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.36 100.41 6.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.425 ' CG2' ' OD1' ' A' ' 263' ' ' ASN . 1.3 m -141.48 128.25 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.547 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 263' ' ' ASN . 22.4 t70 -68.54 -116.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.528 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 10.9 m120 65.15 41.09 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.565 ' O ' ' OD1' ' A' ' 270' ' ' ASN . 10.5 m -31.92 -74.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.648 ' ND2' ' N ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.573 0.225 . . . . 0.0 111.329 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.1 mm -72.67 -51.97 6.58 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.705 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.4 Cg_endo -62.0 -30.22 82.82 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.934 1.756 . . . . 0.0 112.115 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -48.76 74.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.179 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 12.0 p -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.54 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.91 64.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 272' ' ' PRO . 6.9 tt0 -61.12 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.517 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -33.12 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.59 -33.99 76.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -43.31 84.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.3 -37.2 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.3 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.48 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.312 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.48 80.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -41.73 84.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.335 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -70.69 -42.34 70.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 285' ' ' LEU . 1.7 mm? -59.76 -49.19 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.93 -34.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.5 67.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.298 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 240' ' ' LEU . 3.1 tpt85 -80.77 -1.24 42.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.0 0.429 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.63 3.51 43.31 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.3 128.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -79.99 107.85 13.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.745 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -55.96 -4.25 0.68 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -68.52 -10.6 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -134.97 52.64 2.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 17.6 tt -133.04 139.3 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.27 142.33 43.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.2 p -122.62 142.15 50.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.887 0.375 . . . . 0.0 110.955 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.39 116.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.282 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.3 107.45 3.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.574 ' O ' ' O ' ' A' ' 301' ' ' GLY . 10.2 mp -97.65 62.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.449 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -34.94 -102.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -112.49 99.86 8.3 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 122.99 -0.124 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 304' ' ' ASN . 54.4 t -119.59 -95.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 303' ' ' VAL . 0.4 OUTLIER -89.16 -52.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.649 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 68.4 Cg_endo -80.72 153.33 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.772 2.315 . . . . 0.0 112.309 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.8 tt -167.62 137.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.416 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.21 137.66 47.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 309' ' ' ASN . 13.3 t -74.18 79.95 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 309' ' ' ASN . 0.0 OUTLIER -32.23 116.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.394 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -174.87 -50.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.482 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 164.38 15.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.39 -43.01 46.29 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.868 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -45.86 92.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.13 97.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -60.8 -40.92 94.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.48 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.21 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -68.05 -37.47 81.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 318' ' ' ASN . 1.1 t30 -72.08 -6.55 43.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.28 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -160.0 89.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.318 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -134.43 149.09 50.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.012 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.3 t -123.83 145.25 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.837 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.94 129.8 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.43 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.69 109.87 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 135.86 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.93 135.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 20.3 t30 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.645 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' C ' ' OG ' ' A' ' 78' ' ' SER . 3.7 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.818 0.342 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -168.93 121.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.68 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 79' ' ' LEU . 1.9 mm? -110.46 151.79 27.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.466 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.95 151.84 18.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.445 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' H ' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -66.07 129.49 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.49 130.77 42.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.68 121.17 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.95 118.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.606 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 t -130.52 132.45 45.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.456 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -112.86 143.71 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.787 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 p -140.57 120.68 13.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.315 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 48.68 -135.77 19.4 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.48 17.08 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.824 0.345 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -109.97 139.06 45.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.688 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -112.95 114.13 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.458 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 116.45 32.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -109.8 122.26 47.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.28 124.73 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.7 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.25 -135.83 4.48 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -154.36 156.91 37.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.749 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.92 153.99 80.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.497 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.2 -26.96 41.83 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.24 . . . . 0.0 112.011 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 4.3 p-10 -168.07 158.38 10.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.344 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.76 74.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.328 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.66 77.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -42.98 73.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.04 -40.61 73.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.29 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.54 -46.02 60.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.4 mtm -59.74 -33.14 71.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 2.9 m -62.01 -40.54 96.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.99 -29.51 66.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.79 -0.65 57.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.466 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.667 ' ND2' ' N ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -52.47 -22.66 5.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.667 ' N ' ' ND2' ' A' ' 111' ' ' ASN . . . -83.48 -10.07 82.44 Favored Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -97.4 -51.25 4.23 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.447 -0.443 . . . . 0.0 110.546 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -35.23 106.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.598 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -149.38 173.55 4.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.76 164.81 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.632 2.221 . . . . 0.0 112.288 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.38 13.41 2.69 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -102.36 138.66 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.209 -0.583 . . . . 0.0 110.754 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.4 137.95 45.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.273 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.98 122.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.96 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.44 128.04 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.918 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.13 81.78 1.94 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -92.12 48.43 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.253 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.408 ' C ' ' HD1' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -105.4 130.54 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.489 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.571 ' N ' ' HD1' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -93.37 146.54 23.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.783 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.8 111.58 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 129' ' ' VAL . 31.6 m-20 -125.44 103.9 28.62 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -52.36 69.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.494 2.13 . . . . 0.0 112.293 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.677 ' O ' ' NE ' ' A' ' 131' ' ' ARG . 3.4 p -179.27 -30.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.742 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.02 164.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.677 ' NE ' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -122.45 159.17 28.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 t -133.86 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.247 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.76 135.65 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.64 137.44 43.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -105.94 6.83 31.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.057 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t -45.72 132.71 8.54 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m 45.47 38.21 3.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 135' ' ' PHE . . . -101.6 -10.95 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -53.18 -47.32 96.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.367 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 32.0 Cg_exo -58.26 -36.55 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.782 2.321 . . . . 0.0 111.654 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.39 -44.4 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.49 -38.62 91.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.314 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 35.6 p -62.69 -37.24 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.44 -21.08 56.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.03 10.84 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -77.71 -43.58 2.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.493 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 28.1 Cg_exo -57.56 -9.6 5.58 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.512 2.142 . . . . 0.0 111.534 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.464 HD13 ' CE1' ' A' ' 171' ' ' HIS . 1.3 mm -108.57 93.46 11.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.321 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.8 7.99 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.628 2.219 . . . . 0.0 112.311 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.38 50.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.38 141.57 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.23 123.07 4.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.51 135.28 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 130.22 49.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.19 133.86 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.044 0.449 . . . . 0.0 111.266 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -140.79 78.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 159' ' ' THR . 7.4 ttp180 70.11 -137.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.989 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -75.97 25.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.47 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 157' ' ' ARG . 3.6 m -127.8 139.97 52.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.55 134.82 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.284 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.2 m -127.35 136.88 52.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.963 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.625 ' CD1' ' N ' ' A' ' 162' ' ' LEU . 2.2 mp -106.64 125.23 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.951 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -137.93 146.89 43.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.09 163.18 10.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.2 p -87.03 126.75 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.749 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -99.84 146.86 32.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.418 ' CD ' HG21 ' A' ' 148' ' ' ILE . 43.6 Cg_endo -71.2 -23.76 24.08 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.784 2.323 . . . . 0.0 111.901 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.86 137.93 21.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -36.33 83.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.86 -35.3 79.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.464 ' CE1' HD13 ' A' ' 148' ' ' ILE . 1.7 m-70 -57.47 -43.7 84.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.894 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -36.17 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.683 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.87 -40.18 87.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.37 99.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.45 -37.04 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -61.83 -48.62 79.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -55.8 -48.27 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.488 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.39 87.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.29 -41.3 96.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.664 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.0 -38.88 90.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 m -71.04 -37.47 72.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.37 -22.11 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.823 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' ALA . 7.9 m0 -141.69 88.36 9.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.664 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 186' ' ' MET . 71.5 Cg_endo -82.96 15.73 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.073 2.515 . . . . 0.0 112.291 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.9 OUTLIER -31.58 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 184' ' ' PRO . 9.3 ttt 80.47 -23.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 185' ' ' ASP . 7.0 mttp -103.24 68.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.85 134.43 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.1 t -115.4 130.18 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 3.3 p-10 -97.02 119.12 34.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.96 50.49 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 pp -101.59 129.56 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -98.7 139.41 34.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.356 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 6.8 m -109.52 119.91 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.319 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 52.8 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -68.45 147.2 52.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.177 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 35.78 27.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 109.815 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 209' ' ' ALA . 56.9 tp -56.28 -31.7 63.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' A' ' 213' ' ' SER . 14.3 pt20 -54.65 -44.76 73.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.79 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.443 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 74.1 m -69.78 -40.44 76.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.172 0.51 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.15 78.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.6 -36.53 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 220' ' ' GLY . 0.7 OUTLIER -57.3 -42.0 80.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.804 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.13 -41.45 63.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.698 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.96 -45.12 95.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.706 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 221' ' ' GLY . 75.0 p -94.52 -23.24 17.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 65.95 -2.46 3.8 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -171.15 -172.82 37.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.97 151.47 62.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.732 2.288 . . . . 0.0 112.048 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.572 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -58.86 -34.66 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.899 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.77 -46.37 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.05 -34.37 73.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.626 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 -45.32 80.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -61.06 -43.74 98.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.333 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 51.0 t -68.18 -39.38 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.453 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.81 -46.6 81.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -60.53 -50.77 72.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -60.47 -31.66 70.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.441 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 0.9 OUTLIER -62.67 -32.92 74.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.252 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.65 -18.59 64.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.92 -2.05 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 0.0 110.73 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.687 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.4 m -74.97 -28.72 0.82 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 43.6 Cg_exo -53.6 -16.04 7.34 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.148 1.899 . . . . 0.0 112.405 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -62.4 -9.43 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -136.07 -157.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.878 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -108.79 138.2 45.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.08 133.31 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.007 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.843 HG22 ' ND2' ' A' ' 258' ' ' ASN . 95.2 m -120.75 116.13 24.64 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.0 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.96 112.54 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.768 0.318 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.843 ' ND2' HG22 ' A' ' 256' ' ' THR . 2.3 m-80 -112.6 122.65 48.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -122.85 133.98 9.36 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.64 ' HH ' ' HE ' ' A' ' 320' ' ' ARG . 29.6 p90 -130.52 154.67 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.799 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 262' ' ' ASP . 30.8 p -117.42 -118.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.603 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.63 ' CG ' ' H ' ' A' ' 263' ' ' ASN . 14.6 p-10 -134.58 -99.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.264 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.63 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 1.7 p30 -174.82 -123.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.562 ' CD1' ' C ' ' A' ' 271' ' ' ILE . 0.1 OUTLIER -55.85 -49.96 89.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 21.8 Cg_endo -62.69 -39.93 40.26 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.594 1.529 . . . . 0.0 111.883 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.62 -34.08 77.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -40.0 94.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.763 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.62 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -65.9 -34.62 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.554 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -60.26 -45.67 92.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.67 76.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.46 -44.46 87.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 280' ' ' ILE . 1.6 mp -69.98 -36.96 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.298 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.87 -41.93 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.66 95.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.95 -41.6 87.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.04 -44.28 85.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.729 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.72 -41.37 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.279 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.06 -36.31 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.167 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.24 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.772 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -1.85 58.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 18.15 11.79 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.552 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 74.6 t -87.2 124.06 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 110.433 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.596 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -70.12 98.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.68 16.5 0.4 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.596 ' H ' ' C ' ' A' ' 291' ' ' ALA . 25.3 t0 -93.21 -13.36 28.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.775 0.321 . . . . 0.0 110.518 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -132.48 24.72 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.815 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 295' ' ' ILE . 16.1 tt -116.36 125.34 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.468 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.86 48.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.552 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p -124.05 138.48 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.387 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.11 122.13 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.528 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -98.12 107.73 3.5 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.0 OUTLIER -38.96 -61.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.723 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.15 106.57 2.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.0 p 40.24 90.01 0.01 OUTLIER 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.971 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' ASP . 0.7 OUTLIER -107.24 160.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 303' ' ' VAL . 0.6 OUTLIER -40.33 152.76 0.22 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.402 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.2 114.64 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.746 2.297 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 16.2 mt -103.03 -42.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.73 168.88 11.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.506 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 310' ' ' ALA . 0.5 OUTLIER -82.45 90.41 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.483 ' CG ' ' O ' ' A' ' 309' ' ' ASN . 3.7 t30 -65.73 -1.06 2.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -57.68 -11.1 1.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.515 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.99 158.44 69.71 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.62 -36.59 81.52 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.85 2.366 . . . . 0.0 111.918 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -64.62 -31.45 72.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.406 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.99 99.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.683 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 6.7 ttm180 -60.8 -37.77 83.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.403 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.09 -36.23 82.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.55 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -36.88 64.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.784 HD21 ' N ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -74.99 -25.12 58.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.785 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.784 ' N ' HD21 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -95.57 84.41 3.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.611 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.64 ' HE ' ' HH ' ' A' ' 260' ' ' TYR . 12.6 mtm180 -122.87 154.52 38.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.1 t -129.36 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.091 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -128.44 127.17 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -102.69 111.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.148 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.1 121.03 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.63 135.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.504 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.47 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.858 0.361 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -130.34 126.04 36.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 mt -103.76 139.65 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.751 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -81.13 153.3 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.516 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.65 121.26 7.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.35 118.49 26.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.5 t -101.85 117.2 34.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.32 116.25 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -134.05 128.31 34.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.454 HH22 HD23 ' A' ' 113' ' ' LEU . 11.2 mtp85 -110.69 130.78 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.585 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 p -130.01 115.94 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 42.3 -131.32 4.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.478 ' O ' ' CG2' ' A' ' 118' ' ' VAL . 22.2 m-20 -86.4 21.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.678 0.275 . . . . 0.0 110.606 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 75.6 m -122.07 125.73 46.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.59 132.9 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.5 m -119.31 116.56 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.382 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.93 123.35 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mt -142.08 124.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.291 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.57 -143.78 8.47 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 96' ' ' ASP . 26.1 p30 -154.34 153.06 31.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -137.26 150.43 68.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.83 -20.49 22.46 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.738 2.292 . . . . 0.0 112.242 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -165.87 145.75 6.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' C ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -53.75 -10.63 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 99' ' ' ASP . . . -60.86 -40.16 91.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.5 77.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -68.37 -37.05 80.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.86 81.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.54 77.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 tt -72.19 -43.02 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -39.87 80.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -61.2 -28.36 69.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.32 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.741 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.5 mt -86.63 -17.42 33.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -45.88 -35.43 4.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.632 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.73 -17.19 66.36 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 114' ' ' LEU . 5.6 tp -95.77 -33.51 12.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.67 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 113' ' ' LEU . 1.7 tt -33.71 104.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.575 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -131.72 135.45 26.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -43.6 162.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.213 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.8 13.88 41.74 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.591 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 8.7 p -102.54 130.14 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 121.903 -0.763 . . . . 0.0 110.761 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.81 126.08 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.56 127.31 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.91 134.05 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.164 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -120.74 91.62 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.996 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.05 50.31 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.966 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.33 130.22 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.587 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -93.38 146.1 23.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.299 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 p -100.02 120.06 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.45 129.87 16.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.368 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.48 41.91 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.377 2.051 . . . . 0.0 112.17 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.6 t -147.45 -35.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.21 164.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -115.56 158.61 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.246 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -126.12 155.94 40.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.472 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 37.1 tp -78.73 130.62 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.197 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.7 OUTLIER -64.18 134.53 55.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.857 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' O ' ' C ' ' A' ' 136' ' ' SER . 83.0 m-85 -120.54 6.55 10.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.22 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.558 ' C ' ' O ' ' A' ' 135' ' ' PHE . 90.0 p -24.08 -65.86 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.462 0.649 . . . . 0.0 110.985 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.41 47.69 1.97 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.845 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.58 -7.85 39.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.506 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.4 tt0 -48.49 -49.01 66.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.0 Cg_exo -55.36 -42.24 70.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.848 2.365 . . . . 0.0 112.14 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.74 -45.98 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.89 -41.63 95.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.55 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.8 p -65.73 -40.07 91.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.54 -18.66 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.444 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -105.55 2.58 28.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.651 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -64.54 -41.08 55.69 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 46.0 Cg_exo -53.25 -7.88 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.632 2.221 . . . . 0.0 111.719 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 146' ' ' VAL . 29.1 mt -122.77 101.53 39.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.415 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.66 19.26 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.187 1.925 . . . . 0.0 111.926 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 148' ' ' ILE . 22.4 m-20 -145.9 80.56 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.54 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.64 139.63 53.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.231 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.32 123.2 5.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.19 127.08 52.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 110.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.4 126.43 44.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.4 t -119.82 128.48 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -140.71 84.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.283 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 159' ' ' THR . 2.8 mtt180 60.77 -141.4 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.444 ' C ' ' OD2' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -68.81 27.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.413 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.626 ' H ' ' C ' ' A' ' 157' ' ' ARG . 1.8 m -139.15 129.72 25.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -131.94 135.12 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.21 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.402 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 66.0 m -131.53 130.99 43.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.946 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.76 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -113.25 123.86 51.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.379 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 149.4 49.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 148.97 158.58 8.12 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.71 136.7 37.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.08 140.61 27.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.517 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.02 -30.57 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.506 2.137 . . . . 0.0 111.947 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 t -122.39 128.0 50.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.03 72.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.642 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 171' ' ' HIS . 3.9 pt-20 -59.36 -35.86 74.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.726 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.43 ' N ' ' HG2' ' A' ' 170' ' ' GLU . 5.4 m-70 -63.19 -37.95 89.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -64.15 -38.56 91.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.89 -47.07 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.28 -41.37 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -58.05 -51.31 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -45.54 94.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.23 -33.23 75.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.991 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.2 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.179 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 m -67.44 -36.36 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.226 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.1 t -71.02 -43.01 68.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 3.1 m -72.88 -44.4 61.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.568 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.509 ' C ' ' H ' ' A' ' 185' ' ' ASP . 6.0 m0 -126.12 77.05 71.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 186' ' ' MET . 15.4 Cg_exo -65.34 12.3 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.016 2.478 . . . . 0.0 112.424 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 186' ' ' MET . 21.1 t0 -31.3 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.829 0.347 . . . . 0.0 110.551 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 4.6 tpt 86.99 -28.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -93.1 63.75 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.9 121.26 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.785 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.58 125.28 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.173 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.433 ' OD1' ' C ' ' A' ' 190' ' ' ASN . 47.2 t-20 -91.93 124.13 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.82 44.56 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.193 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.04 133.19 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.641 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -102.72 149.15 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.435 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 19.8 m -108.79 108.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.787 -179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -78.42 -164.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.872 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -91.43 56.32 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.725 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.57 ' CB ' ' O ' ' A' ' 245' ' ' ASP . 4.0 mm? -58.19 -30.33 66.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.622 ' CD ' ' N ' ' A' ' 213' ' ' SER . 2.9 pp0? -53.2 -34.81 58.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.611 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.622 ' N ' ' CD ' ' A' ' 212' ' ' GLN . 89.9 p -65.61 -35.5 80.99 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.928 0.871 . . . . 0.0 110.974 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.13 -32.51 63.2 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.371 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.16 -35.94 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.414 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.1 t30 -53.89 -44.08 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.669 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.46 -28.83 61.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.59 ' CG1' HH11 ' A' ' 242' ' ' ARG . 65.8 t -58.04 -49.64 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.386 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.605 ' C ' ' H ' ' A' ' 221' ' ' GLY . 12.8 p -103.58 -11.4 17.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.13 -35.75 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -173.66 178.7 45.46 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 153.63 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.728 2.286 . . . . 0.0 112.009 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 238' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.709 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 3.8 pt-20 -61.14 -38.71 87.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -42.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.941 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 0.9 OUTLIER -65.27 -47.54 76.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.667 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -31.71 71.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.319 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.59 HH11 ' CG1' ' A' ' 218' ' ' VAL . 2.4 ttp-105 -60.92 -45.69 93.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.433 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 240' ' ' LEU . 10.8 m -63.73 -36.26 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.29 81.44 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.995 0.426 . . . . 0.0 109.859 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 211' ' ' LEU . 33.8 m-20 -56.07 -48.85 75.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 3.1 pttt -62.38 -30.47 71.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.806 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.64 ' CD1' ' O ' ' A' ' 288' ' ' ARG . 5.3 tt -53.13 -32.91 49.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -61.13 -11.35 8.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -68.07 10.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.638 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.607 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -38.52 -48.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.928 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.0 Cg_exo -54.23 -13.73 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.98 1.786 . . . . 0.0 111.353 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' ARG . 23.0 t0 -160.42 30.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.604 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -55.89 67.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.675 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' ASP . 2.6 ttt180 -116.17 135.01 54.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.94 135.86 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.923 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -122.45 120.0 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.045 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.89 127.51 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.95 122.16 41.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.276 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.69 145.44 16.88 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.534 ' C ' ' HG1' ' A' ' 261' ' ' THR . 40.3 m-85 -134.24 149.48 50.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.645 0.259 . . . . 0.0 110.328 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.591 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -162.61 -173.06 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.558 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.543 ' OD1' ' OD1' ' A' ' 270' ' ' ASN . 2.4 p30 -92.28 -164.36 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.64 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.624 ' C ' ' H ' ' A' ' 265' ' ' GLY . 0.9 OUTLIER -125.14 -116.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.486 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.595 ' HG1' ' C ' ' A' ' 263' ' ' ASN . 0.2 OUTLIER 68.52 -29.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.528 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.543 ' OD1' ' OD1' ' A' ' 262' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.5 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.4 mm -54.79 -52.22 72.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.3 Cg_endo -61.26 -35.83 82.81 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.853 1.702 . . . . 0.0 111.876 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.5 -46.55 69.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 23.6 p -65.65 -39.76 91.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.575 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.96 95.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.441 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.98 -36.48 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -63.24 -35.17 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.448 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.25 69.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.034 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -73.97 -47.97 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.61 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 281' ' ' VAL . 1.7 tp -60.39 -44.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.137 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.529 ' N ' ' CG2' ' A' ' 280' ' ' ILE . 27.6 m -61.28 -40.85 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.428 ' N ' HG21 ' A' ' 281' ' ' VAL . . . -59.3 -39.0 81.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.01 -47.04 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.717 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -57.01 -39.92 75.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.464 ' O ' ' CG2' ' A' ' 290' ' ' VAL . 1.0 OUTLIER -60.84 -42.53 97.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.58 -36.25 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.64 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.003 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.64 ' O ' ' CD1' ' A' ' 247' ' ' LEU . 2.2 tpm_? -82.53 -2.79 54.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.798 0.333 . . . . 0.0 110.304 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.97 10.63 29.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 285' ' ' LEU . 35.0 t -79.24 128.67 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.78 96.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.637 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -48.78 -8.28 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 291' ' ' ALA . 72.8 m-20 -75.93 -6.42 50.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.556 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -124.92 26.17 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.6 131.99 67.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.739 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.63 52.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 127.21 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 110.864 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.8 140.83 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.326 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.2 117.88 3.11 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 59.84 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.524 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 303' ' ' VAL . . . -77.99 -96.12 0.23 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 301' ' ' GLY . 90.1 p -36.87 -29.47 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.214 0.53 . . . . 0.0 110.955 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 301' ' ' GLY . 66.1 t -61.53 -47.41 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 301' ' ' GLY . 0.4 OUTLIER -139.73 86.42 13.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.645 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.79 163.48 9.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.952 2.435 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 74.3 mt -136.68 -22.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.321 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 308' ' ' SER . . . -119.9 151.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.437 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 307' ' ' ALA . 0.6 OUTLIER -50.29 -165.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.634 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.85 50.56 0.54 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.618 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.19 -2.86 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.523 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 p -146.62 148.63 34.28 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.374 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.45 -31.11 76.61 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.681 2.254 . . . . 0.0 111.918 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.03 -33.86 76.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.129 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.36 -44.98 97.35 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -65.27 -43.97 89.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.17 94.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.82 -32.61 74.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.235 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 261' ' ' THR . 0.7 OUTLIER -76.48 -25.43 54.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.426 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 319' ' ' ARG . 2.8 ttm180 -70.36 78.23 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.282 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -122.4 150.19 42.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.07 149.16 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.68 131.97 53.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.077 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.98 110.3 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.28 120.21 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.54 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 p 178.38 111.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.1 mp -84.77 147.61 26.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -79.62 159.86 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 119.35 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.714 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.11 131.3 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.34 120.73 30.64 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.047 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.487 HG21 ' H ' ' A' ' 153' ' ' LEU . 2.1 tt -123.15 122.64 65.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.062 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.59 127.51 35.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 149' ' ' PRO . 55.9 mtt180 -114.21 141.26 47.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.218 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 126.39 16.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.66 -125.41 29.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.09 19.44 15.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.756 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.4 m -125.3 135.1 52.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.1 t -115.14 122.22 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 120.89 43.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.33 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.272 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.19 129.04 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.777 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.69 -152.1 21.18 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -154.39 154.37 33.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.417 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -125.96 158.95 64.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.845 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.16 -24.71 27.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.322 . . . . 0.0 112.025 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -157.91 -173.59 4.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -88.71 -19.61 25.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.515 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.78 75.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.538 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.04 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -61.89 -37.67 85.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.622 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.07 67.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.64 91.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt -62.5 -43.85 97.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.84 -42.89 85.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -62.76 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 mt -103.0 -12.79 17.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.734 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -51.91 -42.47 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.617 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.99 -13.71 57.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -98.01 -26.46 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.603 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -161.65 163.79 19.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 118' ' ' VAL . 58.2 Cg_endo -76.15 166.64 27.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.842 2.361 . . . . 0.0 112.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.96 1.71 3.14 Favored Glycine 0 N--CA 1.461 0.325 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 116' ' ' PRO . 54.9 t -99.81 135.11 36.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 O-C-N 122.278 -0.543 . . . . 0.0 110.818 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.86 128.63 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.288 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.34 134.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.022 0.439 . . . . 0.0 111.282 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.452 HG21 HD11 ' A' ' 121' ' ' ILE . 2.2 mm -123.79 125.31 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.755 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.501 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 13.3 p-10 -136.15 83.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.505 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.447 ' CA ' HE21 ' A' ' 123' ' ' GLN . 0.6 OUTLIER -97.42 72.22 2.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.56 ' CG2' ' CE2' ' A' ' 97' ' ' PHE . 12.3 mt -105.53 130.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.93 146.2 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -100.3 116.07 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.6 m-20 -133.6 103.14 12.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.541 ' O ' ' CG2' ' A' ' 129' ' ' VAL . 17.3 Cg_exo -61.57 56.73 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.468 2.112 . . . . 0.0 112.405 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 128' ' ' PRO . 56.0 t -162.68 -39.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.814 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.35 -178.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -123.87 159.58 29.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.315 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.419 ' HG ' ' HB3' ' A' ' 97' ' ' PHE . 1.7 m -134.65 155.5 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.08 113.17 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.276 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.6 136.35 57.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.56 ' O ' ' C ' ' A' ' 136' ' ' SER . 7.7 m-85 -92.0 2.05 56.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.38 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 135' ' ' PHE . 94.4 p -24.51 -80.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.656 0.741 . . . . 0.0 110.988 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.7 20.55 16.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.761 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.47 -11.09 24.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER -55.6 -45.85 99.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.696 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 31.8 Cg_exo -54.69 -38.95 91.19 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.007 2.471 . . . . 0.0 112.508 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.423 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 40.6 t -59.79 -47.61 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -63.26 -39.35 94.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 11.4 p -62.81 -34.68 77.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.79 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.62 66.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -104.46 11.26 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.707 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -73.71 -34.67 2.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 37.4 Cg_exo -54.17 -28.75 53.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.615 2.21 . . . . 0.0 112.263 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 148' ' ' ILE . 1.4 tp -118.68 109.33 40.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.47 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 86' ' ' ARG . 57.3 Cg_endo -76.7 17.34 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.09 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.43 ' H ' HG13 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -114.14 53.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.544 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.59 144.86 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -125.9 134.8 8.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.487 ' H ' HG21 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -127.95 127.99 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 110.83 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.16 131.41 56.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.63 131.32 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.75 77.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 67.2 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.14 -18.17 8.76 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.36 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -104.23 131.39 51.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.913 0.387 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.15 135.48 63.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.2 m -109.19 129.82 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.85 117.98 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 m -130.21 153.2 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.55 155.07 6.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.5 p -81.25 141.91 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -109.73 138.4 20.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.492 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.42 -39.53 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.482 2.121 . . . . 0.0 111.961 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.03 130.59 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.448 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 172' ' ' LYS . 47.1 m -54.85 -33.12 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.77 -35.52 77.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.5 -48.04 82.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.961 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 169' ' ' SER . 21.2 pttt -67.24 -35.2 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.857 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.49 -43.25 83.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.486 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -70.41 -35.89 73.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.3 t -66.73 -43.65 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -62.32 -47.93 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -60.17 -51.43 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.643 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.64 72.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.37 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 185' ' ' ASP . 4.5 m -64.57 -48.86 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.3 m -72.22 -26.62 62.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.423 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 2.4 m -70.33 -72.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.086 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 185' ' ' ASP . 28.0 m95 -131.36 -67.65 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.618 ' C ' ' H ' ' A' ' 186' ' ' MET . 11.4 Cg_endo -56.54 32.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.858 2.372 . . . . 0.0 113.361 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 183' ' ' TRP . 2.3 t0 -63.39 9.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.427 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.618 ' H ' ' C ' ' A' ' 184' ' ' PRO . 6.5 mtt -116.95 -89.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.903 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -108.92 115.89 30.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.622 ' CD1' ' N ' ' A' ' 188' ' ' ILE . 0.0 OUTLIER -125.68 147.55 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.724 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.27 124.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -98.9 128.39 45.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -144.2 42.66 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.3 mt -114.55 133.3 61.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.687 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.66 141.83 50.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -96.6 117.84 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.604 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.574 -179.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.586 ' O ' ' O ' ' A' ' 209' ' ' ALA . 43.3 t . . . . . 0 C--O 1.23 0.061 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -25.62 146.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 24.0 m-20 44.04 64.09 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -43.33 77.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.25 -51.34 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.331 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.1 m -71.0 -45.15 64.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -61.51 -44.28 97.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.23 -0.294 . . . . 0.0 111.573 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 2.5 tp -69.55 -39.25 78.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -70.11 -42.92 72.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.711 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.3 -49.53 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 t -59.22 -46.09 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.6 p -84.93 -29.29 25.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.748 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 74.72 -48.0 1.89 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -151.55 151.55 23.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 223' ' ' ILE . 40.3 Cg_endo -70.38 140.23 39.87 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.749 2.299 . . . . 0.0 112.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.442 ' CB ' ' O ' ' A' ' 222' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 237' ' ' TYR . 25.1 t80 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.776 0.322 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -46.19 75.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 49.7 mt -67.71 -38.69 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -36.74 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.439 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.04 96.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.334 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -61.32 -45.35 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.33 -38.97 81.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.483 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.94 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -51.06 70.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.529 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.681 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 8.0 mttt -66.1 -32.83 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.456 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 3.3 tp -54.56 -30.85 55.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.488 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 0.8 OUTLIER -63.81 -36.98 85.68 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.576 ' O ' ' OD1' ' A' ' 252' ' ' ASP . . . -101.57 5.27 41.65 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.972 0.415 . . . . 0.0 111.351 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.716 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.9 m -74.84 -27.51 0.73 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 52.1 Cg_exo -54.21 -15.66 8.4 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.372 2.048 . . . . 0.0 112.891 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -42.1 -18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 326' ' ' ASN . . . -125.65 -154.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.624 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 1.2 mtm180 -110.27 136.0 50.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.15 132.81 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.955 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.3 m -122.74 122.29 38.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.04 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.1 mt -102.23 116.71 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -101.77 130.21 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.363 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.59 127.74 7.02 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 318' ' ' ASN . 43.1 m-85 -106.57 136.58 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.405 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -128.47 -161.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.656 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 262' ' ' ASP . 2.5 p30 -132.83 125.47 30.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.2 p30 -42.92 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.9 m 51.06 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 271' ' ' ILE . 23.7 p-10 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.631 0.253 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.559 ' N ' ' OD1' ' A' ' 270' ' ' ASN . 1.9 mm -57.59 -51.62 80.37 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.917 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 9.4 Cg_endo -57.36 -31.96 92.53 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.906 1.737 . . . . 0.0 112.083 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.58 -40.32 80.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.433 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.462 ' CB ' ' HG1' ' A' ' 261' ' ' THR . 7.9 p -69.82 -37.78 76.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.73 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.85 -40.42 92.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 277' ' ' ARG . 6.4 mtt-85 -60.0 -44.28 94.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.72 -32.6 73.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.416 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -70.92 -46.27 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.29 -46.28 95.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.46 -38.75 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.391 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.06 79.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.441 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.38 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -72.43 -34.91 68.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.05 -48.27 82.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 12.0 t -63.44 -36.17 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.37 -20.17 65.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -2.14 58.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.629 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 19.94 9.69 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.465 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.74 129.65 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.405 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -74.53 101.04 4.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.943 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.02 9.53 0.97 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.7 OUTLIER -83.27 -12.32 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 110.651 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -134.67 11.66 3.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.981 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.1 tt -88.33 133.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -138.66 135.52 34.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 128.26 48.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.1 116.71 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.58 114.72 4.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.35 54.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -54.49 -92.65 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.47 ' C ' ' CG2' ' A' ' 303' ' ' VAL . 89.8 p -79.8 69.08 6.06 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 122.939 -0.154 . . . . 0.0 110.955 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 304' ' ' ASN . 0.2 OUTLIER -154.93 163.97 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.531 ' O ' ' O ' ' A' ' 303' ' ' VAL . 2.4 m-80 33.29 96.2 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.424 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.52 162.98 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.625 2.217 . . . . 0.0 112.298 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.46 HD13 ' CD1' ' A' ' 260' ' ' TYR . 24.1 mt -153.5 -79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.308 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -125.1 155.58 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.518 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.07 141.12 58.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.598 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 4.7 p-10 -98.77 41.14 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.55 -36.21 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.683 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . 0.485 ' H ' ' HG1' ' A' ' 311' ' ' THR . 0.6 OUTLIER -100.79 153.75 37.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.718 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -36.1 98.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.803 2.336 . . . . 0.0 112.02 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -66.29 -32.15 73.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.15 87.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -62.59 -45.74 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.5 80.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.97 -30.32 68.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.4 t-20 -74.95 -23.03 58.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -87.45 87.91 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.562 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.33 145.55 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.638 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.67 148.54 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.325 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.15 130.65 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.18 113.33 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.536 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.74 135.54 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.8 135.56 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 253' ' ' ALA . 7.6 t-20 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.003 0.43 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -156.12 111.82 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.0 mt -115.28 155.1 27.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -84.98 140.97 30.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.561 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -53.41 125.85 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.31 122.89 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -102.69 122.55 44.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.07 123.23 60.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -135.03 124.81 25.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' ' CE2' ' A' ' 151' ' ' PHE . 20.1 ttm180 -116.15 120.23 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.496 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.07 123.38 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.46 -138.73 43.2 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.64 18.22 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.24 46.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.572 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.2 122.44 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.6 m -113.62 116.82 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.91 130.37 53.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.729 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -142.86 131.49 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.575 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.82 -156.63 26.18 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.62 151.09 47.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -135.63 156.61 77.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.95 -22.29 19.92 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.777 2.318 . . . . 0.0 112.075 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.38 152.21 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 -27.0 68.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.43 94.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.94 79.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -60.04 -36.01 76.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.454 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.55 -37.17 57.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.64 87.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.26 -40.94 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.2 mtm -61.38 -31.85 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 m -61.28 -33.17 73.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.632 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.449 ' HB1' ' CG ' ' A' ' 142' ' ' PHE . . . -70.58 -26.86 63.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' LEU . 15.8 mt -88.36 -16.14 33.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -50.98 -28.92 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.56 -9.89 82.58 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -100.16 -42.7 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 113' ' ' LEU . 6.7 tt -32.55 113.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.575 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.32 31.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 118' ' ' VAL . 14.2 Cg_endo -59.47 149.88 78.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.852 2.368 . . . . 0.0 112.297 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 -12.98 8.31 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.1 t -95.99 126.63 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 O-C-N 122.278 -0.542 . . . . 0.0 110.534 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.04 137.89 37.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.99 118.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.16 136.69 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.61 105.48 10.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.987 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -98.35 64.82 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.058 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.25 128.59 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.692 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.62 146.17 24.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.949 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.91 113.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 128.68 16.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.134 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.36 38.32 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.383 2.055 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.85 -34.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.92 167.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 80' ' ' SER . 0.1 OUTLIER -121.08 160.26 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.3 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -119.87 156.06 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.671 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 183' ' ' TRP . 20.0 tp -78.59 126.39 30.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.487 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -58.47 150.03 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -140.42 74.11 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.533 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.9 p -95.34 7.34 46.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 p -176.59 31.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.77 40.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 7.7 mt-10 -49.16 -58.9 7.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 15.9 Cg_endo -61.13 -28.13 85.07 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.446 2.097 . . . . 0.0 111.961 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.08 -43.11 89.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 m-85 -64.09 -40.72 96.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.351 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 p -63.29 -35.26 79.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.85 -28.96 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -93.72 -9.55 37.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.494 ' N ' ' HD2' ' A' ' 147' ' ' PRO . 1.1 t -53.24 -48.67 91.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.531 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 56.3 Cg_endo -75.21 1.5 7.77 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.186 1.924 . . . . 0.0 111.666 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.66 85.55 27.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.81 22.15 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.844 2.363 . . . . 0.0 112.354 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -141.27 55.66 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.751 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.639 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 1.7 p90 -123.71 143.7 50.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 163' ' ' THR . . . -126.81 145.04 15.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.9 129.39 36.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 110.779 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.6 53.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.2 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.92 134.7 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.659 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -145.61 77.68 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.656 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 62.14 -96.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -111.21 33.58 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.64 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 m -136.47 133.56 36.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.519 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.41 134.24 66.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.354 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 82.2 m -132.35 128.26 37.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.699 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -111.75 118.96 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 152' ' ' GLY . 87.8 m -128.22 147.49 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.675 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 150.38 166.41 13.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.02 142.0 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.73 149.4 46.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.11 -40.63 1.63 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.743 2.296 . . . . 0.0 111.69 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 146.68 52.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.236 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -36.97 85.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.4 -48.16 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.798 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -66.58 -33.7 76.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.577 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.5 -44.34 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.8 90.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.61 -40.94 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -62.55 -52.01 65.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.057 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -62.12 -39.66 93.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.858 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.16 97.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.9 -40.0 94.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.588 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.4 m -67.81 -40.08 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' A' ' 182' ' ' THR . 2.4 p -68.63 -39.22 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.649 ' N ' ' HG ' ' A' ' 181' ' ' SER . 55.8 m -83.53 -38.43 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.577 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 179' ' ' ALA . 4.7 m-90 -127.18 73.13 77.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.686 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 61.2 Cg_endo -77.87 28.0 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.857 2.371 . . . . 0.0 111.923 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 187' ' ' LYS . 1.2 t70 -41.58 -12.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.679 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 74.78 -26.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 185' ' ' ASP . 18.2 mttm -95.6 61.42 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.1 136.04 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.79 129.68 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -88.52 107.76 19.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.441 ' CB ' ' OG1' ' A' ' 163' ' ' THR . 4.7 m-80 -122.23 52.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.8 mt -86.33 133.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -120.12 124.79 46.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.913 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 21.4 m -105.25 109.86 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.128 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.447 ' OG1' ' OD2' ' A' ' 245' ' ' ASP . 1.8 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.807 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . 0.563 ' O ' ' O ' ' A' ' 209' ' ' ALA . 9.4 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.627 0.251 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -48.88 -111.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.347 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -81.95 18.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.305 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 215' ' ' ILE . 6.7 mp -56.55 -29.93 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -50.62 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.701 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -62.72 -39.92 95.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 110.975 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.22 68.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.448 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LEU . 6.2 mt -58.95 -37.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 220' ' ' GLY . 9.3 t-20 -54.78 -41.67 70.81 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.28 -31.28 62.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.517 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.32 -41.4 81.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -106.43 -27.53 10.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 78.47 -14.7 11.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.17 173.25 43.6 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.91 148.46 57.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.793 2.328 . . . . 0.0 112.128 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 23.2 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.88 0.372 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.02 -34.58 78.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 239' ' ' ILE . 7.7 mm -59.55 -45.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.745 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -31.96 68.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -42.97 76.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.13 -45.68 93.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.974 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.26 -38.0 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.186 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.76 91.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 195' ' ' THR . 0.2 OUTLIER -57.07 -50.38 72.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.521 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -65.49 -32.08 73.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.407 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.4 OUTLIER -63.44 -32.27 73.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -63.83 -26.13 68.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.791 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.5 1.95 47.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.023 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.678 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.2 m -74.69 -28.57 0.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.2 Cg_exo -53.43 -14.15 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.854 1.703 . . . . 0.0 111.819 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -2.66 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 251' ' ' PRO . . . -141.02 -159.0 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.463 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -103.44 139.99 38.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.203 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.52 133.01 67.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.438 ' HB ' HG23 ' A' ' 324' ' ' VAL . 93.7 m -123.02 111.96 17.22 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.055 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.35 121.46 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -101.09 126.02 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.55 134.79 11.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -120.39 116.7 26.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 111.042 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.497 ' C ' ' OD1' ' A' ' 318' ' ' ASN . 2.9 t -134.74 159.28 41.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.667 ' N ' ' OD1' ' A' ' 318' ' ' ASN . 39.9 p-10 -113.24 97.33 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.6 t-20 38.36 -94.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 262' ' ' ASP . 1.1 m 62.14 -69.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.71 0.291 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 3.1 mm -63.04 -51.36 71.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.754 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.3 Cg_endo -61.72 -39.84 50.17 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.055 1.837 . . . . 0.0 112.004 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.76 -43.98 91.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -38.0 67.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.76 71.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.402 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -60.97 -38.72 86.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -68.09 -39.05 82.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.55 68.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.177 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -45.6 76.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.357 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.23 -40.99 85.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.373 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.25 -39.38 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.86 94.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.492 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.72 -42.04 83.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -49.72 76.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.391 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.51 -48.0 83.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.287 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.66 -38.07 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.09 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.63 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.496 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.2 12.99 24.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.18 130.89 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -72.44 113.36 9.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.439 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -75.47 11.02 10.17 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.1 OUTLIER -89.37 -16.71 30.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -113.83 2.34 15.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.87 124.79 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.69 154.12 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.38 132.83 38.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.73 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.9 t -125.62 116.48 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -83.26 105.34 2.69 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.6 mm? -31.28 -61.47 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.63 49.62 63.39 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 303' ' ' VAL . 94.3 p -99.58 -23.98 14.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.58 0.228 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 302' ' ' SER . 1.3 m 51.68 124.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.157 0.504 . . . . 0.0 110.512 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.476 ' N ' ' HD3' ' A' ' 305' ' ' PRO . 0.1 OUTLIER 60.2 53.25 3.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.621 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 304' ' ' ASN . 67.6 Cg_endo -77.61 -101.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.838 2.358 . . . . 0.0 112.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.6 mm -81.27 -38.59 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -115.79 160.75 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.44 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 p -102.83 16.15 27.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.731 HD22 ' CZ ' ' A' ' 315' ' ' ARG . 2.3 t30 44.63 53.81 6.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.615 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -127.25 -5.0 6.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.447 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.56 148.88 63.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.53 -31.81 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.674 2.249 . . . . 0.0 111.936 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.24 -33.39 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 318' ' ' ASN . . . -66.76 -44.38 89.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.731 ' CZ ' HD22 ' A' ' 309' ' ' ASN . 1.8 mtt-85 -62.06 -44.94 95.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 110.444 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.05 -45.53 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -34.69 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.667 ' OD1' ' N ' ' A' ' 262' ' ' ASP . 2.4 t30 -63.11 -25.4 68.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.733 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -79.68 98.97 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -133.79 146.86 51.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . 0.436 HG11 ' N ' ' A' ' 322' ' ' GLU . 70.0 t -144.85 144.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.321 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.436 ' N ' HG11 ' A' ' 321' ' ' VAL . 20.4 tt0 -137.43 148.52 46.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 323' ' ' ILE . 4.5 mp -123.58 129.64 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.438 HG23 ' HB ' ' A' ' 256' ' ' THR . 0.6 OUTLIER -130.73 123.56 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.681 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.424 HG13 ' SG ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -107.33 134.6 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.305 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 326' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.641 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.17 117.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 69.6 mt -99.34 152.54 19.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 p -75.47 162.4 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.28 106.51 13.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.596 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.17 140.94 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.352 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -128.23 117.67 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.25 120.12 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.112 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.51 132.66 44.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.696 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.434 ' NH1' ' HA ' ' A' ' 149' ' ' PRO . 45.8 ttt180 -121.23 138.08 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.404 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.1 p -143.6 109.58 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 149' ' ' PRO . . . 75.57 -125.52 8.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.55 18.28 22.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.397 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.5 m -118.81 138.96 52.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.54 121.41 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.812 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.7 m -104.22 124.73 49.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.194 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.76 125.51 48.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.75 119.65 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.353 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.549 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . -175.5 -171.56 39.56 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.549 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -131.46 145.11 51.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.576 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.454 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 3.8 m-85 -134.5 155.87 79.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.14 -28.37 48.59 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.774 2.316 . . . . 0.0 112.483 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.09 169.45 20.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -24.82 50.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.683 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.24 89.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.814 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.67 78.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -59.74 -38.91 83.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.16 -37.76 62.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.02 -44.82 62.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 110.427 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.498 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER -57.49 -26.76 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.455 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.403 ' N ' ' HG3' ' A' ' 107' ' ' MET . 51.9 m -66.5 -32.12 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.72 -18.47 63.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 pp -125.49 3.74 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.637 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' MET . 32.5 t-20 -54.82 -42.27 71.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.639 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.66 -16.87 70.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.52 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 0.0 110.461 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 tt -45.52 105.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.8 160.53 30.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.674 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' A' ' 118' ' ' VAL . 52.0 Cg_exo -47.46 155.59 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 112.426 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.04 -25.45 0.31 Allowed Glycine 0 N--CA 1.461 0.316 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.585 ' H ' ' C ' ' A' ' 116' ' ' PRO . 12.7 t -93.22 140.04 17.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.173 -0.604 . . . . 0.0 110.635 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.55 130.29 54.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.605 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.2 t -134.22 119.82 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.7 pt -125.24 125.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -104.23 104.24 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.171 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -109.93 63.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.846 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.7 125.36 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.579 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -90.63 146.42 24.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.78 121.06 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.76 132.19 18.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.97 60.41 7.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.35 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 130' ' ' VAL . 7.4 p -174.2 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 129' ' ' VAL . 26.3 m -52.03 142.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -99.55 158.03 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.154 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.454 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 13.8 t -120.46 155.02 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.76 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 ' CE2' ' A' ' 183' ' ' TRP . 55.6 tp -81.61 127.87 33.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.01 139.22 52.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -130.36 24.03 5.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' PHE . 68.9 m -30.41 -39.95 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.393 0.616 . . . . 0.0 110.962 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.7 m -152.59 61.51 0.81 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.436 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.16 -7.62 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.427 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -56.29 -43.47 99.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.513 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.0 Cg_exo -58.37 -41.43 65.96 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.31 -49.07 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.076 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' N ' ' A' ' 146' ' ' VAL . 2.4 m-85 -65.01 -37.12 86.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.474 ' HG1' ' HA ' ' A' ' 140' ' ' PRO . 1.3 p -58.27 -37.89 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.417 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.73 53.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.692 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 p -101.65 -2.06 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.2 t -65.62 -40.01 37.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 56.4 Cg_endo -82.65 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.712 2.274 . . . . 0.0 112.256 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.411 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 5.2 mt -128.99 104.01 18.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 88' ' ' GLY . 59.6 Cg_endo -78.24 21.1 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.205 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 12.3 t70 -152.63 64.18 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.478 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.647 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -130.01 139.67 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.659 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 130.5 6.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -119.11 129.96 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.586 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 131.26 51.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.585 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.25 134.59 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.388 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 158' ' ' ASP . 69.8 mt-10 -141.95 95.82 2.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 8.3 mtt180 53.84 -90.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' GLU . 5.0 p30 -117.97 9.06 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.884 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 m -110.06 129.11 55.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.693 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 t -119.9 131.77 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.357 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 p -130.95 116.86 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 tt -112.0 118.7 36.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.8 p -128.59 149.2 50.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.789 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.55 -168.04 28.57 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.8 p -108.03 135.7 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.685 0.279 . . . . 0.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -98.36 159.08 31.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.358 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.732 2.288 . . . . 0.0 112.142 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.38 166.4 16.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -41.45 94.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.44 -41.49 98.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -63.94 -37.81 88.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.402 ' HZ3' ' HG2' ' A' ' 172' ' ' LYS . 8.7 ttpp -60.44 -43.25 97.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.734 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.9 t70 -66.73 -36.85 83.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.7 -32.83 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -51.83 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.727 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 177' ' ' ARG . 8.3 ptpt -66.35 -39.26 89.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 176' ' ' LYS . 7.8 ttm-85 -56.17 -51.03 69.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.39 -31.74 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.661 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.41 99.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 40.7 p -67.4 -37.59 83.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.474 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -27.06 64.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.8 m -96.02 -52.62 3.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.989 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.454 ' CE2' HD22 ' A' ' 133' ' ' LEU . 6.1 m-90 -116.71 99.09 52.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.264 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 58.2 Cg_endo -80.19 17.09 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.508 2.139 . . . . 0.0 111.349 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.3 OUTLIER -30.86 -29.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.718 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 78.52 -29.21 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.594 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 185' ' ' ASP . 23.5 mttt -105.2 76.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.546 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.92 125.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.25 124.27 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -98.31 123.53 42.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.19 45.69 1.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -114.56 129.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.16 126.64 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.396 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.98 112.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 213' ' ' SER . 15.7 m-20 62.18 72.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -40.48 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.243 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.43 ' HG2' ' H ' ' A' ' 213' ' ' SER . 0.0 OUTLIER -68.5 -50.51 51.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.058 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 212' ' ' GLN . 74.4 m -70.73 -45.02 65.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.957 0.408 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.7 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.246 -0.284 . . . . 0.0 111.715 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 1.2 tp -69.56 -41.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.563 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 21.0 t30 -70.33 -36.85 74.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.57 -30.11 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.2 -34.64 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.752 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 221' ' ' GLY . 0.8 OUTLIER -109.08 -15.89 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.752 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 56.03 4.13 0.68 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -165.98 -172.88 33.86 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.11 147.68 79.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.579 2.186 . . . . 0.0 111.982 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.2 -37.11 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.724 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 4.2 tt -63.69 -37.43 79.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.787 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.432 ' HB3' HH21 ' A' ' 288' ' ' ARG . 2.2 mp -59.91 -43.25 94.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.722 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -38.49 70.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -45.42 94.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.133 0.492 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.36 -35.17 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.421 ' HB1' ' CG ' ' A' ' 288' ' ' ARG . . . -55.82 -47.18 77.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.903 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.08 -50.6 72.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.786 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -68.91 -32.09 71.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.916 0.389 . . . . 0.0 110.668 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.682 ' O ' ' CD ' ' A' ' 251' ' ' PRO . 1.4 tp -55.07 -33.65 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.398 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -63.27 -37.69 88.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.894 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.45 -2.23 17.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -74.4 -46.59 5.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.941 -178.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 253' ' ' ALA . 31.5 Cg_exo -53.2 -13.75 3.46 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.986 2.458 . . . . 0.0 112.374 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 253' ' ' ALA . 0.6 OUTLIER -37.08 -23.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -107.19 -149.07 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.847 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.463 ' HE ' HD21 ' A' ' 326' ' ' ASN . 0.2 OUTLIER -103.77 138.23 40.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.03 132.12 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.95 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.421 HG22 ' OD1' ' A' ' 258' ' ' ASN . 95.0 m -123.48 124.37 42.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.067 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.99 114.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.57 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.421 ' OD1' HG22 ' A' ' 256' ' ' THR . 0.0 OUTLIER -111.85 128.88 56.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.6 148.83 19.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -139.65 130.79 26.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 110.379 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.7 p -124.99 -155.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.479 ' OD1' ' OD1' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -143.85 158.02 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.578 ' O ' ' OG1' ' A' ' 264' ' ' THR . 0.3 OUTLIER 172.43 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 265' ' ' GLY . 10.6 p 66.74 -90.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.908 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 299' ' ' GLY . 0.6 OUTLIER -76.07 -47.05 3.71 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.625 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 39.8 Cg_exo -53.9 -32.62 68.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.259 1.973 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 28.2 tp -68.2 -48.36 65.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.477 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -32.92 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.17 -41.84 60.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -64.88 -37.38 87.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' CZ ' ' A' ' 319' ' ' ARG . 38.8 mtt-85 -61.38 -41.87 97.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.352 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.96 -28.84 67.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.174 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 277' ' ' ARG . 10.9 pt -70.87 -44.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.86 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.422 ' N ' HG13 ' A' ' 280' ' ' ILE . 71.0 t -58.6 -48.49 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.67 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.11 70.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -38.78 92.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -42.0 83.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.636 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.55 -37.22 77.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.372 . . . . 0.0 110.012 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.35 -36.28 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.079 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.16 -20.1 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ARG . . . . . 0.432 HH21 ' HB3' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -81.42 -2.67 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.794 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.23 20.09 13.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.6 134.6 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.685 ' O ' ' CE1' ' A' ' 294' ' ' HIS . . . -87.8 104.54 16.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.1 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.4 OUTLIER -79.29 -16.72 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 0.0 110.648 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.685 ' CE1' ' O ' ' A' ' 291' ' ' ALA . 0.9 OUTLIER -133.74 35.02 3.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.738 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.96 136.79 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.668 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -137.29 143.59 42.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.1 124.46 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.01 119.05 60.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 271' ' ' ILE . . . -95.68 120.89 6.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 300' ' ' LEU . 4.0 mm? -99.0 111.45 23.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.328 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 302' ' ' SER . . . -78.42 120.44 5.39 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 301' ' ' GLY . 45.7 t 37.72 98.16 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.995 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.72 -38.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.964 0.411 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -133.67 70.23 75.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.127 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.81 131.51 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 0.0 112.196 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 8.4 mm -122.47 -57.19 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -116.84 156.67 26.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 309' ' ' ASN . 13.1 p -61.71 -136.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.786 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.61 ' C ' HD21 ' A' ' 309' ' ' ASN . 0.4 OUTLIER -173.15 34.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -92.78 -15.6 26.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 162.26 32.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.571 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -50.51 -33.1 37.25 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.446 2.098 . . . . 0.0 112.102 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.78 -40.11 91.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.04 -46.99 93.46 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -65.61 -38.57 89.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.44 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.94 89.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.674 ' O ' ' NH1' ' A' ' 320' ' ' ARG . 41.1 mttm -71.02 -29.73 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.469 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -77.01 -16.13 59.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.541 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.578 ' CZ ' ' NH1' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -83.85 99.76 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.566 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 317' ' ' LYS . 0.0 OUTLIER -134.53 140.76 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.386 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.64 156.07 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -142.6 142.85 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.1 mt -107.48 113.7 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.535 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.1 m -112.27 121.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.525 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.87 135.14 49.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.507 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . 0.563 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 5.9 m-20 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.783 0.325 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.35 179.48 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.27 -20.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.71 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 154.94 40.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.08 159.74 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.758 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -88.94 168.39 12.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.36 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.79 107.93 11.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.03 136.07 54.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 121.05 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.609 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.76 125.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.03 132.56 50.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -124.22 126.51 46.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.4 p -135.12 122.77 22.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.78 2.94 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.47 27.66 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -119.8 134.56 55.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.59 115.25 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.488 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.2 p -109.77 116.27 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.32 121.27 44.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.25 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 129.36 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.23 -152.54 20.15 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.57 154.3 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.39 144.74 44.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.5 -19.2 37.68 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.629 2.219 . . . . 0.0 111.873 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.65 -157.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.438 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.02 -26.45 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.389 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.26 98.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.353 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.35 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -58.45 -36.92 74.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.49 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.08 75.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.363 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.89 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.312 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.67 -39.98 93.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.439 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mmt -56.38 -37.16 69.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.478 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -65.98 -42.7 89.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.291 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.69 -22.87 62.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.44 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.03 -44.2 20.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.541 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -45.73 -37.47 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.7 -44.16 40.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' A' ' 114' ' ' LEU . 1.2 tp -43.53 -73.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 161.17 -156.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.698 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.628 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . 175.83 -48.89 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.573 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.666 ' C ' ' H ' ' A' ' 118' ' ' VAL . 86.3 Cg_exo -40.03 -129.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.547 2.831 . . . . 0.0 113.834 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.37 -2.36 0.03 OUTLIER Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.666 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.9 t -95.72 134.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 122.353 -0.498 . . . . 0.0 110.362 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.89 129.38 35.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.532 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 t -129.33 116.7 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.24 140.04 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.259 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -126.36 96.65 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -99.33 61.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.949 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 124' ' ' ILE . 0.8 OUTLIER -105.63 128.71 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.678 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.58 146.59 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.3 t -99.6 119.2 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.63 125.07 20.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.289 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.17 42.88 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.368 2.045 . . . . 0.0 112.16 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.82 -35.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.57 167.34 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.07 159.29 34.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -143.94 155.8 44.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.705 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.11 135.8 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.37 139.46 57.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -102.73 38.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.81 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -66.6 -58.68 4.66 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.615 0.721 . . . . 0.0 110.988 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 m -109.31 15.51 23.06 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.002 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -96.87 -23.26 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.797 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.8 OUTLIER -55.74 -46.26 99.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 23.2 Cg_exo -59.98 -29.59 89.69 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.805 2.337 . . . . 0.0 111.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.55 -44.96 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -62.59 -32.4 73.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 39.3 p -65.59 -36.17 82.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.714 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.28 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -97.77 0.71 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.7 t -65.68 -38.78 27.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 72.4 Cg_endo -85.02 20.44 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.692 2.261 . . . . 0.0 112.336 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.57 116.62 22.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.676 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.36 178.61 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.14 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 54.38 20.29 2.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -82.69 139.51 33.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.772 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.08 153.24 24.89 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.6 127.92 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.63 123.25 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.29 136.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.43 79.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.474 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 54.87 -115.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.732 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 158' ' ' ASP . 16.2 t70 -82.98 18.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -125.25 124.63 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.55 117.91 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.137 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -128.29 127.53 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.869 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.16 124.96 48.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.166 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.55 151.71 46.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.48 164.01 24.48 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 123.82 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.48 106.44 40.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 197' ' ' GLN . 32.1 Cg_exo -53.85 -62.52 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.338 2.026 . . . . 0.0 112.046 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.16 121.53 27.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.59 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.534 ' HG ' ' N ' ' A' ' 170' ' ' GLU . 4.9 p -61.67 -30.6 70.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.534 ' N ' ' HG ' ' A' ' 169' ' ' SER . 80.4 tt0 -58.99 -38.6 79.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.48 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -41.94 96.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -64.57 -39.95 94.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.62 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.81 -46.9 71.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.64 86.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.24 -37.8 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -58.34 -44.29 88.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.457 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.44 -37.16 82.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.59 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.86 -41.27 97.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' HA ' ' HG1' ' A' ' 182' ' ' THR . . . -62.15 -46.83 87.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 76.3 p -63.81 -40.87 97.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.903 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.7 t -71.37 -29.97 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.154 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 22.8 m -50.71 -63.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.468 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -144.05 79.27 13.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.58 -33.56 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.921 2.414 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -75.82 55.87 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 187' ' ' LYS . 23.3 tpp -176.7 166.12 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.603 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.469 ' HZ2' ' HB3' ' A' ' 187' ' ' LYS . 5.5 mtpm? -86.76 126.24 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.47 137.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.671 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.84 118.66 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -94.38 108.81 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.42 71.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.164 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.58 128.63 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.798 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -111.82 145.73 38.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.295 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' A' ' 196' ' ' GLY . 20.0 m -88.38 129.4 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.59 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 t -75.49 18.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.747 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 194' ' ' VAL . . . 112.02 -2.75 27.08 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 167' ' ' PRO . 2.1 tp60 -113.49 147.54 37.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.463 ' N ' ' HD2' ' A' ' 199' ' ' PRO . . . -175.91 -55.09 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.721 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 201' ' ' GLY . 86.4 Cg_exo -41.79 130.66 4.1 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.671 2.247 . . . . 0.0 112.064 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -43.05 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.165 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -116.03 178.16 17.36 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -46.19 102.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.043 2.495 . . . . 0.0 112.538 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.33 102.08 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.514 2.142 . . . . 0.0 111.887 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -179.99 29.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.607 ' O ' ' N ' ' A' ' 207' ' ' PRO . 4.0 m 50.75 70.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.479 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 205' ' ' SER . . . -15.38 81.18 0.0 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.607 ' N ' ' O ' ' A' ' 205' ' ' SER . 72.4 Cg_endo -82.6 -169.28 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.012 2.475 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.624 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 39.2 t -76.56 33.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -72.12 137.81 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 209' ' ' ALA . 16.0 m-20 37.81 19.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.7 OUTLIER -56.3 -30.81 63.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.523 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.515 ' OE1' ' N ' ' A' ' 212' ' ' GLN . 0.3 OUTLIER -54.28 -40.89 68.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -69.47 -42.05 75.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.404 0.621 . . . . 0.0 110.989 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.77 -34.69 64.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.079 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 216' ' ' ASN . 2.8 tt -59.03 -37.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.527 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 215' ' ' ILE . 2.6 t-20 -54.16 -32.69 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.213 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.18 -45.7 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.664 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.486 ' CG2' ' HZ1' ' A' ' 246' ' ' LYS . 13.0 t -60.46 -38.85 79.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.532 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 220' ' ' GLY . 20.2 p -78.82 -31.44 45.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 219' ' ' THR . . . 19.57 52.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 219' ' ' THR . . . -153.88 166.32 31.89 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.74 138.93 39.05 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.89 2.394 . . . . 0.0 112.071 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 224' ' ' ALA . 1.7 tp -160.25 -24.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.691 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.444 ' N ' HG21 ' A' ' 223' ' ' ILE . . . -173.08 129.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.6 t80 53.32 77.98 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -126.94 123.79 4.78 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.06 48.47 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.479 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.522 ' O ' ' C ' ' A' ' 229' ' ' GLY . 7.7 p30 -100.01 111.6 23.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.53 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 228' ' ' ASP . . . -28.58 -68.04 0.08 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -168.51 76.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.19 109.41 19.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 32.1 mt 60.99 128.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.05 70.38 74.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.387 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.16 135.01 11.91 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.968 2.446 . . . . 0.0 112.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -115.06 58.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.417 ' C ' ' CD1' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -120.21 177.84 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 236' ' ' ASP . 45.9 m-85 -143.18 -3.66 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.62 -32.86 73.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.91 -36.96 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.809 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -46.15 87.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.409 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -63.29 -35.58 80.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -66.26 -45.25 81.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.499 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.88 86.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.528 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.3 -41.91 76.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.35 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.486 ' HZ1' ' CG2' ' A' ' 218' ' ' VAL . 20.0 mtmt -69.83 -32.41 70.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.452 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -64.45 -31.07 72.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.828 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.25 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -106.01 3.78 28.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.247 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.689 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.7 m -75.41 -27.59 0.7 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.6 Cg_exo -53.58 -14.21 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.466 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 251' ' ' PRO . 40.2 t0 -39.88 -23.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -115.41 -148.82 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.76 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -109.61 139.39 44.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.9 t -118.83 132.15 69.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.894 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 95.5 m -123.4 125.77 45.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -113.81 120.25 63.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.874 0.369 . . . . 0.0 110.493 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.49 149.51 27.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -124.87 123.79 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -100.6 133.93 44.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.7 165.19 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.362 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 -158.85 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 2.7 t-20 -176.34 129.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 35.9 m -150.6 -15.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 266' ' ' SER . . . 82.04 105.44 0.4 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 265' ' ' GLY . 14.2 t 80.38 -67.44 0.13 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.574 0.702 . . . . 0.0 110.963 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -64.35 -30.09 71.14 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.429 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -96.73 -50.7 1.77 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.461 ' O ' ' CG2' ' A' ' 269' ' ' ILE . 2.2 tt 38.51 17.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.353 0.597 . . . . 0.0 110.843 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.676 ' ND2' ' NH1' ' A' ' 315' ' ' ARG . 11.3 m120 -69.82 -34.45 73.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.912 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 0.7 OUTLIER -57.43 -51.82 78.89 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 12.4 Cg_endo -59.87 -41.91 49.89 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.947 1.765 . . . . 0.0 112.508 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.457 ' C ' HH22 ' A' ' 319' ' ' ARG . 5.4 tp -68.8 -37.97 79.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.502 ' N ' HH22 ' A' ' 319' ' ' ARG . 1.4 p -64.86 -40.18 94.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.9 -51.99 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.7 -34.59 78.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -60.51 -41.77 95.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.47 91.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -57.26 -40.21 77.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.596 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 11.1 mm -61.05 -40.68 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.589 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.45 -45.99 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.507 ' O ' ' CG2' ' A' ' 286' ' ' VAL . . . -61.93 -43.14 99.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.49 -39.4 87.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.13 -52.09 31.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.65 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 57.2 mt -59.6 -45.46 91.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.543 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 282' ' ' ALA . 59.4 t -58.95 -36.36 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.194 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.8 -25.13 68.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 288' ' ' ARG . 0.0 OUTLIER -84.16 -2.43 56.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.296 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.47 12.6 26.4 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 90.4 t -77.34 118.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 110.467 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.72 109.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.79 1.81 71.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.41 -15.84 59.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.409 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.41 5.98 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 295' ' ' ILE . 10.4 tt -91.07 133.83 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -130.0 135.98 48.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.41 134.05 51.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 122.13 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.71 106.67 3.39 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.405 ' H ' ' CD1' ' A' ' 300' ' ' LEU . 0.0 OUTLIER -103.49 89.39 3.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.658 ' O ' ' OG ' ' A' ' 302' ' ' SER . . . -91.5 167.82 31.49 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.658 ' OG ' ' O ' ' A' ' 301' ' ' GLY . 89.7 p 69.64 -43.71 0.53 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.312 0.577 . . . . 0.0 110.963 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 301' ' ' GLY . 27.4 m -64.37 166.32 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.468 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 303' ' ' VAL . 10.3 m120 30.18 60.91 0.94 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.526 ' O ' ' C ' ' A' ' 306' ' ' ILE . 37.5 Cg_endo -69.72 67.16 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.784 2.323 . . . . 0.0 112.272 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 305' ' ' PRO . 6.4 mm -30.92 -66.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.391 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.7 160.4 22.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.33 160.27 30.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -100.81 108.55 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.206 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -163.84 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.59 161.32 28.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.69 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -50.23 -33.04 34.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.523 2.149 . . . . 0.0 112.08 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -68.51 -31.87 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.748 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.64 97.63 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.676 ' NH1' ' ND2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -63.44 -45.8 89.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.779 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -62.78 -40.43 97.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.717 HD21 ' N ' ' A' ' 319' ' ' ARG . 0.4 OUTLIER -83.79 -25.11 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.906 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.717 ' N ' HD21 ' A' ' 318' ' ' ASN . 0.7 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -137.22 157.77 45.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 111.048 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.9 t -144.87 152.58 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.73 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.97 142.95 29.17 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.507 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.1 mt -119.03 120.67 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.13 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 256' ' ' THR . 2.7 m -127.76 131.52 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.37 136.1 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.478 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.551 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 1.8 m-20 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.535 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.73 67.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -45.53 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 131' ' ' ARG . 24.2 p -129.3 138.27 51.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.24 159.29 15.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.6 p -97.18 159.67 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.745 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.45 115.77 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.637 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.96 144.09 49.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.81 125.94 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -133.43 115.49 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.347 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 m -137.26 127.37 26.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HE ' HG13 ' A' ' 91' ' ' VAL . 7.9 mtt85 -114.91 126.46 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.302 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 p -134.23 116.71 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 150' ' ' ASP . . . 71.73 -137.14 25.29 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -95.22 15.68 18.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 110.497 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -121.61 125.76 47.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.48 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 5.8 m -107.36 118.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.38 127.72 45.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 94' ' ' ILE . 14.0 tp -133.15 120.41 21.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.284 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -134.13 129.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.614 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.5 -156.21 23.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 154.1 41.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 20.9 m-85 -138.67 146.59 51.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.535 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 24.9 Cg_endo -64.48 -25.47 63.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.676 2.251 . . . . 0.0 112.144 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 98' ' ' PRO . 35.5 m-20 -155.76 119.82 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.611 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -45.23 -21.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.43 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ASP . . . -60.41 -36.82 79.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.64 81.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -36.88 85.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.14 -38.52 79.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.351 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.37 90.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.28 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.54 -43.22 85.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -26.42 61.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -60.56 -42.81 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.799 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.09 67.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.469 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mt -79.74 -21.15 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.61 -30.38 8.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.56 61.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 1.9 tt -88.04 -47.53 8.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.835 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 mt -21.2 116.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.157 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.606 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -142.98 -178.27 0.77 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.35 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 115' ' ' ALA . 71.7 Cg_endo -89.01 153.58 5.8 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.127 2.552 . . . . 0.0 112.594 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.86 -10.04 21.06 Favored Glycine 0 C--O 1.24 0.483 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 115' ' ' ALA . 3.2 m -92.86 130.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.01 -0.7 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.44 HD21 ' N ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -92.26 130.47 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.524 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.44 ' N ' HD21 ' A' ' 119' ' ' ASN . 0.8 OUTLIER -102.3 129.06 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.425 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.0 mm -130.16 110.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.31 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 78.78 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.059 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -85.94 75.98 9.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.9 130.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.736 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.01 146.47 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.054 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 p -99.76 111.74 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.813 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.654 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -137.54 102.94 8.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.351 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.71 26.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.391 2.061 . . . . 0.0 112.183 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.654 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.3 t -124.46 -4.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.902 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 171.41 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.735 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 78' ' ' SER . 6.2 mmt-85 -117.82 159.27 23.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.678 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -125.22 155.23 40.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.704 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.48 ' CD2' ' CE2' ' A' ' 183' ' ' TRP . 4.4 tp -86.91 134.98 33.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.61 132.41 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.734 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -117.68 27.31 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.302 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.1 m -32.65 -47.2 0.16 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.171 0.51 . . . . 0.0 110.978 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -100.22 -91.49 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.802 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 69.99 -43.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.694 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 137' ' ' SER . 2.8 mm-40 -51.75 -58.86 9.52 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.958 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 20.6 Cg_endo -64.28 -35.13 52.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.514 2.143 . . . . 0.0 112.143 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.447 ' CG2' ' HG1' ' A' ' 182' ' ' THR . 20.9 t -69.92 -48.27 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.84 -42.8 94.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 63.0 p -65.97 -33.98 77.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.72 -22.03 59.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 p -111.99 5.54 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -63.86 -42.68 72.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.245 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 26.3 Cg_exo -57.92 -10.98 8.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.592 2.195 . . . . 0.0 111.756 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.6 mm -125.03 89.7 52.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.494 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.63 16.36 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.666 2.244 . . . . 0.0 112.059 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 88' ' ' GLY . 6.3 m-20 -132.4 61.66 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 2.7 p90 -125.55 143.17 51.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.54 142.2 15.61 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.6 tp -141.93 127.22 18.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -125.16 128.8 48.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.024 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.28 127.48 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.132 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 157' ' ' ARG . 2.2 tt0 -110.45 176.16 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.12 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 156' ' ' GLU . 25.6 mtt180 -32.26 -43.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.633 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 30.55 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 m -135.82 130.38 33.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.632 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.49 127.2 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 m -131.14 127.22 37.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.608 ' CD1' ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -117.19 121.31 40.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.722 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.9 m -122.76 147.15 46.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.522 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.97 158.47 8.64 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.6 p -96.47 135.3 38.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.05 142.22 26.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.62 -39.19 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.687 2.258 . . . . 0.0 112.272 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.464 ' HB3' ' HD1' ' A' ' 171' ' ' HIS . 44.5 t -123.61 137.66 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.638 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -33.17 75.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -59.01 -48.56 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.464 ' HD1' ' HB3' ' A' ' 168' ' ' SER . 29.9 m80 -58.35 -40.84 83.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.353 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.78 ' HZ2' ' NZ ' ' A' ' 176' ' ' LYS . 8.5 tttm -62.89 -36.18 82.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.6 t70 -63.93 -38.64 91.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.64 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.38 71.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.93 -51.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.78 ' NZ ' ' HZ2' ' A' ' 172' ' ' LYS . 1.5 ptpt -63.52 -36.73 84.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.799 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 176' ' ' LYS . 9.3 ttm180 -59.76 -53.99 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.723 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.576 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -66.8 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.98 77.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.693 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.6 OUTLIER -63.25 -38.59 91.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.716 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 p -70.88 -36.32 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.2 OUTLIER -66.48 -68.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.845 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.48 ' CE2' ' CD2' ' A' ' 133' ' ' LEU . 8.5 m-90 -114.8 90.44 22.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 186' ' ' MET . 72.4 Cg_endo -83.53 22.52 0.91 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 123.017 2.478 . . . . 0.0 111.671 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 186' ' ' MET . 54.2 m-20 -36.56 -20.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.671 ' N ' ' O ' ' A' ' 184' ' ' PRO . 5.4 tpt 91.1 -39.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.564 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.12 53.53 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.44 119.08 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.93 129.68 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -104.41 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -125.13 59.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.291 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.39 129.16 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -121.99 139.63 53.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.232 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -88.28 129.42 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.8 p -76.85 45.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.485 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.31 35.42 65.49 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 140.69 47.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 56.73 88.27 0.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 201' ' ' GLY . 39.3 Cg_exo -52.5 148.58 26.29 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.689 2.259 . . . . 0.0 111.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -39.11 83.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.783 2.322 . . . . 0.0 112.111 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 156.45 -89.35 0.12 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -39.45 98.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.842 2.361 . . . . 0.0 112.123 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.64 52.69 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.112 2.541 . . . . 0.0 112.26 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.635 ' O ' ' CB ' ' A' ' 205' ' ' SER . . . -132.84 -27.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 204' ' ' ALA . 0.9 OUTLIER 90.44 120.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.91 93.85 0.65 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.619 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.19 -91.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.801 2.334 . . . . 0.0 111.838 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 250' ' ' CYS . 0.0 OUTLIER -118.14 17.07 14.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -65.32 134.37 53.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.822 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.0 OUTLIER 39.03 16.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.784 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -56.25 -30.85 62.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.077 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -38.2 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.402 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -65.73 -42.48 90.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.521 0.677 . . . . 0.0 110.984 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.05 -34.83 64.21 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.37 -39.12 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 220' ' ' GLY . 2.6 m120 -59.91 -38.52 82.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.29 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -58.6 -34.9 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 220' ' ' GLY . 3.5 t -105.54 -30.38 9.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 122.95 -37.93 2.66 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.21 -170.04 33.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 143.06 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.794 2.329 . . . . 0.0 111.976 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.738 ' CD1' ' H ' ' A' ' 223' ' ' ILE . 3.1 mp -59.34 104.22 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.64 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -140.16 -52.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 17.6 p90 -174.71 117.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -88.75 143.02 17.41 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.629 ' CG ' ' H ' ' A' ' 228' ' ' ASP . 25.6 p-10 -127.36 -124.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.749 0.309 . . . . 0.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 227' ' ' ASN . 1.1 m-20 79.68 112.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.558 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 99.64 -58.79 0.8 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -146.4 -142.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 0.0 110.639 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 232' ' ' LEU . 32.7 t -149.15 -25.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 231' ' ' SER . 5.4 mt -31.31 119.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.2 mm 39.46 83.87 0.19 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.63 -178.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.803 2.336 . . . . 0.0 111.941 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.406 ' C ' ' OD1' ' A' ' 236' ' ' ASP . . . 70.06 150.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 235' ' ' ALA . 1.3 m-20 -148.15 178.14 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.539 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.67 -16.25 5.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.566 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.44 -39.52 88.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 58.8 mt -68.89 -36.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.73 -32.74 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.595 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -56.1 -43.08 77.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -45.92 79.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.6 -45.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.25 83.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.35 -50.64 70.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -31.7 71.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.115 0.483 . . . . 0.0 109.757 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -55.07 -30.19 59.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.49 11.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -104.36 -2.92 24.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.469 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.6 m -74.85 -27.17 0.7 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 51.4 Cg_exo -51.91 -13.83 2.02 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.728 1.618 . . . . 0.0 111.857 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.36 -14.65 63.11 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.9 -166.29 1.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.703 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -113.43 138.7 49.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 11.6 p -119.36 133.13 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.944 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.2 m -117.34 118.85 33.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.051 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.493 HG21 HD12 ' A' ' 257' ' ' ILE . 65.6 mt -101.62 120.2 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -100.21 134.93 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.97 125.63 8.26 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -109.18 112.51 24.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.451 ' CG2' ' OD1' ' A' ' 270' ' ' ASN . 8.8 t -116.67 -158.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.251 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.432 ' N ' ' OG1' ' A' ' 261' ' ' THR . 1.0 OUTLIER -122.81 -151.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -119.7 28.46 8.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.3 m -58.68 -68.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -91.65 147.96 19.03 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.0 t -44.07 161.72 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.649 0.261 . . . . 0.0 110.945 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.15 -36.46 63.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 110.417 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.94 -5.99 49.82 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.63 -24.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.639 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' CG2' ' A' ' 261' ' ' THR . 0.6 OUTLIER -68.3 -44.25 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.2 mm -59.96 -51.94 77.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.4 Cg_endo -61.67 -33.25 86.64 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.111 1.874 . . . . 0.0 112.106 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.31 -42.61 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.423 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 p -74.33 -37.8 63.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.635 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.13 -35.8 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 41.7 mtt-85 -63.05 -47.11 84.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.91 70.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.393 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -55.82 -39.1 70.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.469 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.8 -43.62 89.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.328 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.73 -38.19 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.21 93.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.644 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.96 -37.25 86.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.514 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -52.33 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.49 -48.94 79.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.7 t -56.36 -39.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.187 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.7 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.196 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 0.4 47.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.865 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.7 12.05 42.01 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.45 133.93 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.563 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.74 102.8 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -85.93 1.71 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.602 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -133.4 6.99 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.2 mt -96.57 133.84 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.327 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.53 147.04 50.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 128.31 40.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.84 140.23 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.722 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -105.38 112.44 3.99 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 299' ' ' GLY . 11.4 mt -46.27 -96.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 302' ' ' SER . . . 132.05 82.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 301' ' ' GLY . 47.0 t 30.21 68.76 0.09 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.017 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.67 -82.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.704 0.288 . . . . 0.0 110.263 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.675 ' C ' ' H ' ' A' ' 306' ' ' ILE . 0.7 OUTLIER -178.45 -51.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 32.1 Cg_exo -57.34 16.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.58 2.187 . . . . 0.0 112.346 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.675 ' H ' ' C ' ' A' ' 304' ' ' ASN . 14.4 pt -77.34 178.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.309 . . . . 0.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.74 171.91 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.726 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 14.5 m -81.18 152.88 27.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.41 31.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.86 -35.13 69.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.631 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.63 154.38 79.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.01 -34.2 97.17 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.89 2.393 . . . . 0.0 111.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.433 ' CG ' ' N ' ' A' ' 314' ' ' GLY . 7.8 pt-20 -65.24 -36.66 84.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.287 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 313' ' ' GLU . . . -59.82 -39.23 95.13 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.528 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -65.57 -44.64 86.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.42 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.418 ' HA ' ' NH2' ' A' ' 319' ' ' ARG . . . -55.45 -40.33 71.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.384 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -65.52 -29.95 70.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.546 ' C ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -76.23 -16.1 59.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.517 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 316' ' ' ALA . 52.9 mtm180 -94.6 95.73 8.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -132.11 146.63 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.261 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.26 147.92 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.88 136.82 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.582 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.7 mt -130.19 117.9 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.62 131.64 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.438 HG12 ' SG ' ' A' ' 250' ' ' CYS . 2.3 p -109.69 135.36 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.555 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.549 ' O ' ' OD1' ' A' ' 326' ' ' ASN . 19.2 t-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.612 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.724 0.297 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -166.83 83.2 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.629 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -8.01 14.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.343 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.81 144.68 8.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.412 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 5.8 mt -129.28 159.34 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.795 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.7 p -86.71 167.36 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 123.98 21.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.97 118.04 15.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.272 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 p -127.83 129.25 46.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' A' ' 84' ' ' ILE . 1.4 pt -134.53 132.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.472 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -124.81 126.85 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.524 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -113.4 131.2 56.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 90' ' ' THR . 41.2 t -142.8 112.5 6.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.12 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.65 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 27.08 106.04 0.0 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.14 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.7 1.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.65 ' H ' ' C ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -106.99 124.91 50.31 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.476 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.86 125.64 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 78.2 m -123.12 118.59 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 tt -119.77 127.25 52.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.766 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 mt -135.32 128.19 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.475 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.56 -161.15 33.38 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.76 146.04 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CD2' ' OG ' ' A' ' 132' ' ' SER . 11.4 m-85 -125.32 156.01 70.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.356 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 -20.76 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.779 2.319 . . . . 0.0 112.945 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 18.2 t0 -156.45 157.75 36.06 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.222 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -76.25 -26.99 56.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.062 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.06 79.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.08 86.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.203 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -57.07 -36.7 70.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.59 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.59 -40.42 68.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.98 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -41.34 76.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.301 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 39.3 mtp -58.58 -33.4 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.457 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.2 OUTLIER -61.29 -35.17 76.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.48 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.8 mt -78.36 -20.61 50.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -46.83 -23.02 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.93 -22.43 55.31 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 14.6 tp -98.28 -44.58 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.77 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -24.38 101.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.29 69.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.621 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 118' ' ' VAL . 17.8 Cg_endo -61.91 -79.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.884 2.389 . . . . 0.0 112.217 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -43.9 -10.35 0.01 OUTLIER Glycine 0 N--CA 1.46 0.246 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 116' ' ' PRO . 38.4 t -102.37 120.8 52.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 O-C-N 122.238 -0.566 . . . . 0.0 110.623 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.35 118.7 31.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -118.73 125.95 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.435 ' C ' ' OD1' ' A' ' 122' ' ' ASP . 13.5 pt -123.71 138.22 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.125 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -126.78 90.94 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.296 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.55 68.81 9.69 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.69 119.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.871 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -91.48 145.99 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.02 112.27 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.875 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.74 125.35 22.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.15 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.49 49.27 1.73 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.298 1.999 . . . . 0.0 112.171 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.4 t -154.1 -35.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.23 153.6 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -110.08 159.54 17.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.609 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 1.4 m -120.78 150.55 40.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 29.8 tp -83.24 129.82 35.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -53.3 147.35 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.8 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -125.21 11.75 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.151 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.4 p -39.63 -25.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -140.63 31.05 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.809 -179.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.83 24.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.3 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -51.59 -58.95 9.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.971 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 17.9 Cg_endo -63.39 -31.63 72.51 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.396 2.064 . . . . 0.0 112.042 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.6 t -64.75 -47.74 87.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.75 -37.47 87.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 p -68.08 -33.15 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.693 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.0 -27.41 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -100.54 0.45 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.002 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.729 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -70.76 -36.16 5.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 16.4 Cg_exo -64.04 18.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.945 2.43 . . . . 0.0 112.208 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 150' ' ' ASP . 60.2 mt -139.73 86.65 13.57 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.19 2.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.836 2.357 . . . . 0.0 112.008 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.2 p-10 -130.26 70.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.453 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -127.71 140.66 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.87 133.67 7.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.48 131.65 53.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 0.0 110.714 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 124.76 45.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.374 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.9 124.34 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -136.03 93.79 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.412 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 3.5 mtp180 58.79 -93.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.42 15.38 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -114.15 125.27 53.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.19 117.21 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.619 ' CG2' HD21 ' A' ' 191' ' ' ASN . 9.0 m -134.32 135.78 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.41 124.25 46.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.507 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.55 149.12 45.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 154.7 160.07 9.64 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.532 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 95.9 m -91.28 139.27 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.87 108.48 42.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.12 -27.28 1.78 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.416 2.077 . . . . 0.0 112.147 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -130.05 131.81 45.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -34.35 77.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -36.04 75.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.427 ' HD1' ' HA ' ' A' ' 171' ' ' HIS . 2.2 m-70 -63.67 -35.94 82.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -46.22 91.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.38 -44.43 95.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.38 86.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.75 -41.19 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.314 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 -52.13 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.115 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -57.17 -40.47 77.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -65.65 -36.43 83.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.424 ' HA ' ' HG1' ' A' ' 182' ' ' THR . . . -68.62 -46.21 69.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.3 m -60.58 -41.0 93.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -67.73 -29.16 68.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 2.6 m -68.38 -66.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.491 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.456 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 6.3 m-90 -118.42 67.24 6.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.693 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.67 1.93 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.627 2.218 . . . . 0.0 111.829 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.77 60.71 0.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.54 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 ttt -171.84 -163.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 104.98 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.93 127.75 57.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.488 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.49 121.14 58.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 190' ' ' ASN . 0.9 OUTLIER -97.58 116.95 30.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.742 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.619 HD21 ' CG2' ' A' ' 161' ' ' THR . 12.4 m-80 -117.29 48.53 1.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.219 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.15 125.78 52.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.12 142.96 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.3 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.73 107.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.412 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 p -119.38 -7.51 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -110.44 -18.03 8.87 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.431 ' O ' ' CB ' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -76.92 131.76 38.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.484 ' H ' ' HD2' ' A' ' 200' ' ' PRO . . . 164.23 -51.75 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.078 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 16.6 Cg_exo -54.06 -43.14 60.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.456 2.104 . . . . 0.0 112.512 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 86.6 Cg_endo -87.02 -91.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.671 2.247 . . . . 0.0 112.29 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.94 -68.04 0.52 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -50.58 154.27 6.68 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.813 2.342 . . . . 0.0 112.065 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.13 73.41 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.735 2.29 . . . . 0.0 112.088 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 205' ' ' SER . . . -176.77 101.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 204' ' ' ALA . 1.0 OUTLIER -35.77 131.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.441 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 207' ' ' PRO . . . -147.4 106.77 0.37 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 209' ' ' ALA . 51.6 Cg_exo -50.62 -139.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.689 ' SG ' ' O ' ' A' ' 246' ' ' LYS . 1.3 m -38.02 -21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.622 ' N ' ' O ' ' A' ' 207' ' ' PRO . . . 53.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 2.7 m-20 33.46 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.615 ' H ' ' CD2' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -56.24 -46.05 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.123 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.458 ' C ' ' CD ' ' A' ' 212' ' ' GLN . 10.2 tp60 -72.73 -50.38 25.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.249 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -71.17 -44.42 65.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.601 0.36 . . . . 0.0 110.948 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.597 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -71.33 -45.27 63.38 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.028 -0.42 . . . . 0.0 111.943 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 211' ' ' LEU . 1.7 tp -69.48 -36.62 72.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.942 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 216' ' ' ASN . 0.7 OUTLIER -69.92 -43.96 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.662 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.81 95.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.703 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.8 -50.15 80.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 221' ' ' GLY . 57.4 p -69.29 -22.22 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 74.5 -40.18 1.1 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -168.56 174.76 43.27 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.35 141.68 94.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.834 2.356 . . . . 0.0 111.986 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.3 mt -65.16 108.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -178.1 66.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -108.79 97.23 6.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.475 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -78.8 -83.01 0.64 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -178.24 4.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 110.711 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.94 -151.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.609 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 147.1 -106.22 0.35 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 231' ' ' SER . . . -112.64 -40.17 4.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.31 . . . . 0.0 110.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 230' ' ' ALA . 0.1 OUTLIER -27.7 106.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.596 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.0 124.95 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 234' ' ' PRO . 20.6 mt 42.59 79.93 0.31 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.532 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 233' ' ' ILE . 52.7 Cg_exo -48.33 -172.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.866 2.377 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 46.81 93.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 238' ' ' GLU . 14.0 t0 -178.73 90.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.701 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.564 ' O ' ' OD1' ' A' ' 241' ' ' ASN . 0.2 OUTLIER -68.19 19.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.324 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.62 ' H ' ' C ' ' A' ' 236' ' ' ASP . 2.2 mt-10 -67.61 -46.04 73.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.809 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 24.5 mt -59.49 -38.06 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 77.6 mt -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 237' ' ' TYR . 11.1 m120 -55.82 -49.03 74.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.903 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -65.03 -45.78 84.03 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.724 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.04 -48.42 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.31 82.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -50.71 70.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.689 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 6.0 mtpm? -69.18 -33.41 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.981 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.441 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.9 OUTLIER -54.81 -31.29 58.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.594 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -62.5 -16.88 58.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.22 22.27 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.34 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 57.8 m -74.98 -28.63 0.81 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.3 Cg_exo -53.63 -14.23 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.327 2.018 . . . . 0.0 112.646 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -52.36 -10.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 251' ' ' PRO . . . -128.98 -157.87 0.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.217 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -100.23 139.1 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 50.7 t -119.41 132.95 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.112 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.512 ' HB ' HG21 ' A' ' 324' ' ' VAL . 95.2 m -121.23 119.43 32.26 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 257' ' ' ILE . 36.4 mt -106.17 121.02 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.79 0.328 . . . . 0.0 110.786 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.68 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -109.45 125.1 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -112.4 166.21 12.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 261' ' ' THR . 1.2 t80 -172.99 109.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.688 ' O ' ' CE1' ' A' ' 260' ' ' TYR . 1.3 t -105.08 -162.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.714 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 261' ' ' THR . 12.6 p-10 -89.75 174.69 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 265' ' ' GLY . 2.4 m-20 -96.6 -86.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 54.2 m 61.09 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.458 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -63.52 -125.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 89.6 p -129.34 170.92 13.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 120.732 0.301 . . . . 0.0 110.998 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -59.74 -19.8 52.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.611 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.88 -35.17 40.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mm -90.51 -21.87 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.375 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -68.64 -33.12 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.46 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.7 mm -68.26 -52.49 21.7 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.8 Cg_endo -61.7 -35.59 79.28 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.085 1.856 . . . . 0.0 112.292 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.26 -47.25 68.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.5 p -73.3 -35.19 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.54 -38.49 71.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.32 -43.79 98.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.658 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -60.15 -39.76 87.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.608 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.34 -31.21 70.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -73.57 -37.5 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.81 -46.52 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 28.1 m -63.69 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.15 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.123 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -30.83 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -46.69 51.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.712 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.46 ' O ' ' CG2' ' A' ' 290' ' ' VAL . 9.7 mt -59.91 -49.25 78.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.15 -36.21 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.76 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 -2.33 58.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.419 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.4 2.67 38.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 285' ' ' LEU . 22.0 t -68.74 131.91 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.349 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.77 97.66 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.596 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -77.46 12.86 12.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.14 -16.29 38.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -121.31 27.68 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.328 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 295' ' ' ILE . 35.4 mt -117.75 124.85 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.3 135.5 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 124.44 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.99 116.47 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.152 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.8 105.37 2.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.679 ' O ' ' N ' ' A' ' 302' ' ' SER . 27.5 mt -74.29 0.07 15.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 110.42 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.5 -72.18 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 300' ' ' LEU . 89.4 p -174.73 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 120.352 0.12 . . . . 0.0 110.955 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 304' ' ' ASN . 66.2 t -41.89 -84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.63 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 0.1 OUTLIER -86.38 -39.58 0.56 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.14 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 60.4 Cg_endo -82.53 143.64 12.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.667 2.245 . . . . 0.0 112.465 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.24 137.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.92 163.04 30.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 158.72 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -122.07 49.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -106.78 -40.06 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.852 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.91 157.99 67.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -50.04 -30.11 23.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.609 2.206 . . . . 0.0 112.056 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.09 -40.54 89.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.452 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -67.99 -44.13 79.39 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.409 ' HG2' ' NH1' ' A' ' 315' ' ' ARG . 27.1 mtt-85 -66.08 -46.15 78.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.76 80.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.316 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -72.7 -24.38 60.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 260' ' ' TYR . 65.5 m-20 -72.8 -24.27 60.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -91.72 101.68 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.23 139.52 39.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.759 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.32 155.11 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.04 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -145.09 143.17 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 111.018 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 17.8 mt -125.89 112.7 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.054 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.512 HG21 ' HB ' ' A' ' 256' ' ' THR . 2.5 m -122.03 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.169 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.51 135.05 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.465 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 41.5 t30 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.703 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.49 59.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.2 -15.4 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 p -92.08 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.113 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 2.5 mt -121.35 159.65 25.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.2 m -81.31 178.91 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.245 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 3.7 pp -83.1 132.71 35.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.662 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.95 138.33 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.09 123.08 39.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.41 115.72 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.394 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -136.5 130.36 32.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 149' ' ' PRO . 42.1 mtt85 -112.22 140.15 47.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.8 p -142.89 114.82 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.623 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 56.66 -161.09 7.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.72 7.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 110.49 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.594 ' H ' ' C ' ' A' ' 88' ' ' GLY . 99.7 m -107.58 130.93 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.35 116.93 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.3 m -103.25 121.38 42.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.582 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -123.05 127.62 49.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.31 123.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.386 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . 178.36 -161.39 28.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER -137.33 156.36 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.624 0.249 . . . . 0.0 110.447 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -133.28 150.88 76.5 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.569 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.6 -19.66 31.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.772 2.315 . . . . 0.0 112.132 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.8 173.36 10.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -82.05 -34.8 29.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.89 85.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.9 78.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HZ1' ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -55.86 -36.75 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.717 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -37.5 64.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.536 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -60.56 -38.07 83.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.28 -43.98 69.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.016 0.436 . . . . 0.0 110.3 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.0 mtp -58.0 -26.31 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.531 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -43.97 96.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.79 -21.95 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.415 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.8 mt -99.64 -1.43 38.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -47.79 -34.39 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 -32.13 29.98 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.38 -34.91 69.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.317 . . . . 0.0 110.595 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mt -39.28 116.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.506 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.14 155.15 23.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.672 ' O ' ' N ' ' A' ' 118' ' ' VAL . 26.7 Cg_endo -65.11 -83.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.753 2.302 . . . . 0.0 112.108 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -41.86 -11.71 0.01 OUTLIER Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.672 ' N ' ' O ' ' A' ' 116' ' ' PRO . 27.8 t -92.38 137.51 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 122.416 -0.461 . . . . 0.0 110.743 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -100.44 134.9 42.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.236 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.46 114.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.998 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -124.74 122.59 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.792 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 121' ' ' ILE . 49.5 m-20 -133.56 86.85 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.007 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' LEU . 11.6 mm100 -83.84 55.39 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.033 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.1 128.44 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.47 143.29 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.32 112.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.4 OUTLIER -136.5 134.6 19.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.401 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.69 33.06 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.6 t -136.18 -51.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.14 150.03 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.632 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -104.03 159.04 16.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.406 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.08 151.16 41.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.425 HD23 ' CD1' ' A' ' 183' ' ' TRP . 11.4 tp -80.99 133.12 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.656 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.68 133.42 56.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.457 ' O ' ' C ' ' A' ' 136' ' ' SER . 26.5 p90 -102.35 -22.87 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.584 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.2 m -34.17 -61.8 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.516 0.674 . . . . 0.0 110.988 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.18 20.76 9.8 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.747 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.4 -9.78 7.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.654 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -56.86 -43.85 99.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.803 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.2 Cg_exo -55.05 -36.49 92.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.39 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.404 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 43.4 t -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.39 -42.72 99.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.807 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -71.34 -36.04 71.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.664 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.06 -20.42 61.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.562 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -116.34 12.08 15.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -68.83 -43.28 27.16 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 12.2 Cg_exo -66.21 6.5 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.643 2.228 . . . . 0.0 111.901 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mm -111.91 99.99 47.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.722 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 86' ' ' ARG . 65.4 Cg_endo -79.83 -5.57 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.615 2.21 . . . . 0.0 112.187 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.52 40.49 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.517 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 4.0 t80 -127.65 137.87 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.631 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -142.94 160.46 27.5 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.49 138.55 24.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.756 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -106.15 128.65 54.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.2 t -112.81 138.55 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 158' ' ' ASP . 21.8 tt0 -150.39 102.83 3.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.46 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 15.7 mtt180 49.83 -91.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 156' ' ' GLU . 4.4 p30 -121.57 33.98 5.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.92 130.75 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.338 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.4 129.88 62.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.696 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.02 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.67 105.29 12.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 p -118.04 149.72 40.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.29 175.32 14.38 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 66.7 p -100.17 119.27 38.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.48 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -87.09 145.79 38.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 197' ' ' GLN . 51.4 Cg_endo -72.52 -60.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.759 2.306 . . . . 0.0 111.845 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 t -124.47 153.87 41.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.469 ' H ' ' HG ' ' A' ' 169' ' ' SER . 0.0 OUTLIER -66.73 -30.89 71.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.872 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.26 -43.46 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -58.45 -37.08 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.013 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -69.09 -39.03 79.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.001 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -59.28 -47.78 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.877 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.68 77.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.09 -39.12 65.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -64.32 -44.31 91.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -64.95 -44.44 89.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.586 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -31.92 72.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.83 71.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 -47.76 83.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.7 t -70.72 -27.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.556 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 183' ' ' TRP . 0.9 OUTLIER -66.38 -60.92 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.642 ' C ' ' H ' ' A' ' 185' ' ' ASP . 21.7 m95 -120.67 85.14 38.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.139 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.67 ' O ' ' N ' ' A' ' 186' ' ' MET . 17.6 Cg_exo -62.35 20.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.88 2.387 . . . . 0.0 111.73 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.642 ' H ' ' C ' ' A' ' 183' ' ' TRP . 0.8 OUTLIER -35.9 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.67 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.5 ttm 78.08 -8.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -120.05 80.98 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.19 136.71 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.1 t -126.97 121.72 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.761 HD21 ' H ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -87.73 125.99 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.57 40.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.466 . . . . 0.0 110.427 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.48 126.43 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -126.91 148.51 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.03 110.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.716 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -74.63 62.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.427 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . 47.43 32.68 7.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.576 ' O ' ' O ' ' A' ' 167' ' ' PRO . 18.4 mt-30 -113.58 156.67 23.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 205' ' ' SER . . . -179.94 65.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.519 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 21.1 Cg_exo -56.15 -42.7 63.6 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.643 2.229 . . . . 0.0 112.723 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 73.1 Cg_endo -81.8 -33.99 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.373 2.049 . . . . 0.0 112.105 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.57 81.31 0.35 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.522 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 21.3 Cg_exo -56.32 -42.66 63.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.644 2.229 . . . . 0.0 112.694 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 56.7 Cg_exo -47.23 -18.61 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.204 1.936 . . . . 0.0 112.008 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.73 -56.06 4.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.55 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.474 ' HG ' ' HB3' ' A' ' 198' ' ' ALA . 0.9 OUTLIER -162.82 -83.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.385 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 196' ' ' GLY . . . 83.13 151.75 11.05 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.98 -67.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.742 2.295 . . . . 0.0 112.067 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 31.1 t -110.29 35.74 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.368 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 210' ' ' ASP . . . -38.65 160.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.761 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.498 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 33.12 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.154 0.502 . . . . 0.0 110.15 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.572 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -56.76 -42.94 80.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.065 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 216' ' ' ASN . 12.7 pt20 -71.96 -49.74 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.191 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.401 ' H ' ' HG3' ' A' ' 212' ' ' GLN . 72.7 m -71.08 -48.69 51.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 210' ' ' ASP . . . -62.51 -44.84 95.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.426 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.572 ' CG2' ' O ' ' A' ' 211' ' ' LEU . 3.6 tp -69.36 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.6 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 220' ' ' GLY . 3.1 m120 -67.8 -39.77 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.422 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.33 70.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.273 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 214' ' ' ALA . 74.3 t -58.46 -47.03 89.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.189 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 221' ' ' GLY . 68.1 p -87.83 -21.5 25.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.584 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.32 -37.57 0.21 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -160.48 179.75 35.78 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.6 154.22 9.46 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.763 2.308 . . . . 0.0 112.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.462 HG23 ' H ' ' A' ' 225' ' ' PHE . 41.2 mt -103.41 113.38 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . -96.41 15.17 22.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.462 ' H ' HG23 ' A' ' 223' ' ' ILE . 0.9 OUTLIER 34.16 85.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.523 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.409 ' C ' ' OD1' ' A' ' 227' ' ' ASN . . . -108.67 134.51 12.28 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 226' ' ' GLY . 0.4 OUTLIER -165.93 55.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.548 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -121.96 68.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.38 71.74 0.46 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 61.64 152.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.781 0.325 . . . . 0.0 110.477 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.97 -178.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.6 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.51 -5.31 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 16.6 pt -126.35 61.07 40.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.91 41.3 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.831 2.354 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 47.96 -147.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.772 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 236' ' ' ASP . 0.5 OUTLIER 64.77 46.65 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.56 -17.86 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -66.21 -37.72 86.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.04 -43.42 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.64 -32.35 68.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.374 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -44.73 94.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -63.67 -41.29 98.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.87 -40.91 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.51 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.91 85.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.715 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -56.11 -50.81 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.67 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 0.4 OUTLIER -65.01 -35.54 81.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.531 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 9.0 tp -55.29 -30.2 59.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.368 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 8.5 ptmt -63.63 -36.13 82.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.406 ' N ' ' CG ' ' A' ' 248' ' ' LYS . . . -107.49 3.24 24.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.714 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 85.7 m -74.63 -28.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 41.1 Cg_exo -55.12 -14.37 8.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.539 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 251' ' ' PRO . 9.0 t70 -40.89 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -119.99 -153.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.082 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -106.83 138.06 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.94 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.1 131.72 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -124.13 124.28 42.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 77.9 mt -113.01 117.44 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 110.715 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.42 131.99 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.383 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -108.07 133.19 11.52 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 318' ' ' ASN . 11.8 m-85 -100.49 107.82 19.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.56 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -143.84 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.282 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 262' ' ' ASP . 36.2 t0 -145.92 -99.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.497 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 0.2 OUTLIER -177.96 44.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.606 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.0 m -45.97 -58.74 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.465 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -146.6 -92.62 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 95.0 p -125.01 179.87 4.85 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 120.976 0.417 . . . . 0.0 110.977 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 269' ' ' ILE . 2.6 mt-10 -59.18 -31.19 68.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.538 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.76 6.66 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 267' ' ' GLU . 0.4 OUTLIER -143.56 -36.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.625 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -68.59 -46.47 69.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.436 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 272' ' ' PRO . 0.4 OUTLIER -73.46 -48.33 7.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.163 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 28.0 Cg_exo -53.53 -39.51 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.993 1.795 . . . . 0.0 111.669 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.21 -44.7 75.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.22 77.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.48 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.551 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.85 -45.18 90.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.439 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -44.51 94.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.335 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -68.19 -45.74 72.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.367 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.27 -45.99 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.529 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.39 -46.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.368 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.28 88.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.39 -32.97 69.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.546 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.6 -48.19 27.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 46.8 mt -59.45 -44.69 92.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.313 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 65.3 t -59.34 -37.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.291 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.32 -20.7 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 288' ' ' ARG . 0.0 OUTLIER -87.94 0.15 56.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.27 18.13 20.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.1 132.79 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -75.98 104.45 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.63 16.74 7.58 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.0 OUTLIER -96.4 -12.2 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.703 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.652 ' N ' ' ND1' ' A' ' 294' ' ' HIS . 0.2 OUTLIER -119.45 23.38 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.633 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 4.9 mt -117.19 134.13 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.39 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.119 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.94 129.16 49.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.867 0.365 . . . . 0.0 110.992 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 12.1 t -133.26 116.69 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 301' ' ' GLY . . . -89.15 105.59 3.21 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 302' ' ' SER . 26.0 mt -56.64 77.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 299' ' ' GLY . . . -47.49 80.6 0.0 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.634 ' N ' ' O ' ' A' ' 300' ' ' LEU . 70.3 m 73.91 -52.89 0.69 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.292 0.567 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.541 ' C ' ' O ' ' A' ' 302' ' ' SER . 2.8 m -27.99 130.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 304' ' ' ASN . 0.1 OUTLIER 58.19 56.82 6.65 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 110.338 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 41.8 Cg_endo -71.69 176.78 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.905 2.403 . . . . 0.0 112.369 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 20.9 mt -132.52 -72.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.28 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.449 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 310' ' ' ALA . 5.3 p -68.02 171.05 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -76.18 24.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -44.29 -52.88 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.365 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.41 161.93 56.27 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -50.37 -41.06 52.57 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.255 1.97 . . . . 0.0 111.738 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.84 -42.26 98.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.04 -47.53 59.1 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.568 ' CZ ' ' NH2' ' A' ' 319' ' ' ARG . 58.2 ttt180 -60.16 -46.26 90.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.339 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.22 78.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.382 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -31.42 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.65 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -79.95 -25.13 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.549 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' A' ' 315' ' ' ARG . 1.5 mtt85 -80.38 82.21 6.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.317 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.3 ttm180 -129.03 141.97 51.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.33 161.12 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.033 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.24 127.9 16.18 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.086 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.47 110.33 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.37 135.65 60.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.76 135.62 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.225 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.525 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 2.0 t30 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.663 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.779 0.323 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.01 161.83 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.46 -4.18 59.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.86 121.42 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 5.1 mp -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 p -50.64 134.95 23.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -47.56 124.11 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.61 125.57 38.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.356 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -101.91 131.54 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.892 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -133.85 120.0 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 92' ' ' THR . 15.5 t -133.34 140.05 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -125.22 150.01 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.421 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 90' ' ' THR . 8.9 t -145.23 95.09 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 46.72 -130.45 12.1 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -69.65 4.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' SER . 30.9 m -115.98 126.05 53.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.535 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -117.48 117.57 55.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.518 ' O ' ' O ' ' A' ' 85' ' ' SER . 7.8 m -106.6 126.07 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.825 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 mt -129.88 121.19 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.486 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.86 141.49 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.07 -157.28 27.72 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -130.98 156.8 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 0.0 110.563 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -141.42 153.35 65.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.3 -29.73 80.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.925 2.417 . . . . 0.0 112.455 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.56 176.1 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.648 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -74.85 -16.03 60.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.524 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.42 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.202 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.41 77.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.129 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 122' ' ' ASP . 2.6 tttp -63.81 -36.45 83.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.375 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.31 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.72 79.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.14 -41.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.603 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.7 mmt -58.35 -39.44 79.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -38.6 89.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.39 -16.12 62.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.86 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -100.77 -13.95 18.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -52.17 -25.6 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -10.81 81.51 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tt -111.13 -17.25 13.27 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.261 -0.553 . . . . 0.0 110.646 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.74 95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . -151.73 140.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 118' ' ' VAL . 81.8 Cg_exo -41.17 173.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.6 2.2 . . . . 0.0 112.276 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.0 -14.64 0.18 Allowed Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.617 ' H ' ' C ' ' A' ' 116' ' ' PRO . 48.8 t -101.72 139.39 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 122.218 -0.578 . . . . 0.0 110.646 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -108.06 123.55 48.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.619 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.19 114.43 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.463 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.409 HD12 ' HG1' ' A' ' 92' ' ' THR . 0.8 OUTLIER -130.34 139.6 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 103' ' ' LYS . 7.7 p-10 -154.43 110.43 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -95.21 90.16 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.67 129.09 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.009 0.433 . . . . 0.0 111.132 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 148.94 22.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.566 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.02 117.95 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.228 0.537 . . . . 0.0 110.987 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -112.66 141.26 25.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.083 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 127' ' ' ASP . 91.1 Cg_exo -29.3 -62.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.06 2.507 . . . . 0.0 112.856 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 130' ' ' VAL . 6.1 p -164.09 47.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.267 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 129' ' ' VAL . 1.5 m -50.4 -169.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -108.86 158.81 17.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -148.97 155.86 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.458 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -79.04 136.16 37.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.04 129.24 39.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 136' ' ' SER . 0.0 OUTLIER -105.45 -8.32 18.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.579 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.8 t -21.51 -47.74 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.403 0.621 . . . . 0.0 111.002 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.4 t -133.42 65.64 1.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.284 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -123.56 -15.5 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.5 tt0 -48.11 -49.32 61.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.7 Cg_exo -57.97 -30.94 91.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.728 2.285 . . . . 0.0 112.105 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.504 ' O ' ' OG ' ' A' ' 145' ' ' SER . 18.3 t -67.07 -42.98 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -62.35 -41.7 98.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.245 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 21.3 p -60.88 -37.69 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.081 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.61 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.797 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 141' ' ' VAL . 0.7 OUTLIER -106.44 11.24 31.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.739 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 3.5 t -88.23 -32.24 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 60.3 Cg_endo -85.84 9.6 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.862 2.374 . . . . 0.0 112.357 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.458 HG22 HD13 ' A' ' 148' ' ' ILE . 8.8 mt -126.63 98.56 31.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 173.71 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.6 2.2 . . . . 0.0 112.058 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 52.88 54.19 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.69 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.651 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -127.08 145.8 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.36 149.03 16.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 154' ' ' LYS . 17.3 tp -139.02 126.48 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -126.08 126.7 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.852 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 154' ' ' LYS . 88.8 t -114.82 122.83 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.14 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 158' ' ' ASP . 4.8 tt0 -110.98 163.42 13.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -25.52 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.782 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 156' ' ' GLU . 1.4 p-10 -156.14 29.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.536 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 125.97 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.534 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.54 121.65 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -130.38 136.96 49.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.592 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.19 109.22 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 147.99 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.542 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.81 -169.28 36.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.2 m -107.37 137.44 45.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.464 ' O ' ' CG1' ' A' ' 194' ' ' VAL . . . -124.62 109.65 28.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.43 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.31 -16.11 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.435 2.09 . . . . 0.0 112.417 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.21 129.37 35.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.03 -41.71 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.647 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -35.75 76.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.582 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -63.06 -42.18 99.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -66.84 -39.4 87.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.98 -46.1 90.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.863 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.24 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.59 -37.59 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.804 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -62.38 -49.32 75.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.797 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.89 -39.42 94.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.17 96.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.09 68.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.4 m -58.16 -39.57 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.412 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.416 ' H ' ' HG ' ' A' ' 181' ' ' SER . 3.8 p -65.85 -27.05 67.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.335 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.86 -44.07 28.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.466 ' CD2' ' HB ' ' A' ' 182' ' ' THR . 2.3 m-90 -138.21 67.26 46.85 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.627 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.27 -10.75 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.814 2.343 . . . . 0.0 111.973 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.71 58.47 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.433 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -176.57 -170.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.533 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -107.21 110.75 22.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.41 131.41 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.02 121.4 49.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.57 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.46 ' C ' HD21 ' A' ' 191' ' ' ASN . 2.6 m-20 -89.56 110.17 21.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 191' ' ' ASN . 2.1 m120 -104.1 55.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.662 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.41 115.85 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.385 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.545 ' CD ' ' O ' ' A' ' 193' ' ' GLU . 2.9 pp20? -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.683 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 166' ' ' ALA . 3.0 m -93.53 134.99 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.313 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.4 -26.53 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -104.7 -5.93 41.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 5.0 tt0 -63.81 156.21 28.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.655 ' H ' ' CD ' ' A' ' 199' ' ' PRO . . . -151.58 -46.6 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.253 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.655 ' CD ' ' H ' ' A' ' 198' ' ' ALA . 6.4 Cg_endo -84.47 110.07 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.267 2.644 . . . . 0.0 111.735 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.28 106.36 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.608 2.205 . . . . 0.0 112.399 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 122.76 -82.66 0.35 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -38.47 148.34 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.104 2.536 . . . . 0.0 112.311 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 204' ' ' ALA . 61.3 Cg_endo -75.52 172.74 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.816 2.344 . . . . 0.0 112.12 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.577 ' O ' ' O ' ' A' ' 203' ' ' PRO . . . 50.47 163.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.6 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.5 m -162.63 -74.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 208' ' ' CYS . . . -152.39 57.93 0.42 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.06 33.78 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.794 2.329 . . . . 0.0 112.28 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.463 ' SG ' ' HD3' ' A' ' 251' ' ' PRO . 1.9 t 50.4 87.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -135.82 -147.89 0.28 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.256 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -70.01 50.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.151 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -31.52 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.402 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 0.0 OUTLIER -54.19 -31.62 53.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 72.8 m -65.94 -48.55 70.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.706 0.765 . . . . 0.0 110.996 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -75.26 -34.55 61.39 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.848 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 0.3 OUTLIER -58.37 -39.5 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 2.2 m-20 -53.63 -34.42 58.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.083 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.88 62.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.53 -43.38 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.643 ' C ' ' H ' ' A' ' 221' ' ' GLY . 6.3 p -93.67 -31.56 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.463 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.96 -35.33 0.1 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -174.56 -173.15 40.26 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.66 154.07 32.98 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.735 2.29 . . . . 0.0 111.895 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.1 tt -115.74 145.05 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.527 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . -157.18 112.72 2.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.601 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 224' ' ' ALA . 64.5 t80 28.0 -104.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.551 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.539 ' O ' ' OD1' ' A' ' 228' ' ' ASP . . . -107.25 -147.77 14.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 226' ' ' GLY . 14.2 t-20 37.02 89.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.812 0.339 . . . . 0.0 110.598 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 226' ' ' GLY . 1.6 m-20 -142.94 -109.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -170.98 -168.64 32.98 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 60.03 177.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 0.0 110.519 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.38 22.97 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 232' ' ' LEU . 2.6 mm? -75.83 163.18 27.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 pt -119.1 73.73 13.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.2 133.44 13.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.938 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -138.31 -100.33 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.56 59.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.783 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.2 t80 179.61 -36.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.48 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.47 -32.92 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.292 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -40.94 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.468 ' O ' ' NE ' ' A' ' 288' ' ' ARG . 12.5 mt -58.56 -47.28 84.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.344 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.515 ' OD1' ' C ' ' A' ' 241' ' ' ASN . 8.7 t-20 -63.52 -33.19 75.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.296 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.75 84.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.513 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.06 -42.55 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.59 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 109.897 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.58 -40.14 74.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.4 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 28.9 ttmt -69.6 -31.29 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -33.04 54.24 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.571 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.3 OUTLIER -62.0 -12.11 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.496 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -69.04 11.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.879 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.571 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -37.63 -48.8 2.68 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.23 -178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.463 ' HD3' ' SG ' ' A' ' 208' ' ' CYS . 31.3 Cg_exo -56.29 -18.64 24.97 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.904 1.736 . . . . 0.0 111.596 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 254' ' ' ARG . 14.0 m-20 -156.74 39.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.668 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -62.65 62.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.711 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 252' ' ' ASP . 1.6 mtm180 -111.52 134.91 52.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.05 139.5 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.926 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.9 m -122.54 127.05 49.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.1 123.19 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 111.254 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.41 120.1 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.15 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -100.55 139.57 14.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.36 100.41 6.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.425 ' CG2' ' OD1' ' A' ' 263' ' ' ASN . 1.3 m -141.48 128.25 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.547 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 263' ' ' ASN . 22.4 t70 -68.54 -116.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.528 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 10.9 m120 65.15 41.09 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.565 ' O ' ' OD1' ' A' ' 270' ' ' ASN . 10.5 m -31.92 -74.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 264' ' ' THR . . . 27.12 -92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.561 ' O ' ' ND2' ' A' ' 270' ' ' ASN . 48.1 t -142.83 137.74 29.85 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 122.967 -0.137 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' A' ' 269' ' ' ILE . 1.9 pm0 -58.44 -30.42 66.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.348 . . . . 0.0 110.434 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -61.08 6.8 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.612 ' H ' ' C ' ' A' ' 267' ' ' GLU . 0.5 OUTLIER -140.71 -42.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.675 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.648 ' ND2' ' N ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -68.35 -34.0 75.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.1 mm -72.67 -51.97 6.58 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.705 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.4 Cg_endo -62.0 -30.22 82.82 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.934 1.756 . . . . 0.0 112.115 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -48.76 74.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.179 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 12.0 p -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.54 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.91 64.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 272' ' ' PRO . 6.9 tt0 -61.12 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.517 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -33.12 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.59 -33.99 76.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -43.31 84.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.3 -37.2 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.3 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.48 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.312 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.48 80.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -41.73 84.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.335 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -70.69 -42.34 70.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 285' ' ' LEU . 1.7 mm? -59.76 -49.19 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.93 -34.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.5 67.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.298 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 240' ' ' LEU . 3.1 tpt85 -80.77 -1.24 42.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.0 0.429 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.63 3.51 43.31 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.3 128.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.467 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -79.99 107.85 13.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.745 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -55.96 -4.25 0.68 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -68.52 -10.6 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -134.97 52.64 2.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 17.6 tt -133.04 139.3 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.27 142.33 43.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.2 p -122.62 142.15 50.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.887 0.375 . . . . 0.0 110.955 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.39 116.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.282 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.3 107.45 3.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.574 ' O ' ' O ' ' A' ' 301' ' ' GLY . 10.2 mp -97.65 62.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.449 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -34.94 -102.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -112.49 99.86 8.3 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 122.99 -0.124 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 304' ' ' ASN . 54.4 t -119.59 -95.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.461 ' N ' ' CG1' ' A' ' 303' ' ' VAL . 0.4 OUTLIER -89.16 -52.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.649 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 68.4 Cg_endo -80.72 153.33 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.772 2.315 . . . . 0.0 112.309 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.8 tt -167.62 137.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.416 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.21 137.66 47.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 309' ' ' ASN . 13.3 t -74.18 79.95 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 309' ' ' ASN . 0.0 OUTLIER -32.23 116.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.394 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -174.87 -50.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.482 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 164.38 15.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.39 -43.01 46.29 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.868 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -45.86 92.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.13 97.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -60.8 -40.92 94.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.48 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.21 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -68.05 -37.47 81.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 318' ' ' ASN . 1.1 t30 -72.08 -6.55 43.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.28 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -160.0 89.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.318 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -134.43 149.09 50.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.012 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.3 t -123.83 145.25 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.837 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.94 129.8 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.43 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.69 109.87 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 135.86 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 2.4 p -107.93 135.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 20.3 t30 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.645 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.588 ' HG ' ' H ' ' A' ' 76' ' ' ALA . 12.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.846 0.355 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.588 ' H ' ' HG ' ' A' ' 75' ' ' SER . . . 53.81 106.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' C ' ' OG ' ' A' ' 78' ' ' SER . 3.7 mt -108.27 -29.53 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -168.93 121.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.68 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 79' ' ' LEU . 1.9 mm? -110.46 151.79 27.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.466 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.95 151.84 18.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.445 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' H ' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -66.07 129.49 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.49 130.77 42.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.68 121.17 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.95 118.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.606 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 t -130.52 132.45 45.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.456 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -112.86 143.71 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.787 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 p -140.57 120.68 13.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.315 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 48.68 -135.77 19.4 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.48 17.08 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.824 0.345 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -109.97 139.06 45.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.688 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -112.95 114.13 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.458 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 116.45 32.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -109.8 122.26 47.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.356 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.28 124.73 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.7 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.25 -135.83 4.48 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -154.36 156.91 37.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.749 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.92 153.99 80.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.497 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.2 -26.96 41.83 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.24 . . . . 0.0 112.011 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 4.3 p-10 -168.07 158.38 10.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.344 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.76 74.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.328 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.66 77.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -42.98 73.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.04 -40.61 73.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.29 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.54 -46.02 60.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.4 mtm -59.74 -33.14 71.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 2.9 m -62.01 -40.54 96.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.99 -29.51 66.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.79 -0.65 57.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.466 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.667 ' ND2' ' N ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -52.47 -22.66 5.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.667 ' N ' ' ND2' ' A' ' 111' ' ' ASN . . . -83.48 -10.07 82.44 Favored Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -97.4 -51.25 4.23 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.447 -0.443 . . . . 0.0 110.546 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -35.23 106.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.598 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -149.38 173.55 4.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.76 164.81 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.632 2.221 . . . . 0.0 112.288 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.38 13.41 2.69 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -102.36 138.66 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.209 -0.583 . . . . 0.0 110.754 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.4 137.95 45.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.273 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.98 122.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.96 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.44 128.04 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.918 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.13 81.78 1.94 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -92.12 48.43 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.253 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.408 ' C ' ' HD1' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -105.4 130.54 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.489 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.571 ' N ' ' HD1' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -93.37 146.54 23.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.783 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.8 111.58 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 129' ' ' VAL . 31.6 m-20 -125.44 103.9 28.62 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -52.36 69.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.494 2.13 . . . . 0.0 112.293 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.677 ' O ' ' NE ' ' A' ' 131' ' ' ARG . 3.4 p -179.27 -30.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.742 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.02 164.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.677 ' NE ' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -122.45 159.17 28.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 t -133.86 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.247 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.76 135.65 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.64 137.44 43.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -105.94 6.83 31.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.057 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t -45.72 132.71 8.54 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m 45.47 38.21 3.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 135' ' ' PHE . . . -101.6 -10.95 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -53.18 -47.32 96.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.367 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 32.0 Cg_exo -58.26 -36.55 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.782 2.321 . . . . 0.0 111.654 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.39 -44.4 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.49 -38.62 91.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.314 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 35.6 p -62.69 -37.24 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.44 -21.08 56.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.03 10.84 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -77.71 -43.58 2.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.493 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 28.1 Cg_exo -57.56 -9.6 5.58 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.512 2.142 . . . . 0.0 111.534 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.464 HD13 ' CE1' ' A' ' 171' ' ' HIS . 1.3 mm -108.57 93.46 11.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.321 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.8 7.99 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.628 2.219 . . . . 0.0 112.311 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.38 50.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.38 141.57 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.23 123.07 4.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.51 135.28 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 130.22 49.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.19 133.86 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.044 0.449 . . . . 0.0 111.266 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -140.79 78.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 159' ' ' THR . 7.4 ttp180 70.11 -137.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.989 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -75.97 25.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.47 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 157' ' ' ARG . 3.6 m -127.8 139.97 52.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.55 134.82 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.284 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.2 m -127.35 136.88 52.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.963 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.625 ' CD1' ' N ' ' A' ' 162' ' ' LEU . 2.2 mp -106.64 125.23 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.951 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -137.93 146.89 43.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.09 163.18 10.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.2 p -87.03 126.75 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.749 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.523 ' O ' ' OE1' ' A' ' 197' ' ' GLN . . . -99.84 146.86 32.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.675 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 43.6 Cg_endo -71.2 -23.76 24.08 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.784 2.323 . . . . 0.0 111.901 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.86 137.93 21.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -36.33 83.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.86 -35.3 79.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.464 ' CE1' HD13 ' A' ' 148' ' ' ILE . 1.7 m-70 -57.47 -43.7 84.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.894 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -36.17 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.683 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.87 -40.18 87.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.37 99.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.45 -37.04 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -61.83 -48.62 79.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -55.8 -48.27 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.488 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.39 87.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.29 -41.3 96.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.664 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.0 -38.88 90.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 m -71.04 -37.47 72.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.37 -22.11 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.823 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' ALA . 7.9 m0 -141.69 88.36 9.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.664 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 186' ' ' MET . 71.5 Cg_endo -82.96 15.73 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.073 2.515 . . . . 0.0 112.291 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.9 OUTLIER -31.58 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 184' ' ' PRO . 9.3 ttt 80.47 -23.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 185' ' ' ASP . 7.0 mttp -103.24 68.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.85 134.43 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.1 t -115.4 130.18 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 3.3 p-10 -97.02 119.12 34.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.96 50.49 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 pp -101.59 129.56 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -98.7 139.41 34.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.356 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 6.8 m -109.52 119.91 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 t -98.71 65.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.319 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.94 31.09 54.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.675 ' NE2' ' O ' ' A' ' 167' ' ' PRO . 1.0 OUTLIER -68.84 156.24 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.67 99.59 34.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.533 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 21.3 Cg_exo -56.0 -42.54 65.62 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.36 2.04 . . . . 0.0 112.446 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 74.1 Cg_endo -81.02 50.61 3.63 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.229 1.953 . . . . 0.0 111.859 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.05 98.27 0.18 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 21.0 Cg_exo -55.36 -42.8 64.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.374 2.049 . . . . 0.0 112.405 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 71.5 Cg_endo -83.03 -1.63 10.49 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.452 2.101 . . . . 0.0 112.2 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 70.53 179.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.698 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.2 t -99.73 -55.97 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.538 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 114.6 179.91 18.65 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 209' ' ' ALA . 75.5 Cg_endo -81.37 139.57 11.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 123.18 2.587 . . . . 0.0 112.703 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 52.8 t 39.38 13.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.978 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 207' ' ' PRO . . . -68.45 147.2 52.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.177 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 35.78 27.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 109.815 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 209' ' ' ALA . 56.9 tp -56.28 -31.7 63.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' A' ' 213' ' ' SER . 14.3 pt20 -54.65 -44.76 73.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.79 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.443 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 74.1 m -69.78 -40.44 76.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.172 0.51 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -68.83 -37.15 78.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.6 -36.53 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.709 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 220' ' ' GLY . 0.7 OUTLIER -57.3 -42.0 80.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.804 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.13 -41.45 63.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.698 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.96 -45.12 95.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.706 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 221' ' ' GLY . 75.0 p -94.52 -23.24 17.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 65.95 -2.46 3.8 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -171.15 -172.82 37.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.97 151.47 62.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.732 2.288 . . . . 0.0 112.048 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.4 mt -89.16 118.67 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -168.39 78.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.3 t80 61.92 121.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -134.23 -115.62 1.58 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.75 88.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -94.98 115.34 27.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -94.73 133.29 11.5 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 -67.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.5 m -133.59 -86.1 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.572 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.38 54.22 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 233' ' ' ILE . 18.3 tt -177.09 75.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.615 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.03 93.51 1.1 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.971 2.447 . . . . 0.0 112.158 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -141.07 97.05 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.547 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.51 91.91 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -113.73 9.25 17.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.249 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -58.86 -34.66 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.899 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.77 -46.37 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.05 -34.37 73.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.626 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 -45.32 80.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -61.06 -43.74 98.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.333 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 51.0 t -68.18 -39.38 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.453 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -64.81 -46.6 81.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -60.53 -50.77 72.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -60.47 -31.66 70.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.441 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 0.9 OUTLIER -62.67 -32.92 74.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.252 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.65 -18.59 64.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.92 -2.05 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 0.0 110.73 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.687 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.4 m -74.97 -28.72 0.82 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 43.6 Cg_exo -53.6 -16.04 7.34 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.148 1.899 . . . . 0.0 112.405 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -62.4 -9.43 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -136.07 -157.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.878 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -108.79 138.2 45.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.08 133.31 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.007 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.843 HG22 ' ND2' ' A' ' 258' ' ' ASN . 95.2 m -120.75 116.13 24.64 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.0 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.96 112.54 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.768 0.318 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.843 ' ND2' HG22 ' A' ' 256' ' ' THR . 2.3 m-80 -112.6 122.65 48.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -122.85 133.98 9.36 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.64 ' HH ' ' HE ' ' A' ' 320' ' ' ARG . 29.6 p90 -130.52 154.67 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.799 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 262' ' ' ASP . 30.8 p -117.42 -118.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.603 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.63 ' CG ' ' H ' ' A' ' 263' ' ' ASN . 14.6 p-10 -134.58 -99.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.264 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.63 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 1.7 p30 -174.82 -123.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 266' ' ' SER . . . 78.85 128.74 0.56 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.576 ' HB3' ' O ' ' A' ' 265' ' ' GLY . 14.1 t 82.61 -77.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.623 0.725 . . . . 0.0 110.99 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.54 -28.95 67.55 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.238 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -99.23 -35.93 4.58 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 269' ' ' ILE . 3.1 tt 34.87 23.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.346 0.593 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 268' ' ' GLY . 11.6 t-20 -69.85 -36.54 75.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.259 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.562 ' CD1' ' C ' ' A' ' 271' ' ' ILE . 0.1 OUTLIER -55.85 -49.96 89.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 21.8 Cg_endo -62.69 -39.93 40.26 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.594 1.529 . . . . 0.0 111.883 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.62 -34.08 77.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -40.0 94.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.763 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.62 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -65.9 -34.62 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.554 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -60.26 -45.67 92.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.67 76.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.46 -44.46 87.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 280' ' ' ILE . 1.6 mp -69.98 -36.96 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.298 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.87 -41.93 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.66 95.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.95 -41.6 87.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.04 -44.28 85.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.729 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.72 -41.37 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.279 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.06 -36.31 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.167 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.24 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.772 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.6 -1.85 58.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 18.15 11.79 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.552 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 74.6 t -87.2 124.06 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 110.433 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.596 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -70.12 98.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.68 16.5 0.4 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.596 ' H ' ' C ' ' A' ' 291' ' ' ALA . 25.3 t0 -93.21 -13.36 28.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.775 0.321 . . . . 0.0 110.518 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -132.48 24.72 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.815 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 295' ' ' ILE . 16.1 tt -116.36 125.34 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.468 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.86 48.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.552 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p -124.05 138.48 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.387 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.11 122.13 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.528 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -98.12 107.73 3.5 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.0 OUTLIER -38.96 -61.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.723 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 96.15 106.57 2.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.0 p 40.24 90.01 0.01 OUTLIER 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.971 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' ASP . 0.7 OUTLIER -107.24 160.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 303' ' ' VAL . 0.6 OUTLIER -40.33 152.76 0.22 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.402 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.2 114.64 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.746 2.297 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 16.2 mt -103.03 -42.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.73 168.88 11.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.506 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 310' ' ' ALA . 0.5 OUTLIER -82.45 90.41 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.483 ' CG ' ' O ' ' A' ' 309' ' ' ASN . 3.7 t30 -65.73 -1.06 2.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -57.68 -11.1 1.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.515 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.99 158.44 69.71 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.62 -36.59 81.52 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.85 2.366 . . . . 0.0 111.918 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -64.62 -31.45 72.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.406 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.99 99.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.683 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 6.7 ttm180 -60.8 -37.77 83.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.403 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.09 -36.23 82.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.55 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -36.88 64.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.784 HD21 ' N ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -74.99 -25.12 58.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.785 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.784 ' N ' HD21 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -95.57 84.41 3.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.611 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.64 ' HE ' ' HH ' ' A' ' 260' ' ' TYR . 12.6 mtm180 -122.87 154.52 38.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.1 t -129.36 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.091 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -128.44 127.17 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -102.69 111.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.148 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.1 121.03 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.63 135.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.504 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.47 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.74 0.305 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.36 135.54 35.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.31 -88.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.579 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -130.34 126.04 36.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 mt -103.76 139.65 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.751 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -81.13 153.3 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.516 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.65 121.26 7.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.35 118.49 26.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.5 t -101.85 117.2 34.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.32 116.25 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -134.05 128.31 34.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.454 HH22 HD23 ' A' ' 113' ' ' LEU . 11.2 mtp85 -110.69 130.78 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.585 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 p -130.01 115.94 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 42.3 -131.32 4.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.478 ' O ' ' CG2' ' A' ' 118' ' ' VAL . 22.2 m-20 -86.4 21.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.678 0.275 . . . . 0.0 110.606 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 75.6 m -122.07 125.73 46.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.59 132.9 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.5 m -119.31 116.56 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.382 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.93 123.35 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mt -142.08 124.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.291 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.57 -143.78 8.47 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 96' ' ' ASP . 26.1 p30 -154.34 153.06 31.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -137.26 150.43 68.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.83 -20.49 22.46 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.738 2.292 . . . . 0.0 112.242 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -165.87 145.75 6.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' C ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -53.75 -10.63 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 99' ' ' ASP . . . -60.86 -40.16 91.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.5 77.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -68.37 -37.05 80.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.86 81.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.54 77.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 tt -72.19 -43.02 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -39.87 80.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -61.2 -28.36 69.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.32 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.741 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.5 mt -86.63 -17.42 33.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -45.88 -35.43 4.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.632 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.73 -17.19 66.36 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 114' ' ' LEU . 5.6 tp -95.77 -33.51 12.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.67 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 113' ' ' LEU . 1.7 tt -33.71 104.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.575 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -131.72 135.45 26.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -43.6 162.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.213 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.8 13.88 41.74 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.591 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 8.7 p -102.54 130.14 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 121.903 -0.763 . . . . 0.0 110.761 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.81 126.08 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.56 127.31 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.91 134.05 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.164 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -120.74 91.62 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.996 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -94.05 50.31 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.966 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.33 130.22 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.587 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -93.38 146.1 23.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.299 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 p -100.02 120.06 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.45 129.87 16.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.368 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.48 41.91 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.377 2.051 . . . . 0.0 112.17 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.6 t -147.45 -35.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -67.21 164.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -115.56 158.61 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.246 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -126.12 155.94 40.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.472 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 37.1 tp -78.73 130.62 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.197 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.7 OUTLIER -64.18 134.53 55.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.857 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.558 ' O ' ' C ' ' A' ' 136' ' ' SER . 83.0 m-85 -120.54 6.55 10.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.22 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.558 ' C ' ' O ' ' A' ' 135' ' ' PHE . 90.0 p -24.08 -65.86 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.462 0.649 . . . . 0.0 110.985 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.41 47.69 1.97 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.845 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.58 -7.85 39.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.506 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.4 tt0 -48.49 -49.01 66.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.0 Cg_exo -55.36 -42.24 70.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.848 2.365 . . . . 0.0 112.14 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.74 -45.98 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.89 -41.63 95.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.55 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.8 p -65.73 -40.07 91.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.54 -18.66 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.444 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -105.55 2.58 28.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.651 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -64.54 -41.08 55.69 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 46.0 Cg_exo -53.25 -7.88 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.632 2.221 . . . . 0.0 111.719 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 146' ' ' VAL . 29.1 mt -122.77 101.53 39.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.415 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.66 19.26 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.187 1.925 . . . . 0.0 111.926 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 148' ' ' ILE . 22.4 m-20 -145.9 80.56 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.54 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.64 139.63 53.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.231 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.32 123.2 5.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.19 127.08 52.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 110.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.4 126.43 44.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.4 t -119.82 128.48 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -140.71 84.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.283 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 159' ' ' THR . 2.8 mtt180 60.77 -141.4 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.444 ' C ' ' OD2' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -68.81 27.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.413 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.626 ' H ' ' C ' ' A' ' 157' ' ' ARG . 1.8 m -139.15 129.72 25.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -131.94 135.12 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.21 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.402 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 66.0 m -131.53 130.99 43.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.946 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.76 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -113.25 123.86 51.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.379 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 149.4 49.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 148.97 158.58 8.12 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.71 136.7 37.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.08 140.61 27.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.517 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.02 -30.57 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.506 2.137 . . . . 0.0 111.947 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 t -122.39 128.0 50.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.03 72.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.642 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 171' ' ' HIS . 3.9 pt-20 -59.36 -35.86 74.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.726 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.43 ' N ' ' HG2' ' A' ' 170' ' ' GLU . 5.4 m-70 -63.19 -37.95 89.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -64.15 -38.56 91.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.89 -47.07 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.28 -41.37 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -58.05 -51.31 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -45.54 94.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.23 -33.23 75.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.991 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.2 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.179 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 m -67.44 -36.36 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.226 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.1 t -71.02 -43.01 68.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 3.1 m -72.88 -44.4 61.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.568 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.509 ' C ' ' H ' ' A' ' 185' ' ' ASP . 6.0 m0 -126.12 77.05 71.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 186' ' ' MET . 15.4 Cg_exo -65.34 12.3 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.016 2.478 . . . . 0.0 112.424 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 186' ' ' MET . 21.1 t0 -31.3 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.829 0.347 . . . . 0.0 110.551 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 4.6 tpt 86.99 -28.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -93.1 63.75 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.9 121.26 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.785 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.58 125.28 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.173 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.433 ' OD1' ' C ' ' A' ' 190' ' ' ASN . 47.2 t-20 -91.93 124.13 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.82 44.56 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.193 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.04 133.19 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.641 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -102.72 149.15 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.435 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 19.8 m -108.79 108.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.475 ' HG1' ' N ' ' A' ' 196' ' ' GLY . 71.3 p -109.01 -37.67 5.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.787 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.475 ' N ' ' HG1' ' A' ' 195' ' ' THR . . . -121.62 -1.96 10.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.81 146.09 18.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.383 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -144.22 167.23 15.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.65 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 201' ' ' GLY . 74.9 Cg_exo -42.54 163.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.917 2.411 . . . . 0.0 112.002 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -43.23 88.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.697 2.265 . . . . 0.0 112.059 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -150.15 109.2 0.42 Allowed Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.6 ' C ' ' H ' ' A' ' 204' ' ' ALA . 17.6 Cg_exo -52.05 -42.39 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.082 1.854 . . . . 0.0 112.466 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 24.2 Cg_exo -60.42 9.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.027 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 202' ' ' PRO . . . -103.35 50.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.802 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 32.8 p -118.58 21.66 12.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 208' ' ' CYS . . . 56.67 54.91 32.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 206' ' ' GLY . 50.3 Cg_exo -46.72 -6.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.556 2.171 . . . . 0.0 111.864 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.593 ' H ' ' C ' ' A' ' 206' ' ' GLY . 1.2 m 45.76 44.41 10.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -78.42 -164.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.872 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -91.43 56.32 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.725 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.57 ' CB ' ' O ' ' A' ' 245' ' ' ASP . 4.0 mm? -58.19 -30.33 66.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.622 ' CD ' ' N ' ' A' ' 213' ' ' SER . 2.9 pp0? -53.2 -34.81 58.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.611 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.622 ' N ' ' CD ' ' A' ' 212' ' ' GLN . 89.9 p -65.61 -35.5 80.99 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.928 0.871 . . . . 0.0 110.974 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.13 -32.51 63.2 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.371 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.16 -35.94 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.414 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.1 t30 -53.89 -44.08 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.669 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.46 -28.83 61.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.59 ' CG1' HH11 ' A' ' 242' ' ' ARG . 65.8 t -58.04 -49.64 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.386 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.605 ' C ' ' H ' ' A' ' 221' ' ' GLY . 12.8 p -103.58 -11.4 17.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.13 -35.75 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -173.66 178.7 45.46 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 153.63 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.728 2.286 . . . . 0.0 112.009 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.1 mt -140.43 -141.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 226' ' ' GLY . . . 177.31 104.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.518 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 18.4 t80 -56.96 74.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.519 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 224' ' ' ALA . . . -170.75 -60.28 0.04 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.69 -68.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 110.678 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -168.37 -142.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 230' ' ' ALA . . . 88.36 -177.58 45.7 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 229' ' ' GLY . . . 39.4 78.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.9 t -112.39 -54.33 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.4 tp -100.64 28.44 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.25 63.3 48.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.583 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.46 92.39 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.789 2.326 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 171.0 125.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 109.96 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 238' ' ' GLU . 0.4 OUTLIER -173.76 -29.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.816 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.709 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 3.8 pt-20 -61.14 -38.71 87.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -42.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.941 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 0.9 OUTLIER -65.27 -47.54 76.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.667 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -31.71 71.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.319 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.59 HH11 ' CG1' ' A' ' 218' ' ' VAL . 2.4 ttp-105 -60.92 -45.69 93.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.433 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 240' ' ' LEU . 10.8 m -63.73 -36.26 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.29 81.44 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.995 0.426 . . . . 0.0 109.859 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 211' ' ' LEU . 33.8 m-20 -56.07 -48.85 75.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 3.1 pttt -62.38 -30.47 71.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.806 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.64 ' CD1' ' O ' ' A' ' 288' ' ' ARG . 5.3 tt -53.13 -32.91 49.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.607 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -61.13 -11.35 8.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -68.07 10.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.638 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.607 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -38.52 -48.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.928 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.0 Cg_exo -54.23 -13.73 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.98 1.786 . . . . 0.0 111.353 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' ARG . 23.0 t0 -160.42 30.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.604 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -55.89 67.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.675 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' ASP . 2.6 ttt180 -116.17 135.01 54.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.94 135.86 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.923 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -122.45 120.0 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.045 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.89 127.51 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.95 122.16 41.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.276 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.69 145.44 16.88 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.534 ' C ' ' HG1' ' A' ' 261' ' ' THR . 40.3 m-85 -134.24 149.48 50.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.645 0.259 . . . . 0.0 110.328 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.591 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -162.61 -173.06 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.558 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.543 ' OD1' ' OD1' ' A' ' 270' ' ' ASN . 2.4 p30 -92.28 -164.36 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.64 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.624 ' C ' ' H ' ' A' ' 265' ' ' GLY . 0.9 OUTLIER -125.14 -116.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.486 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.595 ' HG1' ' C ' ' A' ' 263' ' ' ASN . 0.2 OUTLIER 68.52 -29.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.528 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 267' ' ' GLU . . . 56.84 150.56 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.2 t 58.49 -71.28 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.588 0.709 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 265' ' ' GLY . 2.1 tt0 -55.99 -37.25 68.85 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.102 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -93.73 -47.38 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 269' ' ' ILE . 3.0 tt 34.67 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.337 0.589 . . . . 0.0 110.561 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 268' ' ' GLY . 0.8 OUTLIER -69.57 -30.92 68.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.918 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.5 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.4 mm -54.79 -52.22 72.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.3 Cg_endo -61.26 -35.83 82.81 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.853 1.702 . . . . 0.0 111.876 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.5 -46.55 69.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 23.6 p -65.65 -39.76 91.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.575 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.96 95.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.441 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.98 -36.48 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -63.24 -35.17 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.448 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.25 69.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.034 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -73.97 -47.97 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.61 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 281' ' ' VAL . 1.7 tp -60.39 -44.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.137 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.529 ' N ' ' CG2' ' A' ' 280' ' ' ILE . 27.6 m -61.28 -40.85 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.428 ' N ' HG21 ' A' ' 281' ' ' VAL . . . -59.3 -39.0 81.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.01 -47.04 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.717 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -57.01 -39.92 75.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.464 ' O ' ' CG2' ' A' ' 290' ' ' VAL . 1.0 OUTLIER -60.84 -42.53 97.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.58 -36.25 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.64 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.003 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.64 ' O ' ' CD1' ' A' ' 247' ' ' LEU . 2.2 tpm_? -82.53 -2.79 54.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.798 0.333 . . . . 0.0 110.304 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.97 10.63 29.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 285' ' ' LEU . 35.0 t -79.24 128.67 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.78 96.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.637 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -48.78 -8.28 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 291' ' ' ALA . 72.8 m-20 -75.93 -6.42 50.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.556 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -124.92 26.17 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.6 131.99 67.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.739 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.63 52.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 127.21 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 110.864 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.8 140.83 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.326 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.2 117.88 3.11 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 59.84 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.524 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 303' ' ' VAL . . . -77.99 -96.12 0.23 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 301' ' ' GLY . 90.1 p -36.87 -29.47 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.214 0.53 . . . . 0.0 110.955 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 301' ' ' GLY . 66.1 t -61.53 -47.41 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 301' ' ' GLY . 0.4 OUTLIER -139.73 86.42 13.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.645 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.79 163.48 9.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.952 2.435 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 74.3 mt -136.68 -22.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.321 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 308' ' ' SER . . . -119.9 151.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.437 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 307' ' ' ALA . 0.6 OUTLIER -50.29 -165.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.634 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.85 50.56 0.54 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.618 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.19 -2.86 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.523 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 p -146.62 148.63 34.28 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.374 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.45 -31.11 76.61 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.681 2.254 . . . . 0.0 111.918 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.03 -33.86 76.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.129 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.36 -44.98 97.35 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -65.27 -43.97 89.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.17 94.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.82 -32.61 74.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.235 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 261' ' ' THR . 0.7 OUTLIER -76.48 -25.43 54.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.426 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 319' ' ' ARG . 2.8 ttm180 -70.36 78.23 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.282 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -122.4 150.19 42.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.07 149.16 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.68 131.97 53.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.077 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.98 110.3 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.28 120.21 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.54 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.638 ' C ' ' H ' ' A' ' 77' ' ' LEU . 1.1 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.788 0.327 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.55 -9.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.516 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' H ' ' C ' ' A' ' 75' ' ' SER . 19.6 tp -178.53 -57.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.641 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 p 178.38 111.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.1 mp -84.77 147.61 26.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -79.62 159.86 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 119.35 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.714 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.11 131.3 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.34 120.73 30.64 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.047 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 HG21 ' H ' ' A' ' 153' ' ' LEU . 2.1 tt -123.15 122.64 65.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.062 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.59 127.51 35.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 149' ' ' PRO . 55.9 mtt180 -114.21 141.26 47.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.218 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 126.39 16.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.66 -125.41 29.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.09 19.44 15.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.756 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.4 m -125.3 135.1 52.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.1 t -115.14 122.22 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 120.89 43.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.33 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.272 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.19 129.04 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.777 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.69 -152.1 21.18 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -154.39 154.37 33.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.417 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -125.96 158.95 64.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.845 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.16 -24.71 27.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.322 . . . . 0.0 112.025 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -157.91 -173.59 4.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -88.71 -19.61 25.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.515 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.78 75.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.538 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.04 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -61.89 -37.67 85.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.622 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.07 67.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.64 91.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt -62.5 -43.85 97.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.84 -42.89 85.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -62.76 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 mt -103.0 -12.79 17.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.734 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -51.91 -42.47 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.617 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.99 -13.71 57.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -98.01 -26.46 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.603 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -161.65 163.79 19.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.488 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 118' ' ' VAL . 58.2 Cg_endo -76.15 166.64 27.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.842 2.361 . . . . 0.0 112.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.96 1.71 3.14 Favored Glycine 0 N--CA 1.461 0.325 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 116' ' ' PRO . 54.9 t -99.81 135.11 36.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 O-C-N 122.278 -0.543 . . . . 0.0 110.818 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.86 128.63 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.288 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.34 134.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.022 0.439 . . . . 0.0 111.282 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.452 HG21 HD11 ' A' ' 121' ' ' ILE . 2.2 mm -123.79 125.31 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.755 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.501 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 13.3 p-10 -136.15 83.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.505 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.447 ' CA ' HE21 ' A' ' 123' ' ' GLN . 0.6 OUTLIER -97.42 72.22 2.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.56 ' CG2' ' CE2' ' A' ' 97' ' ' PHE . 12.3 mt -105.53 130.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.93 146.2 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 126' ' ' VAL . 7.7 p -100.3 116.07 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.6 m-20 -133.6 103.14 12.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.541 ' O ' ' CG2' ' A' ' 129' ' ' VAL . 17.3 Cg_exo -61.57 56.73 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.468 2.112 . . . . 0.0 112.405 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 128' ' ' PRO . 56.0 t -162.68 -39.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.814 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.35 -178.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -123.87 159.58 29.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.315 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.419 ' HG ' ' HB3' ' A' ' 97' ' ' PHE . 1.7 m -134.65 155.5 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.1 tp -80.08 113.17 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.276 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.6 136.35 57.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.56 ' O ' ' C ' ' A' ' 136' ' ' SER . 7.7 m-85 -92.0 2.05 56.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.38 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 135' ' ' PHE . 94.4 p -24.51 -80.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.656 0.741 . . . . 0.0 110.988 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.7 20.55 16.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.761 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.47 -11.09 24.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER -55.6 -45.85 99.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.696 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 31.8 Cg_exo -54.69 -38.95 91.19 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.007 2.471 . . . . 0.0 112.508 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.423 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 40.6 t -59.79 -47.61 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -63.26 -39.35 94.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 11.4 p -62.81 -34.68 77.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.79 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.62 66.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -104.46 11.26 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.707 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -73.71 -34.67 2.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 37.4 Cg_exo -54.17 -28.75 53.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.615 2.21 . . . . 0.0 112.263 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 148' ' ' ILE . 1.4 tp -118.68 109.33 40.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.47 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 86' ' ' ARG . 57.3 Cg_endo -76.7 17.34 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.09 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.43 ' H ' HG13 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -114.14 53.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.544 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.59 144.86 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -125.9 134.8 8.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.487 ' H ' HG21 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -127.95 127.99 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 110.83 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.16 131.41 56.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.63 131.32 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.75 77.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 67.2 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.14 -18.17 8.76 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.36 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -104.23 131.39 51.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.913 0.387 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.15 135.48 63.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.2 m -109.19 129.82 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.85 117.98 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 m -130.21 153.2 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.55 155.07 6.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.5 p -81.25 141.91 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -109.73 138.4 20.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.492 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 197' ' ' GLN . 44.3 Cg_endo -71.42 -39.53 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.482 2.121 . . . . 0.0 111.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.03 130.59 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.448 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 172' ' ' LYS . 47.1 m -54.85 -33.12 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.77 -35.52 77.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -58.5 -48.04 82.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.961 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 169' ' ' SER . 21.2 pttt -67.24 -35.2 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.857 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.49 -43.25 83.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.486 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -70.41 -35.89 73.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.3 t -66.73 -43.65 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -62.32 -47.93 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -60.17 -51.43 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.643 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.64 72.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.37 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 185' ' ' ASP . 4.5 m -64.57 -48.86 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.3 m -72.22 -26.62 62.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.423 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 2.4 m -70.33 -72.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.086 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.594 ' O ' ' N ' ' A' ' 185' ' ' ASP . 28.0 m95 -131.36 -67.65 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.618 ' C ' ' H ' ' A' ' 186' ' ' MET . 11.4 Cg_endo -56.54 32.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.858 2.372 . . . . 0.0 113.361 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 183' ' ' TRP . 2.3 t0 -63.39 9.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.427 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.618 ' H ' ' C ' ' A' ' 184' ' ' PRO . 6.5 mtt -116.95 -89.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.903 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -108.92 115.89 30.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.622 ' CD1' ' N ' ' A' ' 188' ' ' ILE . 0.0 OUTLIER -125.68 147.55 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.724 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.27 124.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -98.9 128.39 45.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -144.2 42.66 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.3 mt -114.55 133.3 61.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.687 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.66 141.83 50.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.403 ' C ' ' H ' ' A' ' 196' ' ' GLY . 27.1 m -96.6 117.84 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.604 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -77.58 42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.574 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 194' ' ' VAL . . . 71.92 26.05 73.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 167' ' ' PRO . 4.8 mt-30 -86.77 128.24 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.524 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 41.56 73.66 0.86 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 20.9 Cg_exo -55.99 -42.58 65.3 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.697 2.265 . . . . 0.0 112.541 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 65.6 Cg_exo -47.59 -69.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.259 1.973 . . . . 0.0 112.013 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 137.26 -73.0 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 204' ' ' ALA . 54.0 Cg_exo -41.96 -52.75 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.874 2.383 . . . . 0.0 112.899 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.599 ' C ' ' H ' ' A' ' 205' ' ' SER . 8.9 Cg_exo -34.23 -25.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.485 2.123 . . . . 0.0 112.154 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 202' ' ' PRO . . . 67.56 -15.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 203' ' ' PRO . 16.0 t -177.03 137.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -130.41 74.81 0.43 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.608 ' C ' ' H ' ' A' ' 209' ' ' ALA . 72.4 Cg_endo -85.03 -162.11 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 123.11 2.54 . . . . 0.0 111.85 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.586 ' O ' ' O ' ' A' ' 209' ' ' ALA . 43.3 t -67.59 15.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.034 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.608 ' H ' ' C ' ' A' ' 207' ' ' PRO . . . -25.62 146.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 24.0 m-20 44.04 64.09 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -43.33 77.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.25 -51.34 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.331 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.1 m -71.0 -45.15 64.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -61.51 -44.28 97.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.23 -0.294 . . . . 0.0 111.573 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 2.5 tp -69.55 -39.25 78.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -70.11 -42.92 72.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.711 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.3 -49.53 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 t -59.22 -46.09 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.6 p -84.93 -29.29 25.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.748 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 74.72 -48.0 1.89 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -151.55 151.55 23.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 223' ' ' ILE . 40.3 Cg_endo -70.38 140.23 39.87 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.749 2.299 . . . . 0.0 112.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.442 ' CB ' ' O ' ' A' ' 222' ' ' PRO . 1.0 OUTLIER 163.93 -47.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . 55.07 -120.19 1.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 224' ' ' ALA . 0.6 OUTLIER -36.48 132.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.667 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 102.63 178.0 27.07 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 227' ' ' ASN . 4.6 p-10 -105.22 154.1 20.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.777 0.322 . . . . 0.0 110.554 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -32.77 69.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 146.67 -62.56 0.45 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 231' ' ' SER . . . -93.82 -154.17 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.712 0.291 . . . . 0.0 110.518 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 230' ' ' ALA . 9.2 p 51.51 116.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.626 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.16 94.2 9.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 233' ' ' ILE . 0.8 OUTLIER -119.61 116.6 33.23 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.547 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.93 113.47 3.64 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.331 2.021 . . . . 0.0 112.085 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 71.51 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.551 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.96 81.15 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 237' ' ' TYR . 25.1 t80 -129.25 -13.39 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -46.19 75.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 49.7 mt -67.71 -38.69 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -36.74 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.439 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.04 96.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.334 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -61.32 -45.35 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.33 -38.97 81.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.483 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.94 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -51.06 70.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.529 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.681 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 8.0 mttt -66.1 -32.83 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.456 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 3.3 tp -54.56 -30.85 55.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.488 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 0.8 OUTLIER -63.81 -36.98 85.68 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.576 ' O ' ' OD1' ' A' ' 252' ' ' ASP . . . -101.57 5.27 41.65 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.972 0.415 . . . . 0.0 111.351 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.716 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.9 m -74.84 -27.51 0.73 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 52.1 Cg_exo -54.21 -15.66 8.4 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.372 2.048 . . . . 0.0 112.891 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -42.1 -18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 326' ' ' ASN . . . -125.65 -154.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.624 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 1.2 mtm180 -110.27 136.0 50.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.15 132.81 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.955 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.3 m -122.74 122.29 38.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.04 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.1 mt -102.23 116.71 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -101.77 130.21 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.363 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.59 127.74 7.02 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 318' ' ' ASN . 43.1 m-85 -106.57 136.58 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.405 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -128.47 -161.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.656 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 262' ' ' ASP . 2.5 p30 -132.83 125.47 30.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.2 p30 -42.92 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 1.9 m 51.06 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -73.05 -132.78 0.18 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 59.6 m -117.13 168.84 9.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.95 -31.31 72.48 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.95 5.5 84.48 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mt -122.41 -45.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 271' ' ' ILE . 23.7 p-10 -68.18 -46.25 71.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.136 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.559 ' N ' ' OD1' ' A' ' 270' ' ' ASN . 1.9 mm -57.59 -51.62 80.37 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.917 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 9.4 Cg_endo -57.36 -31.96 92.53 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.906 1.737 . . . . 0.0 112.083 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.58 -40.32 80.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.433 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.462 ' CB ' ' HG1' ' A' ' 261' ' ' THR . 7.9 p -69.82 -37.78 76.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.73 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.85 -40.42 92.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 277' ' ' ARG . 6.4 mtt-85 -60.0 -44.28 94.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.72 -32.6 73.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.416 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -70.92 -46.27 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.29 -46.28 95.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.46 -38.75 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.391 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.06 79.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.441 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.38 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -72.43 -34.91 68.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.05 -48.27 82.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 12.0 t -63.44 -36.17 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.298 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.37 -20.17 65.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -2.14 58.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.629 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 19.94 9.69 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.465 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 64.9 t -87.74 129.65 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.405 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -74.53 101.04 4.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.943 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.02 9.53 0.97 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.7 OUTLIER -83.27 -12.32 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 110.651 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -134.67 11.66 3.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.981 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 14.1 tt -88.33 133.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -138.66 135.52 34.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 128.26 48.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.1 116.71 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.58 114.72 4.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.35 54.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -54.49 -92.65 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.47 ' C ' ' CG2' ' A' ' 303' ' ' VAL . 89.8 p -79.8 69.08 6.06 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 122.939 -0.154 . . . . 0.0 110.955 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 304' ' ' ASN . 0.2 OUTLIER -154.93 163.97 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.531 ' O ' ' O ' ' A' ' 303' ' ' VAL . 2.4 m-80 33.29 96.2 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.424 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.52 162.98 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.625 2.217 . . . . 0.0 112.298 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.46 HD13 ' CD1' ' A' ' 260' ' ' TYR . 24.1 mt -153.5 -79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.308 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -125.1 155.58 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.518 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.07 141.12 58.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.598 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 4.7 p-10 -98.77 41.14 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.55 -36.21 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.683 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . 0.485 ' H ' ' HG1' ' A' ' 311' ' ' THR . 0.6 OUTLIER -100.79 153.75 37.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.718 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -36.1 98.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.803 2.336 . . . . 0.0 112.02 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -66.29 -32.15 73.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.15 87.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -62.59 -45.74 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.5 80.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.97 -30.32 68.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.4 t-20 -74.95 -23.03 58.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -87.45 87.91 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.562 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.33 145.55 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.638 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.67 148.54 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.325 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.15 130.65 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.18 113.33 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.536 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.74 135.54 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.8 135.56 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 253' ' ' ALA . 7.6 t-20 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.94 20.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.563 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.6 tp -90.69 -57.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -156.12 111.82 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.0 mt -115.28 155.1 27.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -84.98 140.97 30.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.561 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -53.41 125.85 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.31 122.89 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.021 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -102.69 122.55 44.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.07 123.23 60.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -135.03 124.81 25.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' ' CE2' ' A' ' 151' ' ' PHE . 20.1 ttm180 -116.15 120.23 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.496 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.07 123.38 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.46 -138.73 43.2 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.64 18.22 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.24 46.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.572 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.2 122.44 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.6 m -113.62 116.82 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.91 130.37 53.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.729 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -142.86 131.49 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.575 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.82 -156.63 26.18 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.62 151.09 47.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -135.63 156.61 77.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.95 -22.29 19.92 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.777 2.318 . . . . 0.0 112.075 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.38 152.21 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 -27.0 68.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.43 94.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.94 79.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -60.04 -36.01 76.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.454 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.55 -37.17 57.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.64 87.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.26 -40.94 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.2 mtm -61.38 -31.85 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 m -61.28 -33.17 73.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.632 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' HB1' ' CG ' ' A' ' 142' ' ' PHE . . . -70.58 -26.86 63.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' LEU . 15.8 mt -88.36 -16.14 33.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -50.98 -28.92 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.56 -9.89 82.58 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -100.16 -42.7 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 113' ' ' LEU . 6.7 tt -32.55 113.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.575 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.32 31.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 118' ' ' VAL . 14.2 Cg_endo -59.47 149.88 78.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.852 2.368 . . . . 0.0 112.297 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 -12.98 8.31 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.1 t -95.99 126.63 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 O-C-N 122.278 -0.542 . . . . 0.0 110.534 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.04 137.89 37.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.99 118.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.16 136.69 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.61 105.48 10.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.987 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -98.35 64.82 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.058 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.25 128.59 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.692 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.62 146.17 24.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.949 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.91 113.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.89 128.68 16.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.134 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.36 38.32 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.383 2.055 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.85 -34.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.92 167.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 80' ' ' SER . 0.1 OUTLIER -121.08 160.26 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.3 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -119.87 156.06 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.671 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 183' ' ' TRP . 20.0 tp -78.59 126.39 30.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.487 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -58.47 150.03 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -140.42 74.11 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.533 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.9 p -95.34 7.34 46.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 p -176.59 31.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.77 40.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 7.7 mt-10 -49.16 -58.9 7.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 15.9 Cg_endo -61.13 -28.13 85.07 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.446 2.097 . . . . 0.0 111.961 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.08 -43.11 89.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 m-85 -64.09 -40.72 96.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.351 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 p -63.29 -35.26 79.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.85 -28.96 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -93.72 -9.55 37.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.494 ' N ' ' HD2' ' A' ' 147' ' ' PRO . 1.1 t -53.24 -48.67 91.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.531 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 56.3 Cg_endo -75.21 1.5 7.77 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.186 1.924 . . . . 0.0 111.666 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.66 85.55 27.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.81 22.15 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.844 2.363 . . . . 0.0 112.354 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -141.27 55.66 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.751 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.639 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 1.7 p90 -123.71 143.7 50.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 163' ' ' THR . . . -126.81 145.04 15.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.9 129.39 36.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 110.779 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.6 53.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.2 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.2 t -117.92 134.7 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.659 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -145.61 77.68 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.656 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 62.14 -96.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -111.21 33.58 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.64 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 m -136.47 133.56 36.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.519 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.41 134.24 66.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.354 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 82.2 m -132.35 128.26 37.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.699 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -111.75 118.96 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 152' ' ' GLY . 87.8 m -128.22 147.49 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.675 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 150.38 166.41 13.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.02 142.0 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.73 149.4 46.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.11 -40.63 1.63 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.743 2.296 . . . . 0.0 111.69 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 146.68 52.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.236 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -36.97 85.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -63.4 -48.16 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.798 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -66.58 -33.7 76.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.577 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.5 -44.34 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.8 90.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.61 -40.94 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -62.55 -52.01 65.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.057 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -62.12 -39.66 93.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.858 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.16 97.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.9 -40.0 94.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.588 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.4 m -67.81 -40.08 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' A' ' 182' ' ' THR . 2.4 p -68.63 -39.22 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.649 ' N ' ' HG ' ' A' ' 181' ' ' SER . 55.8 m -83.53 -38.43 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.577 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 179' ' ' ALA . 4.7 m-90 -127.18 73.13 77.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.686 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 61.2 Cg_endo -77.87 28.0 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.857 2.371 . . . . 0.0 111.923 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 187' ' ' LYS . 1.2 t70 -41.58 -12.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.679 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 74.78 -26.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 185' ' ' ASP . 18.2 mttm -95.6 61.42 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.1 136.04 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.79 129.68 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -88.52 107.76 19.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.441 ' CB ' ' OG1' ' A' ' 163' ' ' THR . 4.7 m-80 -122.23 52.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.8 mt -86.33 133.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -120.12 124.79 46.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.913 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 21.4 m -105.25 109.86 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.128 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.447 ' OG1' ' OD2' ' A' ' 245' ' ' ASP . 1.8 t -115.56 -24.5 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.807 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 195' ' ' THR . . . -151.38 16.34 0.87 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -65.04 156.39 31.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 110.815 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.2 106.67 52.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.405 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.517 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 23.8 Cg_exo -54.67 -42.53 67.52 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.154 1.903 . . . . 0.0 112.428 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 58.2 Cg_exo -48.92 -69.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 111.893 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 134.33 -57.52 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.541 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 38.0 Cg_exo -49.88 -40.84 48.6 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.7 2.266 . . . . 0.0 113.001 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 21.3 Cg_exo -62.73 -175.64 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.196 1.93 . . . . 0.0 112.02 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 203' ' ' PRO . . . 166.77 128.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 204' ' ' ALA . 0.7 OUTLIER 75.34 64.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -119.74 70.86 0.34 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.9 -91.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.932 2.422 . . . . 0.0 112.19 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . 0.563 ' O ' ' O ' ' A' ' 209' ' ' ALA . 9.4 m -124.94 35.3 4.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.568 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -48.88 -111.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.347 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -81.95 18.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.305 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 215' ' ' ILE . 6.7 mp -56.55 -29.93 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -50.62 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.701 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -62.72 -39.92 95.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 110.975 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.22 68.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.448 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LEU . 6.2 mt -58.95 -37.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 220' ' ' GLY . 9.3 t-20 -54.78 -41.67 70.81 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.28 -31.28 62.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.517 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.32 -41.4 81.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -106.43 -27.53 10.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 78.47 -14.7 11.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.17 173.25 43.6 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.91 148.46 57.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.793 2.328 . . . . 0.0 112.128 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 23.2 mt -54.27 96.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -155.29 62.43 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.697 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.59 125.74 40.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.17 30.75 9.7 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -115.71 132.71 56.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 0.0 110.635 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.25 70.78 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.65 6.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -144.94 -83.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.97 171.82 8.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 233' ' ' ILE . 2.1 mm? -46.84 162.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.416 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 232' ' ' LEU . 5.2 mt 33.93 77.41 0.37 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.436 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.83 -66.92 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.841 2.361 . . . . 0.0 112.333 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 43.07 72.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER 72.64 -140.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.547 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.411 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.02 -34.58 78.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 239' ' ' ILE . 7.7 mm -59.55 -45.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.745 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -31.96 68.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -42.97 76.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.13 -45.68 93.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.974 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.26 -38.0 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.186 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.76 91.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 195' ' ' THR . 0.2 OUTLIER -57.07 -50.38 72.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.521 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -65.49 -32.08 73.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.407 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.4 OUTLIER -63.44 -32.27 73.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -63.83 -26.13 68.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.791 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.5 1.95 47.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.023 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.678 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.2 m -74.69 -28.57 0.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.2 Cg_exo -53.43 -14.15 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.854 1.703 . . . . 0.0 111.819 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -2.66 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 251' ' ' PRO . . . -141.02 -159.0 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.463 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -103.44 139.99 38.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.203 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.52 133.01 67.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.438 ' HB ' HG23 ' A' ' 324' ' ' VAL . 93.7 m -123.02 111.96 17.22 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.055 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.35 121.46 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -101.09 126.02 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.55 134.79 11.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -120.39 116.7 26.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 111.042 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.497 ' C ' ' OD1' ' A' ' 318' ' ' ASN . 2.9 t -134.74 159.28 41.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.667 ' N ' ' OD1' ' A' ' 318' ' ' ASN . 39.9 p-10 -113.24 97.33 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.6 t-20 38.36 -94.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 262' ' ' ASP . 1.1 m 62.14 -69.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -90.33 -161.15 37.19 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.872 ' OG ' HG13 ' A' ' 269' ' ' ILE . 88.7 p -89.49 162.79 15.53 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.79 0.329 . . . . 0.0 110.974 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.62 -17.08 63.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.735 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.69 -20.31 22.28 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.872 HG13 ' OG ' ' A' ' 266' ' ' SER . 5.1 mt -111.97 4.4 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -44.02 76.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.001 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.545 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 3.1 mm -63.04 -51.36 71.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.754 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.3 Cg_endo -61.72 -39.84 50.17 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.055 1.837 . . . . 0.0 112.004 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.76 -43.98 91.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -38.0 67.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.76 71.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.402 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -60.97 -38.72 86.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -68.09 -39.05 82.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.55 68.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.177 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -45.6 76.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.357 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.23 -40.99 85.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.373 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.25 -39.38 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.86 94.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.492 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.72 -42.04 83.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -49.72 76.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.391 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.51 -48.0 83.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.287 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.66 -38.07 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.09 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.63 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.496 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.2 12.99 24.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.18 130.89 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -72.44 113.36 9.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.439 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -75.47 11.02 10.17 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.1 OUTLIER -89.37 -16.71 30.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -113.83 2.34 15.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.87 124.79 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.69 154.12 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.38 132.83 38.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.73 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.9 t -125.62 116.48 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -83.26 105.34 2.69 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.6 mm? -31.28 -61.47 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.63 49.62 63.39 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 303' ' ' VAL . 94.3 p -99.58 -23.98 14.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.58 0.228 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 302' ' ' SER . 1.3 m 51.68 124.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.157 0.504 . . . . 0.0 110.512 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.476 ' N ' ' HD3' ' A' ' 305' ' ' PRO . 0.1 OUTLIER 60.2 53.25 3.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.621 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 304' ' ' ASN . 67.6 Cg_endo -77.61 -101.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.838 2.358 . . . . 0.0 112.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.6 mm -81.27 -38.59 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -115.79 160.75 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.44 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 p -102.83 16.15 27.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.731 HD22 ' CZ ' ' A' ' 315' ' ' ARG . 2.3 t30 44.63 53.81 6.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.615 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -127.25 -5.0 6.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.447 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.56 148.88 63.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.53 -31.81 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.674 2.249 . . . . 0.0 111.936 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.24 -33.39 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 318' ' ' ASN . . . -66.76 -44.38 89.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.731 ' CZ ' HD22 ' A' ' 309' ' ' ASN . 1.8 mtt-85 -62.06 -44.94 95.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 110.444 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.05 -45.53 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -34.69 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.667 ' OD1' ' N ' ' A' ' 262' ' ' ASP . 2.4 t30 -63.11 -25.4 68.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.733 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -79.68 98.97 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -133.79 146.86 51.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . 0.436 HG11 ' N ' ' A' ' 322' ' ' GLU . 70.0 t -144.85 144.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.321 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.436 ' N ' HG11 ' A' ' 321' ' ' VAL . 20.4 tt0 -137.43 148.52 46.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 323' ' ' ILE . 4.5 mp -123.58 129.64 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.438 HG23 ' HB ' ' A' ' 256' ' ' THR . 0.6 OUTLIER -130.73 123.56 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.681 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.424 HG13 ' SG ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -107.33 134.6 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.305 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 326' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.641 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.748 0.308 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.98 17.51 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.23 -42.16 84.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.806 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.17 117.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 69.6 mt -99.34 152.54 19.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.0 p -75.47 162.4 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.28 106.51 13.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.596 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.17 140.94 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.352 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -128.23 117.67 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.25 120.12 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.112 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.51 132.66 44.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.696 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.434 ' NH1' ' HA ' ' A' ' 149' ' ' PRO . 45.8 ttt180 -121.23 138.08 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.404 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.1 p -143.6 109.58 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 149' ' ' PRO . . . 75.57 -125.52 8.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.55 18.28 22.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.397 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.5 m -118.81 138.96 52.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.54 121.41 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.812 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.7 m -104.22 124.73 49.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.194 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.76 125.51 48.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.75 119.65 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.353 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.549 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . -175.5 -171.56 39.56 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -131.46 145.11 51.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.576 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.454 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 3.8 m-85 -134.5 155.87 79.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.14 -28.37 48.59 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.774 2.316 . . . . 0.0 112.483 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.09 169.45 20.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -24.82 50.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.683 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.24 89.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.814 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.67 78.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -59.74 -38.91 83.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.16 -37.76 62.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.02 -44.82 62.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 110.427 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.498 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER -57.49 -26.76 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.455 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.403 ' N ' ' HG3' ' A' ' 107' ' ' MET . 51.9 m -66.5 -32.12 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.72 -18.47 63.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 pp -125.49 3.74 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.637 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' MET . 32.5 t-20 -54.82 -42.27 71.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.639 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.66 -16.87 70.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.52 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 0.0 110.461 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 tt -45.52 105.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.8 160.53 30.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.674 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' A' ' 118' ' ' VAL . 52.0 Cg_exo -47.46 155.59 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 112.426 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.04 -25.45 0.31 Allowed Glycine 0 N--CA 1.461 0.316 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.585 ' H ' ' C ' ' A' ' 116' ' ' PRO . 12.7 t -93.22 140.04 17.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.173 -0.604 . . . . 0.0 110.635 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.55 130.29 54.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.605 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.2 t -134.22 119.82 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.7 pt -125.24 125.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -104.23 104.24 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.171 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -109.93 63.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.846 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.7 125.36 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.579 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -90.63 146.42 24.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.78 121.06 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.76 132.19 18.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.97 60.41 7.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.35 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 130' ' ' VAL . 7.4 p -174.2 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' N ' ' CG1' ' A' ' 129' ' ' VAL . 26.3 m -52.03 142.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -99.55 158.03 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.154 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.454 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 13.8 t -120.46 155.02 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.76 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 ' CE2' ' A' ' 183' ' ' TRP . 55.6 tp -81.61 127.87 33.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.01 139.22 52.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -130.36 24.03 5.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' PHE . 68.9 m -30.41 -39.95 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.393 0.616 . . . . 0.0 110.962 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.7 m -152.59 61.51 0.81 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.436 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.16 -7.62 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.427 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -56.29 -43.47 99.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.513 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.0 Cg_exo -58.37 -41.43 65.96 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.31 -49.07 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.076 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' N ' ' A' ' 146' ' ' VAL . 2.4 m-85 -65.01 -37.12 86.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.474 ' HG1' ' HA ' ' A' ' 140' ' ' PRO . 1.3 p -58.27 -37.89 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.417 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.73 53.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.692 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 p -101.65 -2.06 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.2 t -65.62 -40.01 37.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 56.4 Cg_endo -82.65 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.712 2.274 . . . . 0.0 112.256 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.411 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 5.2 mt -128.99 104.01 18.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 88' ' ' GLY . 59.6 Cg_endo -78.24 21.1 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.205 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 12.3 t70 -152.63 64.18 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.478 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.647 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -130.01 139.67 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.659 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 130.5 6.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -119.11 129.96 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.586 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 131.26 51.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.585 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.25 134.59 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.388 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 158' ' ' ASP . 69.8 mt-10 -141.95 95.82 2.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 8.3 mtt180 53.84 -90.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' GLU . 5.0 p30 -117.97 9.06 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.884 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 m -110.06 129.11 55.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.693 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 t -119.9 131.77 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.357 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 p -130.95 116.86 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.6 tt -112.0 118.7 36.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.436 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.8 p -128.59 149.2 50.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.789 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.55 -168.04 28.57 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.8 p -108.03 135.7 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.685 0.279 . . . . 0.0 110.731 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -98.36 159.08 31.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.358 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 197' ' ' GLN . 46.4 Cg_endo -73.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.732 2.288 . . . . 0.0 112.142 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.38 166.4 16.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -41.45 94.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.44 -41.49 98.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -63.94 -37.81 88.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.402 ' HZ3' ' HG2' ' A' ' 172' ' ' LYS . 8.7 ttpp -60.44 -43.25 97.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.734 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.9 t70 -66.73 -36.85 83.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.7 -32.83 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -51.83 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.727 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 177' ' ' ARG . 8.3 ptpt -66.35 -39.26 89.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 176' ' ' LYS . 7.8 ttm-85 -56.17 -51.03 69.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.39 -31.74 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.661 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.41 99.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 40.7 p -67.4 -37.59 83.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.474 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -27.06 64.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.8 m -96.02 -52.62 3.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.989 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.454 ' CE2' HD22 ' A' ' 133' ' ' LEU . 6.1 m-90 -116.71 99.09 52.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.264 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 58.2 Cg_endo -80.19 17.09 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.508 2.139 . . . . 0.0 111.349 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.3 OUTLIER -30.86 -29.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.718 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 78.52 -29.21 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.594 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 185' ' ' ASP . 23.5 mttt -105.2 76.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.546 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.92 125.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.25 124.27 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -98.31 123.53 42.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.19 45.69 1.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -114.56 129.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.16 126.64 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.396 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.3 p -84.71 56.5 3.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 53.45 26.31 30.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.596 ' O ' ' O ' ' A' ' 167' ' ' PRO . 6.7 mt-30 -113.27 157.04 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 110.527 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 169.46 64.83 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.56 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 18.2 Cg_exo -50.8 -42.05 52.63 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.325 2.017 . . . . 0.0 111.989 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 72.8 Cg_endo -91.2 3.27 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.983 2.455 . . . . 0.0 112.548 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.49 72.69 0.43 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.516 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 17.1 Cg_exo -57.1 -42.58 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.774 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 54.0 Cg_exo -47.69 -12.97 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.42 2.08 . . . . 0.0 112.395 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 202' ' ' PRO . . . -89.38 -82.44 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.579 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.0 m -143.56 -54.54 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.6 171.79 42.33 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.14 -95.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.81 2.34 . . . . 0.0 112.316 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.92 71.16 0.88 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.807 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.98 112.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 213' ' ' SER . 15.7 m-20 62.18 72.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -40.48 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.243 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.43 ' HG2' ' H ' ' A' ' 213' ' ' SER . 0.0 OUTLIER -68.5 -50.51 51.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.058 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 212' ' ' GLN . 74.4 m -70.73 -45.02 65.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.957 0.408 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.7 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.246 -0.284 . . . . 0.0 111.715 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 1.2 tp -69.56 -41.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.563 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 21.0 t30 -70.33 -36.85 74.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.57 -30.11 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.2 -34.64 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.752 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 221' ' ' GLY . 0.8 OUTLIER -109.08 -15.89 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.752 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 56.03 4.13 0.68 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -165.98 -172.88 33.86 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.11 147.68 79.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.579 2.186 . . . . 0.0 111.982 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.3 145.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . 176.59 -174.51 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.97 154.22 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -46.87 122.26 6.64 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -107.22 24.0 13.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.23 -15.97 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.514 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 143.56 68.1 0.02 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.9 62.52 1.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.752 0.31 . . . . 0.0 110.536 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.649 ' C ' ' H ' ' A' ' 233' ' ' ILE . 0.5 OUTLIER -84.81 100.84 11.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.625 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 232' ' ' LEU . 4.6 mp 56.01 -1.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.649 ' H ' ' C ' ' A' ' 231' ' ' SER . 89.3 mt -133.59 82.03 52.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.936 0.398 . . . . 0.0 110.613 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 235' ' ' ALA . 50.1 Cg_exo -51.04 152.32 10.58 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.745 2.297 . . . . 0.0 112.027 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -28.18 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.668 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -128.21 163.61 24.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.719 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.82 -30.51 2.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.2 -37.11 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.724 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 4.2 tt -63.69 -37.43 79.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.787 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.432 ' HB3' HH21 ' A' ' 288' ' ' ARG . 2.2 mp -59.91 -43.25 94.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.722 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -38.49 70.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -45.42 94.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.133 0.492 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.36 -35.17 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.421 ' HB1' ' CG ' ' A' ' 288' ' ' ARG . . . -55.82 -47.18 77.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.903 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.08 -50.6 72.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.786 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -68.91 -32.09 71.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.916 0.389 . . . . 0.0 110.668 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.682 ' O ' ' CD ' ' A' ' 251' ' ' PRO . 1.4 tp -55.07 -33.65 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.398 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -63.27 -37.69 88.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.894 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.45 -2.23 17.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -74.4 -46.59 5.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.941 -178.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 253' ' ' ALA . 31.5 Cg_exo -53.2 -13.75 3.46 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.986 2.458 . . . . 0.0 112.374 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 253' ' ' ALA . 0.6 OUTLIER -37.08 -23.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -107.19 -149.07 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.847 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.463 ' HE ' HD21 ' A' ' 326' ' ' ASN . 0.2 OUTLIER -103.77 138.23 40.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.03 132.12 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.95 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.421 HG22 ' OD1' ' A' ' 258' ' ' ASN . 95.0 m -123.48 124.37 42.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.067 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.99 114.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.57 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.421 ' OD1' HG22 ' A' ' 256' ' ' THR . 0.0 OUTLIER -111.85 128.88 56.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.6 148.83 19.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -139.65 130.79 26.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 110.379 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.7 p -124.99 -155.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.479 ' OD1' ' OD1' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -143.85 158.02 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.578 ' O ' ' OG1' ' A' ' 264' ' ' THR . 0.3 OUTLIER 172.43 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 265' ' ' GLY . 10.6 p 66.74 -90.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.908 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 264' ' ' THR . . . 26.7 -103.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 1.046 ' HG ' HD13 ' A' ' 269' ' ' ILE . 88.9 p -142.25 166.41 24.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.54 -20.38 64.6 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.66 7.12 56.02 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 1.046 HD13 ' HG ' ' A' ' 266' ' ' SER . 3.1 mp -141.4 -35.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 0.0 110.888 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -68.8 -46.8 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.782 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 299' ' ' GLY . 0.6 OUTLIER -76.07 -47.05 3.71 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.625 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 39.8 Cg_exo -53.9 -32.62 68.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.259 1.973 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 28.2 tp -68.2 -48.36 65.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.477 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -32.92 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.17 -41.84 60.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -64.88 -37.38 87.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' CZ ' ' A' ' 319' ' ' ARG . 38.8 mtt-85 -61.38 -41.87 97.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.352 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.96 -28.84 67.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.174 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 277' ' ' ARG . 10.9 pt -70.87 -44.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.86 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.422 ' N ' HG13 ' A' ' 280' ' ' ILE . 71.0 t -58.6 -48.49 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.67 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.83 -39.11 70.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -38.78 92.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -42.0 83.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.636 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.55 -37.22 77.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.372 . . . . 0.0 110.012 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.35 -36.28 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.079 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.16 -20.1 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . 0.432 HH21 ' HB3' ' A' ' 240' ' ' LEU . 0.0 OUTLIER -81.42 -2.67 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.794 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.23 20.09 13.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.6 134.6 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.685 ' O ' ' CE1' ' A' ' 294' ' ' HIS . . . -87.8 104.54 16.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.1 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.4 OUTLIER -79.29 -16.72 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 0.0 110.648 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.685 ' CE1' ' O ' ' A' ' 291' ' ' ALA . 0.9 OUTLIER -133.74 35.02 3.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.738 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.96 136.79 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.668 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -137.29 143.59 42.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.1 124.46 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.01 119.05 60.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 271' ' ' ILE . . . -95.68 120.89 6.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 300' ' ' LEU . 4.0 mm? -99.0 111.45 23.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.328 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 302' ' ' SER . . . -78.42 120.44 5.39 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 301' ' ' GLY . 45.7 t 37.72 98.16 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.995 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.72 -38.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.964 0.411 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -133.67 70.23 75.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.127 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.81 131.51 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 0.0 112.196 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 8.4 mm -122.47 -57.19 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -116.84 156.67 26.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 309' ' ' ASN . 13.1 p -61.71 -136.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.786 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.61 ' C ' HD21 ' A' ' 309' ' ' ASN . 0.4 OUTLIER -173.15 34.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -92.78 -15.6 26.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 162.26 32.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.571 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -50.51 -33.1 37.25 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.446 2.098 . . . . 0.0 112.102 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.78 -40.11 91.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.04 -46.99 93.46 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -65.61 -38.57 89.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.44 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.94 89.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.674 ' O ' ' NH1' ' A' ' 320' ' ' ARG . 41.1 mttm -71.02 -29.73 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.469 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -77.01 -16.13 59.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.541 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.578 ' CZ ' ' NH1' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -83.85 99.76 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.566 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 317' ' ' LYS . 0.0 OUTLIER -134.53 140.76 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.386 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.64 156.07 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -142.6 142.85 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.1 mt -107.48 113.7 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.535 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.1 m -112.27 121.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.525 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.87 135.14 49.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.507 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . 0.563 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 5.9 m-20 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.786 0.327 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 154.94 40.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.08 159.74 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.758 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -88.94 168.39 12.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.36 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.79 107.93 11.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.03 136.07 54.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 121.05 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.609 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.0 pp -130.76 125.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.03 132.56 50.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -124.22 126.51 46.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.4 p -135.12 122.77 22.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.78 2.94 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.47 27.66 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -119.8 134.56 55.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.59 115.25 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.488 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.43 ' C ' HD12 ' A' ' 93' ' ' LEU . 72.2 p -109.77 116.27 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 92' ' ' THR . 9.1 mp -112.32 121.27 44.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.25 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 129.36 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.23 -152.54 20.15 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.57 154.3 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.39 144.74 44.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.5 -19.2 37.68 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.629 2.219 . . . . 0.0 111.873 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.65 -157.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.438 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.02 -26.45 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.389 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.26 98.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.353 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.35 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -58.45 -36.92 74.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.49 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.08 75.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.363 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.89 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.312 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.67 -39.98 93.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.439 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mmt -56.38 -37.16 69.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.478 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -65.98 -42.7 89.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.291 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.444 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -70.69 -22.87 62.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.44 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.03 -44.2 20.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.541 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -45.73 -37.47 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.7 -44.16 40.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' A' ' 114' ' ' LEU . 1.2 tp -43.53 -73.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 161.17 -156.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.698 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.628 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . 175.83 -48.89 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.573 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 118' ' ' VAL . 86.3 Cg_exo -40.03 -129.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.547 2.831 . . . . 0.0 113.834 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.37 -2.36 0.03 OUTLIER Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.9 t -95.72 134.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 122.353 -0.498 . . . . 0.0 110.362 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.89 129.38 35.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.532 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 t -129.33 116.7 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.24 140.04 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.259 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -126.36 96.65 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -99.33 61.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.949 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.63 128.71 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.58 146.59 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.3 t -99.6 119.2 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.63 125.07 20.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.289 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.17 42.88 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.368 2.045 . . . . 0.0 112.16 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.82 -35.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.57 167.34 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.07 159.29 34.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -143.94 155.8 44.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.705 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.11 135.8 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.37 139.46 57.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.576 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 17.4 m-85 -102.73 38.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.81 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -66.6 -58.68 4.66 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.615 0.721 . . . . 0.0 110.988 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 m -109.31 15.51 23.06 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.002 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.576 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -96.87 -23.26 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.797 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.8 OUTLIER -55.74 -46.26 99.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 23.2 Cg_exo -59.98 -29.59 89.69 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.805 2.337 . . . . 0.0 111.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 182' ' ' THR . 25.0 t -68.55 -44.96 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.5 m-85 -62.59 -32.4 73.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -65.59 -36.17 82.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.714 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.28 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -97.77 0.71 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.7 t -65.68 -38.78 27.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 72.4 Cg_endo -85.02 20.44 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.692 2.261 . . . . 0.0 112.336 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.57 116.62 22.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.676 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.36 178.61 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.14 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 54.38 20.29 2.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -82.69 139.51 33.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.772 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.08 153.24 24.89 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER -140.6 127.92 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.797 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.559 ' N ' HD23 ' A' ' 153' ' ' LEU . 0.4 OUTLIER -115.63 123.25 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.29 136.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.43 79.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.474 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 54.87 -115.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.732 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 16.2 t70 -82.98 18.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -125.25 124.63 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.55 117.91 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.137 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -128.29 127.53 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.869 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.581 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.16 124.96 48.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.166 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.55 151.71 46.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.48 164.01 24.48 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 123.82 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.48 106.44 40.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.85 -62.52 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.338 2.026 . . . . 0.0 112.046 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.16 121.53 27.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.59 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.9 p -61.67 -30.6 70.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.437 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.99 -38.6 79.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.48 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -41.94 96.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -64.57 -39.95 94.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.62 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.81 -46.9 71.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.64 86.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.24 -37.8 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -58.34 -44.29 88.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.457 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.44 -37.16 82.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.55 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -63.86 -41.27 97.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.375 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 76.3 p -63.81 -40.87 97.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.903 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.7 t -71.37 -29.97 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.154 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 141' ' ' VAL . 22.8 m -50.71 -63.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.468 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CD1' HG22 ' A' ' 182' ' ' THR . 68.6 m95 -144.05 79.27 13.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.58 -33.56 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.921 2.414 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -75.82 55.87 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 158' ' ' ASP . 23.3 tpp -176.7 166.12 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.603 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 186' ' ' MET . 5.5 mtpm? -86.76 126.24 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.47 137.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.671 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.84 118.66 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.38 108.81 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.42 71.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.164 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.58 128.63 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.798 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -111.82 145.73 38.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.295 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 194' ' ' VAL . 20.0 m -88.38 129.4 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.59 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.747 -179.87 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.792 ' HA ' HD12 ' A' ' 211' ' ' LEU . 39.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.864 0.364 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -72.12 137.81 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 209' ' ' ALA . 16.0 m-20 37.81 19.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 208' ' ' CYS . 0.7 OUTLIER -56.3 -30.81 63.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.523 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.596 ' H ' ' CD ' ' A' ' 212' ' ' GLN . 0.3 OUTLIER -54.28 -40.89 68.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -69.47 -42.05 75.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.404 0.621 . . . . 0.0 110.989 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.77 -34.69 64.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.079 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.572 HD11 HG13 ' A' ' 243' ' ' VAL . 2.8 tt -59.03 -37.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.527 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.16 -32.69 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.213 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.18 -45.7 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.664 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 246' ' ' LYS . 13.0 t -60.46 -38.85 79.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.532 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 220' ' ' GLY . 20.2 p -78.82 -31.44 45.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 219' ' ' THR . . . 19.57 52.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 219' ' ' THR . . . -153.88 166.32 31.89 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.74 138.93 39.05 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.89 2.394 . . . . 0.0 112.071 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.691 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.798 0.332 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.62 -32.86 73.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -58.91 -36.96 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.809 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 240' ' ' LEU . 0.7 OUTLIER -58.47 -46.15 87.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.409 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -63.29 -35.58 80.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -66.26 -45.25 81.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.499 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.572 HG13 HD11 ' A' ' 215' ' ' ILE . 57.9 t -62.79 -39.88 86.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -56.3 -41.91 76.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.35 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 218' ' ' VAL . 20.0 mtmt -69.83 -32.41 70.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -64.45 -31.07 72.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.828 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.25 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.401 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -106.01 3.78 28.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.247 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.689 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.7 m -75.41 -27.59 0.7 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.6 Cg_exo -53.58 -14.21 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.466 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 251' ' ' PRO . 40.2 t0 -39.88 -23.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -115.41 -148.82 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.76 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.464 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 12.5 ttm180 -109.61 139.39 44.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.9 t -118.83 132.15 69.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.894 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 95.5 m -123.4 125.77 45.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -113.81 120.25 63.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.874 0.369 . . . . 0.0 110.493 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.49 149.51 27.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -124.87 123.79 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 261' ' ' THR . 74.4 m-85 -100.6 133.93 44.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -165.7 165.19 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 -158.85 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 51.6 t30 -176.34 129.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 264' ' ' THR . 35.9 m -150.6 -15.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.527 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.525 ' OD1' ' NH1' ' A' ' 315' ' ' ARG . 49.9 m-20 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 0.7 OUTLIER -57.43 -51.82 78.89 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 12.4 Cg_endo -59.87 -41.91 49.89 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.947 1.765 . . . . 0.0 112.508 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.474 ' C ' HH22 ' A' ' 319' ' ' ARG . 5.4 tp -68.8 -37.97 79.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.522 ' N ' HH22 ' A' ' 319' ' ' ARG . 1.4 p -64.86 -40.18 94.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.9 -51.99 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.7 -34.59 78.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -60.51 -41.77 95.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.47 91.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -57.26 -40.21 77.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.596 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 11.1 mm -61.05 -40.68 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.589 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.45 -45.99 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.93 -43.14 99.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.49 -39.4 87.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.13 -52.09 31.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.65 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 285' ' ' LEU . 57.2 mt -59.6 -45.46 91.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.543 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 282' ' ' ALA . 59.4 t -58.95 -36.36 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.194 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.8 -25.13 68.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -84.16 -2.43 56.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.296 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.47 12.6 26.4 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 90.4 t -77.34 118.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 110.467 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.72 109.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -78.79 1.81 71.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.41 -15.84 59.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.409 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.41 5.98 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 292' ' ' GLY . 10.4 tt -91.07 133.83 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -130.0 135.98 48.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.41 134.05 51.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 122.13 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.71 106.67 3.39 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.789 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.0 OUTLIER -103.49 89.39 3.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.658 ' O ' ' OG ' ' A' ' 302' ' ' SER . . . -91.5 167.82 31.49 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.658 ' OG ' ' O ' ' A' ' 301' ' ' GLY . 89.7 p 69.64 -43.71 0.53 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.312 0.577 . . . . 0.0 110.963 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 304' ' ' ASN . 27.4 m -64.37 166.32 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.468 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 303' ' ' VAL . 96.2 m-20 30.18 60.91 0.94 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.526 ' O ' ' C ' ' A' ' 306' ' ' ILE . 37.5 Cg_endo -69.72 67.16 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.784 2.323 . . . . 0.0 112.272 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 305' ' ' PRO . 6.4 mm -30.92 -66.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.391 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.7 160.4 22.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.33 160.27 30.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -100.81 108.55 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.206 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -163.84 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.59 161.32 28.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.69 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -50.23 -33.04 34.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.523 2.149 . . . . 0.0 112.08 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -68.51 -31.87 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.748 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.64 97.63 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.803 ' HA ' HD22 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -63.44 -45.8 89.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.779 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -62.78 -40.43 97.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.803 HD22 ' HA ' ' A' ' 315' ' ' ARG . 25.3 p30 -83.79 -25.11 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.906 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.522 HH22 ' N ' ' A' ' 274' ' ' SER . 0.7 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -137.22 157.77 45.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 111.048 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.9 t -144.87 152.58 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.73 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.97 142.95 29.17 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.507 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.1 mt -119.03 120.67 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.13 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 256' ' ' THR . 2.7 m -127.76 131.52 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.4 p -120.37 136.1 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.478 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.551 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 1.8 m-20 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.535 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 131' ' ' ARG . 24.2 p -129.3 138.27 51.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.24 159.29 15.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.6 p -97.18 159.67 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.745 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.45 115.77 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.637 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.96 144.09 49.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.81 125.94 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -133.43 115.49 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.347 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 m -137.26 127.37 26.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.519 ' NH2' HD21 ' A' ' 110' ' ' LEU . 7.9 mtt85 -114.91 126.46 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.302 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 p -134.23 116.71 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 150' ' ' ASP . . . 71.73 -137.14 25.29 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -95.22 15.68 18.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 110.497 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -121.61 125.76 47.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 91' ' ' VAL . 5.8 m -107.36 118.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.38 127.72 45.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 94' ' ' ILE . 14.0 tp -133.15 120.41 21.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.284 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -134.13 129.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.614 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.5 -156.21 23.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 154.1 41.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 20.9 m-85 -138.67 146.59 51.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.535 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 24.9 Cg_endo -64.48 -25.47 63.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.676 2.251 . . . . 0.0 112.144 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 98' ' ' PRO . 35.5 m-20 -155.76 119.82 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.611 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -45.23 -21.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.43 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ASP . . . -60.41 -36.82 79.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.64 81.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -36.88 85.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.14 -38.52 79.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.351 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.37 90.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.28 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.54 -43.22 85.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -26.42 61.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -60.56 -42.81 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.799 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.09 67.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.469 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.7 mt -79.74 -21.15 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -49.61 -30.38 8.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.56 61.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.9 tt -88.04 -47.53 8.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.835 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 mt -21.2 116.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.157 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -142.98 -178.27 0.77 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.35 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 71.7 Cg_endo -89.01 153.58 5.8 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.127 2.552 . . . . 0.0 112.594 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.86 -10.04 21.06 Favored Glycine 0 C--O 1.24 0.483 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 115' ' ' ALA . 3.2 m -92.86 130.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.01 -0.7 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -92.26 130.47 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.524 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.3 129.06 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.425 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.0 mm -130.16 110.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.31 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 78.78 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.059 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -85.94 75.98 9.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 93' ' ' LEU . 3.9 mt -104.9 130.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.736 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.01 146.47 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.054 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 126' ' ' VAL . 2.3 p -99.76 111.74 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.813 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.621 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -137.54 102.94 8.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.351 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.71 26.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.391 2.061 . . . . 0.0 112.183 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.621 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.3 t -124.46 -4.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.902 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 171.41 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.735 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 78' ' ' SER . 6.2 mmt-85 -117.82 159.27 23.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.678 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -125.22 155.23 40.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.704 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.4 tp -86.91 134.98 33.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.61 132.41 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.734 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -117.68 27.31 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.302 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.1 m -32.65 -47.2 0.16 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.171 0.51 . . . . 0.0 110.978 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -100.22 -91.49 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.802 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . 69.99 -43.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.694 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.616 ' O ' HG23 ' A' ' 143' ' ' THR . 2.8 mm-40 -51.75 -58.86 9.52 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.958 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 20.6 Cg_endo -64.28 -35.13 52.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.514 2.143 . . . . 0.0 112.143 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 182' ' ' THR . 20.9 t -69.92 -48.27 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.84 -42.8 94.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 139' ' ' GLU . 63.0 p -65.97 -33.98 77.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.72 -22.03 59.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 p -111.99 5.54 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -63.86 -42.68 72.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.245 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 26.3 Cg_exo -57.92 -10.98 8.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.592 2.195 . . . . 0.0 111.756 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 147' ' ' PRO . 11.6 mm -125.03 89.7 52.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.63 16.36 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.666 2.244 . . . . 0.0 112.059 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 6.3 m-20 -132.4 61.66 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 2.7 p90 -125.55 143.17 51.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.54 142.2 15.61 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.6 tp -141.93 127.22 18.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -125.16 128.8 48.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.024 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.28 127.48 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.132 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 157' ' ' ARG . 2.2 tt0 -110.45 176.16 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.12 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 156' ' ' GLU . 25.6 mtt180 -32.26 -43.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.633 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 30.55 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 m -135.82 130.38 33.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.632 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.49 127.2 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 m -131.14 127.22 37.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.029 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -117.19 121.31 40.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.722 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.9 m -122.76 147.15 46.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.522 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.856 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 153.97 158.47 8.64 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.6 p -96.47 135.3 38.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.05 142.22 26.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.62 -39.19 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.687 2.258 . . . . 0.0 112.272 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.5 t -123.61 137.66 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.638 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -33.17 75.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -59.01 -48.56 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -58.35 -40.84 83.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.353 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.409 ' HZ1' ' HZ3' ' A' ' 176' ' ' LYS . 8.5 tttm -62.89 -36.18 82.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 173' ' ' ASP . 1.6 t70 -63.93 -38.64 91.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.64 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.38 71.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.93 -51.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 177' ' ' ARG . 1.5 ptpt -63.52 -36.73 84.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.799 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.481 ' N ' ' HG3' ' A' ' 176' ' ' LYS . 9.3 ttm180 -59.76 -53.99 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.723 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.576 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -66.8 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.98 77.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.693 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -38.59 91.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.716 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 p -70.88 -36.32 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.2 OUTLIER -66.48 -68.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.845 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.826 ' CE2' HD21 ' A' ' 133' ' ' LEU . 8.5 m-90 -114.8 90.44 22.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 186' ' ' MET . 72.4 Cg_endo -83.53 22.52 0.91 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 123.017 2.478 . . . . 0.0 111.671 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 186' ' ' MET . 54.2 m-20 -36.56 -20.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.671 ' N ' ' O ' ' A' ' 184' ' ' PRO . 5.4 tpt 91.1 -39.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.564 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.12 53.53 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.44 119.08 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -108.93 129.68 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -104.41 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -125.13 59.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.291 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 164' ' ' GLY . 21.6 mt -113.39 129.16 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -121.99 139.63 53.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.232 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -88.28 129.42 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.485 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 250' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -65.32 134.37 53.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.822 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER 39.03 16.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.784 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -56.25 -30.85 62.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.077 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -54.47 -38.2 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.402 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -65.73 -42.48 90.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.521 0.677 . . . . 0.0 110.984 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 211' ' ' LEU . . . -74.05 -34.83 64.21 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.37 -39.12 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.91 -38.52 82.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.29 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -58.6 -34.9 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 221' ' ' GLY . 3.5 t -105.54 -30.38 9.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.95 -37.93 2.66 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.42 ' H ' HG23 ' A' ' 219' ' ' THR . . . -169.21 -170.04 33.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 143.06 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.794 2.329 . . . . 0.0 111.976 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 1.09 ' H ' HD12 ' A' ' 223' ' ' ILE . 3.1 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.64 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.78 0.324 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.44 -39.52 88.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 58.8 mt -68.89 -36.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 240' ' ' LEU . 2.8 mm? -59.73 -32.74 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.595 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -56.1 -43.08 77.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -45.92 79.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.6 -45.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -57.11 -45.25 83.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.35 -50.64 70.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -31.7 71.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.115 0.483 . . . . 0.0 109.757 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -55.07 -30.19 59.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.49 11.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -104.36 -2.92 24.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.469 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.6 m -74.85 -27.17 0.7 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 51.4 Cg_exo -51.91 -13.83 2.02 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.728 1.618 . . . . 0.0 111.857 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.36 -14.65 63.11 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -126.9 -166.29 1.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -113.43 138.7 49.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 255' ' ' VAL . 11.6 p -119.36 133.13 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.944 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.2 m -117.34 118.85 33.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.051 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.568 HG12 HG23 ' A' ' 323' ' ' ILE . 65.6 mt -101.62 120.2 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -100.21 134.93 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.97 125.63 8.26 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -109.18 112.51 24.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.451 ' CG2' ' OD1' ' A' ' 270' ' ' ASN . 8.8 t -116.67 -158.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.251 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.432 ' N ' ' OG1' ' A' ' 261' ' ' THR . 1.0 OUTLIER -122.81 -151.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -119.7 28.46 8.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 265' ' ' GLY . 3.3 m -58.68 -68.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' CG2' ' A' ' 261' ' ' THR . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.714 0.292 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.566 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.2 mm -59.96 -51.94 77.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.4 Cg_endo -61.67 -33.25 86.64 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.111 1.874 . . . . 0.0 112.106 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.31 -42.61 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.423 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 p -74.33 -37.8 63.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.635 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.13 -35.8 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 41.7 mtt-85 -63.05 -47.11 84.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.91 70.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.393 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -55.82 -39.1 70.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.469 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 280' ' ' ILE . 1.7 mp -66.8 -43.62 89.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.328 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.73 -38.19 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -60.39 -41.21 93.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.644 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.96 -37.25 86.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.514 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -52.33 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 290' ' ' VAL . 4.5 mp -60.49 -48.94 79.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.7 t -56.36 -39.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.187 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.7 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.196 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.432 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -83.83 0.4 47.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.865 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.7 12.05 42.01 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 285' ' ' LEU . 21.2 t -81.45 133.93 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.563 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.74 102.8 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.93 1.71 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -133.4 6.99 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.2 mt -96.57 133.84 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.327 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.53 147.04 50.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 128.31 40.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.84 140.23 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.722 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -105.38 112.44 3.99 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 299' ' ' GLY . 11.4 mt -46.27 -96.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 302' ' ' SER . . . 132.05 82.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 301' ' ' GLY . 47.0 t 30.21 68.76 0.09 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.017 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.67 -82.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.704 0.288 . . . . 0.0 110.263 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 306' ' ' ILE . 0.3 OUTLIER -178.45 -51.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 32.1 Cg_exo -57.34 16.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.58 2.187 . . . . 0.0 112.346 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.641 ' H ' ' C ' ' A' ' 304' ' ' ASN . 14.4 pt -77.34 178.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.309 . . . . 0.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.74 171.91 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.726 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 14.5 m -81.18 152.88 27.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.41 31.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.86 -35.13 69.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.631 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.63 154.38 79.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.01 -34.2 97.17 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.89 2.393 . . . . 0.0 111.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.433 ' CG ' ' N ' ' A' ' 314' ' ' GLY . 7.8 pt-20 -65.24 -36.66 84.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.287 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 313' ' ' GLU . . . -59.82 -39.23 95.13 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.528 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -65.57 -44.64 86.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.42 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.426 ' HA ' ' NH2' ' A' ' 319' ' ' ARG . . . -55.45 -40.33 71.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.384 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -65.52 -29.95 70.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.546 ' C ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -76.23 -16.1 59.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.517 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.426 ' NH2' ' HA ' ' A' ' 316' ' ' ALA . 52.9 mtm180 -94.6 95.73 8.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -132.11 146.63 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.261 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.26 147.92 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.88 136.82 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.582 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.568 HG23 HG12 ' A' ' 257' ' ' ILE . 3.7 mt -130.19 117.9 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.62 131.64 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 250' ' ' CYS . 2.3 p -109.69 135.36 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.555 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.704 ' ND2' ' O ' ' A' ' 326' ' ' ASN . 2.0 t30 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.612 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.979 0.418 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.655 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -163.81 144.68 8.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 78' ' ' SER . 5.8 mt -129.28 159.34 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.795 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.7 p -86.71 167.36 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 123.98 21.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.97 118.04 15.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.272 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 p -127.83 129.25 46.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 153' ' ' LEU . 1.4 pt -134.53 132.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.472 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -124.81 126.85 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.524 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 151' ' ' PHE . 28.5 ttm180 -113.4 131.2 56.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 90' ' ' THR . 41.2 t -142.8 112.5 6.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.12 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 27.08 106.04 0.0 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.14 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.7 1.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -106.99 124.91 50.31 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.476 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.86 125.64 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 78.2 m -123.12 118.59 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.5 tt -119.77 127.25 52.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.9 mt -135.32 128.19 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.475 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.56 -161.15 33.38 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.76 146.04 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.587 ' CD2' ' OG ' ' A' ' 132' ' ' SER . 11.4 m-85 -125.32 156.01 70.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.356 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 -20.76 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.779 2.319 . . . . 0.0 112.945 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 18.2 t0 -156.45 157.75 36.06 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.222 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -76.25 -26.99 56.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.062 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.06 79.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.08 86.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.203 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -57.07 -36.7 70.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.59 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.59 -40.42 68.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.98 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -41.34 76.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.301 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 39.3 mtp -58.58 -33.4 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.457 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -35.17 76.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.48 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.8 mt -78.36 -20.61 50.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -46.83 -23.02 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.93 -22.43 55.31 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 14.6 tp -98.28 -44.58 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.77 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -24.38 101.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -140.51 156.29 69.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 118' ' ' VAL . 17.8 Cg_endo -61.91 -79.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.884 2.389 . . . . 0.0 112.217 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -43.9 -10.35 0.01 OUTLIER Glycine 0 N--CA 1.46 0.246 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 116' ' ' PRO . 38.4 t -102.37 120.8 52.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 O-C-N 122.238 -0.566 . . . . 0.0 110.623 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.35 118.7 31.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -118.73 125.95 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.435 ' C ' ' OD1' ' A' ' 122' ' ' ASP . 13.5 pt -123.71 138.22 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.125 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -126.78 90.94 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.296 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.55 68.81 9.69 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.69 119.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.871 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -91.48 145.99 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.02 112.27 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.875 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.74 125.35 22.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.15 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.409 ' C ' HG23 ' A' ' 129' ' ' VAL . 55.9 Cg_endo -73.49 49.27 1.73 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.298 1.999 . . . . 0.0 112.171 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.409 HG23 ' C ' ' A' ' 128' ' ' PRO . 78.4 t -154.1 -35.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.23 153.6 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -110.08 159.54 17.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.587 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 1.4 m -120.78 150.55 40.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 183' ' ' TRP . 29.8 tp -83.24 129.82 35.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.419 ' N ' HD12 ' A' ' 133' ' ' LEU . 19.7 m-20 -53.3 147.35 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.8 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -125.21 11.75 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.151 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.4 p -39.63 -25.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -140.63 31.05 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.809 -179.105 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.83 24.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.3 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -51.59 -58.95 9.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.971 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 17.9 Cg_endo -63.39 -31.63 72.51 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.396 2.064 . . . . 0.0 112.042 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.6 t -64.75 -47.74 87.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 m-85 -63.75 -37.47 87.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 12.4 p -68.08 -33.15 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.0 -27.41 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -100.54 0.45 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.002 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.729 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -70.76 -36.16 5.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 16.4 Cg_exo -64.04 18.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.945 2.43 . . . . 0.0 112.208 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.55 ' C ' ' H ' ' A' ' 150' ' ' ASP . 60.2 mt -139.73 86.65 13.57 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.19 2.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.836 2.357 . . . . 0.0 112.008 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.2 p-10 -130.26 70.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.453 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.416 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 2.3 t80 -127.71 140.66 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.87 133.67 7.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.615 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -123.48 131.65 53.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 0.0 110.714 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 124.76 45.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.374 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.9 124.34 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -136.03 93.79 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.504 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 3.5 mtp180 58.79 -93.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.42 15.38 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -114.15 125.27 53.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.19 117.21 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.565 HG23 ' HB ' ' A' ' 189' ' ' VAL . 9.0 m -134.32 135.78 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.41 124.25 46.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.507 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.55 149.12 45.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 154.7 160.07 9.64 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.532 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 95.9 m -91.28 139.27 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.87 108.48 42.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.12 -27.28 1.78 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.416 2.077 . . . . 0.0 112.147 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -130.05 131.81 45.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -34.35 77.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -36.04 75.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.439 ' HD1' ' HA ' ' A' ' 171' ' ' HIS . 2.2 m-70 -63.67 -35.94 82.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -46.22 91.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.38 -44.43 95.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.38 86.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.75 -41.19 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.314 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 -52.13 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.115 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -57.17 -40.47 77.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -65.65 -36.43 83.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.21 69.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.3 m -60.58 -41.0 93.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -67.73 -29.16 68.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 2.6 m -68.38 -66.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.491 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.566 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.3 m-90 -118.42 67.24 6.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.693 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.67 1.93 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.627 2.218 . . . . 0.0 111.829 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.77 60.71 0.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.54 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 ttt -171.84 -163.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 104.98 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.93 127.75 57.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.488 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.565 ' HB ' HG23 ' A' ' 161' ' ' THR . 59.6 t -126.49 121.14 58.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 190' ' ' ASN . 5.3 p30 -97.58 116.95 30.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.29 48.53 1.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.219 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.15 125.78 52.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.12 142.96 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.3 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.73 107.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.412 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 179.775 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.689 ' SG ' ' O ' ' A' ' 246' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.702 0.287 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . 53.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 2.7 m-20 33.46 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -56.24 -46.05 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.123 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.458 ' C ' ' CD ' ' A' ' 212' ' ' GLN . 10.2 tp60 -72.73 -50.38 25.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.249 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -71.17 -44.42 65.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.601 0.36 . . . . 0.0 110.948 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 210' ' ' ASP . . . -71.33 -45.27 63.38 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.028 -0.42 . . . . 0.0 111.943 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 211' ' ' LEU . 1.7 tp -69.48 -36.62 72.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.942 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 12.9 t30 -69.92 -43.96 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.81 95.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.703 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 214' ' ' ALA . 54.7 t -62.8 -50.15 80.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 221' ' ' GLY . 57.4 p -69.29 -22.22 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 74.5 -40.18 1.1 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -168.56 174.76 43.27 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.35 141.68 94.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.834 2.356 . . . . 0.0 111.986 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.631 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.564 ' O ' ' OD1' ' A' ' 241' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.915 0.388 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.61 -46.04 73.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 239' ' ' ILE . 24.5 mt -59.49 -38.06 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 77.6 mt -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 237' ' ' TYR . 11.1 m120 -55.82 -49.03 74.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.903 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -65.03 -45.78 84.03 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.724 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 218' ' ' VAL . 89.7 t -64.04 -48.42 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.31 82.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -50.71 70.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.689 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 6.0 mtpm? -69.18 -33.41 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.981 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.9 OUTLIER -54.81 -31.29 58.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.594 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -62.5 -16.88 58.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.22 22.27 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.34 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 57.8 m -74.98 -28.63 0.81 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.3 Cg_exo -53.63 -14.23 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.327 2.018 . . . . 0.0 112.646 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -52.36 -10.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.635 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -128.98 -157.87 0.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.217 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -100.23 139.1 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 50.7 t -119.41 132.95 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.112 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.536 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.2 m -121.23 119.43 32.26 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 257' ' ' ILE . 36.4 mt -106.17 121.02 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.79 0.328 . . . . 0.0 110.786 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.68 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -109.45 125.1 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -112.4 166.21 12.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 261' ' ' THR . 1.2 t80 -172.99 109.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.744 HG23 ' N ' ' A' ' 262' ' ' ASP . 1.3 t -105.08 -162.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.714 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 261' ' ' THR . 12.6 p-10 -89.75 174.69 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 265' ' ' GLY . 2.4 m-20 -96.6 -86.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 54.2 m 61.09 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.458 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.567 0.222 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.7 mm -68.26 -52.49 21.7 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.8 Cg_endo -61.7 -35.59 79.28 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.085 1.856 . . . . 0.0 112.292 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.0 mm? -68.26 -47.25 68.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.5 p -73.3 -35.19 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.54 -38.49 71.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.32 -43.79 98.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.658 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.402 ' CD ' ' HE ' ' A' ' 319' ' ' ARG . 13.6 ttp85 -60.15 -39.76 87.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.608 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.34 -31.21 70.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -73.57 -37.5 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.81 -46.52 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 282' ' ' ALA . 28.1 m -63.69 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.15 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -63.58 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.123 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -30.83 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -46.69 51.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.712 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 290' ' ' VAL . 9.7 mt -59.91 -49.25 78.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.15 -36.21 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.76 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 -2.33 58.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.419 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.4 2.67 38.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 285' ' ' LEU . 22.0 t -68.74 131.91 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.349 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.77 97.66 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.596 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -77.46 12.86 12.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.14 -16.29 38.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -121.31 27.68 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.328 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 295' ' ' ILE . 35.4 mt -117.75 124.85 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.3 135.5 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 124.44 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.99 116.47 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.152 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.8 105.37 2.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.679 ' O ' ' N ' ' A' ' 302' ' ' SER . 27.5 mt -74.29 0.07 15.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 110.42 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.5 -72.18 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 300' ' ' LEU . 89.4 p -174.73 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 120.352 0.12 . . . . 0.0 110.955 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 304' ' ' ASN . 66.2 t -41.89 -84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.63 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 0.1 OUTLIER -86.38 -39.58 0.56 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.14 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 60.4 Cg_endo -82.53 143.64 12.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.667 2.245 . . . . 0.0 112.465 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.24 137.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.92 163.04 30.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 158.72 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -122.07 49.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -106.78 -40.06 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.852 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.91 157.99 67.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -50.04 -30.11 23.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.609 2.206 . . . . 0.0 112.056 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.09 -40.54 89.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.452 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -67.99 -44.13 79.39 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.429 ' HA ' HD22 ' A' ' 318' ' ' ASN . 27.1 mtt-85 -66.08 -46.15 78.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.76 80.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.316 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -72.7 -24.38 60.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 260' ' ' TYR . 65.5 m-20 -72.8 -24.27 60.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 277' ' ' ARG . 12.7 ttt-85 -91.72 101.68 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.23 139.52 39.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.759 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.32 155.11 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.04 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 323' ' ' ILE . 2.7 tp10 -145.09 143.17 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 111.018 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.402 ' N ' ' HG3' ' A' ' 322' ' ' GLU . 17.8 mt -125.89 112.7 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.5 m -122.03 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.169 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -115.51 135.05 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.635 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 41.5 t30 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.703 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.836 0.35 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 p -92.08 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.113 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 157' ' ' ARG . 2.5 mt -121.35 159.65 25.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.2 m -81.31 178.91 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.245 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.7 pp -83.1 132.71 35.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.662 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.632 HD23 HD11 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -131.95 138.33 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.7 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -124.09 123.08 39.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.717 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -129.41 115.72 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.394 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -136.5 130.36 32.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 149' ' ' PRO . 42.1 mtt85 -112.22 140.15 47.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.8 p -142.89 114.82 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.623 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 56.66 -161.09 7.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.72 7.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 110.49 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 88' ' ' GLY . 99.7 m -107.58 130.93 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.35 116.93 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.3 m -103.25 121.38 42.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.582 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -123.05 127.62 49.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 123' ' ' GLN . 1.7 mt -139.31 123.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.386 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . 178.36 -161.39 28.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -137.33 156.36 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.624 0.249 . . . . 0.0 110.447 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -133.28 150.88 76.5 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.569 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.6 -19.66 31.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.772 2.315 . . . . 0.0 112.132 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.8 173.36 10.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -82.05 -34.8 29.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.89 85.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.9 78.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -36.75 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.717 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -37.5 64.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.536 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -60.56 -38.07 83.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.28 -43.98 69.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.016 0.436 . . . . 0.0 110.3 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.0 mtp -58.0 -26.31 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.531 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -43.97 96.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.79 -21.95 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.415 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.8 mt -99.64 -1.43 38.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -47.79 -34.39 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 -32.13 29.98 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.38 -34.91 69.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.317 . . . . 0.0 110.595 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mt -39.28 116.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.506 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -159.14 155.15 23.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.354 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.672 ' O ' ' N ' ' A' ' 118' ' ' VAL . 26.7 Cg_endo -65.11 -83.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.753 2.302 . . . . 0.0 112.108 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -41.86 -11.71 0.01 OUTLIER Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.672 ' N ' ' O ' ' A' ' 116' ' ' PRO . 27.8 t -92.38 137.51 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 122.416 -0.461 . . . . 0.0 110.743 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -100.44 134.9 42.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.236 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.46 114.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.998 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -124.74 122.59 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.792 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 121' ' ' ILE . 49.5 m-20 -133.56 86.85 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.007 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 93' ' ' LEU . 11.6 mm100 -83.84 55.39 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.033 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.1 128.44 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.47 143.29 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.32 112.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.5 134.6 19.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.69 33.06 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.18 -51.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' ASP . 35.3 m -56.14 150.03 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.632 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -104.03 159.04 16.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.406 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.08 151.16 41.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 183' ' ' TRP . 11.4 tp -80.99 133.12 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.656 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.68 133.42 56.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 105' ' ' ALA . 26.5 p90 -102.35 -22.87 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.584 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.2 m -34.17 -61.8 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.516 0.674 . . . . 0.0 110.988 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.18 20.76 9.8 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.747 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.763 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -124.4 -9.78 7.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -56.86 -43.85 99.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.803 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.2 Cg_exo -55.05 -36.49 92.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.39 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.478 HG23 ' OG1' ' A' ' 182' ' ' THR . 43.4 t -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.9 m-85 -62.39 -42.72 99.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.807 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -71.34 -36.04 71.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.664 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.06 -20.42 61.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.562 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -116.34 12.08 15.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -68.83 -43.28 27.16 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 12.2 Cg_exo -66.21 6.5 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.643 2.228 . . . . 0.0 111.901 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mm -111.91 99.99 47.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.722 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 86' ' ' ARG . 65.4 Cg_endo -79.83 -5.57 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.615 2.21 . . . . 0.0 112.187 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -117.52 40.49 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.517 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 4.0 t80 -127.65 137.87 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.631 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -142.94 160.46 27.5 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.49 138.55 24.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.756 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -106.15 128.65 54.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.2 t -112.81 138.55 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 158' ' ' ASP . 21.8 tt0 -150.39 102.83 3.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.754 ' O ' HD12 ' A' ' 79' ' ' LEU . 15.7 mtt180 49.83 -91.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 156' ' ' GLU . 4.4 p30 -121.57 33.98 5.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.92 130.75 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.338 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.4 129.88 62.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.696 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.02 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.67 105.29 12.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 p -118.04 149.72 40.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.29 175.32 14.38 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 66.7 p -100.17 119.27 38.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.48 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -87.09 145.79 38.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.52 -60.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.759 2.306 . . . . 0.0 111.845 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 t -124.47 153.87 41.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -30.89 71.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.872 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.26 -43.46 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -58.45 -37.08 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.013 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -69.09 -39.03 79.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.001 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -59.28 -47.78 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.877 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.68 77.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.09 -39.12 65.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -64.32 -44.31 91.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -64.95 -44.44 89.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.586 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -31.92 72.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.83 71.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 -47.76 83.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.7 t -70.72 -27.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.556 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 183' ' ' TRP . 0.9 OUTLIER -66.38 -60.92 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.625 ' CD1' HD21 ' A' ' 133' ' ' LEU . 21.7 m95 -120.67 85.14 38.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.139 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.67 ' O ' ' N ' ' A' ' 186' ' ' MET . 17.6 Cg_exo -62.35 20.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.88 2.387 . . . . 0.0 111.73 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 183' ' ' TRP . 0.8 OUTLIER -35.9 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.67 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.5 ttm 78.08 -8.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -120.05 80.98 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.19 136.71 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.1 t -126.97 121.72 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -87.73 125.99 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.57 40.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.466 . . . . 0.0 110.427 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.48 126.43 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -126.91 148.51 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 194' ' ' VAL . 2.3 p -97.03 110.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.716 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 195' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.427 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.662 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 31.1 t . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.905 0.383 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 210' ' ' ASP . . . -38.65 160.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.761 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 0.0 OUTLIER 33.12 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.154 0.502 . . . . 0.0 110.15 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -56.76 -42.94 80.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.065 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 216' ' ' ASN . 12.7 pt20 -71.96 -49.74 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.191 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 72.7 m -71.08 -48.69 51.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -62.51 -44.84 95.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.426 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 211' ' ' LEU . 3.6 tp -69.36 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.6 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 220' ' ' GLY . 3.1 m120 -67.8 -39.77 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.422 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.33 70.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.273 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' ALA . 74.3 t -58.46 -47.03 89.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.189 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 221' ' ' GLY . 68.1 p -87.83 -21.5 25.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.584 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.32 -37.57 0.21 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -160.48 179.75 35.78 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.6 154.22 9.46 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.763 2.308 . . . . 0.0 112.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -66.21 -37.72 86.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.04 -43.42 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 240' ' ' LEU . 10.4 tt -58.64 -32.35 68.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.374 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -44.73 94.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -63.67 -41.29 98.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.87 -40.91 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.51 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.518 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.91 -45.91 85.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -56.11 -50.81 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.67 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 0.4 OUTLIER -65.01 -35.54 81.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.702 HD21 HD13 ' A' ' 285' ' ' LEU . 9.0 tp -55.29 -30.2 59.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.368 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 249' ' ' ALA . 8.5 ptmt -63.63 -36.13 82.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.407 ' N ' ' HG2' ' A' ' 248' ' ' LYS . . . -107.49 3.24 24.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.714 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 85.7 m -74.63 -28.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 41.1 Cg_exo -55.12 -14.37 8.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.539 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 251' ' ' PRO . 9.0 t70 -40.89 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -119.99 -153.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.082 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 2.7 ttp180 -106.83 138.06 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.94 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.1 131.72 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -124.13 124.28 42.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 77.9 mt -113.01 117.44 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 110.715 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.42 131.99 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.383 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -108.07 133.19 11.52 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 318' ' ' ASN . 11.8 m-85 -100.49 107.82 19.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.56 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -143.84 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.282 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 262' ' ' ASP . 36.2 t0 -145.92 -99.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.497 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 0.2 OUTLIER -177.96 44.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.606 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.0 m -45.97 -58.74 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.465 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.439 0.162 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 272' ' ' PRO . 0.4 OUTLIER -73.46 -48.33 7.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.163 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 28.0 Cg_exo -53.53 -39.51 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.993 1.795 . . . . 0.0 111.669 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.21 -44.7 75.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.22 77.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.48 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.551 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.85 -45.18 90.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.439 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.621 ' O ' HG23 ' A' ' 281' ' ' VAL . 0.3 OUTLIER -60.14 -44.51 94.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.335 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -68.19 -45.74 72.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.367 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.27 -45.99 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.529 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 277' ' ' ARG . 57.3 t -61.39 -46.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.28 88.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.39 -32.97 69.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.546 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.6 -48.19 27.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.702 HD13 HD21 ' A' ' 247' ' ' LEU . 46.8 mt -59.45 -44.69 92.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.313 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 65.3 t -59.34 -37.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.291 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.32 -20.7 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.518 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.94 0.15 56.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.27 18.13 20.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 247' ' ' LEU . 98.2 t -86.1 132.79 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.602 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.98 104.45 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.63 16.74 7.58 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.648 ' N ' ' OD1' ' A' ' 293' ' ' ASP . 0.0 OUTLIER -96.4 -12.2 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.703 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.652 ' N ' ' ND1' ' A' ' 294' ' ' HIS . 0.2 OUTLIER -119.45 23.38 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.633 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 4.9 mt -117.19 134.13 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.39 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.119 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.94 129.16 49.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.867 0.365 . . . . 0.0 110.992 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 12.1 t -133.26 116.69 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 301' ' ' GLY . . . -89.15 105.59 3.21 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 302' ' ' SER . 26.0 mt -56.64 77.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 299' ' ' GLY . . . -47.49 80.6 0.0 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.634 ' N ' ' O ' ' A' ' 300' ' ' LEU . 70.3 m 73.91 -52.89 0.69 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.292 0.567 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 300' ' ' LEU . 2.8 m -27.99 130.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 29.4 t-20 58.19 56.82 6.65 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 110.338 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 41.8 Cg_endo -71.69 176.78 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.905 2.403 . . . . 0.0 112.369 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 20.9 mt -132.52 -72.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.532 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -130.19 137.28 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.449 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 310' ' ' ALA . 5.3 p -68.02 171.05 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -76.18 24.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -44.29 -52.88 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.365 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.41 161.93 56.27 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -50.37 -41.06 52.57 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.255 1.97 . . . . 0.0 111.738 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.84 -42.26 98.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.04 -47.53 59.1 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.568 ' CZ ' ' NH2' ' A' ' 319' ' ' ARG . 58.2 ttt180 -60.16 -46.26 90.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.339 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.22 78.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.382 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -31.42 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.65 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.5 t-20 -79.95 -25.13 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.549 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' A' ' 315' ' ' ARG . 1.5 mtt85 -80.38 82.21 6.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.317 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.3 ttm180 -129.03 141.97 51.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.33 161.12 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.033 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.24 127.9 16.18 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.086 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.47 110.33 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.37 135.65 60.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.3 p -115.76 135.62 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.225 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.618 ' O ' HD13 ' A' ' 211' ' ' LEU . 2.0 t30 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.663 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.679 0.276 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.86 121.42 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 5.1 mp -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 p -50.64 134.95 23.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -47.56 124.11 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.61 125.57 38.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.356 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -101.91 131.54 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.892 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.489 HG23 ' CD2' ' A' ' 93' ' ' LEU . 79.8 mt -133.85 120.0 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 92' ' ' THR . 15.5 t -133.34 140.05 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.502 ' CG ' HG12 ' A' ' 91' ' ' VAL . 1.5 ttt180 -125.22 150.01 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' THR . 8.9 t -145.23 95.09 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 46.72 -130.45 12.1 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 118' ' ' VAL . 32.5 m-20 -69.65 4.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 87' ' ' SER . 30.9 m -115.98 126.05 53.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.535 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 91' ' ' VAL . 22.7 m -117.48 117.57 55.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.407 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.571 HG22 ' CD1' ' A' ' 94' ' ' ILE . 7.8 m -106.6 126.07 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.825 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 84' ' ' ILE . 6.9 mt -129.88 121.19 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.486 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.571 ' CD1' HG22 ' A' ' 92' ' ' THR . 2.4 mp -133.86 141.49 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.631 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.07 -157.28 27.72 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -130.98 156.8 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 0.0 110.563 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -141.42 153.35 65.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.3 -29.73 80.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.925 2.417 . . . . 0.0 112.455 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.56 176.1 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.648 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -74.85 -16.03 60.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.524 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.42 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.202 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.41 77.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.129 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 122' ' ' ASP . 2.6 tttp -63.81 -36.45 83.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.375 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.31 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.72 79.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.14 -41.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.603 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.7 mmt -58.35 -39.44 79.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -38.6 89.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.39 -16.12 62.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.86 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -100.77 -13.95 18.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -52.17 -25.6 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -10.81 81.51 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.3 tt -111.13 -17.25 13.27 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.261 -0.553 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.74 95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . -151.73 140.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' C ' ' H ' ' A' ' 118' ' ' VAL . 81.8 Cg_exo -41.17 173.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.6 2.2 . . . . 0.0 112.276 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.0 -14.64 0.18 Allowed Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 113' ' ' LEU . 48.8 t -101.72 139.39 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 122.218 -0.578 . . . . 0.0 110.646 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -108.06 123.55 48.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.619 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.19 114.43 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.463 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 92' ' ' THR . 0.8 OUTLIER -130.34 139.6 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 103' ' ' LYS . 7.7 p-10 -154.43 110.43 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -95.21 90.16 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.67 129.09 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.009 0.433 . . . . 0.0 111.132 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 148.94 22.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.566 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.02 117.95 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.228 0.537 . . . . 0.0 110.987 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.611 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -112.66 141.26 25.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.083 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 127' ' ' ASP . 91.1 Cg_exo -29.3 -62.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.06 2.507 . . . . 0.0 112.856 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 129' ' ' VAL . 6.1 p -164.09 47.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.267 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 127' ' ' ASP . 1.5 m -50.4 -169.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -108.86 158.81 17.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -148.97 155.86 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.04 136.16 37.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.04 129.24 39.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 136' ' ' SER . 0.0 OUTLIER -105.45 -8.32 18.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.579 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.8 t -21.51 -47.74 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.403 0.621 . . . . 0.0 111.002 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.4 t -133.42 65.64 1.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.284 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -123.56 -15.5 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.5 tt0 -48.11 -49.32 61.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.7 Cg_exo -57.97 -30.94 91.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.728 2.285 . . . . 0.0 112.105 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.503 ' O ' ' OG ' ' A' ' 145' ' ' SER . 18.3 t -67.07 -42.98 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.9 m-85 -62.35 -41.7 98.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.245 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 21.3 p -60.88 -37.69 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.081 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.61 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.797 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 141' ' ' VAL . 0.7 OUTLIER -106.44 11.24 31.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 142' ' ' PHE . 3.5 t -88.23 -32.24 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 60.3 Cg_endo -85.84 9.6 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.862 2.374 . . . . 0.0 112.357 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 148' ' ' ILE . 8.8 mt -126.63 98.56 31.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 173.71 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.6 2.2 . . . . 0.0 112.058 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 52.88 54.19 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.69 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.651 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -127.08 145.8 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.36 149.03 16.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 162' ' ' LEU . 17.3 tp -139.02 126.48 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' N ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -126.08 126.7 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.852 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 154' ' ' LYS . 88.8 t -114.82 122.83 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.14 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 158' ' ' ASP . 4.8 tt0 -110.98 163.42 13.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -25.52 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.782 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 156' ' ' GLU . 1.4 p-10 -156.14 29.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.536 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 125.97 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.534 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.54 121.65 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 189' ' ' VAL . 24.4 m -130.38 136.96 49.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.592 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -119.19 109.22 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 147.99 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.542 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.81 -169.28 36.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.2 m -107.37 137.44 45.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.737 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -124.62 109.65 28.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.43 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.31 -16.11 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.435 2.09 . . . . 0.0 112.417 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.21 129.37 35.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.03 -41.71 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.647 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -35.75 76.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.582 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.644 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.3 m170 -63.06 -42.18 99.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -66.84 -39.4 87.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.98 -46.1 90.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.863 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.24 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 171' ' ' HIS . 17.9 t -70.59 -37.59 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.804 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -62.38 -49.32 75.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.797 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.89 -39.42 94.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.17 96.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.09 68.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.4 m -58.16 -39.57 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.412 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.8 p -65.85 -27.05 67.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.335 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.476 ' HB ' ' CD2' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.86 -44.07 28.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.476 ' CD2' ' HB ' ' A' ' 182' ' ' THR . 2.3 m-90 -138.21 67.26 46.85 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.627 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.27 -10.75 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.814 2.343 . . . . 0.0 111.973 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.71 58.47 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.433 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -176.57 -170.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.533 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -107.21 110.75 22.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 183' ' ' TRP . 39.7 mt -116.41 131.41 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 161' ' ' THR . 17.0 m -131.02 121.4 49.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.57 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -89.56 110.17 21.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.613 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -104.1 55.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.662 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.41 115.85 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.385 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 2.9 pp20? -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.683 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 166' ' ' ALA . 3.0 m -93.53 134.99 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.313 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.479 ' SG ' ' HD3' ' A' ' 251' ' ' PRO . 1.9 t . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.686 0.279 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -135.82 -147.89 0.28 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.256 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -70.01 50.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.151 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 211' ' ' LEU . 0.1 OUTLIER -66.66 -31.52 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 212' ' ' GLN . 0.0 OUTLIER -54.19 -31.62 53.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 72.8 m -65.94 -48.55 70.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.706 0.765 . . . . 0.0 110.996 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -75.26 -34.55 61.39 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.848 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.718 HG21 HG11 ' A' ' 325' ' ' VAL . 0.3 OUTLIER -58.37 -39.5 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 2.2 m-20 -53.63 -34.42 58.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.083 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.88 62.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.53 -43.38 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 221' ' ' GLY . 6.3 p -93.67 -31.56 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.463 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.96 -35.33 0.1 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -174.56 -173.15 40.26 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.66 154.07 32.98 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.735 2.29 . . . . 0.0 111.895 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.806 0.336 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.47 -32.92 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.292 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.0 OUTLIER -66.46 -40.94 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.52 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.468 ' O ' ' NE ' ' A' ' 288' ' ' ARG . 12.5 mt -58.56 -47.28 84.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.344 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.515 ' C ' ' OD1' ' A' ' 241' ' ' ASN . 8.7 t-20 -63.52 -33.19 75.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.296 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.75 84.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.513 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 285' ' ' LEU . 48.3 t -62.06 -42.55 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 247' ' ' LEU . . . -56.43 -41.59 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 109.897 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.58 -40.14 74.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.4 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 28.9 ttmt -69.6 -31.29 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.453 HD11 HG23 ' A' ' 290' ' ' VAL . 0.1 OUTLIER -53.71 -33.04 54.24 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.3 OUTLIER -62.0 -12.11 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.496 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -69.04 11.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.879 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.563 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -37.63 -48.8 2.68 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.23 -178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.479 ' HD3' ' SG ' ' A' ' 208' ' ' CYS . 31.3 Cg_exo -56.29 -18.64 24.97 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.904 1.736 . . . . 0.0 111.596 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 254' ' ' ARG . 14.0 m-20 -156.74 39.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.668 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -62.65 62.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.711 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 252' ' ' ASP . 1.6 mtm180 -111.52 134.91 52.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.05 139.5 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.926 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.9 m -122.54 127.05 49.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 295' ' ' ILE . 74.1 mt -102.1 123.19 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 111.254 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.41 120.1 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.15 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -100.55 139.57 14.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.36 100.41 6.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.568 ' CG2' ' ND2' ' A' ' 263' ' ' ASN . 1.3 m -141.48 128.25 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.547 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.51 ' CG ' ' N ' ' A' ' 263' ' ' ASN . 22.4 t70 -68.54 -116.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.568 ' ND2' ' CG2' ' A' ' 261' ' ' THR . 50.9 m-20 65.15 41.09 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.706 ' O ' ' ND2' ' A' ' 270' ' ' ASN . 10.5 m -31.92 -74.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.706 ' ND2' ' O ' ' A' ' 264' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.573 0.225 . . . . 0.0 111.329 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.1 mm -72.67 -51.97 6.58 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.705 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.4 Cg_endo -62.0 -30.22 82.82 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.934 1.756 . . . . 0.0 112.115 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 273' ' ' LEU . 0.3 OUTLIER -64.4 -48.76 74.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.179 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 12.0 p -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.54 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.91 64.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 272' ' ' PRO . 6.9 tt0 -61.12 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.517 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -33.12 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.59 -33.99 76.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -43.31 84.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.3 -37.2 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.3 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.48 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.312 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.48 80.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -41.73 84.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.335 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -70.69 -42.34 70.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 243' ' ' VAL . 1.7 mm? -59.76 -49.19 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.93 -34.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.5 67.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.298 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 240' ' ' LEU . 3.1 tpt85 -80.77 -1.24 42.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.0 0.429 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.63 3.51 43.31 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.453 HG23 HD11 ' A' ' 247' ' ' LEU . 95.5 t -67.3 128.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.467 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -79.99 107.85 13.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.745 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -55.96 -4.25 0.68 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -68.52 -10.6 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -134.97 52.64 2.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 292' ' ' GLY . 17.6 tt -133.04 139.3 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.27 142.33 43.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.2 p -122.62 142.15 50.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.887 0.375 . . . . 0.0 110.955 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.39 116.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.282 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.3 107.45 3.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 300' ' ' LEU . 10.2 mp -97.65 62.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.449 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -34.94 -102.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -112.49 99.86 8.3 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 122.99 -0.124 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.717 HG12 ' N ' ' A' ' 304' ' ' ASN . 54.4 t -119.59 -95.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.717 ' N ' HG12 ' A' ' 303' ' ' VAL . 0.4 OUTLIER -89.16 -52.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.649 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 68.4 Cg_endo -80.72 153.33 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.772 2.315 . . . . 0.0 112.309 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.8 tt -167.62 137.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.416 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.21 137.66 47.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 309' ' ' ASN . 13.3 t -74.18 79.95 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 308' ' ' SER . 20.9 p-10 -32.23 116.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -174.87 -50.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.482 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 164.38 15.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.39 -43.01 46.29 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.868 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -45.86 92.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.13 97.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -60.8 -40.92 94.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.48 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.21 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -68.05 -37.47 81.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 13.2 t-20 -72.08 -6.55 43.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.28 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -160.0 89.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.318 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -134.43 149.09 50.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.012 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.3 t -123.83 145.25 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.837 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.94 129.8 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.43 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.69 109.87 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 178.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 135.86 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.718 HG11 HG21 ' A' ' 215' ' ' ILE . 2.4 p -107.93 135.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 20.3 t30 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.645 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' C ' ' OG ' ' A' ' 78' ' ' SER . 3.7 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.818 0.342 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -168.93 121.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.68 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 132' ' ' SER . 1.9 mm? -110.46 151.79 27.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.466 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.95 151.84 18.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.445 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -66.07 129.49 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -131.49 130.77 42.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -109.68 121.17 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.95 118.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.606 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 t -130.52 132.45 45.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.456 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.48 HH11 HG22 ' A' ' 91' ' ' VAL . 25.4 ttm-85 -112.86 143.71 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 p -140.57 120.68 13.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.315 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 48.68 -135.77 19.4 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -88.48 17.08 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.824 0.345 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -109.97 139.06 45.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.688 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 HH11 ' A' ' 86' ' ' ARG . 89.6 t -112.95 114.13 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.458 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 116.45 32.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 93' ' ' LEU . 1.2 mm? -109.8 122.26 47.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.356 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.28 124.73 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.7 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.25 -135.83 4.48 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -154.36 156.91 37.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.749 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.92 153.99 80.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.497 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.2 -26.96 41.83 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.24 . . . . 0.0 112.011 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.3 p-10 -168.07 158.38 10.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.344 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.76 74.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.328 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.66 77.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -42.98 73.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.04 -40.61 73.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.29 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.54 -46.02 60.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.4 mtm -59.74 -33.14 71.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 2.9 m -62.01 -40.54 96.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.99 -29.51 66.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.79 -0.65 57.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.466 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 112' ' ' GLY . 4.2 p-10 -52.47 -22.66 5.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 111' ' ' ASN . . . -83.48 -10.07 82.44 Favored Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -97.4 -51.25 4.23 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.447 -0.443 . . . . 0.0 110.546 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -35.23 106.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -149.38 173.55 4.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 25.2 Cg_exo -57.76 164.81 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.632 2.221 . . . . 0.0 112.288 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.38 13.41 2.69 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -102.36 138.66 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.209 -0.583 . . . . 0.0 110.754 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.4 137.95 45.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.273 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.98 122.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.96 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.44 128.04 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.918 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.13 81.78 1.94 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -92.12 48.43 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.253 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -105.4 130.54 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -93.37 146.54 23.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.783 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.8 111.58 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 129' ' ' VAL . 31.6 m-20 -125.44 103.9 28.62 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -52.36 69.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.494 2.13 . . . . 0.0 112.293 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.677 ' O ' ' NE ' ' A' ' 131' ' ' ARG . 3.4 p -179.27 -30.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.742 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.02 164.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.677 ' NE ' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -122.45 159.17 28.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.478 ' C ' HD11 ' A' ' 79' ' ' LEU . 10.2 t -133.86 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -81.76 135.65 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.64 137.44 43.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -105.94 6.83 31.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.057 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t -45.72 132.71 8.54 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m 45.47 38.21 3.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 135' ' ' PHE . . . -101.6 -10.95 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -53.18 -47.32 96.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.367 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 32.0 Cg_exo -58.26 -36.55 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.782 2.321 . . . . 0.0 111.654 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.39 -44.4 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.49 -38.62 91.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.314 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 35.6 p -62.69 -37.24 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.44 -21.08 56.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.03 10.84 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -77.71 -43.58 2.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.493 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 28.1 Cg_exo -57.56 -9.6 5.58 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.512 2.142 . . . . 0.0 111.534 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 171' ' ' HIS . 1.3 mm -108.57 93.46 11.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.321 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.8 7.99 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.628 2.219 . . . . 0.0 112.311 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.38 50.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.38 141.57 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.23 123.07 4.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -118.51 135.28 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 130.22 49.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.19 133.86 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.044 0.449 . . . . 0.0 111.266 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -140.79 78.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 159' ' ' THR . 7.4 ttp180 70.11 -137.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.989 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -75.97 25.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.47 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ARG . 3.6 m -127.8 139.97 52.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.55 134.82 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.284 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 189' ' ' VAL . 11.2 m -127.35 136.88 52.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.913 ' N ' HD12 ' A' ' 162' ' ' LEU . 2.2 mp -106.64 125.23 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.951 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -137.93 146.89 43.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.09 163.18 10.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.2 p -87.03 126.75 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.749 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -99.84 146.86 32.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.2 -23.76 24.08 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.784 2.323 . . . . 0.0 111.901 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.86 137.93 21.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -36.33 83.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.86 -35.3 79.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.574 ' CE1' HD11 ' A' ' 148' ' ' ILE . 1.7 m-70 -57.47 -43.7 84.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.894 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -36.17 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.683 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.87 -40.18 87.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.37 99.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.45 -37.04 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -61.83 -48.62 79.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -55.8 -48.27 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.488 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.39 87.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.29 -41.3 96.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.664 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.0 -38.88 90.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 m -71.04 -37.47 72.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.37 -22.11 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.823 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' ALA . 7.9 m0 -141.69 88.36 9.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.664 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 186' ' ' MET . 71.5 Cg_endo -82.96 15.73 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.073 2.515 . . . . 0.0 112.291 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.9 OUTLIER -31.58 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 184' ' ' PRO . 9.3 ttt 80.47 -23.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -103.24 68.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.85 134.43 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 161' ' ' THR . 94.1 t -115.4 130.18 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.65 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 3.3 p-10 -97.02 119.12 34.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.96 50.49 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 192' ' ' ILE . 1.6 pp -101.59 129.56 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -98.7 139.41 34.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.356 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 194' ' ' VAL . 6.8 m -109.52 119.91 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 195' ' ' THR . 3.0 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.319 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 52.8 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -68.45 147.2 52.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.177 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 35.78 27.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 109.815 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 209' ' ' ALA . 56.9 tp -56.28 -31.7 63.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 213' ' ' SER . 14.3 pt20 -54.65 -44.76 73.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.79 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 74.1 m -69.78 -40.44 76.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.172 0.51 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -68.83 -37.15 78.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.514 ' CD1' HG22 ' A' ' 243' ' ' VAL . 3.5 mm -59.6 -36.53 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.709 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 220' ' ' GLY . 0.7 OUTLIER -57.3 -42.0 80.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.804 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.13 -41.45 63.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.698 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 214' ' ' ALA . 85.4 t -59.96 -45.12 95.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.706 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 221' ' ' GLY . 75.0 p -94.52 -23.24 17.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 65.95 -2.46 3.8 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -171.15 -172.82 37.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.97 151.47 62.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.732 2.288 . . . . 0.0 112.048 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.572 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -58.86 -34.66 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.899 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.77 -46.37 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.05 -34.37 73.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.626 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.23 -45.32 80.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -61.06 -43.74 98.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.333 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 215' ' ' ILE . 51.0 t -68.18 -39.38 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.453 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.728 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -64.81 -46.6 81.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -60.53 -50.77 72.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -60.47 -31.66 70.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.482 HD13 HD22 ' A' ' 285' ' ' LEU . 0.9 OUTLIER -62.67 -32.92 74.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.252 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.65 -18.59 64.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.92 -2.05 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 0.0 110.73 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.687 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.4 m -74.97 -28.72 0.82 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 43.6 Cg_exo -53.6 -16.04 7.34 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.148 1.899 . . . . 0.0 112.405 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.511 ' C ' ' OD1' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -62.4 -9.43 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.553 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -136.07 -157.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.878 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -108.79 138.2 45.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.08 133.31 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.007 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.651 HG22 ' OD1' ' A' ' 258' ' ' ASN . 95.2 m -120.75 116.13 24.64 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.0 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 295' ' ' ILE . 53.3 mt -100.96 112.54 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.768 0.318 . . . . 0.0 110.557 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.651 ' OD1' HG22 ' A' ' 256' ' ' THR . 4.4 m120 -112.6 122.65 48.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -122.85 133.98 9.36 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.649 ' HB2' HG11 ' A' ' 303' ' ' VAL . 29.6 p90 -130.52 154.67 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.799 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 262' ' ' ASP . 30.8 p -117.42 -118.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.603 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 303' ' ' VAL . 14.6 p-10 -134.58 -99.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.264 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.599 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 1.7 p30 -174.82 -123.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.943 ' O ' HD12 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -55.85 -49.96 89.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.657 ' HD3' HG23 ' A' ' 271' ' ' ILE . 21.8 Cg_endo -62.69 -39.93 40.26 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.594 1.529 . . . . 0.0 111.883 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.62 -34.08 77.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -40.0 94.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.763 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.62 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -65.9 -34.62 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.554 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -60.26 -45.67 92.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.67 76.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.46 -44.46 87.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.98 -36.96 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.298 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.87 -41.93 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -62.97 -39.66 95.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.95 -41.6 87.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.04 -44.28 85.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.729 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 247' ' ' LEU . 89.7 mt -59.72 -41.37 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.5 t -60.06 -36.31 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.167 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.24 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.772 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.728 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -86.6 -1.85 58.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 18.15 11.79 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.552 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 74.6 t -87.2 124.06 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 110.433 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -70.12 98.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.68 16.5 0.4 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 291' ' ' ALA . 25.3 t0 -93.21 -13.36 28.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.775 0.321 . . . . 0.0 110.518 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -132.48 24.72 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.815 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 295' ' ' ILE . 16.1 tt -116.36 125.34 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.468 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.86 48.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.552 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p -124.05 138.48 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.387 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.11 122.13 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.528 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -98.12 107.73 3.5 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.0 OUTLIER -38.96 -61.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.723 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.64 ' HA2' HD13 ' A' ' 271' ' ' ILE . . . 96.15 106.57 2.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.0 p 40.24 90.01 0.01 OUTLIER 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.971 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 260' ' ' TYR . 0.7 OUTLIER -107.24 160.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 303' ' ' VAL . 0.6 OUTLIER -40.33 152.76 0.22 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.402 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.2 114.64 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.746 2.297 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 16.2 mt -103.03 -42.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.73 168.88 11.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.506 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.45 90.41 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.483 ' CG ' ' O ' ' A' ' 309' ' ' ASN . 3.7 t30 -65.73 -1.06 2.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.68 -11.1 1.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.99 158.44 69.71 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.62 -36.59 81.52 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.85 2.366 . . . . 0.0 111.918 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -64.62 -31.45 72.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.406 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.99 99.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.683 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 6.7 ttm180 -60.8 -37.77 83.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.403 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.09 -36.23 82.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.55 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -36.88 64.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.806 HD22 ' N ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -74.99 -25.12 58.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.785 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.806 ' N ' HD22 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -95.57 84.41 3.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.611 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 260' ' ' TYR . 12.6 mtm180 -122.87 154.52 38.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.1 t -129.36 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.091 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.483 ' C ' HD13 ' A' ' 323' ' ' ILE . 2.8 tt0 -128.44 127.17 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -102.69 111.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.148 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 256' ' ' THR . 4.4 m -118.1 121.03 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.437 HG21 ' SG ' ' A' ' 208' ' ' CYS . 0.2 OUTLIER -105.63 135.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.553 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 3.7 t-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.858 0.361 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -130.34 126.04 36.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 27.3 mt -103.76 139.65 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.751 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -81.13 153.3 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.516 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 82' ' ' LEU . 1.3 tt -53.65 121.26 7.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -125.35 118.49 26.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.5 t -101.85 117.2 34.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.32 116.25 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -134.05 128.31 34.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.461 HH21 ' HA ' ' A' ' 149' ' ' PRO . 11.2 mtp85 -110.69 130.78 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.585 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.4 ' HG ' ' HB ' ' A' ' 90' ' ' THR . 19.9 p -130.01 115.94 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 42.3 -131.32 4.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.832 ' O ' HG23 ' A' ' 118' ' ' VAL . 22.2 m-20 -86.4 21.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.678 0.275 . . . . 0.0 110.606 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 87' ' ' SER . 75.6 m -122.07 125.73 46.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.397 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.59 132.9 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.5 m -119.31 116.56 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.382 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.93 123.35 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 123' ' ' GLN . 2.0 mt -142.08 124.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.291 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.57 -143.78 8.47 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.449 ' OD2' HG11 ' A' ' 130' ' ' VAL . 26.1 p30 -154.34 153.06 31.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 124' ' ' ILE . 33.9 p90 -137.26 150.43 68.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.83 -20.49 22.46 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.738 2.292 . . . . 0.0 112.242 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -165.87 145.75 6.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' C ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -53.75 -10.63 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' ASP . . . -60.86 -40.16 91.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.5 77.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -68.37 -37.05 80.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.86 81.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.54 77.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 106' ' ' LEU . 1.5 tt -72.19 -43.02 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -39.87 80.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -61.2 -28.36 69.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.32 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.741 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.5 mt -86.63 -17.42 33.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -45.88 -35.43 4.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.632 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.73 -17.19 66.36 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 114' ' ' LEU . 5.6 tp -95.77 -33.51 12.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.67 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 113' ' ' LEU . 1.7 tt -33.71 104.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.575 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -131.72 135.45 26.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -43.6 162.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.213 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.8 13.88 41.74 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' ASN . 8.7 p -102.54 130.14 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 121.903 -0.763 . . . . 0.0 110.761 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.81 126.08 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 120' ' ' VAL . 9.0 p -118.56 127.31 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.91 134.05 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.164 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -120.74 91.62 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.996 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.44 ' HB2' HG23 ' A' ' 94' ' ' ILE . 4.5 mm-40 -94.05 50.31 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.966 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 97' ' ' PHE . 1.3 pt -105.33 130.22 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -93.38 146.1 23.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.299 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 126' ' ' VAL . 13.7 p -100.02 120.06 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -137.45 129.87 16.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.368 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.48 41.91 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.377 2.051 . . . . 0.0 112.17 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.6 t -147.45 -35.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.449 HG11 ' OD2' ' A' ' 96' ' ' ASP . 34.0 m -67.21 164.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -115.56 158.61 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.246 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -126.12 155.94 40.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.699 HD21 ' CE2' ' A' ' 183' ' ' TRP . 37.1 tp -78.73 130.62 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.197 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.7 OUTLIER -64.18 134.53 55.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.857 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' O ' ' C ' ' A' ' 136' ' ' SER . 83.0 m-85 -120.54 6.55 10.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.22 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.558 ' C ' ' O ' ' A' ' 135' ' ' PHE . 90.0 p -24.08 -65.86 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.462 0.649 . . . . 0.0 110.985 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.41 47.69 1.97 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.845 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.58 -7.85 39.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.506 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.4 tt0 -48.49 -49.01 66.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.0 Cg_exo -55.36 -42.24 70.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.848 2.365 . . . . 0.0 112.14 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.74 -45.98 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.89 -41.63 95.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.55 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 21.8 p -65.73 -40.07 91.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.54 -18.66 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.444 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -105.55 2.58 28.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.651 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -64.54 -41.08 55.69 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 46.0 Cg_exo -53.25 -7.88 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.632 2.221 . . . . 0.0 111.719 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 150' ' ' ASP . 29.1 mt -122.77 101.53 39.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.415 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HA ' HH21 ' A' ' 86' ' ' ARG . 47.6 Cg_endo -75.66 19.26 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.187 1.925 . . . . 0.0 111.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 148' ' ' ILE . 22.4 m-20 -145.9 80.56 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.54 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.64 139.63 53.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.231 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.32 123.2 5.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.19 127.08 52.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 110.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.4 126.43 44.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.4 t -119.82 128.48 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -140.71 84.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.283 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 159' ' ' THR . 2.8 mtt180 60.77 -141.4 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.444 ' C ' ' OD2' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -68.81 27.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.413 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.602 ' H ' ' C ' ' A' ' 157' ' ' ARG . 1.8 m -139.15 129.72 25.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -131.94 135.12 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.21 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.937 ' C ' HD13 ' A' ' 162' ' ' LEU . 66.0 m -131.53 130.99 43.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.946 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.056 HD22 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -113.25 123.86 51.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.379 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 149.4 49.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 148.97 158.58 8.12 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.71 136.7 37.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.08 140.61 27.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.517 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.02 -30.57 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.506 2.137 . . . . 0.0 111.947 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 t -122.39 128.0 50.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.03 72.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.642 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 171' ' ' HIS . 3.9 pt-20 -59.36 -35.86 74.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.726 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.4 m-70 -63.19 -37.95 89.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -64.15 -38.56 91.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.89 -47.07 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 171' ' ' HIS . 47.3 t -71.28 -41.37 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.958 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -58.05 -51.31 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -45.54 94.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.23 75.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.991 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.2 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.179 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 m -67.44 -36.36 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.226 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.1 t -71.02 -43.01 68.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.1 m -72.88 -44.4 61.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.568 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.699 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.0 m0 -126.12 77.05 71.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 186' ' ' MET . 15.4 Cg_exo -65.34 12.3 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.016 2.478 . . . . 0.0 112.424 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 186' ' ' MET . 21.1 t0 -31.3 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.829 0.347 . . . . 0.0 110.551 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.583 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.6 tpt 86.99 -28.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -93.1 63.75 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -101.9 121.26 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.785 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.601 ' O ' HD22 ' A' ' 162' ' ' LEU . 2.6 t -100.58 125.28 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.173 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.433 ' C ' ' OD1' ' A' ' 190' ' ' ASN . 47.2 t-20 -91.93 124.13 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.82 44.56 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.193 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.04 133.19 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.641 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -102.72 149.15 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.435 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.8 m -108.79 108.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.787 -179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -78.42 -164.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.872 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -91.43 56.32 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.725 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.57 ' CB ' ' O ' ' A' ' 245' ' ' ASP . 4.0 mm? -58.19 -30.33 66.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.622 ' CD ' ' N ' ' A' ' 213' ' ' SER . 2.9 pp0? -53.2 -34.81 58.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.611 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.622 ' N ' ' CD ' ' A' ' 212' ' ' GLN . 89.9 p -65.61 -35.5 80.99 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.928 0.871 . . . . 0.0 110.974 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.13 -32.51 63.2 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.371 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.16 -35.94 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.414 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.1 t30 -53.89 -44.08 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.669 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.46 -28.83 61.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.608 ' CG1' HH11 ' A' ' 242' ' ' ARG . 65.8 t -58.04 -49.64 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.386 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.574 ' C ' ' H ' ' A' ' 221' ' ' GLY . 12.8 p -103.58 -11.4 17.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.13 -35.75 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -173.66 178.7 45.46 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 153.63 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.728 2.286 . . . . 0.0 112.009 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 238' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.709 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 3.8 pt-20 -61.14 -38.71 87.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.457 HG23 HH21 ' A' ' 242' ' ' ARG . 0.8 OUTLIER -71.81 -42.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.941 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 243' ' ' VAL . 0.9 OUTLIER -65.27 -47.54 76.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.667 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -68.01 -31.71 71.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.319 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.608 HH11 ' CG1' ' A' ' 218' ' ' VAL . 2.4 ttp-105 -60.92 -45.69 93.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.433 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 240' ' ' LEU . 10.8 m -63.73 -36.26 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.29 81.44 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.995 0.426 . . . . 0.0 109.859 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 211' ' ' LEU . 33.8 m-20 -56.07 -48.85 75.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 3.1 pttt -62.38 -30.47 71.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.806 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 247' ' ' LEU . 5.3 tt -53.13 -32.91 49.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -61.13 -11.35 8.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -68.07 10.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.638 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.568 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -38.52 -48.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.928 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.0 Cg_exo -54.23 -13.73 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.98 1.786 . . . . 0.0 111.353 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' ARG . 23.0 t0 -160.42 30.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.604 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -55.89 67.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.675 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' ASP . 2.6 ttt180 -116.17 135.01 54.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.94 135.86 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.923 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -122.45 120.0 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.045 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.89 127.51 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.95 122.16 41.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.276 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.69 145.44 16.88 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -134.24 149.48 50.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.645 0.259 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.591 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -162.61 -173.06 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.558 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.543 ' OD1' ' OD1' ' A' ' 270' ' ' ASN . 2.4 p30 -92.28 -164.36 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.64 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 265' ' ' GLY . 0.9 OUTLIER -125.14 -116.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.486 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 265' ' ' GLY . 0.2 OUTLIER 68.52 -29.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.528 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.543 ' OD1' ' OD1' ' A' ' 262' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.4 mm -54.79 -52.22 72.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.3 Cg_endo -61.26 -35.83 82.81 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.853 1.702 . . . . 0.0 111.876 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.6 mm? -68.5 -46.55 69.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 23.6 p -65.65 -39.76 91.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.575 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.96 95.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.441 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.98 -36.48 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 277' ' ' ARG . 4.1 mtt85 -63.24 -35.17 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.448 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.25 69.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.034 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -73.97 -47.97 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.61 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 281' ' ' VAL . 1.7 tp -60.39 -44.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.137 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.529 ' N ' ' CG2' ' A' ' 280' ' ' ILE . 27.6 m -61.28 -40.85 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -59.3 -39.0 81.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.01 -47.04 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.717 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -57.01 -39.92 75.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 290' ' ' VAL . 1.0 OUTLIER -60.84 -42.53 97.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.58 -36.25 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.64 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.003 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.64 ' O ' ' CD1' ' A' ' 247' ' ' LEU . 2.2 tpm_? -82.53 -2.79 54.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.798 0.333 . . . . 0.0 110.304 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.484 ' C ' HD11 ' A' ' 247' ' ' LEU . . . 105.97 10.63 29.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 285' ' ' LEU . 35.0 t -79.24 128.67 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.78 96.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.637 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -48.78 -8.28 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 291' ' ' ALA . 72.8 m-20 -75.93 -6.42 50.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.556 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -124.92 26.17 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 292' ' ' GLY . 61.9 mt -116.6 131.99 67.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.63 52.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 127.21 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 110.864 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.8 140.83 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.326 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.2 117.88 3.11 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.1 OUTLIER -119.23 59.84 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.524 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.515 ' HA2' ' H ' ' A' ' 261' ' ' THR . . . -77.99 -96.12 0.23 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 301' ' ' GLY . 90.1 p -36.87 -29.47 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.214 0.53 . . . . 0.0 110.955 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 301' ' ' GLY . 66.1 t -61.53 -47.41 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 301' ' ' GLY . 0.4 OUTLIER -139.73 86.42 13.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.645 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.79 163.48 9.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.952 2.435 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 74.3 mt -136.68 -22.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.321 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 308' ' ' SER . . . -119.9 151.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.437 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 307' ' ' ALA . 0.6 OUTLIER -50.29 -165.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.634 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.85 50.56 0.54 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.618 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.19 -2.86 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.523 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 p -146.62 148.63 34.28 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.374 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.45 -31.11 76.61 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.681 2.254 . . . . 0.0 111.918 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.03 -33.86 76.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.129 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.36 -44.98 97.35 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -65.27 -43.97 89.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.17 94.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.82 -32.61 74.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.235 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 261' ' ' THR . 0.7 OUTLIER -76.48 -25.43 54.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.426 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 319' ' ' ARG . 2.8 ttm180 -70.36 78.23 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.282 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -122.4 150.19 42.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.07 149.16 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.68 131.97 53.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.077 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.98 110.3 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.28 120.21 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 325' ' ' VAL . 11.8 p -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.54 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 77' ' ' LEU . 19.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 p 178.38 111.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -84.77 147.61 26.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -79.62 159.86 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.51 119.35 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.714 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.11 131.3 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.34 120.73 30.64 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.047 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.1 tt -123.15 122.64 65.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.062 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.59 127.51 35.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.621 ' HG2' HG13 ' A' ' 91' ' ' VAL . 55.9 mtt180 -114.21 141.26 47.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.218 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 126.39 16.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.66 -125.41 29.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -99.09 19.44 15.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.756 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.4 m -125.3 135.1 52.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.621 HG13 ' HG2' ' A' ' 86' ' ' ARG . 17.1 t -115.14 122.22 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 120.89 43.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -124.33 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.272 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -142.19 129.04 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.777 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.69 -152.1 21.18 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -154.39 154.37 33.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.417 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -125.96 158.95 64.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.845 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.16 -24.71 27.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.322 . . . . 0.0 112.025 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -157.91 -173.59 4.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -88.71 -19.61 25.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.515 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.78 75.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.538 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.04 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -61.89 -37.67 85.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.622 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.07 67.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 135' ' ' PHE . . . -65.96 -40.64 91.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt -62.5 -43.85 97.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.84 -42.89 85.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -62.76 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 mt -103.0 -12.79 17.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.734 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -51.91 -42.47 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.617 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.99 -13.71 57.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -98.01 -26.46 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.603 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -161.65 163.79 19.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.488 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 58.2 Cg_endo -76.15 166.64 27.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.842 2.361 . . . . 0.0 112.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.96 1.71 3.14 Favored Glycine 0 N--CA 1.461 0.325 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 116' ' ' PRO . 54.9 t -99.81 135.11 36.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 O-C-N 122.278 -0.543 . . . . 0.0 110.818 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.86 128.63 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.288 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.34 134.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.022 0.439 . . . . 0.0 111.282 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 121' ' ' ILE . 2.2 mm -123.79 125.31 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.755 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 13.3 p-10 -136.15 83.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.505 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -97.42 72.22 2.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.717 HG21 ' CE2' ' A' ' 97' ' ' PHE . 12.3 mt -105.53 130.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.93 146.2 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 126' ' ' VAL . 7.7 p -100.3 116.07 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.6 m-20 -133.6 103.14 12.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.695 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.3 Cg_exo -61.57 56.73 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.468 2.112 . . . . 0.0 112.405 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 128' ' ' PRO . 56.0 t -162.68 -39.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.814 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.35 -178.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -123.87 159.58 29.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.315 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 m -134.65 155.5 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 183' ' ' TRP . 16.1 tp -80.08 113.17 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.276 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.6 136.35 57.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.56 ' O ' ' C ' ' A' ' 136' ' ' SER . 7.7 m-85 -92.0 2.05 56.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.38 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 135' ' ' PHE . 94.4 p -24.51 -80.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.656 0.741 . . . . 0.0 110.988 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.7 20.55 16.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.761 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.47 -11.09 24.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER -55.6 -45.85 99.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.696 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 31.8 Cg_exo -54.69 -38.95 91.19 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.007 2.471 . . . . 0.0 112.508 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.423 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 40.6 t -59.79 -47.61 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -63.26 -39.35 94.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 11.4 p -62.81 -34.68 77.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.79 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.62 66.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -104.46 11.26 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.707 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -73.71 -34.67 2.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 37.4 Cg_exo -54.17 -28.75 53.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.615 2.21 . . . . 0.0 112.263 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.4 tp -118.68 109.33 40.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.47 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 86' ' ' ARG . 57.3 Cg_endo -76.7 17.34 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.09 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.512 ' H ' HG13 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -114.14 53.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.544 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.59 144.86 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -125.9 134.8 8.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -127.95 127.99 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 110.83 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.16 131.41 56.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.63 131.32 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.75 77.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 67.2 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.14 -18.17 8.76 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.36 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -104.23 131.39 51.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.913 0.387 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.15 135.48 63.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.2 m -109.19 129.82 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.85 117.98 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 m -130.21 153.2 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 140.55 155.07 6.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.5 p -81.25 141.91 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 192' ' ' ILE . . . -109.73 138.4 20.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.492 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.42 -39.53 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.482 2.121 . . . . 0.0 111.961 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.03 130.59 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.448 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 172' ' ' LYS . 47.1 m -54.85 -33.12 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.77 -35.52 77.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.5 t60 -58.5 -48.04 82.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.961 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 169' ' ' SER . 21.2 pttt -67.24 -35.2 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.857 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.49 -43.25 83.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.486 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -70.41 -35.89 73.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 171' ' ' HIS . 20.3 t -66.73 -43.65 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -62.32 -47.93 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -60.17 -51.43 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.643 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.64 72.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.37 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 185' ' ' ASP . 4.5 m -64.57 -48.86 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.3 m -72.22 -26.62 62.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 183' ' ' TRP . 2.4 m -70.33 -72.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.086 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 185' ' ' ASP . 28.0 m95 -131.36 -67.65 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 186' ' ' MET . 11.4 Cg_endo -56.54 32.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.858 2.372 . . . . 0.0 113.361 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 183' ' ' TRP . 2.3 t0 -63.39 9.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.427 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.586 ' H ' ' C ' ' A' ' 184' ' ' PRO . 6.5 mtt -116.95 -89.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.903 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -108.92 115.89 30.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.942 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -125.68 147.55 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.724 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.27 124.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -98.9 128.39 45.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -144.2 42.66 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 164' ' ' GLY . 5.3 mt -114.55 133.3 61.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.66 141.83 50.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 194' ' ' VAL . 27.1 m -96.6 117.84 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.604 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.574 -179.892 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.589 ' O ' HD23 ' A' ' 211' ' ' LEU . 43.3 t . . . . . 0 C--O 1.23 0.061 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -25.62 146.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 24.0 m-20 44.04 64.09 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 208' ' ' CYS . 0.0 OUTLIER -56.01 -43.33 77.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.25 -51.34 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.331 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.1 m -71.0 -45.15 64.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -61.51 -44.28 97.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.23 -0.294 . . . . 0.0 111.573 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 2.5 tp -69.55 -39.25 78.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -70.11 -42.92 72.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.711 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.3 -49.53 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 t -59.22 -46.09 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 215' ' ' ILE . 30.6 p -84.93 -29.29 25.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.748 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 74.72 -48.0 1.89 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -151.55 151.55 23.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.692 ' C ' HG22 ' A' ' 223' ' ' ILE . 40.3 Cg_endo -70.38 140.23 39.87 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.749 2.299 . . . . 0.0 112.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.692 HG22 ' C ' ' A' ' 222' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.465 ' O ' ' CD1' ' A' ' 237' ' ' TYR . 25.1 t80 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.776 0.322 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -46.19 75.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 49.7 mt -67.71 -38.69 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -36.74 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.439 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.04 96.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.334 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -61.32 -45.35 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.33 -38.97 81.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.483 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.653 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.11 -45.94 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -51.06 70.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.529 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.681 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 8.0 mttt -66.1 -32.83 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.611 HD23 HG21 ' A' ' 290' ' ' VAL . 3.3 tp -54.56 -30.85 55.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.488 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 0.8 OUTLIER -63.81 -36.98 85.68 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.576 ' O ' ' OD1' ' A' ' 252' ' ' ASP . . . -101.57 5.27 41.65 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.972 0.415 . . . . 0.0 111.351 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.716 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.9 m -74.84 -27.51 0.73 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 52.1 Cg_exo -54.21 -15.66 8.4 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.372 2.048 . . . . 0.0 112.891 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -42.1 -18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 326' ' ' ASN . . . -125.65 -154.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.624 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.499 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 1.2 mtm180 -110.27 136.0 50.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 295' ' ' ILE . 0.6 OUTLIER -119.15 132.81 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.955 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.3 m -122.74 122.29 38.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.04 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.1 mt -102.23 116.71 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -101.77 130.21 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.363 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.59 127.74 7.02 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 318' ' ' ASN . 43.1 m-85 -106.57 136.58 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.405 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -128.47 -161.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.656 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 2.5 p30 -132.83 125.47 30.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.2 p30 -42.92 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.9 m 51.06 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 271' ' ' ILE . 23.7 p-10 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.631 0.253 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.9 mm -57.59 -51.62 80.37 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.917 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 9.4 Cg_endo -57.36 -31.96 92.53 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.906 1.737 . . . . 0.0 112.083 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.58 -40.32 80.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.433 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.9 p -69.82 -37.78 76.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.73 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.85 -40.42 92.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.577 ' O ' HG22 ' A' ' 281' ' ' VAL . 6.4 mtt-85 -60.0 -44.28 94.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' ALA . . . -67.72 -32.6 73.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.416 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -70.92 -46.27 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.29 -46.28 95.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 277' ' ' ARG . 33.2 m -72.46 -38.75 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.391 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -43.06 79.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.38 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -72.43 -34.91 68.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 281' ' ' VAL . 5.2 mp -60.05 -48.27 82.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 282' ' ' ALA . 12.0 t -63.44 -36.17 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.298 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.37 -20.17 65.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.653 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -90.25 -2.14 58.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.629 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 19.94 9.69 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.465 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.611 HG21 HD23 ' A' ' 247' ' ' LEU . 64.9 t -87.74 129.65 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.405 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -74.53 101.04 4.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.943 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.02 9.53 0.97 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.7 OUTLIER -83.27 -12.32 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 110.651 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -134.67 11.66 3.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.981 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.541 ' HA ' HG13 ' A' ' 255' ' ' VAL . 14.1 tt -88.33 133.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -138.66 135.52 34.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 128.26 48.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.1 116.71 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.58 114.72 4.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.35 54.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -54.49 -92.65 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.47 ' C ' ' CG2' ' A' ' 303' ' ' VAL . 89.8 p -79.8 69.08 6.06 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 122.939 -0.154 . . . . 0.0 110.955 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 304' ' ' ASN . 0.2 OUTLIER -154.93 163.97 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.531 ' O ' ' O ' ' A' ' 303' ' ' VAL . 6.5 m120 33.29 96.2 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.424 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.52 162.98 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.625 2.217 . . . . 0.0 112.298 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 306' ' ' ILE . 24.1 mt -153.5 -79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.308 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -125.1 155.58 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.518 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.07 141.12 58.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.598 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 4.7 p-10 -98.77 41.14 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.55 -36.21 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.683 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.79 153.75 37.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.718 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -36.1 98.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.803 2.336 . . . . 0.0 112.02 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -66.29 -32.15 73.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.15 87.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -62.59 -45.74 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.5 80.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.97 -30.32 68.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.4 t-20 -74.95 -23.03 58.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -87.45 87.91 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.562 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.33 145.55 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.638 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.67 148.54 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.325 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.15 130.65 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.18 113.33 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.536 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 255' ' ' VAL . 2.2 t -114.74 135.54 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 326' ' ' ASN . 1.5 p -115.8 135.56 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 253' ' ' ALA . 7.6 t-20 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.003 0.43 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -156.12 111.82 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.597 HD13 HD12 ' A' ' 133' ' ' LEU . 17.0 mt -115.28 155.1 27.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -84.98 140.97 30.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -53.41 125.85 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.44 ' H ' ' HB ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -127.31 122.89 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.021 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -102.69 122.55 44.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.07 123.23 60.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -135.03 124.81 25.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD2' ' CE2' ' A' ' 151' ' ' PHE . 20.1 ttm180 -116.15 120.23 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.496 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.07 123.38 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.46 -138.73 43.2 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.64 18.22 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.24 46.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.572 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.2 122.44 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.6 m -113.62 116.82 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -120.91 130.37 53.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.729 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.696 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.5 mt -142.86 131.49 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.82 -156.63 26.18 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.62 151.09 47.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -135.63 156.61 77.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.95 -22.29 19.92 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.777 2.318 . . . . 0.0 112.075 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.38 152.21 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 -27.0 68.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.43 94.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.94 79.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -60.04 -36.01 76.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.454 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.55 -37.17 57.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.64 87.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.26 -40.94 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.2 mtm -61.38 -31.85 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 m -61.28 -33.17 73.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.632 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB1' ' CG ' ' A' ' 142' ' ' PHE . . . -70.58 -26.86 63.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.36 -16.14 33.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -50.98 -28.92 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.56 -9.89 82.58 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -100.16 -42.7 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 114' ' ' LEU . 6.7 tt -32.55 113.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.575 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -156.75 158.32 31.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.485 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 14.2 Cg_endo -59.47 149.88 78.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.852 2.368 . . . . 0.0 112.297 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 -12.98 8.31 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 126.63 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 O-C-N 122.278 -0.542 . . . . 0.0 110.534 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.04 137.89 37.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.99 118.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.16 136.69 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.61 105.48 10.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.987 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -98.35 64.82 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.058 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.25 128.59 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.692 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.62 146.17 24.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.949 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.91 113.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -136.89 128.68 16.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.134 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.36 38.32 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.383 2.055 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.85 -34.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 127' ' ' ASP . 27.2 m -65.92 167.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 80' ' ' SER . 0.1 OUTLIER -121.08 160.26 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.3 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -119.87 156.06 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.671 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 79' ' ' LEU . 20.0 tp -78.59 126.39 30.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.487 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -58.47 150.03 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -140.42 74.11 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.533 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.9 p -95.34 7.34 46.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 182' ' ' THR . 2.1 p -176.59 31.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.77 40.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 7.7 mt-10 -49.16 -58.9 7.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 15.9 Cg_endo -61.13 -28.13 85.07 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.446 2.097 . . . . 0.0 111.961 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.08 -43.11 89.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 m-85 -64.09 -40.72 96.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.351 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 p -63.29 -35.26 79.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.85 -28.96 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -93.72 -9.55 37.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.518 ' N ' ' HD2' ' A' ' 147' ' ' PRO . 1.1 t -53.24 -48.67 91.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.531 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 56.3 Cg_endo -75.21 1.5 7.77 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.186 1.924 . . . . 0.0 111.666 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 171' ' ' HIS . 5.5 mm -118.66 85.55 27.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.81 22.15 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.844 2.363 . . . . 0.0 112.354 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -141.27 55.66 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.751 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.639 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 1.7 p90 -123.71 143.7 50.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 163' ' ' THR . . . -126.81 145.04 15.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.9 129.39 36.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 110.779 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.6 53.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.2 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 82' ' ' LEU . 57.2 t -117.92 134.7 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.659 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -145.61 77.68 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.656 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 62.14 -96.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.21 33.58 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.64 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 m -136.47 133.56 36.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.519 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.41 134.24 66.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.354 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.579 HG23 ' HB ' ' A' ' 189' ' ' VAL . 82.2 m -132.35 128.26 37.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.699 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -111.75 118.96 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 152' ' ' GLY . 87.8 m -128.22 147.49 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.675 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 150.38 166.41 13.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 193' ' ' GLU . 0.6 OUTLIER -100.02 142.0 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.73 149.4 46.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.11 -40.63 1.63 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.743 2.296 . . . . 0.0 111.69 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 146.68 52.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.236 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -36.97 85.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.457 ' HB3' HD11 ' A' ' 148' ' ' ILE . 1.8 m170 -63.4 -48.16 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.798 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -66.58 -33.7 76.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.577 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.5 -44.34 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.8 90.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.61 -40.94 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -62.55 -52.01 65.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.057 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -62.12 -39.66 93.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.858 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.16 97.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.9 -40.0 94.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.588 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.4 m -67.81 -40.08 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.4 p -68.63 -39.22 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.533 HG23 ' OG ' ' A' ' 137' ' ' SER . 55.8 m -83.53 -38.43 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.577 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 179' ' ' ALA . 4.7 m-90 -127.18 73.13 77.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.686 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 61.2 Cg_endo -77.87 28.0 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.857 2.371 . . . . 0.0 111.923 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 187' ' ' LYS . 1.2 t70 -41.58 -12.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.679 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 74.78 -26.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 185' ' ' ASP . 18.2 mttm -95.6 61.42 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 162' ' ' LEU . 3.9 mp -97.1 136.04 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 161' ' ' THR . 42.4 t -110.79 129.68 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.52 107.76 19.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.441 ' CB ' ' OG1' ' A' ' 163' ' ' THR . 1.1 m120 -122.23 52.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.8 mt -86.33 133.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.599 ' O ' HG22 ' A' ' 165' ' ' THR . 17.5 mt-10 -120.12 124.79 46.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.913 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.4 m -105.25 109.86 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.128 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.807 179.333 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 208' ' ' CYS . . . . . 0.563 ' O ' ' O ' ' A' ' 209' ' ' ALA . 9.4 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.627 0.251 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -48.88 -111.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.347 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -81.95 18.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.305 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 215' ' ' ILE . 6.7 mp -56.55 -29.93 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -50.62 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.701 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -62.72 -39.92 95.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 110.975 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.22 68.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.448 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LEU . 6.2 mt -58.95 -37.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 220' ' ' GLY . 9.3 t-20 -54.78 -41.67 70.81 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.28 -31.28 62.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.517 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.32 -41.4 81.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -106.43 -27.53 10.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 78.47 -14.7 11.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.17 173.25 43.6 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.91 148.46 57.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.793 2.328 . . . . 0.0 112.128 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 23.2 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.88 0.372 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.02 -34.58 78.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 239' ' ' ILE . 7.7 mm -59.55 -45.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.745 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -31.96 68.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -42.97 76.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.13 -45.68 93.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.974 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 247' ' ' LEU . 54.8 t -69.26 -38.0 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.186 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.749 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -62.53 -45.76 91.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -50.38 72.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -65.49 -32.08 73.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.9 HD13 HD22 ' A' ' 285' ' ' LEU . 0.4 OUTLIER -63.44 -32.27 73.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -63.83 -26.13 68.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.791 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.5 1.95 47.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.023 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.678 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.2 m -74.69 -28.57 0.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.2 Cg_exo -53.43 -14.15 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.854 1.703 . . . . 0.0 111.819 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -2.66 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -141.02 -159.0 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.545 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -103.44 139.99 38.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.203 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.52 133.01 67.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.622 ' HB ' HG23 ' A' ' 324' ' ' VAL . 93.7 m -123.02 111.96 17.22 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.055 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.35 121.46 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -101.09 126.02 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.55 134.79 11.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -120.39 116.7 26.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 111.042 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.497 ' C ' ' OD1' ' A' ' 318' ' ' ASN . 2.9 t -134.74 159.28 41.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 1.07 ' CG ' HD21 ' A' ' 309' ' ' ASN . 39.9 p-10 -113.24 97.33 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 265' ' ' GLY . 7.9 t30 38.36 -94.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.1 m 62.14 -69.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.651 ' N ' HG22 ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.71 0.291 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 3.1 mm -63.04 -51.36 71.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.754 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.3 Cg_endo -61.72 -39.84 50.17 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.055 1.837 . . . . 0.0 112.004 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.76 -43.98 91.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -38.0 67.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.76 71.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.402 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -60.97 -38.72 86.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -68.09 -39.05 82.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.55 68.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.177 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -45.6 76.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.357 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.23 -40.99 85.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.373 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.25 -39.38 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.86 94.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.492 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.72 -42.04 83.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -49.72 76.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.391 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.9 HD22 HD13 ' A' ' 247' ' ' LEU . 39.5 mt -59.51 -48.0 83.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.287 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.66 -38.07 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.09 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.749 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.63 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.496 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.2 12.99 24.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.18 130.89 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.36 9.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.439 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -75.47 11.02 10.17 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 293' ' ' ASP . 0.1 OUTLIER -89.37 -16.71 30.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -113.83 2.34 15.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.87 124.79 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.69 154.12 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.38 132.83 38.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.73 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.9 t -125.62 116.48 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -83.26 105.34 2.69 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.6 mm? -31.28 -61.47 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.63 49.62 63.39 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 303' ' ' VAL . 94.3 p -99.58 -23.98 14.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.58 0.228 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 302' ' ' SER . 1.3 m 51.68 124.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.157 0.504 . . . . 0.0 110.512 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 305' ' ' PRO . 3.9 t-20 60.2 53.25 3.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 304' ' ' ASN . 67.6 Cg_endo -77.61 -101.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.838 2.358 . . . . 0.0 112.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.6 mm -81.27 -38.59 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -115.79 160.75 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.44 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 p -102.83 16.15 27.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 1.07 HD21 ' CG ' ' A' ' 262' ' ' ASP . 1.4 t-20 44.63 53.81 6.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.615 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -127.25 -5.0 6.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.447 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.56 148.88 63.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.53 -31.81 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.674 2.249 . . . . 0.0 111.936 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.24 -33.39 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 318' ' ' ASN . . . -66.76 -44.38 89.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -62.06 -44.94 95.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 110.444 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.05 -45.53 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -34.69 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.667 ' OD1' ' N ' ' A' ' 262' ' ' ASP . 2.4 t30 -63.11 -25.4 68.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.733 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -79.68 98.97 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -133.79 146.86 51.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.85 144.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.321 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.43 148.52 46.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 323' ' ' ILE . 4.5 mp -123.58 129.64 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 256' ' ' THR . 0.6 OUTLIER -130.73 123.56 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.681 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.535 HG11 ' SG ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -107.33 134.6 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.305 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.568 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.641 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.17 117.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 69.6 mt -99.34 152.54 19.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 82' ' ' LEU . 11.0 p -75.47 162.4 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.28 106.51 13.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.596 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 80' ' ' SER . 17.2 mt -98.17 140.94 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -128.23 117.67 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.25 120.12 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.112 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.51 132.66 44.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.696 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HE ' HG22 ' A' ' 91' ' ' VAL . 45.8 ttt180 -121.23 138.08 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.404 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.1 p -143.6 109.58 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 149' ' ' PRO . . . 75.57 -125.52 8.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.55 18.28 22.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.397 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.5 m -118.81 138.96 52.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 ' HE ' ' A' ' 86' ' ' ARG . 1.3 t -127.54 121.41 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.812 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.7 m -104.22 124.73 49.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.194 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.76 125.51 48.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.75 119.65 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.353 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.549 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . -175.5 -171.56 39.56 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.549 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -131.46 145.11 51.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.576 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.45 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 3.8 m-85 -134.5 155.87 79.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.14 -28.37 48.59 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.774 2.316 . . . . 0.0 112.483 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.09 169.45 20.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -24.82 50.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.683 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.24 89.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.814 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.67 78.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -59.74 -38.91 83.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.16 -37.76 62.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 106' ' ' LEU . 2.5 tt -72.02 -44.82 62.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 110.427 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 107' ' ' MET . 0.0 OUTLIER -57.49 -26.76 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.455 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.9 m -66.5 -32.12 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.72 -18.47 63.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 110' ' ' LEU . 3.3 pp -125.49 3.74 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.637 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' MET . 32.5 t-20 -54.82 -42.27 71.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.639 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.66 -16.87 70.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.52 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 0.0 110.461 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 114' ' ' LEU . 2.3 tt -45.52 105.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -154.8 160.53 30.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 118' ' ' VAL . 52.0 Cg_exo -47.46 155.59 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 112.426 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.04 -25.45 0.31 Allowed Glycine 0 N--CA 1.461 0.316 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 116' ' ' PRO . 12.7 t -93.22 140.04 17.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.173 -0.604 . . . . 0.0 110.635 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.55 130.29 54.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.605 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.2 t -134.22 119.82 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.7 pt -125.24 125.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -104.23 104.24 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.171 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -109.93 63.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.846 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.7 125.36 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.579 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -90.63 146.42 24.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.78 121.06 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 130' ' ' VAL . 1.2 t0 -136.76 132.19 18.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.439 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.97 60.41 7.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.35 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 130' ' ' VAL . 7.4 p -174.2 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 127' ' ' ASP . 26.3 m -52.03 142.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -99.55 158.03 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.154 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.45 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 13.8 t -120.46 155.02 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.76 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 183' ' ' TRP . 55.6 tp -81.61 127.87 33.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.01 139.22 52.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -130.36 24.03 5.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' PHE . 68.9 m -30.41 -39.95 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.393 0.616 . . . . 0.0 110.962 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.7 m -152.59 61.51 0.81 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.436 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.16 -7.62 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.427 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -56.29 -43.47 99.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.513 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.0 Cg_exo -58.37 -41.43 65.96 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.31 -49.07 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.076 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' N ' ' A' ' 146' ' ' VAL . 2.4 m-85 -65.01 -37.12 86.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 1.3 p -58.27 -37.89 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.417 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.73 53.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.692 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 p -101.65 -2.06 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.2 t -65.62 -40.01 37.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 56.4 Cg_endo -82.65 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.712 2.274 . . . . 0.0 112.256 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 165' ' ' THR . 5.2 mt -128.99 104.01 18.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 88' ' ' GLY . 59.6 Cg_endo -78.24 21.1 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.205 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 12.3 t70 -152.63 64.18 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.478 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.647 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -130.01 139.67 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.659 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 130.5 6.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -119.11 129.96 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.586 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 131.26 51.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.585 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.25 134.59 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.388 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 158' ' ' ASP . 69.8 mt-10 -141.95 95.82 2.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 8.3 mtt180 53.84 -90.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' GLU . 5.0 p30 -117.97 9.06 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.884 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 m -110.06 129.11 55.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.693 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 t -119.9 131.77 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.357 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.756 HG22 ' HB ' ' A' ' 189' ' ' VAL . 1.3 p -130.95 116.86 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.656 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 163' ' ' THR . 3.6 tt -112.0 118.7 36.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.436 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.559 ' N ' HD23 ' A' ' 162' ' ' LEU . 4.8 p -128.59 149.2 50.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.789 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.55 -168.04 28.57 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.492 ' O ' HG21 ' A' ' 148' ' ' ILE . 20.8 p -108.03 135.7 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.685 0.279 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.47 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -98.36 159.08 31.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.358 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' ' 166' ' ' ALA . 46.4 Cg_endo -73.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.732 2.288 . . . . 0.0 112.142 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.38 166.4 16.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -41.45 94.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.44 -41.49 98.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.687 ' O ' HG23 ' A' ' 175' ' ' VAL . 2.0 m170 -63.94 -37.81 88.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.44 -43.25 97.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 173' ' ' ASP . 1.9 t70 -66.73 -36.85 83.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.7 -32.83 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 171' ' ' HIS . 73.4 t -65.5 -51.83 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.727 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 177' ' ' ARG . 8.3 ptpt -66.35 -39.26 89.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 176' ' ' LYS . 7.8 ttm-85 -56.17 -51.03 69.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.39 -31.74 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.661 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.41 99.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 40.7 p -67.4 -37.59 83.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.474 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -27.06 64.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.8 m -96.02 -52.62 3.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.989 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.1 m-90 -116.71 99.09 52.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.264 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 58.2 Cg_endo -80.19 17.09 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.508 2.139 . . . . 0.0 111.349 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.3 OUTLIER -30.86 -29.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.718 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 78.52 -29.21 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.594 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 185' ' ' ASP . 23.5 mttt -105.2 76.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.546 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.92 125.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.756 ' HB ' HG22 ' A' ' 161' ' ' THR . 21.9 t -98.25 124.27 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -98.31 123.53 42.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.19 45.69 1.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.16 126.64 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.396 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.98 112.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 213' ' ' SER . 15.7 m-20 62.18 72.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -40.48 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.243 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -50.51 51.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.058 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.4 m -70.73 -45.02 65.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.957 0.408 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.7 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.246 -0.284 . . . . 0.0 111.715 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.596 ' O ' HG12 ' A' ' 218' ' ' VAL . 1.2 tp -69.56 -41.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.563 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 21.0 t30 -70.33 -36.85 74.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.57 -30.11 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.2 -34.64 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.752 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 221' ' ' GLY . 0.8 OUTLIER -109.08 -15.89 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.752 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 56.03 4.13 0.68 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -165.98 -172.88 33.86 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.11 147.68 79.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.579 2.186 . . . . 0.0 111.982 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.0 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 239' ' ' ILE . 10.1 pt-20 -62.2 -37.11 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.724 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 240' ' ' LEU . 4.2 tt -63.69 -37.43 79.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.437 ' HB3' HH21 ' A' ' 288' ' ' ARG . 2.2 mp -59.91 -43.25 94.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.722 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.04 -38.49 70.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.361 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -45.42 94.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.133 0.492 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 247' ' ' LEU . 3.6 t -68.36 -35.17 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.599 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -55.82 -47.18 77.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.903 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.08 -50.6 72.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.786 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -68.91 -32.09 71.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.916 0.389 . . . . 0.0 110.668 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.792 HD13 HG12 ' A' ' 243' ' ' VAL . 1.4 tp -55.07 -33.65 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.398 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -63.27 -37.69 88.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.894 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.45 -2.23 17.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -74.4 -46.59 5.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.941 -178.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 253' ' ' ALA . 31.5 Cg_exo -53.2 -13.75 3.46 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.986 2.458 . . . . 0.0 112.374 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 253' ' ' ALA . 0.6 OUTLIER -37.08 -23.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -107.19 -149.07 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.847 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 0.2 OUTLIER -103.77 138.23 40.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.03 132.12 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.95 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.0 m -123.48 124.37 42.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.067 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.99 114.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.57 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.85 128.88 56.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.6 148.83 19.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -139.65 130.79 26.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 110.379 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.7 p -124.99 -155.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.479 ' OD1' ' OD1' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -143.85 158.02 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.564 ' O ' ' OG1' ' A' ' 264' ' ' THR . 1.1 t-20 172.43 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 265' ' ' GLY . 10.6 p 66.74 -90.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.908 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 299' ' ' GLY . 0.6 OUTLIER -76.07 -47.05 3.71 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.625 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 39.8 Cg_exo -53.9 -32.62 68.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.259 1.973 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 28.2 tp -68.2 -48.36 65.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.477 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -32.92 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.17 -41.84 60.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -64.88 -37.38 87.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' CZ ' ' A' ' 319' ' ' ARG . 38.8 mtt-85 -61.38 -41.87 97.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.352 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.96 -28.84 67.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.174 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 277' ' ' ARG . 10.9 pt -70.87 -44.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.86 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.428 ' N ' HG13 ' A' ' 280' ' ' ILE . 71.0 t -58.6 -48.49 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.67 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -55.83 -39.11 70.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -38.78 92.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -42.0 83.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.636 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.55 -37.22 77.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.372 . . . . 0.0 110.012 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.4 t -62.35 -36.28 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.079 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.16 -20.1 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ARG . . . . . 0.599 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -81.42 -2.67 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.794 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.23 20.09 13.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.6 134.6 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.942 ' HB3' ' NE2' ' A' ' 294' ' ' HIS . . . -87.8 104.54 16.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.1 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.604 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.4 OUTLIER -79.29 -16.72 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 0.0 110.648 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.942 ' NE2' ' HB3' ' A' ' 291' ' ' ALA . 0.9 OUTLIER -133.74 35.02 3.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.738 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.96 136.79 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.668 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -137.29 143.59 42.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.1 124.46 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.01 119.05 60.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 271' ' ' ILE . . . -95.68 120.89 6.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 300' ' ' LEU . 4.0 mm? -99.0 111.45 23.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.328 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 302' ' ' SER . . . -78.42 120.44 5.39 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 301' ' ' GLY . 45.7 t 37.72 98.16 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.995 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.72 -38.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.964 0.411 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -133.67 70.23 75.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.127 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.81 131.51 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 0.0 112.196 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.445 HG21 HH12 ' A' ' 320' ' ' ARG . 8.4 mm -122.47 -57.19 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -116.84 156.67 26.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 309' ' ' ASN . 13.1 p -61.71 -136.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.786 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.53 ' N ' ' OG ' ' A' ' 308' ' ' SER . 25.4 p30 -173.15 34.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -92.78 -15.6 26.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 162.26 32.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.571 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -50.51 -33.1 37.25 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.446 2.098 . . . . 0.0 112.102 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.78 -40.11 91.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.04 -46.99 93.46 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 315' ' ' ARG . 37.7 mtm105 -65.61 -38.57 89.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.94 89.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.674 ' O ' ' NH1' ' A' ' 320' ' ' ARG . 41.1 mttm -71.02 -29.73 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.469 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -77.01 -16.13 59.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.541 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.578 ' CZ ' ' NH1' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -83.85 99.76 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.566 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 317' ' ' LYS . 0.0 OUTLIER -134.53 140.76 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.386 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.64 156.07 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 223' ' ' ILE . 40.6 tt0 -142.6 142.85 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 223' ' ' ILE . 35.1 mt -107.48 113.7 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.535 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.1 m -112.27 121.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 326' ' ' ASN . 0.7 OUTLIER -109.87 135.14 49.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.507 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASN . . . . . 0.563 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.633 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.783 0.325 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.35 179.48 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.27 -20.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.71 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 154.94 40.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.08 159.74 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.758 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -88.94 168.39 12.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.36 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.79 107.93 11.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.03 136.07 54.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 121.05 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.609 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.0 pp -130.76 125.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.03 132.56 50.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -124.22 126.51 46.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.4 p -135.12 122.77 22.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.78 2.94 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.47 27.66 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -119.8 134.56 55.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.59 115.25 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.488 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.43 ' C ' HD12 ' A' ' 93' ' ' LEU . 72.2 p -109.77 116.27 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 92' ' ' THR . 9.1 mp -112.32 121.27 44.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.25 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 129.36 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.23 -152.54 20.15 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.57 154.3 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.39 144.74 44.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.5 -19.2 37.68 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.629 2.219 . . . . 0.0 111.873 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.65 -157.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.438 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.02 -26.45 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.389 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.26 98.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.353 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.35 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -58.45 -36.92 74.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.49 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.08 75.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.363 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.89 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.312 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.67 -39.98 93.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.439 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mmt -56.38 -37.16 69.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.478 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -65.98 -42.7 89.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.291 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.444 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -70.69 -22.87 62.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.44 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.03 -44.2 20.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.541 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -45.73 -37.47 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.7 -44.16 40.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' A' ' 114' ' ' LEU . 1.2 tp -43.53 -73.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 161.17 -156.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.698 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.628 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . 175.83 -48.89 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.573 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 118' ' ' VAL . 86.3 Cg_exo -40.03 -129.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.547 2.831 . . . . 0.0 113.834 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.37 -2.36 0.03 OUTLIER Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.9 t -95.72 134.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 122.353 -0.498 . . . . 0.0 110.362 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.89 129.38 35.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.532 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 t -129.33 116.7 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.24 140.04 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.259 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -126.36 96.65 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -99.33 61.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.949 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.63 128.71 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.58 146.59 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.3 t -99.6 119.2 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.63 125.07 20.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.289 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.17 42.88 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.368 2.045 . . . . 0.0 112.16 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.82 -35.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.57 167.34 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.07 159.29 34.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -143.94 155.8 44.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.705 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.11 135.8 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.37 139.46 57.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.576 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 17.4 m-85 -102.73 38.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.81 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -66.6 -58.68 4.66 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.615 0.721 . . . . 0.0 110.988 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 m -109.31 15.51 23.06 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.002 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.576 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -96.87 -23.26 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.797 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.8 OUTLIER -55.74 -46.26 99.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 23.2 Cg_exo -59.98 -29.59 89.69 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.805 2.337 . . . . 0.0 111.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 182' ' ' THR . 25.0 t -68.55 -44.96 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.5 m-85 -62.59 -32.4 73.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -65.59 -36.17 82.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.714 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.28 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -97.77 0.71 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.7 t -65.68 -38.78 27.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 72.4 Cg_endo -85.02 20.44 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.692 2.261 . . . . 0.0 112.336 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.57 116.62 22.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.676 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.36 178.61 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.14 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 54.38 20.29 2.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -82.69 139.51 33.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.772 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.08 153.24 24.89 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER -140.6 127.92 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.797 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.559 ' N ' HD23 ' A' ' 153' ' ' LEU . 0.4 OUTLIER -115.63 123.25 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.29 136.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.43 79.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.474 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 54.87 -115.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.732 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 16.2 t70 -82.98 18.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -125.25 124.63 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.55 117.91 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.137 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -128.29 127.53 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.869 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.581 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.16 124.96 48.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.166 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.55 151.71 46.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.48 164.01 24.48 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 123.82 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.48 106.44 40.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 197' ' ' GLN . 32.1 Cg_exo -53.85 -62.52 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.338 2.026 . . . . 0.0 112.046 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.16 121.53 27.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.59 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.9 p -61.67 -30.6 70.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.437 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.99 -38.6 79.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.48 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -41.94 96.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -64.57 -39.95 94.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.62 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.81 -46.9 71.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.64 86.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.24 -37.8 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -58.34 -44.29 88.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.457 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.44 -37.16 82.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.55 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -63.86 -41.27 97.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.375 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 76.3 p -63.81 -40.87 97.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.903 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.7 t -71.37 -29.97 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.154 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 141' ' ' VAL . 22.8 m -50.71 -63.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.468 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CD1' HG22 ' A' ' 182' ' ' THR . 68.6 m95 -144.05 79.27 13.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.58 -33.56 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.921 2.414 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -75.82 55.87 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 158' ' ' ASP . 23.3 tpp -176.7 166.12 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.603 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 186' ' ' MET . 5.5 mtpm? -86.76 126.24 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.47 137.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.671 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.84 118.66 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.38 108.81 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.42 71.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.164 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.58 128.63 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.798 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -111.82 145.73 38.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.295 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 194' ' ' VAL . 20.0 m -88.38 129.4 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.59 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 t -75.49 18.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.747 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 194' ' ' VAL . . . 112.02 -2.75 27.08 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 167' ' ' PRO . 2.1 tp60 -113.49 147.54 37.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . . . -175.91 -55.09 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.721 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 198' ' ' ALA . 86.4 Cg_exo -41.79 130.66 4.1 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.671 2.247 . . . . 0.0 112.064 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -43.05 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.165 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -116.03 178.16 17.36 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -46.19 102.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.043 2.495 . . . . 0.0 112.538 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.33 102.08 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.514 2.142 . . . . 0.0 111.887 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -179.99 29.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.607 ' O ' ' N ' ' A' ' 207' ' ' PRO . 4.0 m 50.75 70.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.479 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 205' ' ' SER . . . -15.38 81.18 0.0 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.607 ' N ' ' O ' ' A' ' 205' ' ' SER . 72.4 Cg_endo -82.6 -169.28 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.012 2.475 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.792 ' HA ' HD12 ' A' ' 211' ' ' LEU . 39.2 t -76.56 33.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -72.12 137.81 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 209' ' ' ALA . 16.0 m-20 37.81 19.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 208' ' ' CYS . 0.7 OUTLIER -56.3 -30.81 63.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.523 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.596 ' H ' ' CD ' ' A' ' 212' ' ' GLN . 0.3 OUTLIER -54.28 -40.89 68.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -69.47 -42.05 75.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.404 0.621 . . . . 0.0 110.989 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.77 -34.69 64.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.079 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.572 HD11 HG13 ' A' ' 243' ' ' VAL . 2.8 tt -59.03 -37.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.527 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.16 -32.69 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.213 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.18 -45.7 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.664 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 246' ' ' LYS . 13.0 t -60.46 -38.85 79.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.532 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 220' ' ' GLY . 20.2 p -78.82 -31.44 45.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 219' ' ' THR . . . 19.57 52.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 219' ' ' THR . . . -153.88 166.32 31.89 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.74 138.93 39.05 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.89 2.394 . . . . 0.0 112.071 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 tp -160.25 -24.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.691 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -173.08 129.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.6 t80 53.32 77.98 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -126.94 123.79 4.78 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -141.06 48.47 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.479 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.522 ' O ' ' C ' ' A' ' 229' ' ' GLY . 7.7 p30 -100.01 111.6 23.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.53 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 228' ' ' ASP . . . -28.58 -68.04 0.08 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -168.51 76.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.19 109.41 19.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 32.1 mt 60.99 128.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.05 70.38 74.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.387 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.16 135.01 11.91 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.968 2.446 . . . . 0.0 112.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -115.06 58.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.417 ' C ' ' CD1' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -120.21 177.84 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 236' ' ' ASP . 45.9 m-85 -143.18 -3.66 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.62 -32.86 73.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -58.91 -36.96 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.809 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 240' ' ' LEU . 0.7 OUTLIER -58.47 -46.15 87.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.409 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -63.29 -35.58 80.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -66.26 -45.25 81.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.499 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.572 HG13 HD11 ' A' ' 215' ' ' ILE . 57.9 t -62.79 -39.88 86.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -56.3 -41.91 76.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.35 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 218' ' ' VAL . 20.0 mtmt -69.83 -32.41 70.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -64.45 -31.07 72.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.828 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.25 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.401 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -106.01 3.78 28.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.247 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.689 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.7 m -75.41 -27.59 0.7 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.6 Cg_exo -53.58 -14.21 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.466 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 251' ' ' PRO . 40.2 t0 -39.88 -23.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -115.41 -148.82 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.76 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.464 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 12.5 ttm180 -109.61 139.39 44.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.9 t -118.83 132.15 69.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.894 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 95.5 m -123.4 125.77 45.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -113.81 120.25 63.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.874 0.369 . . . . 0.0 110.493 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.49 149.51 27.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -124.87 123.79 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 261' ' ' THR . 74.4 m-85 -100.6 133.93 44.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -165.7 165.19 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 -158.85 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 51.6 t30 -176.34 129.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 264' ' ' THR . 35.9 m -150.6 -15.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.527 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 266' ' ' SER . . . 82.04 105.44 0.4 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 265' ' ' GLY . 14.2 t 80.38 -67.44 0.13 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.574 0.702 . . . . 0.0 110.963 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -64.35 -30.09 71.14 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.429 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -96.73 -50.7 1.77 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 269' ' ' ILE . 2.2 tt 38.51 17.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.353 0.597 . . . . 0.0 110.843 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 268' ' ' GLY . 49.9 m-20 -69.82 -34.45 73.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.912 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 0.7 OUTLIER -57.43 -51.82 78.89 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 12.4 Cg_endo -59.87 -41.91 49.89 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.947 1.765 . . . . 0.0 112.508 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.474 ' C ' HH22 ' A' ' 319' ' ' ARG . 5.4 tp -68.8 -37.97 79.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.522 ' N ' HH22 ' A' ' 319' ' ' ARG . 1.4 p -64.86 -40.18 94.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.9 -51.99 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.7 -34.59 78.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -60.51 -41.77 95.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.47 91.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -57.26 -40.21 77.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.596 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 11.1 mm -61.05 -40.68 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.589 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.45 -45.99 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.93 -43.14 99.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.49 -39.4 87.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.13 -52.09 31.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.65 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 285' ' ' LEU . 57.2 mt -59.6 -45.46 91.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.543 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 282' ' ' ALA . 59.4 t -58.95 -36.36 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.194 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.8 -25.13 68.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -84.16 -2.43 56.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.296 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.47 12.6 26.4 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 90.4 t -77.34 118.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 110.467 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.72 109.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -78.79 1.81 71.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.41 -15.84 59.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.409 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.41 5.98 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 292' ' ' GLY . 10.4 tt -91.07 133.83 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -130.0 135.98 48.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.41 134.05 51.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 122.13 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.71 106.67 3.39 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.789 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.0 OUTLIER -103.49 89.39 3.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.658 ' O ' ' OG ' ' A' ' 302' ' ' SER . . . -91.5 167.82 31.49 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.658 ' OG ' ' O ' ' A' ' 301' ' ' GLY . 89.7 p 69.64 -43.71 0.53 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.312 0.577 . . . . 0.0 110.963 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 304' ' ' ASN . 27.4 m -64.37 166.32 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.468 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 303' ' ' VAL . 96.2 m-20 30.18 60.91 0.94 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.526 ' O ' ' C ' ' A' ' 306' ' ' ILE . 37.5 Cg_endo -69.72 67.16 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.784 2.323 . . . . 0.0 112.272 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 305' ' ' PRO . 6.4 mm -30.92 -66.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.391 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.7 160.4 22.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.33 160.27 30.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -100.81 108.55 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.206 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -163.84 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.59 161.32 28.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.69 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -50.23 -33.04 34.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.523 2.149 . . . . 0.0 112.08 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -68.51 -31.87 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.748 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.64 97.63 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.803 ' HA ' HD22 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -63.44 -45.8 89.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.779 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -62.78 -40.43 97.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.803 HD22 ' HA ' ' A' ' 315' ' ' ARG . 25.3 p30 -83.79 -25.11 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.906 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.522 HH22 ' N ' ' A' ' 274' ' ' SER . 0.7 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -137.22 157.77 45.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 111.048 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.9 t -144.87 152.58 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.73 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.97 142.95 29.17 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.507 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.1 mt -119.03 120.67 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.13 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 256' ' ' THR . 2.7 m -127.76 131.52 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.4 p -120.37 136.1 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.478 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.551 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 1.8 m-20 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.535 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.73 67.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -45.53 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 131' ' ' ARG . 24.2 p -129.3 138.27 51.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.24 159.29 15.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.6 p -97.18 159.67 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.745 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.45 115.77 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.637 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.96 144.09 49.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.81 125.94 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -133.43 115.49 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.347 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 m -137.26 127.37 26.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.519 ' NH2' HD21 ' A' ' 110' ' ' LEU . 7.9 mtt85 -114.91 126.46 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.302 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 p -134.23 116.71 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 150' ' ' ASP . . . 71.73 -137.14 25.29 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -95.22 15.68 18.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 110.497 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -121.61 125.76 47.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 91' ' ' VAL . 5.8 m -107.36 118.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.38 127.72 45.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 94' ' ' ILE . 14.0 tp -133.15 120.41 21.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.284 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -134.13 129.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.614 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.5 -156.21 23.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 154.1 41.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 20.9 m-85 -138.67 146.59 51.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.535 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 24.9 Cg_endo -64.48 -25.47 63.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.676 2.251 . . . . 0.0 112.144 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 98' ' ' PRO . 35.5 m-20 -155.76 119.82 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.611 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -45.23 -21.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.43 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ASP . . . -60.41 -36.82 79.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.64 81.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -36.88 85.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.14 -38.52 79.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.351 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.37 90.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.28 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.54 -43.22 85.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -26.42 61.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -60.56 -42.81 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.799 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.09 67.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.469 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.7 mt -79.74 -21.15 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -49.61 -30.38 8.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.56 61.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.9 tt -88.04 -47.53 8.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.835 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 mt -21.2 116.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.157 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -142.98 -178.27 0.77 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.35 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 71.7 Cg_endo -89.01 153.58 5.8 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.127 2.552 . . . . 0.0 112.594 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.86 -10.04 21.06 Favored Glycine 0 C--O 1.24 0.483 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 115' ' ' ALA . 3.2 m -92.86 130.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.01 -0.7 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -92.26 130.47 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.524 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.3 129.06 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.425 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.0 mm -130.16 110.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.31 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 78.78 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.059 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -85.94 75.98 9.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 93' ' ' LEU . 3.9 mt -104.9 130.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.736 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.01 146.47 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.054 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 126' ' ' VAL . 2.3 p -99.76 111.74 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.813 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.621 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -137.54 102.94 8.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.351 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.71 26.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.391 2.061 . . . . 0.0 112.183 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.621 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.3 t -124.46 -4.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.902 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 171.41 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.735 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 78' ' ' SER . 6.2 mmt-85 -117.82 159.27 23.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.678 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -125.22 155.23 40.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.704 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.4 tp -86.91 134.98 33.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.61 132.41 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.734 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -117.68 27.31 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.302 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.1 m -32.65 -47.2 0.16 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.171 0.51 . . . . 0.0 110.978 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -100.22 -91.49 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.802 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . 69.99 -43.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.694 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.616 ' O ' HG23 ' A' ' 143' ' ' THR . 2.8 mm-40 -51.75 -58.86 9.52 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.958 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 20.6 Cg_endo -64.28 -35.13 52.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.514 2.143 . . . . 0.0 112.143 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 182' ' ' THR . 20.9 t -69.92 -48.27 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.84 -42.8 94.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 139' ' ' GLU . 63.0 p -65.97 -33.98 77.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.72 -22.03 59.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 p -111.99 5.54 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -63.86 -42.68 72.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.245 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 26.3 Cg_exo -57.92 -10.98 8.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.592 2.195 . . . . 0.0 111.756 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 147' ' ' PRO . 11.6 mm -125.03 89.7 52.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.63 16.36 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.666 2.244 . . . . 0.0 112.059 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 6.3 m-20 -132.4 61.66 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 2.7 p90 -125.55 143.17 51.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.54 142.2 15.61 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.6 tp -141.93 127.22 18.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -125.16 128.8 48.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.024 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.28 127.48 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.132 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 157' ' ' ARG . 2.2 tt0 -110.45 176.16 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.12 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 156' ' ' GLU . 25.6 mtt180 -32.26 -43.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.633 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 30.55 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 m -135.82 130.38 33.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.632 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.49 127.2 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 m -131.14 127.22 37.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.029 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -117.19 121.31 40.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.722 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.9 m -122.76 147.15 46.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.522 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.856 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 153.97 158.47 8.64 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.6 p -96.47 135.3 38.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.05 142.22 26.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.62 -39.19 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.687 2.258 . . . . 0.0 112.272 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.5 t -123.61 137.66 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.638 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -33.17 75.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -59.01 -48.56 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -58.35 -40.84 83.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.353 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.409 ' HZ1' ' HZ3' ' A' ' 176' ' ' LYS . 8.5 tttm -62.89 -36.18 82.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 173' ' ' ASP . 1.6 t70 -63.93 -38.64 91.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.64 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.38 71.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.93 -51.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 177' ' ' ARG . 1.5 ptpt -63.52 -36.73 84.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.799 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.481 ' N ' ' HG3' ' A' ' 176' ' ' LYS . 9.3 ttm180 -59.76 -53.99 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.723 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.576 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -66.8 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.98 77.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.693 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -38.59 91.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.716 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 p -70.88 -36.32 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.2 OUTLIER -66.48 -68.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.845 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.826 ' CE2' HD21 ' A' ' 133' ' ' LEU . 8.5 m-90 -114.8 90.44 22.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 186' ' ' MET . 72.4 Cg_endo -83.53 22.52 0.91 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 123.017 2.478 . . . . 0.0 111.671 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 186' ' ' MET . 54.2 m-20 -36.56 -20.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.671 ' N ' ' O ' ' A' ' 184' ' ' PRO . 5.4 tpt 91.1 -39.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.564 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.12 53.53 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.44 119.08 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -108.93 129.68 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -104.41 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -125.13 59.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.291 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 164' ' ' GLY . 21.6 mt -113.39 129.16 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -121.99 139.63 53.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.232 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -88.28 129.42 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.8 p -76.85 45.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.485 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.31 35.42 65.49 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 140.69 47.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.592 ' HB2' ' HA ' ' A' ' 205' ' ' SER . . . 56.73 88.27 0.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 201' ' ' GLY . 39.3 Cg_exo -52.5 148.58 26.29 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.689 2.259 . . . . 0.0 111.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -39.11 83.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.783 2.322 . . . . 0.0 112.111 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 156.45 -89.35 0.12 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -39.45 98.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.842 2.361 . . . . 0.0 112.123 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.64 52.69 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.112 2.541 . . . . 0.0 112.26 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.635 ' O ' ' CB ' ' A' ' 205' ' ' SER . . . -132.84 -27.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 204' ' ' ALA . 0.9 OUTLIER 90.44 120.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.91 93.85 0.65 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.619 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.19 -91.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.801 2.334 . . . . 0.0 111.838 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 250' ' ' CYS . 0.0 OUTLIER -118.14 17.07 14.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -65.32 134.37 53.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.822 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' A' ' 210' ' ' ASP . 0.0 OUTLIER 39.03 16.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.784 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -56.25 -30.85 62.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.077 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -54.47 -38.2 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.402 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -65.73 -42.48 90.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.521 0.677 . . . . 0.0 110.984 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 211' ' ' LEU . . . -74.05 -34.83 64.21 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.37 -39.12 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.91 -38.52 82.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.29 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -58.6 -34.9 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 221' ' ' GLY . 3.5 t -105.54 -30.38 9.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.95 -37.93 2.66 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.42 ' H ' HG23 ' A' ' 219' ' ' THR . . . -169.21 -170.04 33.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 143.06 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.794 2.329 . . . . 0.0 111.976 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 1.09 ' H ' HD12 ' A' ' 223' ' ' ILE . 3.1 mp -59.34 104.22 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.64 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -140.16 -52.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 17.6 p90 -174.71 117.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -88.75 143.02 17.41 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.612 ' CG ' ' H ' ' A' ' 228' ' ' ASP . 25.6 p-10 -127.36 -124.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.749 0.309 . . . . 0.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.612 ' H ' ' CG ' ' A' ' 227' ' ' ASN . 1.1 m-20 79.68 112.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.558 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 99.64 -58.79 0.8 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -146.4 -142.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 0.0 110.639 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 232' ' ' LEU . 32.7 t -149.15 -25.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 231' ' ' SER . 5.4 mt -31.31 119.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 233' ' ' ILE . 3.2 mm 39.46 83.87 0.19 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 235' ' ' ALA . 52.6 Cg_exo -50.63 -178.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.803 2.336 . . . . 0.0 111.941 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 234' ' ' PRO . . . 70.06 150.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 235' ' ' ALA . 1.3 m-20 -148.15 178.14 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.539 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.67 -16.25 5.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.566 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.44 -39.52 88.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 58.8 mt -68.89 -36.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 240' ' ' LEU . 2.8 mm? -59.73 -32.74 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.595 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -56.1 -43.08 77.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -45.92 79.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.6 -45.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -57.11 -45.25 83.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.35 -50.64 70.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -31.7 71.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.115 0.483 . . . . 0.0 109.757 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -55.07 -30.19 59.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.49 11.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -104.36 -2.92 24.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.469 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.6 m -74.85 -27.17 0.7 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 51.4 Cg_exo -51.91 -13.83 2.02 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.728 1.618 . . . . 0.0 111.857 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.36 -14.65 63.11 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -126.9 -166.29 1.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -113.43 138.7 49.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 255' ' ' VAL . 11.6 p -119.36 133.13 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.944 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.2 m -117.34 118.85 33.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.051 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.568 HG12 HG23 ' A' ' 323' ' ' ILE . 65.6 mt -101.62 120.2 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -100.21 134.93 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.97 125.63 8.26 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -109.18 112.51 24.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.451 ' CG2' ' OD1' ' A' ' 270' ' ' ASN . 8.8 t -116.67 -158.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.251 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.432 ' N ' ' OG1' ' A' ' 261' ' ' THR . 1.0 OUTLIER -122.81 -151.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -119.7 28.46 8.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 265' ' ' GLY . 3.3 m -58.68 -68.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 264' ' ' THR . . . -91.65 147.96 19.03 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 270' ' ' ASN . 47.0 t -44.07 161.72 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.649 0.261 . . . . 0.0 110.945 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.15 -36.46 63.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 110.417 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.94 -5.99 49.82 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.63 -24.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.639 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' CG2' ' A' ' 261' ' ' THR . 0.6 OUTLIER -68.3 -44.25 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.566 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.2 mm -59.96 -51.94 77.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.4 Cg_endo -61.67 -33.25 86.64 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.111 1.874 . . . . 0.0 112.106 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.31 -42.61 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.423 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 p -74.33 -37.8 63.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.635 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.13 -35.8 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 41.7 mtt-85 -63.05 -47.11 84.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.91 70.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.393 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -55.82 -39.1 70.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.469 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 280' ' ' ILE . 1.7 mp -66.8 -43.62 89.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.328 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.73 -38.19 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -60.39 -41.21 93.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.644 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.96 -37.25 86.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.514 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -52.33 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 290' ' ' VAL . 4.5 mp -60.49 -48.94 79.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.7 t -56.36 -39.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.187 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.7 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.196 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.432 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -83.83 0.4 47.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.865 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.7 12.05 42.01 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 285' ' ' LEU . 21.2 t -81.45 133.93 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.563 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.74 102.8 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.93 1.71 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -133.4 6.99 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.2 mt -96.57 133.84 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.327 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.53 147.04 50.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 128.31 40.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.84 140.23 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.722 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -105.38 112.44 3.99 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 299' ' ' GLY . 11.4 mt -46.27 -96.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 302' ' ' SER . . . 132.05 82.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 301' ' ' GLY . 47.0 t 30.21 68.76 0.09 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.017 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.67 -82.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.704 0.288 . . . . 0.0 110.263 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 306' ' ' ILE . 0.3 OUTLIER -178.45 -51.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 32.1 Cg_exo -57.34 16.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.58 2.187 . . . . 0.0 112.346 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.641 ' H ' ' C ' ' A' ' 304' ' ' ASN . 14.4 pt -77.34 178.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.309 . . . . 0.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.74 171.91 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.726 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 14.5 m -81.18 152.88 27.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.41 31.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.86 -35.13 69.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.631 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.63 154.38 79.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.01 -34.2 97.17 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.89 2.393 . . . . 0.0 111.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.433 ' CG ' ' N ' ' A' ' 314' ' ' GLY . 7.8 pt-20 -65.24 -36.66 84.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.287 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 313' ' ' GLU . . . -59.82 -39.23 95.13 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.528 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -65.57 -44.64 86.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.42 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.426 ' HA ' ' NH2' ' A' ' 319' ' ' ARG . . . -55.45 -40.33 71.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.384 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -65.52 -29.95 70.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.546 ' C ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -76.23 -16.1 59.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.517 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.426 ' NH2' ' HA ' ' A' ' 316' ' ' ALA . 52.9 mtm180 -94.6 95.73 8.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -132.11 146.63 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.261 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.26 147.92 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.88 136.82 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.582 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.568 HG23 HG12 ' A' ' 257' ' ' ILE . 3.7 mt -130.19 117.9 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.62 131.64 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 250' ' ' CYS . 2.3 p -109.69 135.36 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.555 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.704 ' ND2' ' O ' ' A' ' 326' ' ' ASN . 2.0 t30 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.612 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.724 0.297 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -166.83 83.2 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.629 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -8.01 14.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.343 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.655 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -163.81 144.68 8.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 78' ' ' SER . 5.8 mt -129.28 159.34 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.795 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.7 p -86.71 167.36 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 123.98 21.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.97 118.04 15.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.272 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 p -127.83 129.25 46.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 153' ' ' LEU . 1.4 pt -134.53 132.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.472 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -124.81 126.85 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.524 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 151' ' ' PHE . 28.5 ttm180 -113.4 131.2 56.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 90' ' ' THR . 41.2 t -142.8 112.5 6.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.12 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 27.08 106.04 0.0 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.14 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.7 1.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -106.99 124.91 50.31 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.476 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.86 125.64 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 78.2 m -123.12 118.59 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.5 tt -119.77 127.25 52.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.9 mt -135.32 128.19 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.475 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.56 -161.15 33.38 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.76 146.04 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.587 ' CD2' ' OG ' ' A' ' 132' ' ' SER . 11.4 m-85 -125.32 156.01 70.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.356 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 -20.76 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.779 2.319 . . . . 0.0 112.945 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 18.2 t0 -156.45 157.75 36.06 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.222 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -76.25 -26.99 56.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.062 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.06 79.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.08 86.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.203 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -57.07 -36.7 70.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.59 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.59 -40.42 68.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.98 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -41.34 76.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.301 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 39.3 mtp -58.58 -33.4 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.457 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -35.17 76.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.48 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.8 mt -78.36 -20.61 50.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -46.83 -23.02 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.93 -22.43 55.31 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 14.6 tp -98.28 -44.58 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.77 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -24.38 101.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -140.51 156.29 69.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 118' ' ' VAL . 17.8 Cg_endo -61.91 -79.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.884 2.389 . . . . 0.0 112.217 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -43.9 -10.35 0.01 OUTLIER Glycine 0 N--CA 1.46 0.246 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 116' ' ' PRO . 38.4 t -102.37 120.8 52.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 O-C-N 122.238 -0.566 . . . . 0.0 110.623 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.35 118.7 31.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -118.73 125.95 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.435 ' C ' ' OD1' ' A' ' 122' ' ' ASP . 13.5 pt -123.71 138.22 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.125 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -126.78 90.94 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.296 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.55 68.81 9.69 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.69 119.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.871 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -91.48 145.99 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.02 112.27 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.875 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.74 125.35 22.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.15 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.409 ' C ' HG23 ' A' ' 129' ' ' VAL . 55.9 Cg_endo -73.49 49.27 1.73 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.298 1.999 . . . . 0.0 112.171 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.409 HG23 ' C ' ' A' ' 128' ' ' PRO . 78.4 t -154.1 -35.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.23 153.6 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -110.08 159.54 17.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.587 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 1.4 m -120.78 150.55 40.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 183' ' ' TRP . 29.8 tp -83.24 129.82 35.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.419 ' N ' HD12 ' A' ' 133' ' ' LEU . 19.7 m-20 -53.3 147.35 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.8 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -125.21 11.75 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.151 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.4 p -39.63 -25.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -140.63 31.05 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.809 -179.105 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.83 24.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.3 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -51.59 -58.95 9.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.971 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 17.9 Cg_endo -63.39 -31.63 72.51 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.396 2.064 . . . . 0.0 112.042 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.6 t -64.75 -47.74 87.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 m-85 -63.75 -37.47 87.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 12.4 p -68.08 -33.15 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.0 -27.41 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -100.54 0.45 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.002 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.729 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -70.76 -36.16 5.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 16.4 Cg_exo -64.04 18.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.945 2.43 . . . . 0.0 112.208 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.55 ' C ' ' H ' ' A' ' 150' ' ' ASP . 60.2 mt -139.73 86.65 13.57 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.19 2.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.836 2.357 . . . . 0.0 112.008 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.2 p-10 -130.26 70.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.453 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.416 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 2.3 t80 -127.71 140.66 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.87 133.67 7.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.615 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -123.48 131.65 53.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 0.0 110.714 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 124.76 45.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.374 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.9 124.34 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -136.03 93.79 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.504 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 3.5 mtp180 58.79 -93.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.42 15.38 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -114.15 125.27 53.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.19 117.21 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.565 HG23 ' HB ' ' A' ' 189' ' ' VAL . 9.0 m -134.32 135.78 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.41 124.25 46.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.507 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.55 149.12 45.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 154.7 160.07 9.64 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.532 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 95.9 m -91.28 139.27 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.87 108.48 42.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.12 -27.28 1.78 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.416 2.077 . . . . 0.0 112.147 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -130.05 131.81 45.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -34.35 77.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -36.04 75.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.439 ' HD1' ' HA ' ' A' ' 171' ' ' HIS . 2.2 m-70 -63.67 -35.94 82.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -46.22 91.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.38 -44.43 95.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.38 86.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.75 -41.19 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.314 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 -52.13 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.115 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -57.17 -40.47 77.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -65.65 -36.43 83.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.21 69.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.3 m -60.58 -41.0 93.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -67.73 -29.16 68.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 2.6 m -68.38 -66.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.491 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.566 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.3 m-90 -118.42 67.24 6.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.693 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.67 1.93 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.627 2.218 . . . . 0.0 111.829 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.77 60.71 0.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.54 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 ttt -171.84 -163.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 104.98 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.93 127.75 57.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.488 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.565 ' HB ' HG23 ' A' ' 161' ' ' THR . 59.6 t -126.49 121.14 58.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 190' ' ' ASN . 5.3 p30 -97.58 116.95 30.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.742 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.29 48.53 1.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.219 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.15 125.78 52.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.12 142.96 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.3 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.73 107.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.412 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 p -119.38 -7.51 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -110.44 -18.03 8.87 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -76.92 131.76 38.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . . . 164.23 -51.75 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.078 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 198' ' ' ALA . 16.6 Cg_exo -54.06 -43.14 60.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.456 2.104 . . . . 0.0 112.512 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' A' ' 198' ' ' ALA . 86.6 Cg_endo -87.02 -91.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.671 2.247 . . . . 0.0 112.29 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.94 -68.04 0.52 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -50.58 154.27 6.68 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.813 2.342 . . . . 0.0 112.065 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.13 73.41 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.735 2.29 . . . . 0.0 112.088 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 205' ' ' SER . . . -176.77 101.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 204' ' ' ALA . 1.0 OUTLIER -35.77 131.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.441 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 207' ' ' PRO . . . -147.4 106.77 0.37 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 209' ' ' ALA . 51.6 Cg_exo -50.62 -139.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.689 ' SG ' ' O ' ' A' ' 246' ' ' LYS . 1.3 m -38.02 -21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.622 ' N ' ' O ' ' A' ' 207' ' ' PRO . . . 53.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 2.7 m-20 33.46 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -56.24 -46.05 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.123 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.458 ' C ' ' CD ' ' A' ' 212' ' ' GLN . 10.2 tp60 -72.73 -50.38 25.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.249 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -71.17 -44.42 65.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.601 0.36 . . . . 0.0 110.948 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 210' ' ' ASP . . . -71.33 -45.27 63.38 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.028 -0.42 . . . . 0.0 111.943 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 211' ' ' LEU . 1.7 tp -69.48 -36.62 72.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.942 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 12.9 t30 -69.92 -43.96 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.81 95.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.703 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 214' ' ' ALA . 54.7 t -62.8 -50.15 80.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 221' ' ' GLY . 57.4 p -69.29 -22.22 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 74.5 -40.18 1.1 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -168.56 174.76 43.27 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.35 141.68 94.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.834 2.356 . . . . 0.0 111.986 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.3 mt -65.16 108.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -178.1 66.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -108.79 97.23 6.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.475 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -78.8 -83.01 0.64 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -178.24 4.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 110.711 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.94 -151.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.609 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 147.1 -106.22 0.35 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 231' ' ' SER . . . -112.64 -40.17 4.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.31 . . . . 0.0 110.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 230' ' ' ALA . 0.1 OUTLIER -27.7 106.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.596 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 230' ' ' ALA . 5.9 mp -65.0 124.95 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 234' ' ' PRO . 20.6 mt 42.59 79.93 0.31 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.532 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 233' ' ' ILE . 52.7 Cg_exo -48.33 -172.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.866 2.377 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 46.81 93.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' GLU . 14.0 t0 -178.73 90.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.701 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.564 ' O ' ' OD1' ' A' ' 241' ' ' ASN . 0.2 OUTLIER -68.19 19.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.324 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' ASP . 2.2 mt-10 -67.61 -46.04 73.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.809 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 239' ' ' ILE . 24.5 mt -59.49 -38.06 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 77.6 mt -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 237' ' ' TYR . 11.1 m120 -55.82 -49.03 74.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.903 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -65.03 -45.78 84.03 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.724 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 218' ' ' VAL . 89.7 t -64.04 -48.42 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.31 82.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -50.71 70.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.689 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 6.0 mtpm? -69.18 -33.41 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.981 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.9 OUTLIER -54.81 -31.29 58.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.594 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -62.5 -16.88 58.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.22 22.27 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.34 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 57.8 m -74.98 -28.63 0.81 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.3 Cg_exo -53.63 -14.23 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.327 2.018 . . . . 0.0 112.646 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -52.36 -10.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.635 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -128.98 -157.87 0.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.217 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -100.23 139.1 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 50.7 t -119.41 132.95 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.112 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.536 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.2 m -121.23 119.43 32.26 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 257' ' ' ILE . 36.4 mt -106.17 121.02 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.79 0.328 . . . . 0.0 110.786 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.68 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -109.45 125.1 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -112.4 166.21 12.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 261' ' ' THR . 1.2 t80 -172.99 109.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.744 HG23 ' N ' ' A' ' 262' ' ' ASP . 1.3 t -105.08 -162.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.714 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 261' ' ' THR . 12.6 p-10 -89.75 174.69 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 265' ' ' GLY . 2.4 m-20 -96.6 -86.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 54.2 m 61.09 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.458 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -63.52 -125.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 89.6 p -129.34 170.92 13.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 120.732 0.301 . . . . 0.0 110.998 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -59.74 -19.8 52.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.611 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.88 -35.17 40.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mm -90.51 -21.87 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.375 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -68.64 -33.12 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.46 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.7 mm -68.26 -52.49 21.7 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.8 Cg_endo -61.7 -35.59 79.28 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.085 1.856 . . . . 0.0 112.292 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.0 mm? -68.26 -47.25 68.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.5 p -73.3 -35.19 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.54 -38.49 71.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.32 -43.79 98.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.658 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.402 ' CD ' ' HE ' ' A' ' 319' ' ' ARG . 13.6 ttp85 -60.15 -39.76 87.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.608 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.34 -31.21 70.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -73.57 -37.5 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.81 -46.52 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 282' ' ' ALA . 28.1 m -63.69 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.15 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -63.58 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.123 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -30.83 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -46.69 51.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.712 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 290' ' ' VAL . 9.7 mt -59.91 -49.25 78.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.15 -36.21 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.76 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 -2.33 58.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.419 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.4 2.67 38.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 285' ' ' LEU . 22.0 t -68.74 131.91 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.349 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.77 97.66 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.596 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -77.46 12.86 12.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.14 -16.29 38.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -121.31 27.68 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.328 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 295' ' ' ILE . 35.4 mt -117.75 124.85 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.3 135.5 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 124.44 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.99 116.47 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.152 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.8 105.37 2.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.679 ' O ' ' N ' ' A' ' 302' ' ' SER . 27.5 mt -74.29 0.07 15.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 110.42 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.5 -72.18 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 300' ' ' LEU . 89.4 p -174.73 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 120.352 0.12 . . . . 0.0 110.955 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 304' ' ' ASN . 66.2 t -41.89 -84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.63 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 0.1 OUTLIER -86.38 -39.58 0.56 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.14 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 60.4 Cg_endo -82.53 143.64 12.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.667 2.245 . . . . 0.0 112.465 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.24 137.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.92 163.04 30.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 158.72 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -122.07 49.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -106.78 -40.06 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.852 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.91 157.99 67.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -50.04 -30.11 23.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.609 2.206 . . . . 0.0 112.056 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.09 -40.54 89.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.452 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -67.99 -44.13 79.39 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.429 ' HA ' HD22 ' A' ' 318' ' ' ASN . 27.1 mtt-85 -66.08 -46.15 78.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.76 80.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.316 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -72.7 -24.38 60.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 260' ' ' TYR . 65.5 m-20 -72.8 -24.27 60.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 277' ' ' ARG . 12.7 ttt-85 -91.72 101.68 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.23 139.52 39.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.759 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.32 155.11 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.04 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 323' ' ' ILE . 2.7 tp10 -145.09 143.17 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 111.018 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.402 ' N ' ' HG3' ' A' ' 322' ' ' GLU . 17.8 mt -125.89 112.7 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.5 m -122.03 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.169 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -115.51 135.05 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.635 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 41.5 t30 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.703 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.49 59.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.2 -15.4 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 p -92.08 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.113 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 157' ' ' ARG . 2.5 mt -121.35 159.65 25.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.2 m -81.31 178.91 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.245 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.7 pp -83.1 132.71 35.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.662 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.632 HD23 HD11 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -131.95 138.33 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.7 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -124.09 123.08 39.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.717 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -129.41 115.72 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.394 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -136.5 130.36 32.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 149' ' ' PRO . 42.1 mtt85 -112.22 140.15 47.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.8 p -142.89 114.82 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.623 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 56.66 -161.09 7.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.72 7.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 110.49 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 88' ' ' GLY . 99.7 m -107.58 130.93 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.35 116.93 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.3 m -103.25 121.38 42.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.582 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -123.05 127.62 49.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 123' ' ' GLN . 1.7 mt -139.31 123.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.386 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . 178.36 -161.39 28.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -137.33 156.36 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.624 0.249 . . . . 0.0 110.447 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -133.28 150.88 76.5 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.569 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.6 -19.66 31.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.772 2.315 . . . . 0.0 112.132 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.8 173.36 10.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -82.05 -34.8 29.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.89 85.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.9 78.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -36.75 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.717 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -37.5 64.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.536 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -60.56 -38.07 83.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.28 -43.98 69.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.016 0.436 . . . . 0.0 110.3 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.0 mtp -58.0 -26.31 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.531 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -43.97 96.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.79 -21.95 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.415 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.8 mt -99.64 -1.43 38.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -47.79 -34.39 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 -32.13 29.98 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.38 -34.91 69.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.317 . . . . 0.0 110.595 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mt -39.28 116.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.506 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -159.14 155.15 23.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.354 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.672 ' O ' ' N ' ' A' ' 118' ' ' VAL . 26.7 Cg_endo -65.11 -83.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.753 2.302 . . . . 0.0 112.108 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -41.86 -11.71 0.01 OUTLIER Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.672 ' N ' ' O ' ' A' ' 116' ' ' PRO . 27.8 t -92.38 137.51 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 122.416 -0.461 . . . . 0.0 110.743 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -100.44 134.9 42.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.236 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.46 114.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.998 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -124.74 122.59 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.792 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 121' ' ' ILE . 49.5 m-20 -133.56 86.85 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.007 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 93' ' ' LEU . 11.6 mm100 -83.84 55.39 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.033 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.1 128.44 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.47 143.29 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.32 112.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.5 134.6 19.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.69 33.06 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.18 -51.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' ASP . 35.3 m -56.14 150.03 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.632 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -104.03 159.04 16.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.406 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.08 151.16 41.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 183' ' ' TRP . 11.4 tp -80.99 133.12 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.656 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.68 133.42 56.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 105' ' ' ALA . 26.5 p90 -102.35 -22.87 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.584 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.2 m -34.17 -61.8 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.516 0.674 . . . . 0.0 110.988 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.18 20.76 9.8 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.747 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.763 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -124.4 -9.78 7.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -56.86 -43.85 99.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.803 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.2 Cg_exo -55.05 -36.49 92.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.39 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.478 HG23 ' OG1' ' A' ' 182' ' ' THR . 43.4 t -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.9 m-85 -62.39 -42.72 99.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.807 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -71.34 -36.04 71.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.664 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.06 -20.42 61.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.562 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -116.34 12.08 15.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -68.83 -43.28 27.16 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 12.2 Cg_exo -66.21 6.5 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.643 2.228 . . . . 0.0 111.901 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mm -111.91 99.99 47.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.722 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 86' ' ' ARG . 65.4 Cg_endo -79.83 -5.57 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.615 2.21 . . . . 0.0 112.187 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -117.52 40.49 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.517 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 4.0 t80 -127.65 137.87 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.631 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -142.94 160.46 27.5 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.49 138.55 24.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.756 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -106.15 128.65 54.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.2 t -112.81 138.55 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 158' ' ' ASP . 21.8 tt0 -150.39 102.83 3.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.754 ' O ' HD12 ' A' ' 79' ' ' LEU . 15.7 mtt180 49.83 -91.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 156' ' ' GLU . 4.4 p30 -121.57 33.98 5.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.92 130.75 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.338 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.4 129.88 62.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.696 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.02 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.67 105.29 12.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 p -118.04 149.72 40.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.29 175.32 14.38 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 66.7 p -100.17 119.27 38.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.48 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -87.09 145.79 38.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 197' ' ' GLN . 51.4 Cg_endo -72.52 -60.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.759 2.306 . . . . 0.0 111.845 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 t -124.47 153.87 41.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -30.89 71.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.872 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.26 -43.46 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -58.45 -37.08 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.013 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -69.09 -39.03 79.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.001 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -59.28 -47.78 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.877 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.68 77.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.09 -39.12 65.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -64.32 -44.31 91.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -64.95 -44.44 89.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.586 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -31.92 72.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.83 71.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 -47.76 83.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.7 t -70.72 -27.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.556 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 183' ' ' TRP . 0.9 OUTLIER -66.38 -60.92 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.625 ' CD1' HD21 ' A' ' 133' ' ' LEU . 21.7 m95 -120.67 85.14 38.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.139 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.67 ' O ' ' N ' ' A' ' 186' ' ' MET . 17.6 Cg_exo -62.35 20.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.88 2.387 . . . . 0.0 111.73 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 183' ' ' TRP . 0.8 OUTLIER -35.9 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.67 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.5 ttm 78.08 -8.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -120.05 80.98 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.19 136.71 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.1 t -126.97 121.72 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -87.73 125.99 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.57 40.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.466 . . . . 0.0 110.427 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.48 126.43 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -126.91 148.51 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 194' ' ' VAL . 2.3 p -97.03 110.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.716 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 195' ' ' THR . 0.0 OUTLIER -74.63 62.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.427 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . 47.43 32.68 7.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.576 ' O ' ' O ' ' A' ' 167' ' ' PRO . 18.4 mt-30 -113.58 156.67 23.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.694 ' HB1' ' O ' ' A' ' 201' ' ' GLY . . . -179.94 65.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.519 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 21.1 Cg_exo -56.15 -42.7 63.6 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.643 2.229 . . . . 0.0 112.723 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 73.1 Cg_endo -81.8 -33.99 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.373 2.049 . . . . 0.0 112.105 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.694 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -126.57 81.31 0.35 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.522 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 21.3 Cg_exo -56.32 -42.66 63.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.644 2.229 . . . . 0.0 112.694 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 56.7 Cg_exo -47.23 -18.61 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.204 1.936 . . . . 0.0 112.008 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.73 -56.06 4.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.55 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.82 -83.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 196' ' ' GLY . . . 83.13 151.75 11.05 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.98 -67.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.742 2.295 . . . . 0.0 112.067 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.662 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 31.1 t -110.29 35.74 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.368 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 210' ' ' ASP . . . -38.65 160.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.761 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 0.0 OUTLIER 33.12 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.154 0.502 . . . . 0.0 110.15 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -56.76 -42.94 80.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.065 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 216' ' ' ASN . 12.7 pt20 -71.96 -49.74 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.191 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 72.7 m -71.08 -48.69 51.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -62.51 -44.84 95.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.426 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 211' ' ' LEU . 3.6 tp -69.36 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.6 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 220' ' ' GLY . 3.1 m120 -67.8 -39.77 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.422 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.33 70.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.273 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' ALA . 74.3 t -58.46 -47.03 89.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.189 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 221' ' ' GLY . 68.1 p -87.83 -21.5 25.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.584 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.32 -37.57 0.21 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -160.48 179.75 35.78 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.6 154.22 9.46 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.763 2.308 . . . . 0.0 112.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 225' ' ' PHE . 41.2 mt -103.41 113.38 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . -96.41 15.17 22.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.485 ' H ' HG22 ' A' ' 223' ' ' ILE . 0.9 OUTLIER 34.16 85.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.523 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.409 ' C ' ' OD1' ' A' ' 227' ' ' ASN . . . -108.67 134.51 12.28 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 226' ' ' GLY . 0.4 OUTLIER -165.93 55.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.548 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -121.96 68.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.38 71.74 0.46 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 61.64 152.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.781 0.325 . . . . 0.0 110.477 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.97 -178.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.6 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.51 -5.31 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 16.6 pt -126.35 61.07 40.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.91 41.3 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.831 2.354 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 47.96 -147.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.772 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 236' ' ' ASP . 0.5 OUTLIER 64.77 46.65 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.56 -17.86 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -66.21 -37.72 86.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.04 -43.42 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 240' ' ' LEU . 10.4 tt -58.64 -32.35 68.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.374 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -44.73 94.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -63.67 -41.29 98.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.87 -40.91 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.51 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.518 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.91 -45.91 85.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -56.11 -50.81 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.67 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 0.4 OUTLIER -65.01 -35.54 81.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.702 HD21 HD13 ' A' ' 285' ' ' LEU . 9.0 tp -55.29 -30.2 59.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.368 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 249' ' ' ALA . 8.5 ptmt -63.63 -36.13 82.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.407 ' N ' ' HG2' ' A' ' 248' ' ' LYS . . . -107.49 3.24 24.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.714 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 85.7 m -74.63 -28.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 41.1 Cg_exo -55.12 -14.37 8.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.539 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 251' ' ' PRO . 9.0 t70 -40.89 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -119.99 -153.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.082 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 2.7 ttp180 -106.83 138.06 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.94 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.1 131.72 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -124.13 124.28 42.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 77.9 mt -113.01 117.44 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 110.715 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.42 131.99 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.383 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -108.07 133.19 11.52 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 318' ' ' ASN . 11.8 m-85 -100.49 107.82 19.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.56 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -143.84 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.282 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 262' ' ' ASP . 36.2 t0 -145.92 -99.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.497 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 0.2 OUTLIER -177.96 44.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.606 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.0 m -45.97 -58.74 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.465 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -146.6 -92.62 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 95.0 p -125.01 179.87 4.85 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 120.976 0.417 . . . . 0.0 110.977 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 269' ' ' ILE . 2.6 mt-10 -59.18 -31.19 68.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.538 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.76 6.66 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.513 ' H ' ' C ' ' A' ' 267' ' ' GLU . 0.4 OUTLIER -143.56 -36.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.625 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -68.59 -46.47 69.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.436 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 272' ' ' PRO . 0.4 OUTLIER -73.46 -48.33 7.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.163 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 28.0 Cg_exo -53.53 -39.51 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.993 1.795 . . . . 0.0 111.669 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.21 -44.7 75.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.22 77.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.48 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.551 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.85 -45.18 90.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.439 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.621 ' O ' HG23 ' A' ' 281' ' ' VAL . 0.3 OUTLIER -60.14 -44.51 94.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.335 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -68.19 -45.74 72.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.367 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.27 -45.99 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.529 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 277' ' ' ARG . 57.3 t -61.39 -46.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.28 88.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.39 -32.97 69.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.546 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.6 -48.19 27.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.702 HD13 HD21 ' A' ' 247' ' ' LEU . 46.8 mt -59.45 -44.69 92.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.313 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 65.3 t -59.34 -37.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.291 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.32 -20.7 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.518 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.94 0.15 56.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.27 18.13 20.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 247' ' ' LEU . 98.2 t -86.1 132.79 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.602 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.98 104.45 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.63 16.74 7.58 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.648 ' N ' ' OD1' ' A' ' 293' ' ' ASP . 0.0 OUTLIER -96.4 -12.2 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.703 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.652 ' N ' ' ND1' ' A' ' 294' ' ' HIS . 0.2 OUTLIER -119.45 23.38 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.633 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 4.9 mt -117.19 134.13 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.39 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.119 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.94 129.16 49.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.867 0.365 . . . . 0.0 110.992 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 12.1 t -133.26 116.69 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 301' ' ' GLY . . . -89.15 105.59 3.21 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 302' ' ' SER . 26.0 mt -56.64 77.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 299' ' ' GLY . . . -47.49 80.6 0.0 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.634 ' N ' ' O ' ' A' ' 300' ' ' LEU . 70.3 m 73.91 -52.89 0.69 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.292 0.567 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 300' ' ' LEU . 2.8 m -27.99 130.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 29.4 t-20 58.19 56.82 6.65 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 110.338 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 41.8 Cg_endo -71.69 176.78 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.905 2.403 . . . . 0.0 112.369 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 20.9 mt -132.52 -72.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.532 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -130.19 137.28 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.449 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 310' ' ' ALA . 5.3 p -68.02 171.05 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -76.18 24.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -44.29 -52.88 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.365 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.41 161.93 56.27 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -50.37 -41.06 52.57 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.255 1.97 . . . . 0.0 111.738 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.84 -42.26 98.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.04 -47.53 59.1 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.568 ' CZ ' ' NH2' ' A' ' 319' ' ' ARG . 58.2 ttt180 -60.16 -46.26 90.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.339 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.22 78.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.382 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -31.42 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.65 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.5 t-20 -79.95 -25.13 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.549 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' A' ' 315' ' ' ARG . 1.5 mtt85 -80.38 82.21 6.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.317 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.3 ttm180 -129.03 141.97 51.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.33 161.12 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.033 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.24 127.9 16.18 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.086 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.47 110.33 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.37 135.65 60.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.3 p -115.76 135.62 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.225 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.618 ' O ' HD13 ' A' ' 211' ' ' LEU . 2.0 t30 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.663 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.779 0.323 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.648 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -137.01 161.83 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.555 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.3 mm? -87.46 -4.18 59.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.86 121.42 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 76' ' ' ALA . 5.1 mp -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 p -50.64 134.95 23.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -47.56 124.11 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.61 125.57 38.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.356 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -101.91 131.54 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.892 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.489 HG23 ' CD2' ' A' ' 93' ' ' LEU . 79.8 mt -133.85 120.0 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 92' ' ' THR . 15.5 t -133.34 140.05 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.502 ' CG ' HG12 ' A' ' 91' ' ' VAL . 1.5 ttt180 -125.22 150.01 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' THR . 8.9 t -145.23 95.09 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 46.72 -130.45 12.1 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 118' ' ' VAL . 32.5 m-20 -69.65 4.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 87' ' ' SER . 30.9 m -115.98 126.05 53.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.535 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 91' ' ' VAL . 22.7 m -117.48 117.57 55.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.407 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.571 HG22 ' CD1' ' A' ' 94' ' ' ILE . 7.8 m -106.6 126.07 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.825 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 84' ' ' ILE . 6.9 mt -129.88 121.19 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.486 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.571 ' CD1' HG22 ' A' ' 92' ' ' THR . 2.4 mp -133.86 141.49 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.631 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.07 -157.28 27.72 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -130.98 156.8 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 0.0 110.563 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -141.42 153.35 65.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.3 -29.73 80.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.925 2.417 . . . . 0.0 112.455 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.56 176.1 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.648 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -74.85 -16.03 60.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.524 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.42 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.202 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.41 77.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.129 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 122' ' ' ASP . 2.6 tttp -63.81 -36.45 83.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.375 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.31 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.72 79.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.14 -41.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.603 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.7 mmt -58.35 -39.44 79.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -38.6 89.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.39 -16.12 62.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.86 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -100.77 -13.95 18.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -52.17 -25.6 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -10.81 81.51 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.3 tt -111.13 -17.25 13.27 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.261 -0.553 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.74 95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . -151.73 140.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' C ' ' H ' ' A' ' 118' ' ' VAL . 81.8 Cg_exo -41.17 173.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.6 2.2 . . . . 0.0 112.276 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.0 -14.64 0.18 Allowed Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 113' ' ' LEU . 48.8 t -101.72 139.39 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 122.218 -0.578 . . . . 0.0 110.646 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -108.06 123.55 48.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.619 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.19 114.43 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.463 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 92' ' ' THR . 0.8 OUTLIER -130.34 139.6 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 103' ' ' LYS . 7.7 p-10 -154.43 110.43 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -95.21 90.16 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.67 129.09 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.009 0.433 . . . . 0.0 111.132 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 148.94 22.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.566 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.02 117.95 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.228 0.537 . . . . 0.0 110.987 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.611 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -112.66 141.26 25.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.083 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 127' ' ' ASP . 91.1 Cg_exo -29.3 -62.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.06 2.507 . . . . 0.0 112.856 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 129' ' ' VAL . 6.1 p -164.09 47.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.267 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 127' ' ' ASP . 1.5 m -50.4 -169.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -108.86 158.81 17.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -148.97 155.86 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.04 136.16 37.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.04 129.24 39.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 136' ' ' SER . 0.0 OUTLIER -105.45 -8.32 18.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.579 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.8 t -21.51 -47.74 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.403 0.621 . . . . 0.0 111.002 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.4 t -133.42 65.64 1.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.284 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -123.56 -15.5 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.5 tt0 -48.11 -49.32 61.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.7 Cg_exo -57.97 -30.94 91.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.728 2.285 . . . . 0.0 112.105 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.503 ' O ' ' OG ' ' A' ' 145' ' ' SER . 18.3 t -67.07 -42.98 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.9 m-85 -62.35 -41.7 98.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.245 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 21.3 p -60.88 -37.69 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.081 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.61 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.797 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 141' ' ' VAL . 0.7 OUTLIER -106.44 11.24 31.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 142' ' ' PHE . 3.5 t -88.23 -32.24 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 60.3 Cg_endo -85.84 9.6 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.862 2.374 . . . . 0.0 112.357 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 148' ' ' ILE . 8.8 mt -126.63 98.56 31.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 173.71 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.6 2.2 . . . . 0.0 112.058 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 52.88 54.19 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.69 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.651 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -127.08 145.8 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.36 149.03 16.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 162' ' ' LEU . 17.3 tp -139.02 126.48 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' N ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -126.08 126.7 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.852 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 154' ' ' LYS . 88.8 t -114.82 122.83 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.14 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 158' ' ' ASP . 4.8 tt0 -110.98 163.42 13.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -25.52 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.782 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 156' ' ' GLU . 1.4 p-10 -156.14 29.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.536 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 125.97 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.534 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.54 121.65 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 189' ' ' VAL . 24.4 m -130.38 136.96 49.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.592 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -119.19 109.22 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 147.99 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.542 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.81 -169.28 36.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.2 m -107.37 137.44 45.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.737 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -124.62 109.65 28.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.43 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.31 -16.11 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.435 2.09 . . . . 0.0 112.417 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.21 129.37 35.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.03 -41.71 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.647 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -35.75 76.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.582 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.644 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.3 m170 -63.06 -42.18 99.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -66.84 -39.4 87.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.98 -46.1 90.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.863 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.24 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 171' ' ' HIS . 17.9 t -70.59 -37.59 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.804 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -62.38 -49.32 75.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.797 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.89 -39.42 94.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.17 96.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.09 68.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.4 m -58.16 -39.57 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.412 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.8 p -65.85 -27.05 67.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.335 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.476 ' HB ' ' CD2' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.86 -44.07 28.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.476 ' CD2' ' HB ' ' A' ' 182' ' ' THR . 2.3 m-90 -138.21 67.26 46.85 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.627 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.27 -10.75 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.814 2.343 . . . . 0.0 111.973 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.71 58.47 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.433 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -176.57 -170.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.533 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -107.21 110.75 22.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 183' ' ' TRP . 39.7 mt -116.41 131.41 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 161' ' ' THR . 17.0 m -131.02 121.4 49.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.57 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -89.56 110.17 21.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.613 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -104.1 55.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.662 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.41 115.85 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.385 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 193' ' ' GLU . 2.9 pp20? -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.683 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 166' ' ' ALA . 3.0 m -93.53 134.99 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.313 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.4 -26.53 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -104.7 -5.93 41.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 198' ' ' ALA . 29.6 tt0 -63.81 156.21 28.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.741 ' H ' ' CD ' ' A' ' 199' ' ' PRO . . . -151.58 -46.6 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.253 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.741 ' CD ' ' H ' ' A' ' 198' ' ' ALA . 6.4 Cg_endo -84.47 110.07 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.267 2.644 . . . . 0.0 111.735 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.28 106.36 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.608 2.205 . . . . 0.0 112.399 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 122.76 -82.66 0.35 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -38.47 148.34 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.104 2.536 . . . . 0.0 112.311 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 204' ' ' ALA . 61.3 Cg_endo -75.52 172.74 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.816 2.344 . . . . 0.0 112.12 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.577 ' O ' ' O ' ' A' ' 203' ' ' PRO . . . 50.47 163.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.6 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.5 m -162.63 -74.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -152.39 57.93 0.42 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.06 33.78 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.794 2.329 . . . . 0.0 112.28 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.479 ' SG ' ' HD3' ' A' ' 251' ' ' PRO . 1.9 t 50.4 87.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -135.82 -147.89 0.28 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.256 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -70.01 50.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.151 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 211' ' ' LEU . 0.1 OUTLIER -66.66 -31.52 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 212' ' ' GLN . 0.0 OUTLIER -54.19 -31.62 53.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 72.8 m -65.94 -48.55 70.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.706 0.765 . . . . 0.0 110.996 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -75.26 -34.55 61.39 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.848 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.718 HG21 HG11 ' A' ' 325' ' ' VAL . 0.3 OUTLIER -58.37 -39.5 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 2.2 m-20 -53.63 -34.42 58.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.083 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.88 62.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.53 -43.38 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 221' ' ' GLY . 6.3 p -93.67 -31.56 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.463 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.96 -35.33 0.1 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -174.56 -173.15 40.26 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.66 154.07 32.98 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.735 2.29 . . . . 0.0 111.895 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.1 tt -115.74 145.05 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.527 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . -157.18 112.72 2.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.601 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 224' ' ' ALA . 64.5 t80 28.0 -104.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.551 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.539 ' O ' ' OD1' ' A' ' 228' ' ' ASP . . . -107.25 -147.77 14.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 227' ' ' ASN . 0.4 OUTLIER 37.02 89.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.812 0.339 . . . . 0.0 110.598 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 226' ' ' GLY . 1.6 m-20 -142.94 -109.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -170.98 -168.64 32.98 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 60.03 177.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 0.0 110.519 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.38 22.97 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.83 163.18 27.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 pt -119.1 73.73 13.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.2 133.44 13.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.938 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -138.31 -100.33 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.56 59.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.783 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.2 t80 179.61 -36.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.48 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.47 -32.92 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.292 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.0 OUTLIER -66.46 -40.94 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.52 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.468 ' O ' ' NE ' ' A' ' 288' ' ' ARG . 12.5 mt -58.56 -47.28 84.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.344 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.515 ' C ' ' OD1' ' A' ' 241' ' ' ASN . 8.7 t-20 -63.52 -33.19 75.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.296 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.75 84.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.513 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 285' ' ' LEU . 48.3 t -62.06 -42.55 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 247' ' ' LEU . . . -56.43 -41.59 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 109.897 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.58 -40.14 74.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.4 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 28.9 ttmt -69.6 -31.29 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.453 HD11 HG23 ' A' ' 290' ' ' VAL . 0.1 OUTLIER -53.71 -33.04 54.24 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.3 OUTLIER -62.0 -12.11 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.496 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -69.04 11.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.879 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.563 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -37.63 -48.8 2.68 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.23 -178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.479 ' HD3' ' SG ' ' A' ' 208' ' ' CYS . 31.3 Cg_exo -56.29 -18.64 24.97 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.904 1.736 . . . . 0.0 111.596 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 254' ' ' ARG . 14.0 m-20 -156.74 39.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.668 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -62.65 62.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.711 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 252' ' ' ASP . 1.6 mtm180 -111.52 134.91 52.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.05 139.5 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.926 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.9 m -122.54 127.05 49.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 295' ' ' ILE . 74.1 mt -102.1 123.19 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 111.254 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.41 120.1 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.15 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -100.55 139.57 14.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.36 100.41 6.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.568 ' CG2' ' ND2' ' A' ' 263' ' ' ASN . 1.3 m -141.48 128.25 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.547 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.51 ' CG ' ' N ' ' A' ' 263' ' ' ASN . 22.4 t70 -68.54 -116.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.568 ' ND2' ' CG2' ' A' ' 261' ' ' THR . 50.9 m-20 65.15 41.09 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.706 ' O ' ' ND2' ' A' ' 270' ' ' ASN . 10.5 m -31.92 -74.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 264' ' ' THR . . . 27.12 -92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 264' ' ' THR . 48.1 t -142.83 137.74 29.85 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 122.967 -0.137 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 267' ' ' GLU . 1.9 pm0 -58.44 -30.42 66.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.348 . . . . 0.0 110.434 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -61.08 6.8 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.564 ' H ' ' C ' ' A' ' 267' ' ' GLU . 0.5 OUTLIER -140.71 -42.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.675 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.706 ' ND2' ' O ' ' A' ' 264' ' ' THR . 0.0 OUTLIER -68.35 -34.0 75.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.1 mm -72.67 -51.97 6.58 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.705 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.4 Cg_endo -62.0 -30.22 82.82 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.934 1.756 . . . . 0.0 112.115 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 273' ' ' LEU . 0.3 OUTLIER -64.4 -48.76 74.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.179 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 12.0 p -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.54 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.91 64.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 272' ' ' PRO . 6.9 tt0 -61.12 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.517 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -33.12 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.59 -33.99 76.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -43.31 84.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.3 -37.2 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.3 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.48 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.312 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.48 80.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -41.73 84.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.335 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -70.69 -42.34 70.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 243' ' ' VAL . 1.7 mm? -59.76 -49.19 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.93 -34.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.5 67.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.298 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 240' ' ' LEU . 3.1 tpt85 -80.77 -1.24 42.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.0 0.429 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.63 3.51 43.31 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.453 HG23 HD11 ' A' ' 247' ' ' LEU . 95.5 t -67.3 128.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.467 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -79.99 107.85 13.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.745 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -55.96 -4.25 0.68 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -68.52 -10.6 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -134.97 52.64 2.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 292' ' ' GLY . 17.6 tt -133.04 139.3 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.27 142.33 43.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.2 p -122.62 142.15 50.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.887 0.375 . . . . 0.0 110.955 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.39 116.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.282 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.3 107.45 3.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 300' ' ' LEU . 10.2 mp -97.65 62.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.449 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -34.94 -102.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -112.49 99.86 8.3 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 122.99 -0.124 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.717 HG12 ' N ' ' A' ' 304' ' ' ASN . 54.4 t -119.59 -95.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.717 ' N ' HG12 ' A' ' 303' ' ' VAL . 0.4 OUTLIER -89.16 -52.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.649 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 68.4 Cg_endo -80.72 153.33 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.772 2.315 . . . . 0.0 112.309 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.8 tt -167.62 137.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.416 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.21 137.66 47.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 309' ' ' ASN . 13.3 t -74.18 79.95 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 308' ' ' SER . 20.9 p-10 -32.23 116.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -174.87 -50.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.482 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 164.38 15.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.39 -43.01 46.29 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.868 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -45.86 92.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.13 97.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -60.8 -40.92 94.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.48 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.21 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -68.05 -37.47 81.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 13.2 t-20 -72.08 -6.55 43.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.28 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -160.0 89.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.318 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -134.43 149.09 50.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.012 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.3 t -123.83 145.25 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.837 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.94 129.8 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.43 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.69 109.87 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 178.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 135.86 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.718 HG11 HG21 ' A' ' 215' ' ' ILE . 2.4 p -107.93 135.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 20.3 t30 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.645 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 76' ' ' ALA . 12.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.846 0.355 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 53.81 106.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' C ' ' OG ' ' A' ' 78' ' ' SER . 3.7 mt -108.27 -29.53 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -168.93 121.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.68 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 132' ' ' SER . 1.9 mm? -110.46 151.79 27.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.466 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.95 151.84 18.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.445 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -66.07 129.49 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -131.49 130.77 42.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -109.68 121.17 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.95 118.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.606 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 t -130.52 132.45 45.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.456 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.48 HH11 HG22 ' A' ' 91' ' ' VAL . 25.4 ttm-85 -112.86 143.71 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 p -140.57 120.68 13.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.315 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 48.68 -135.77 19.4 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -88.48 17.08 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.824 0.345 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -109.97 139.06 45.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.688 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 HH11 ' A' ' 86' ' ' ARG . 89.6 t -112.95 114.13 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.458 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 116.45 32.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 93' ' ' LEU . 1.2 mm? -109.8 122.26 47.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.356 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.28 124.73 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.7 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.25 -135.83 4.48 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -154.36 156.91 37.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.749 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.92 153.99 80.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.497 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.2 -26.96 41.83 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.24 . . . . 0.0 112.011 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.3 p-10 -168.07 158.38 10.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.344 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.76 74.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.328 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.66 77.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -42.98 73.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.04 -40.61 73.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.29 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.54 -46.02 60.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.4 mtm -59.74 -33.14 71.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 2.9 m -62.01 -40.54 96.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.99 -29.51 66.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.79 -0.65 57.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.466 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 112' ' ' GLY . 4.2 p-10 -52.47 -22.66 5.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 111' ' ' ASN . . . -83.48 -10.07 82.44 Favored Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -97.4 -51.25 4.23 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.447 -0.443 . . . . 0.0 110.546 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -35.23 106.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -149.38 173.55 4.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 25.2 Cg_exo -57.76 164.81 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.632 2.221 . . . . 0.0 112.288 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.38 13.41 2.69 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -102.36 138.66 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.209 -0.583 . . . . 0.0 110.754 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.4 137.95 45.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.273 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.98 122.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.96 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.44 128.04 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.918 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.13 81.78 1.94 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -92.12 48.43 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.253 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -105.4 130.54 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' N ' ' ND1' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -93.37 146.54 23.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.783 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.8 111.58 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 129' ' ' VAL . 31.6 m-20 -125.44 103.9 28.62 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -52.36 69.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.494 2.13 . . . . 0.0 112.293 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.677 ' O ' ' NE ' ' A' ' 131' ' ' ARG . 3.4 p -179.27 -30.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.742 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.02 164.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.677 ' NE ' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -122.45 159.17 28.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.478 ' C ' HD11 ' A' ' 79' ' ' LEU . 10.2 t -133.86 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -81.76 135.65 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.64 137.44 43.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -105.94 6.83 31.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.057 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t -45.72 132.71 8.54 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m 45.47 38.21 3.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 135' ' ' PHE . . . -101.6 -10.95 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -53.18 -47.32 96.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.367 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 32.0 Cg_exo -58.26 -36.55 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.782 2.321 . . . . 0.0 111.654 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.39 -44.4 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.49 -38.62 91.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.314 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 35.6 p -62.69 -37.24 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.44 -21.08 56.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.03 10.84 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -77.71 -43.58 2.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.493 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 28.1 Cg_exo -57.56 -9.6 5.58 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.512 2.142 . . . . 0.0 111.534 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 171' ' ' HIS . 1.3 mm -108.57 93.46 11.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.321 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.8 7.99 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.628 2.219 . . . . 0.0 112.311 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.38 50.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.38 141.57 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.23 123.07 4.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -118.51 135.28 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 130.22 49.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.19 133.86 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.044 0.449 . . . . 0.0 111.266 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -140.79 78.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 159' ' ' THR . 7.4 ttp180 70.11 -137.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.989 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -75.97 25.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.47 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ARG . 3.6 m -127.8 139.97 52.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.55 134.82 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.284 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 189' ' ' VAL . 11.2 m -127.35 136.88 52.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.913 ' N ' HD12 ' A' ' 162' ' ' LEU . 2.2 mp -106.64 125.23 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.951 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -137.93 146.89 43.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.09 163.18 10.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.2 p -87.03 126.75 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.749 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.668 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . -99.84 146.86 32.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.527 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 43.6 Cg_endo -71.2 -23.76 24.08 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.784 2.323 . . . . 0.0 111.901 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 0.2 OUTLIER -148.86 137.93 21.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -36.33 83.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.86 -35.3 79.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.574 ' CE1' HD11 ' A' ' 148' ' ' ILE . 1.7 m-70 -57.47 -43.7 84.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.894 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -36.17 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.683 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.87 -40.18 87.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.37 99.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.45 -37.04 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -61.83 -48.62 79.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -55.8 -48.27 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.488 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.39 87.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.29 -41.3 96.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.664 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.0 -38.88 90.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 m -71.04 -37.47 72.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.37 -22.11 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.823 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' ALA . 7.9 m0 -141.69 88.36 9.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.664 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 186' ' ' MET . 71.5 Cg_endo -82.96 15.73 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.073 2.515 . . . . 0.0 112.291 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.9 OUTLIER -31.58 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 184' ' ' PRO . 9.3 ttt 80.47 -23.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -103.24 68.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.85 134.43 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 161' ' ' THR . 94.1 t -115.4 130.18 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.65 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 3.3 p-10 -97.02 119.12 34.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.96 50.49 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 192' ' ' ILE . 1.6 pp -101.59 129.56 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -98.7 139.41 34.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.356 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 194' ' ' VAL . 6.8 m -109.52 119.91 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 195' ' ' THR . 3.0 t -98.71 65.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.319 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.94 31.09 54.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 166' ' ' ALA . 27.5 mm-40 -68.84 156.24 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.67 99.59 34.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.533 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 21.3 Cg_exo -56.0 -42.54 65.62 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.36 2.04 . . . . 0.0 112.446 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 74.1 Cg_endo -81.02 50.61 3.63 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.229 1.953 . . . . 0.0 111.859 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.05 98.27 0.18 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 21.0 Cg_exo -55.36 -42.8 64.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.374 2.049 . . . . 0.0 112.405 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 71.5 Cg_endo -83.03 -1.63 10.49 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.452 2.101 . . . . 0.0 112.2 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 203' ' ' PRO . . . 70.53 179.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.2 t -99.73 -55.97 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.538 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 114.6 179.91 18.65 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.829 ' HB2' ' HB1' ' A' ' 249' ' ' ALA . 75.5 Cg_endo -81.37 139.57 11.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 123.18 2.587 . . . . 0.0 112.703 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 52.8 t 39.38 13.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.978 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 207' ' ' PRO . . . -68.45 147.2 52.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.177 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 35.78 27.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 109.815 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 209' ' ' ALA . 56.9 tp -56.28 -31.7 63.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 213' ' ' SER . 14.3 pt20 -54.65 -44.76 73.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.79 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 74.1 m -69.78 -40.44 76.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.172 0.51 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -68.83 -37.15 78.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.514 ' CD1' HG22 ' A' ' 243' ' ' VAL . 3.5 mm -59.6 -36.53 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.709 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 220' ' ' GLY . 0.7 OUTLIER -57.3 -42.0 80.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.804 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.13 -41.45 63.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.698 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 214' ' ' ALA . 85.4 t -59.96 -45.12 95.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.706 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 221' ' ' GLY . 75.0 p -94.52 -23.24 17.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 65.95 -2.46 3.8 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -171.15 -172.82 37.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.97 151.47 62.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.732 2.288 . . . . 0.0 112.048 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.4 mt -89.16 118.67 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -168.39 78.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.3 t80 61.92 121.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -134.23 -115.62 1.58 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.75 88.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -94.98 115.34 27.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -94.73 133.29 11.5 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 -67.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.5 m -133.59 -86.1 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.572 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.38 54.22 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 233' ' ' ILE . 18.3 tt -177.09 75.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.615 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.03 93.51 1.1 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.971 2.447 . . . . 0.0 112.158 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -141.07 97.05 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.547 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.51 91.91 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -113.73 9.25 17.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.249 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -58.86 -34.66 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.899 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.77 -46.37 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.05 -34.37 73.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.626 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.23 -45.32 80.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -61.06 -43.74 98.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.333 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 215' ' ' ILE . 51.0 t -68.18 -39.38 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.453 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.728 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -64.81 -46.6 81.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -60.53 -50.77 72.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -60.47 -31.66 70.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.482 HD13 HD22 ' A' ' 285' ' ' LEU . 0.9 OUTLIER -62.67 -32.92 74.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.252 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.65 -18.59 64.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.829 ' HB1' ' HB2' ' A' ' 207' ' ' PRO . . . -98.92 -2.05 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 0.0 110.73 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.687 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.4 m -74.97 -28.72 0.82 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 43.6 Cg_exo -53.6 -16.04 7.34 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.148 1.899 . . . . 0.0 112.405 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.511 ' C ' ' OD1' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -62.4 -9.43 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.553 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -136.07 -157.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.878 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -108.79 138.2 45.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.08 133.31 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.007 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.651 HG22 ' OD1' ' A' ' 258' ' ' ASN . 95.2 m -120.75 116.13 24.64 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.0 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 295' ' ' ILE . 53.3 mt -100.96 112.54 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.768 0.318 . . . . 0.0 110.557 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.651 ' OD1' HG22 ' A' ' 256' ' ' THR . 4.4 m120 -112.6 122.65 48.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -122.85 133.98 9.36 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.649 ' HB2' HG11 ' A' ' 303' ' ' VAL . 29.6 p90 -130.52 154.67 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.799 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 262' ' ' ASP . 30.8 p -117.42 -118.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.603 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 303' ' ' VAL . 14.6 p-10 -134.58 -99.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.264 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.599 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 1.7 p30 -174.82 -123.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' A' ' 266' ' ' SER . . . 78.85 128.74 0.56 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' A' ' 265' ' ' GLY . 14.1 t 82.61 -77.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.623 0.725 . . . . 0.0 110.99 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.54 -28.95 67.55 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.238 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -99.23 -35.93 4.58 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 269' ' ' ILE . 3.1 tt 34.87 23.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.346 0.593 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 268' ' ' GLY . 11.6 t-20 -69.85 -36.54 75.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.259 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.943 ' O ' HD12 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -55.85 -49.96 89.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.657 ' HD3' HG23 ' A' ' 271' ' ' ILE . 21.8 Cg_endo -62.69 -39.93 40.26 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.594 1.529 . . . . 0.0 111.883 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.62 -34.08 77.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -40.0 94.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.763 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.62 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -65.9 -34.62 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.554 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -60.26 -45.67 92.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.67 76.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.46 -44.46 87.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.98 -36.96 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.298 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.87 -41.93 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -62.97 -39.66 95.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.95 -41.6 87.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.04 -44.28 85.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.729 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 247' ' ' LEU . 89.7 mt -59.72 -41.37 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.5 t -60.06 -36.31 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.167 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.24 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.772 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.728 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -86.6 -1.85 58.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 18.15 11.79 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.552 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 74.6 t -87.2 124.06 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 110.433 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -70.12 98.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.68 16.5 0.4 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 291' ' ' ALA . 25.3 t0 -93.21 -13.36 28.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.775 0.321 . . . . 0.0 110.518 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -132.48 24.72 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.815 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 295' ' ' ILE . 16.1 tt -116.36 125.34 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.468 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.86 48.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.552 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p -124.05 138.48 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.387 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.11 122.13 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.528 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -98.12 107.73 3.5 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.0 OUTLIER -38.96 -61.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.723 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.64 ' HA2' HD13 ' A' ' 271' ' ' ILE . . . 96.15 106.57 2.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.0 p 40.24 90.01 0.01 OUTLIER 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.971 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 260' ' ' TYR . 0.7 OUTLIER -107.24 160.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 303' ' ' VAL . 0.6 OUTLIER -40.33 152.76 0.22 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.402 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.2 114.64 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.746 2.297 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 16.2 mt -103.03 -42.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.73 168.88 11.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.506 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.45 90.41 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.483 ' CG ' ' O ' ' A' ' 309' ' ' ASN . 3.7 t30 -65.73 -1.06 2.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.68 -11.1 1.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.99 158.44 69.71 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.62 -36.59 81.52 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.85 2.366 . . . . 0.0 111.918 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -64.62 -31.45 72.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.406 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.99 99.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.683 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 6.7 ttm180 -60.8 -37.77 83.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.403 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.09 -36.23 82.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.55 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -36.88 64.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.806 HD22 ' N ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -74.99 -25.12 58.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.785 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.806 ' N ' HD22 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -95.57 84.41 3.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.611 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 260' ' ' TYR . 12.6 mtm180 -122.87 154.52 38.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.1 t -129.36 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.091 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.483 ' C ' HD13 ' A' ' 323' ' ' ILE . 2.8 tt0 -128.44 127.17 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 323' ' ' ILE . 0.0 OUTLIER -102.69 111.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.148 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 256' ' ' THR . 4.4 m -118.1 121.03 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.437 HG21 ' SG ' ' A' ' 208' ' ' CYS . 0.2 OUTLIER -105.63 135.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.553 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 3.7 t-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.74 0.305 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.36 135.54 35.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.31 -88.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.579 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -130.34 126.04 36.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 27.3 mt -103.76 139.65 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.751 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -81.13 153.3 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.516 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 82' ' ' LEU . 1.3 tt -53.65 121.26 7.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -125.35 118.49 26.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.5 t -101.85 117.2 34.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.32 116.25 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -134.05 128.31 34.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.461 HH21 ' HA ' ' A' ' 149' ' ' PRO . 11.2 mtp85 -110.69 130.78 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.585 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.4 ' HG ' ' HB ' ' A' ' 90' ' ' THR . 19.9 p -130.01 115.94 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 42.3 -131.32 4.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.832 ' O ' HG23 ' A' ' 118' ' ' VAL . 22.2 m-20 -86.4 21.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.678 0.275 . . . . 0.0 110.606 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 87' ' ' SER . 75.6 m -122.07 125.73 46.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.397 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.59 132.9 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.5 m -119.31 116.56 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.382 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.93 123.35 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 123' ' ' GLN . 2.0 mt -142.08 124.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.291 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.57 -143.78 8.47 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.449 ' OD2' HG11 ' A' ' 130' ' ' VAL . 26.1 p30 -154.34 153.06 31.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 124' ' ' ILE . 33.9 p90 -137.26 150.43 68.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.83 -20.49 22.46 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.738 2.292 . . . . 0.0 112.242 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -165.87 145.75 6.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' C ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -53.75 -10.63 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' ASP . . . -60.86 -40.16 91.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.5 77.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -68.37 -37.05 80.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.86 81.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.54 77.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 106' ' ' LEU . 1.5 tt -72.19 -43.02 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -39.87 80.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -61.2 -28.36 69.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.32 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.741 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.5 mt -86.63 -17.42 33.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -45.88 -35.43 4.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.632 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.73 -17.19 66.36 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 114' ' ' LEU . 5.6 tp -95.77 -33.51 12.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.67 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 113' ' ' LEU . 1.7 tt -33.71 104.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.575 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -131.72 135.45 26.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -43.6 162.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.213 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.8 13.88 41.74 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' ASN . 8.7 p -102.54 130.14 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 121.903 -0.763 . . . . 0.0 110.761 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.81 126.08 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 120' ' ' VAL . 9.0 p -118.56 127.31 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.91 134.05 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.164 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -120.74 91.62 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.996 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.44 ' HB2' HG23 ' A' ' 94' ' ' ILE . 4.5 mm-40 -94.05 50.31 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.966 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 97' ' ' PHE . 1.3 pt -105.33 130.22 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -93.38 146.1 23.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.299 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 126' ' ' VAL . 13.7 p -100.02 120.06 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -137.45 129.87 16.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.368 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.48 41.91 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.377 2.051 . . . . 0.0 112.17 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.6 t -147.45 -35.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.449 HG11 ' OD2' ' A' ' 96' ' ' ASP . 34.0 m -67.21 164.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -115.56 158.61 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.246 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -126.12 155.94 40.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.699 HD21 ' CE2' ' A' ' 183' ' ' TRP . 37.1 tp -78.73 130.62 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.197 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.7 OUTLIER -64.18 134.53 55.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.857 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.558 ' O ' ' C ' ' A' ' 136' ' ' SER . 83.0 m-85 -120.54 6.55 10.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.22 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.558 ' C ' ' O ' ' A' ' 135' ' ' PHE . 90.0 p -24.08 -65.86 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.462 0.649 . . . . 0.0 110.985 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.41 47.69 1.97 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.845 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.58 -7.85 39.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.506 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.4 tt0 -48.49 -49.01 66.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.0 Cg_exo -55.36 -42.24 70.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.848 2.365 . . . . 0.0 112.14 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.74 -45.98 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.89 -41.63 95.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.55 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 21.8 p -65.73 -40.07 91.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.54 -18.66 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.444 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -105.55 2.58 28.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.651 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -64.54 -41.08 55.69 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 46.0 Cg_exo -53.25 -7.88 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.632 2.221 . . . . 0.0 111.719 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 150' ' ' ASP . 29.1 mt -122.77 101.53 39.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.415 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HA ' HH21 ' A' ' 86' ' ' ARG . 47.6 Cg_endo -75.66 19.26 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.187 1.925 . . . . 0.0 111.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 148' ' ' ILE . 22.4 m-20 -145.9 80.56 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.54 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.64 139.63 53.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.231 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.32 123.2 5.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.19 127.08 52.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 110.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.4 126.43 44.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.4 t -119.82 128.48 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -140.71 84.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.283 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 159' ' ' THR . 2.8 mtt180 60.77 -141.4 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.444 ' C ' ' OD2' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -68.81 27.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.413 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.602 ' H ' ' C ' ' A' ' 157' ' ' ARG . 1.8 m -139.15 129.72 25.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -131.94 135.12 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.21 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.937 ' C ' HD13 ' A' ' 162' ' ' LEU . 66.0 m -131.53 130.99 43.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.946 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.056 HD22 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -113.25 123.86 51.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.379 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 149.4 49.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 148.97 158.58 8.12 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.71 136.7 37.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.08 140.61 27.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.517 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.02 -30.57 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.506 2.137 . . . . 0.0 111.947 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 t -122.39 128.0 50.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.03 72.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.642 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 171' ' ' HIS . 3.9 pt-20 -59.36 -35.86 74.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.726 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.4 m-70 -63.19 -37.95 89.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -64.15 -38.56 91.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.89 -47.07 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 171' ' ' HIS . 47.3 t -71.28 -41.37 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.958 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -58.05 -51.31 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -45.54 94.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.23 75.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.991 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.2 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.179 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 m -67.44 -36.36 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.226 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.1 t -71.02 -43.01 68.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.1 m -72.88 -44.4 61.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.568 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.699 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.0 m0 -126.12 77.05 71.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 186' ' ' MET . 15.4 Cg_exo -65.34 12.3 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.016 2.478 . . . . 0.0 112.424 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 186' ' ' MET . 21.1 t0 -31.3 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.829 0.347 . . . . 0.0 110.551 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.583 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.6 tpt 86.99 -28.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -93.1 63.75 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -101.9 121.26 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.785 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.601 ' O ' HD22 ' A' ' 162' ' ' LEU . 2.6 t -100.58 125.28 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.173 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.433 ' C ' ' OD1' ' A' ' 190' ' ' ASN . 47.2 t-20 -91.93 124.13 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.82 44.56 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.193 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.04 133.19 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.641 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -102.72 149.15 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.435 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.8 m -108.79 108.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.3 p -109.01 -37.67 5.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.787 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -121.62 -1.96 10.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.81 146.09 18.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.383 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -144.22 167.23 15.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 74.9 Cg_exo -42.54 163.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.917 2.411 . . . . 0.0 112.002 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -43.23 88.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.697 2.265 . . . . 0.0 112.059 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -150.15 109.2 0.42 Allowed Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.554 ' C ' ' H ' ' A' ' 204' ' ' ALA . 17.6 Cg_exo -52.05 -42.39 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.082 1.854 . . . . 0.0 112.466 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 24.2 Cg_exo -60.42 9.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.027 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 202' ' ' PRO . . . -103.35 50.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.802 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 32.8 p -118.58 21.66 12.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 208' ' ' CYS . . . 56.67 54.91 32.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 206' ' ' GLY . 50.3 Cg_exo -46.72 -6.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.556 2.171 . . . . 0.0 111.864 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.561 ' H ' ' C ' ' A' ' 206' ' ' GLY . 1.2 m 45.76 44.41 10.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -78.42 -164.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.872 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -91.43 56.32 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.725 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.57 ' CB ' ' O ' ' A' ' 245' ' ' ASP . 4.0 mm? -58.19 -30.33 66.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.622 ' CD ' ' N ' ' A' ' 213' ' ' SER . 2.9 pp0? -53.2 -34.81 58.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.611 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.622 ' N ' ' CD ' ' A' ' 212' ' ' GLN . 89.9 p -65.61 -35.5 80.99 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.928 0.871 . . . . 0.0 110.974 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.13 -32.51 63.2 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.371 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.16 -35.94 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.414 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.1 t30 -53.89 -44.08 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.669 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.46 -28.83 61.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.608 ' CG1' HH11 ' A' ' 242' ' ' ARG . 65.8 t -58.04 -49.64 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.386 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.574 ' C ' ' H ' ' A' ' 221' ' ' GLY . 12.8 p -103.58 -11.4 17.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.13 -35.75 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -173.66 178.7 45.46 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 153.63 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.728 2.286 . . . . 0.0 112.009 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 1.1 mt -140.43 -141.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 226' ' ' GLY . . . 177.31 104.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.518 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 18.4 t80 -56.96 74.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.519 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 224' ' ' ALA . . . -170.75 -60.28 0.04 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.69 -68.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 110.678 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -168.37 -142.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 230' ' ' ALA . . . 88.36 -177.58 45.7 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 229' ' ' GLY . . . 39.4 78.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.9 t -112.39 -54.33 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.4 tp -100.64 28.44 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 233' ' ' ILE . 3.6 mp -136.25 63.3 48.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.583 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 235' ' ' ALA . 48.8 Cg_endo -72.46 92.39 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.789 2.326 . . . . 0.0 111.972 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 234' ' ' PRO . . . 171.0 125.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 109.96 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 238' ' ' GLU . 0.4 OUTLIER -173.76 -29.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.816 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.709 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 3.8 pt-20 -61.14 -38.71 87.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.457 HG23 HH21 ' A' ' 242' ' ' ARG . 0.8 OUTLIER -71.81 -42.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.941 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 243' ' ' VAL . 0.9 OUTLIER -65.27 -47.54 76.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.667 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -68.01 -31.71 71.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.319 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.608 HH11 ' CG1' ' A' ' 218' ' ' VAL . 2.4 ttp-105 -60.92 -45.69 93.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.433 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 240' ' ' LEU . 10.8 m -63.73 -36.26 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.29 81.44 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.995 0.426 . . . . 0.0 109.859 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 211' ' ' LEU . 33.8 m-20 -56.07 -48.85 75.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 3.1 pttt -62.38 -30.47 71.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.806 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.851 HD23 ' O ' ' A' ' 247' ' ' LEU . 5.3 tt -53.13 -32.91 49.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -61.13 -11.35 8.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -68.07 10.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.638 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.568 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -38.52 -48.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.928 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.0 Cg_exo -54.23 -13.73 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.98 1.786 . . . . 0.0 111.353 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' ARG . 23.0 t0 -160.42 30.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.604 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -55.89 67.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.675 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' ASP . 2.6 ttt180 -116.17 135.01 54.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.94 135.86 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.923 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -122.45 120.0 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.045 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.89 127.51 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.95 122.16 41.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.276 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.69 145.44 16.88 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -134.24 149.48 50.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.645 0.259 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.591 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -162.61 -173.06 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.558 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.543 ' OD1' ' OD1' ' A' ' 270' ' ' ASN . 2.4 p30 -92.28 -164.36 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.64 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 265' ' ' GLY . 0.9 OUTLIER -125.14 -116.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.486 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 265' ' ' GLY . 0.2 OUTLIER 68.52 -29.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.528 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 267' ' ' GLU . . . 56.84 150.56 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.2 t 58.49 -71.28 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.588 0.709 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 265' ' ' GLY . 2.1 tt0 -55.99 -37.25 68.85 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.102 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -93.73 -47.38 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 269' ' ' ILE . 3.0 tt 34.67 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.337 0.589 . . . . 0.0 110.561 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 268' ' ' GLY . 0.8 OUTLIER -69.57 -30.92 68.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.918 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.4 mm -54.79 -52.22 72.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.3 Cg_endo -61.26 -35.83 82.81 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.853 1.702 . . . . 0.0 111.876 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.6 mm? -68.5 -46.55 69.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 23.6 p -65.65 -39.76 91.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.575 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.96 95.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.441 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.98 -36.48 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 277' ' ' ARG . 4.1 mtt85 -63.24 -35.17 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.448 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.25 69.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.034 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -73.97 -47.97 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.61 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 281' ' ' VAL . 1.7 tp -60.39 -44.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.137 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.529 ' N ' ' CG2' ' A' ' 280' ' ' ILE . 27.6 m -61.28 -40.85 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -59.3 -39.0 81.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.01 -47.04 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.717 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -57.01 -39.92 75.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 290' ' ' VAL . 1.0 OUTLIER -60.84 -42.53 97.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.58 -36.25 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.64 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.003 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.64 ' O ' ' CD1' ' A' ' 247' ' ' LEU . 2.2 tpm_? -82.53 -2.79 54.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.798 0.333 . . . . 0.0 110.304 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.484 ' C ' HD11 ' A' ' 247' ' ' LEU . . . 105.97 10.63 29.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 285' ' ' LEU . 35.0 t -79.24 128.67 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.78 96.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.637 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -48.78 -8.28 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 291' ' ' ALA . 72.8 m-20 -75.93 -6.42 50.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.556 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -124.92 26.17 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 292' ' ' GLY . 61.9 mt -116.6 131.99 67.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.63 52.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 127.21 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 110.864 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.8 140.83 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.326 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.2 117.88 3.11 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.1 OUTLIER -119.23 59.84 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.524 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.515 ' HA2' ' H ' ' A' ' 261' ' ' THR . . . -77.99 -96.12 0.23 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 301' ' ' GLY . 90.1 p -36.87 -29.47 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.214 0.53 . . . . 0.0 110.955 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 301' ' ' GLY . 66.1 t -61.53 -47.41 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 301' ' ' GLY . 0.4 OUTLIER -139.73 86.42 13.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.645 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.79 163.48 9.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.952 2.435 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 74.3 mt -136.68 -22.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.321 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 308' ' ' SER . . . -119.9 151.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.437 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 307' ' ' ALA . 0.6 OUTLIER -50.29 -165.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.634 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.85 50.56 0.54 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.618 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.19 -2.86 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.523 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 p -146.62 148.63 34.28 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.374 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.45 -31.11 76.61 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.681 2.254 . . . . 0.0 111.918 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.03 -33.86 76.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.129 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.36 -44.98 97.35 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -65.27 -43.97 89.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.17 94.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.82 -32.61 74.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.235 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 261' ' ' THR . 0.7 OUTLIER -76.48 -25.43 54.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.426 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 319' ' ' ARG . 2.8 ttm180 -70.36 78.23 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.282 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -122.4 150.19 42.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.07 149.16 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.68 131.97 53.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.077 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.98 110.3 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.28 120.21 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 325' ' ' VAL . 11.8 p -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.54 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.638 ' O ' ' N ' ' A' ' 77' ' ' LEU . 1.1 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.788 0.327 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.55 -9.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.516 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 75' ' ' SER . 19.6 tp -178.53 -57.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.641 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 p 178.38 111.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -84.77 147.61 26.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -79.62 159.86 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.51 119.35 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.714 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.11 131.3 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.34 120.73 30.64 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.047 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.1 tt -123.15 122.64 65.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.062 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.59 127.51 35.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.621 ' HG2' HG13 ' A' ' 91' ' ' VAL . 55.9 mtt180 -114.21 141.26 47.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.218 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 126.39 16.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.66 -125.41 29.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -99.09 19.44 15.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.756 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.4 m -125.3 135.1 52.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.621 HG13 ' HG2' ' A' ' 86' ' ' ARG . 17.1 t -115.14 122.22 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 120.89 43.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -124.33 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.272 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -142.19 129.04 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.777 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.69 -152.1 21.18 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -154.39 154.37 33.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.417 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -125.96 158.95 64.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.845 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.16 -24.71 27.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.322 . . . . 0.0 112.025 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -157.91 -173.59 4.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -88.71 -19.61 25.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.515 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.78 75.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.538 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.04 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -61.89 -37.67 85.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.622 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.07 67.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 135' ' ' PHE . . . -65.96 -40.64 91.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt -62.5 -43.85 97.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.84 -42.89 85.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -62.76 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 mt -103.0 -12.79 17.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.734 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -51.91 -42.47 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.617 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.99 -13.71 57.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -98.01 -26.46 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.603 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -161.65 163.79 19.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.488 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 58.2 Cg_endo -76.15 166.64 27.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.842 2.361 . . . . 0.0 112.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.96 1.71 3.14 Favored Glycine 0 N--CA 1.461 0.325 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 116' ' ' PRO . 54.9 t -99.81 135.11 36.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 O-C-N 122.278 -0.543 . . . . 0.0 110.818 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.86 128.63 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.288 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.34 134.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.022 0.439 . . . . 0.0 111.282 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 121' ' ' ILE . 2.2 mm -123.79 125.31 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.755 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 13.3 p-10 -136.15 83.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.505 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -97.42 72.22 2.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.717 HG21 ' CE2' ' A' ' 97' ' ' PHE . 12.3 mt -105.53 130.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.93 146.2 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 126' ' ' VAL . 7.7 p -100.3 116.07 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.6 m-20 -133.6 103.14 12.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.695 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.3 Cg_exo -61.57 56.73 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.468 2.112 . . . . 0.0 112.405 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 128' ' ' PRO . 56.0 t -162.68 -39.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.814 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.35 -178.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -123.87 159.58 29.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.315 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 m -134.65 155.5 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 183' ' ' TRP . 16.1 tp -80.08 113.17 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.276 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.6 136.35 57.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.56 ' O ' ' C ' ' A' ' 136' ' ' SER . 7.7 m-85 -92.0 2.05 56.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.38 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 135' ' ' PHE . 94.4 p -24.51 -80.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.656 0.741 . . . . 0.0 110.988 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.7 20.55 16.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.761 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.47 -11.09 24.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER -55.6 -45.85 99.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.696 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 31.8 Cg_exo -54.69 -38.95 91.19 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.007 2.471 . . . . 0.0 112.508 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.423 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 40.6 t -59.79 -47.61 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -63.26 -39.35 94.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 11.4 p -62.81 -34.68 77.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.79 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.62 66.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -104.46 11.26 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.707 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -73.71 -34.67 2.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 37.4 Cg_exo -54.17 -28.75 53.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.615 2.21 . . . . 0.0 112.263 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.4 tp -118.68 109.33 40.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.47 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 86' ' ' ARG . 57.3 Cg_endo -76.7 17.34 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.09 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.512 ' H ' HG13 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -114.14 53.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.544 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.59 144.86 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -125.9 134.8 8.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -127.95 127.99 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 110.83 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.16 131.41 56.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.63 131.32 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.75 77.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 67.2 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.14 -18.17 8.76 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.36 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -104.23 131.39 51.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.913 0.387 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.15 135.48 63.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.2 m -109.19 129.82 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.85 117.98 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 m -130.21 153.2 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 140.55 155.07 6.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.5 p -81.25 141.91 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 192' ' ' ILE . . . -109.73 138.4 20.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.492 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 197' ' ' GLN . 44.3 Cg_endo -71.42 -39.53 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.482 2.121 . . . . 0.0 111.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.03 130.59 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.448 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 172' ' ' LYS . 47.1 m -54.85 -33.12 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.77 -35.52 77.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.5 t60 -58.5 -48.04 82.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.961 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 169' ' ' SER . 21.2 pttt -67.24 -35.2 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.857 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.49 -43.25 83.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.486 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -70.41 -35.89 73.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 171' ' ' HIS . 20.3 t -66.73 -43.65 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -62.32 -47.93 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -60.17 -51.43 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.643 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.64 72.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.37 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 185' ' ' ASP . 4.5 m -64.57 -48.86 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.3 m -72.22 -26.62 62.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 183' ' ' TRP . 2.4 m -70.33 -72.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.086 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 185' ' ' ASP . 28.0 m95 -131.36 -67.65 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 186' ' ' MET . 11.4 Cg_endo -56.54 32.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.858 2.372 . . . . 0.0 113.361 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 183' ' ' TRP . 2.3 t0 -63.39 9.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.427 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.586 ' H ' ' C ' ' A' ' 184' ' ' PRO . 6.5 mtt -116.95 -89.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.903 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -108.92 115.89 30.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.942 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -125.68 147.55 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.724 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.27 124.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -98.9 128.39 45.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -144.2 42.66 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 164' ' ' GLY . 5.3 mt -114.55 133.3 61.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.66 141.83 50.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 194' ' ' VAL . 27.1 m -96.6 117.84 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.604 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -77.58 42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.574 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.92 26.05 73.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 167' ' ' PRO . 4.8 mt-30 -86.77 128.24 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.524 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.431 ' HB2' ' N ' ' A' ' 206' ' ' GLY . . . 41.56 73.66 0.86 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 20.9 Cg_exo -55.99 -42.58 65.3 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.697 2.265 . . . . 0.0 112.541 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 65.6 Cg_exo -47.59 -69.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.259 1.973 . . . . 0.0 112.013 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 137.26 -73.0 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 204' ' ' ALA . 54.0 Cg_exo -41.96 -52.75 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.874 2.383 . . . . 0.0 112.899 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 202' ' ' PRO . 8.9 Cg_exo -34.23 -25.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.485 2.123 . . . . 0.0 112.154 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 202' ' ' PRO . . . 67.56 -15.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 203' ' ' PRO . 16.0 t -177.03 137.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 198' ' ' ALA . . . -130.41 74.81 0.43 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.604 ' C ' ' H ' ' A' ' 209' ' ' ALA . 72.4 Cg_endo -85.03 -162.11 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 123.11 2.54 . . . . 0.0 111.85 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.589 ' O ' HD23 ' A' ' 211' ' ' LEU . 43.3 t -67.59 15.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.034 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 207' ' ' PRO . . . -25.62 146.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 24.0 m-20 44.04 64.09 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 208' ' ' CYS . 0.0 OUTLIER -56.01 -43.33 77.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.25 -51.34 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.331 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.1 m -71.0 -45.15 64.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -61.51 -44.28 97.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.23 -0.294 . . . . 0.0 111.573 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 2.5 tp -69.55 -39.25 78.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -70.11 -42.92 72.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.711 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.3 -49.53 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 t -59.22 -46.09 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 215' ' ' ILE . 30.6 p -84.93 -29.29 25.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.748 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 74.72 -48.0 1.89 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -151.55 151.55 23.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.692 ' C ' HG22 ' A' ' 223' ' ' ILE . 40.3 Cg_endo -70.38 140.23 39.87 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.749 2.299 . . . . 0.0 112.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.692 HG22 ' C ' ' A' ' 222' ' ' PRO . 1.0 OUTLIER 163.93 -47.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . 55.07 -120.19 1.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 224' ' ' ALA . 0.6 OUTLIER -36.48 132.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.667 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 102.63 178.0 27.07 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 227' ' ' ASN . 4.6 p-10 -105.22 154.1 20.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.777 0.322 . . . . 0.0 110.554 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -32.77 69.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 146.67 -62.56 0.45 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 231' ' ' SER . . . -93.82 -154.17 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.712 0.291 . . . . 0.0 110.518 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 230' ' ' ALA . 9.2 p 51.51 116.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.626 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.16 94.2 9.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.61 116.6 33.23 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.547 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 235' ' ' ALA . 59.9 Cg_endo -76.93 113.47 3.64 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.331 2.021 . . . . 0.0 112.085 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 234' ' ' PRO . . . 71.51 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.96 81.15 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.465 ' O ' ' CD1' ' A' ' 237' ' ' TYR . 25.1 t80 -129.25 -13.39 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -46.19 75.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 49.7 mt -67.71 -38.69 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -36.74 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.439 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.04 96.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.334 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -61.32 -45.35 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.33 -38.97 81.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.483 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.653 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.11 -45.94 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -51.06 70.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.529 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.681 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 8.0 mttt -66.1 -32.83 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.611 HD23 HG21 ' A' ' 290' ' ' VAL . 3.3 tp -54.56 -30.85 55.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.488 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 0.8 OUTLIER -63.81 -36.98 85.68 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.576 ' O ' ' OD1' ' A' ' 252' ' ' ASP . . . -101.57 5.27 41.65 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.972 0.415 . . . . 0.0 111.351 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.716 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.9 m -74.84 -27.51 0.73 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 52.1 Cg_exo -54.21 -15.66 8.4 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.372 2.048 . . . . 0.0 112.891 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -42.1 -18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 326' ' ' ASN . . . -125.65 -154.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.624 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.499 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 1.2 mtm180 -110.27 136.0 50.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 295' ' ' ILE . 0.6 OUTLIER -119.15 132.81 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.955 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.3 m -122.74 122.29 38.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.04 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.1 mt -102.23 116.71 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -101.77 130.21 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.363 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.59 127.74 7.02 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 318' ' ' ASN . 43.1 m-85 -106.57 136.58 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.405 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -128.47 -161.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.656 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 2.5 p30 -132.83 125.47 30.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.2 p30 -42.92 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.9 m 51.06 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -73.05 -132.78 0.18 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 59.6 m -117.13 168.84 9.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.95 -31.31 72.48 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.95 5.5 84.48 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mt -122.41 -45.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 271' ' ' ILE . 23.7 p-10 -68.18 -46.25 71.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.136 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.9 mm -57.59 -51.62 80.37 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.917 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 9.4 Cg_endo -57.36 -31.96 92.53 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.906 1.737 . . . . 0.0 112.083 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.58 -40.32 80.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.433 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.9 p -69.82 -37.78 76.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.73 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.85 -40.42 92.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.577 ' O ' HG22 ' A' ' 281' ' ' VAL . 6.4 mtt-85 -60.0 -44.28 94.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' ALA . . . -67.72 -32.6 73.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.416 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -70.92 -46.27 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.29 -46.28 95.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 277' ' ' ARG . 33.2 m -72.46 -38.75 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.391 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -43.06 79.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.38 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -72.43 -34.91 68.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 281' ' ' VAL . 5.2 mp -60.05 -48.27 82.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 282' ' ' ALA . 12.0 t -63.44 -36.17 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.298 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.37 -20.17 65.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.653 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -90.25 -2.14 58.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.629 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 19.94 9.69 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.465 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.611 HG21 HD23 ' A' ' 247' ' ' LEU . 64.9 t -87.74 129.65 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.405 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -74.53 101.04 4.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.943 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.02 9.53 0.97 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.7 OUTLIER -83.27 -12.32 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 110.651 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -134.67 11.66 3.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.981 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.541 ' HA ' HG13 ' A' ' 255' ' ' VAL . 14.1 tt -88.33 133.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -138.66 135.52 34.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 128.26 48.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.1 116.71 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.58 114.72 4.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.35 54.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -54.49 -92.65 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.47 ' C ' ' CG2' ' A' ' 303' ' ' VAL . 89.8 p -79.8 69.08 6.06 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 122.939 -0.154 . . . . 0.0 110.955 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 304' ' ' ASN . 0.2 OUTLIER -154.93 163.97 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.531 ' O ' ' O ' ' A' ' 303' ' ' VAL . 6.5 m120 33.29 96.2 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.424 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.52 162.98 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.625 2.217 . . . . 0.0 112.298 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 306' ' ' ILE . 24.1 mt -153.5 -79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.308 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -125.1 155.58 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.518 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.07 141.12 58.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.598 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 4.7 p-10 -98.77 41.14 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.55 -36.21 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.683 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.79 153.75 37.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.718 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -36.1 98.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.803 2.336 . . . . 0.0 112.02 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -66.29 -32.15 73.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.15 87.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -62.59 -45.74 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.5 80.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.97 -30.32 68.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.4 t-20 -74.95 -23.03 58.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -87.45 87.91 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.562 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.33 145.55 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.638 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.67 148.54 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.325 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.15 130.65 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.18 113.33 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.536 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 255' ' ' VAL . 2.2 t -114.74 135.54 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 326' ' ' ASN . 1.5 p -115.8 135.56 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 253' ' ' ALA . 7.6 t-20 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.94 20.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.563 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.6 tp -90.69 -57.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -156.12 111.82 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.597 HD13 HD12 ' A' ' 133' ' ' LEU . 17.0 mt -115.28 155.1 27.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -84.98 140.97 30.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -53.41 125.85 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.44 ' H ' ' HB ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -127.31 122.89 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.021 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -102.69 122.55 44.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.07 123.23 60.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -135.03 124.81 25.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD2' ' CE2' ' A' ' 151' ' ' PHE . 20.1 ttm180 -116.15 120.23 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.496 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.07 123.38 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.46 -138.73 43.2 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.64 18.22 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.24 46.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.572 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.2 122.44 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.6 m -113.62 116.82 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -120.91 130.37 53.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.729 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.696 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.5 mt -142.86 131.49 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.82 -156.63 26.18 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.62 151.09 47.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -135.63 156.61 77.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.95 -22.29 19.92 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.777 2.318 . . . . 0.0 112.075 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.38 152.21 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 -27.0 68.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.43 94.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.94 79.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -60.04 -36.01 76.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.454 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.55 -37.17 57.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.64 87.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.26 -40.94 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.2 mtm -61.38 -31.85 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 m -61.28 -33.17 73.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.632 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB1' ' CG ' ' A' ' 142' ' ' PHE . . . -70.58 -26.86 63.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.36 -16.14 33.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -50.98 -28.92 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.56 -9.89 82.58 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -100.16 -42.7 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 114' ' ' LEU . 6.7 tt -32.55 113.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.575 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -156.75 158.32 31.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.485 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 14.2 Cg_endo -59.47 149.88 78.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.852 2.368 . . . . 0.0 112.297 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 -12.98 8.31 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 126.63 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 O-C-N 122.278 -0.542 . . . . 0.0 110.534 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.04 137.89 37.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.99 118.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.16 136.69 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.61 105.48 10.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.987 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -98.35 64.82 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.058 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.25 128.59 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.692 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.62 146.17 24.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.949 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.91 113.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -136.89 128.68 16.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.134 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.36 38.32 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.383 2.055 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.85 -34.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 127' ' ' ASP . 27.2 m -65.92 167.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 80' ' ' SER . 0.1 OUTLIER -121.08 160.26 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.3 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -119.87 156.06 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.671 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 79' ' ' LEU . 20.0 tp -78.59 126.39 30.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.487 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -58.47 150.03 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -140.42 74.11 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.533 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.9 p -95.34 7.34 46.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 182' ' ' THR . 2.1 p -176.59 31.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.77 40.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 7.7 mt-10 -49.16 -58.9 7.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 15.9 Cg_endo -61.13 -28.13 85.07 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.446 2.097 . . . . 0.0 111.961 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.08 -43.11 89.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 m-85 -64.09 -40.72 96.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.351 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 p -63.29 -35.26 79.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.85 -28.96 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -93.72 -9.55 37.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.518 ' N ' ' HD2' ' A' ' 147' ' ' PRO . 1.1 t -53.24 -48.67 91.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.531 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 56.3 Cg_endo -75.21 1.5 7.77 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.186 1.924 . . . . 0.0 111.666 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 171' ' ' HIS . 5.5 mm -118.66 85.55 27.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.81 22.15 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.844 2.363 . . . . 0.0 112.354 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -141.27 55.66 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.751 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.639 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 1.7 p90 -123.71 143.7 50.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 163' ' ' THR . . . -126.81 145.04 15.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.9 129.39 36.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 110.779 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.6 53.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.2 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 82' ' ' LEU . 57.2 t -117.92 134.7 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.659 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -145.61 77.68 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.656 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 62.14 -96.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.21 33.58 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.64 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 m -136.47 133.56 36.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.519 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.41 134.24 66.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.354 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.579 HG23 ' HB ' ' A' ' 189' ' ' VAL . 82.2 m -132.35 128.26 37.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.699 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -111.75 118.96 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 152' ' ' GLY . 87.8 m -128.22 147.49 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.675 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 150.38 166.41 13.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 193' ' ' GLU . 0.6 OUTLIER -100.02 142.0 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.73 149.4 46.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.11 -40.63 1.63 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.743 2.296 . . . . 0.0 111.69 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 146.68 52.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.236 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -36.97 85.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.457 ' HB3' HD11 ' A' ' 148' ' ' ILE . 1.8 m170 -63.4 -48.16 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.798 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -66.58 -33.7 76.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.577 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.5 -44.34 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.8 90.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.61 -40.94 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -62.55 -52.01 65.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.057 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -62.12 -39.66 93.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.858 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.16 97.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.9 -40.0 94.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.588 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.4 m -67.81 -40.08 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.4 p -68.63 -39.22 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.533 HG23 ' OG ' ' A' ' 137' ' ' SER . 55.8 m -83.53 -38.43 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.577 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 179' ' ' ALA . 4.7 m-90 -127.18 73.13 77.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.686 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 61.2 Cg_endo -77.87 28.0 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.857 2.371 . . . . 0.0 111.923 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 187' ' ' LYS . 1.2 t70 -41.58 -12.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.679 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 74.78 -26.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 185' ' ' ASP . 18.2 mttm -95.6 61.42 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 162' ' ' LEU . 3.9 mp -97.1 136.04 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 161' ' ' THR . 42.4 t -110.79 129.68 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.52 107.76 19.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.441 ' CB ' ' OG1' ' A' ' 163' ' ' THR . 1.1 m120 -122.23 52.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.8 mt -86.33 133.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.599 ' O ' HG22 ' A' ' 165' ' ' THR . 17.5 mt-10 -120.12 124.79 46.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.913 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.4 m -105.25 109.86 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.128 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.8 t -115.56 -24.5 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.807 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -151.38 16.34 0.87 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -65.04 156.39 31.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 110.815 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.2 106.67 52.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.405 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.517 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 23.8 Cg_exo -54.67 -42.53 67.52 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.154 1.903 . . . . 0.0 112.428 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 58.2 Cg_exo -48.92 -69.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 111.893 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.449 ' H ' ' HD2' ' A' ' 203' ' ' PRO . . . 134.33 -57.52 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.541 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 38.0 Cg_exo -49.88 -40.84 48.6 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.7 2.266 . . . . 0.0 113.001 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.615 ' O ' ' HB2' ' A' ' 204' ' ' ALA . 21.3 Cg_exo -62.73 -175.64 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.196 1.93 . . . . 0.0 112.02 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 203' ' ' PRO . . . 166.77 128.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 204' ' ' ALA . 0.7 OUTLIER 75.34 64.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -119.74 70.86 0.34 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.432 ' O ' HD22 ' A' ' 211' ' ' LEU . 60.7 Cg_endo -76.9 -91.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.932 2.422 . . . . 0.0 112.19 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' CYS . . . . . 0.563 ' O ' ' O ' ' A' ' 209' ' ' ALA . 9.4 m -124.94 35.3 4.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.568 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -48.88 -111.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.347 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -81.95 18.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.305 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 215' ' ' ILE . 6.7 mp -56.55 -29.93 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -50.62 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.701 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -62.72 -39.92 95.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 110.975 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.22 68.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.448 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LEU . 6.2 mt -58.95 -37.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 220' ' ' GLY . 9.3 t-20 -54.78 -41.67 70.81 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.28 -31.28 62.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.517 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.32 -41.4 81.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -106.43 -27.53 10.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 78.47 -14.7 11.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.17 173.25 43.6 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.91 148.46 57.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.793 2.328 . . . . 0.0 112.128 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 23.2 mt -54.27 96.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.406 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . . . -155.29 62.43 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.697 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.59 125.74 40.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.17 30.75 9.7 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -115.71 132.71 56.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 0.0 110.635 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.25 70.78 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.65 6.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -144.94 -83.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.97 171.82 8.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 233' ' ' ILE . 2.1 mm? -46.84 162.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.416 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 232' ' ' LEU . 5.2 mt 33.93 77.41 0.37 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.436 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.83 -66.92 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.841 2.361 . . . . 0.0 112.333 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 43.07 72.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 236' ' ' ASP . 0.0 OUTLIER 72.64 -140.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.547 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.411 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.02 -34.58 78.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 239' ' ' ILE . 7.7 mm -59.55 -45.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.745 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -31.96 68.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -42.97 76.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.13 -45.68 93.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.974 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 247' ' ' LEU . 54.8 t -69.26 -38.0 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.186 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.749 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -62.53 -45.76 91.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -50.38 72.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -65.49 -32.08 73.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.9 HD13 HD22 ' A' ' 285' ' ' LEU . 0.4 OUTLIER -63.44 -32.27 73.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -63.83 -26.13 68.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.791 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.5 1.95 47.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.023 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.678 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.2 m -74.69 -28.57 0.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.2 Cg_exo -53.43 -14.15 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.854 1.703 . . . . 0.0 111.819 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -2.66 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -141.02 -159.0 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.545 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -103.44 139.99 38.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.203 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.52 133.01 67.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.622 ' HB ' HG23 ' A' ' 324' ' ' VAL . 93.7 m -123.02 111.96 17.22 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.055 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.35 121.46 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -101.09 126.02 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.55 134.79 11.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -120.39 116.7 26.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 111.042 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.497 ' C ' ' OD1' ' A' ' 318' ' ' ASN . 2.9 t -134.74 159.28 41.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 1.07 ' CG ' HD21 ' A' ' 309' ' ' ASN . 39.9 p-10 -113.24 97.33 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 265' ' ' GLY . 7.9 t30 38.36 -94.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.1 m 62.14 -69.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.651 ' N ' HG22 ' A' ' 264' ' ' THR . . . -90.33 -161.15 37.19 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.859 ' OG ' HG13 ' A' ' 269' ' ' ILE . 88.7 p -89.49 162.79 15.53 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.79 0.329 . . . . 0.0 110.974 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.62 -17.08 63.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.735 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.69 -20.31 22.28 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.859 HG13 ' OG ' ' A' ' 266' ' ' SER . 5.1 mt -111.97 4.4 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -44.02 76.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.001 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 3.1 mm -63.04 -51.36 71.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.754 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.3 Cg_endo -61.72 -39.84 50.17 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.055 1.837 . . . . 0.0 112.004 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.76 -43.98 91.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -38.0 67.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.76 71.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.402 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -60.97 -38.72 86.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -68.09 -39.05 82.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.55 68.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.177 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -45.6 76.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.357 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.23 -40.99 85.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.373 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.25 -39.38 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.86 94.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.492 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.72 -42.04 83.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -49.72 76.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.391 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.9 HD22 HD13 ' A' ' 247' ' ' LEU . 39.5 mt -59.51 -48.0 83.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.287 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.66 -38.07 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.09 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.749 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.63 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.496 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.2 12.99 24.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.18 130.89 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.36 9.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.439 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -75.47 11.02 10.17 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.571 ' N ' ' OD1' ' A' ' 293' ' ' ASP . 0.1 OUTLIER -89.37 -16.71 30.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -113.83 2.34 15.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.87 124.79 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.69 154.12 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.38 132.83 38.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.73 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.9 t -125.62 116.48 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -83.26 105.34 2.69 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.6 mm? -31.28 -61.47 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.63 49.62 63.39 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 303' ' ' VAL . 94.3 p -99.58 -23.98 14.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.58 0.228 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 302' ' ' SER . 1.3 m 51.68 124.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.157 0.504 . . . . 0.0 110.512 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 305' ' ' PRO . 3.9 t-20 60.2 53.25 3.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.621 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 304' ' ' ASN . 67.6 Cg_endo -77.61 -101.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.838 2.358 . . . . 0.0 112.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.6 mm -81.27 -38.59 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -115.79 160.75 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.44 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 p -102.83 16.15 27.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 1.07 HD21 ' CG ' ' A' ' 262' ' ' ASP . 1.4 t-20 44.63 53.81 6.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.615 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -127.25 -5.0 6.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.447 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.56 148.88 63.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.53 -31.81 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.674 2.249 . . . . 0.0 111.936 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.24 -33.39 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 318' ' ' ASN . . . -66.76 -44.38 89.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -62.06 -44.94 95.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 110.444 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.05 -45.53 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -34.69 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.667 ' OD1' ' N ' ' A' ' 262' ' ' ASP . 2.4 t30 -63.11 -25.4 68.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.733 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -79.68 98.97 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 224' ' ' ALA . 10.0 ttp180 -133.79 146.86 51.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.85 144.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.321 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.43 148.52 46.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 323' ' ' ILE . 4.5 mp -123.58 129.64 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 256' ' ' THR . 0.6 OUTLIER -130.73 123.56 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.681 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.535 HG11 ' SG ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -107.33 134.6 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.305 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.568 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.641 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.748 0.308 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.98 17.51 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.23 -42.16 84.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.806 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.17 117.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 69.6 mt -99.34 152.54 19.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 82' ' ' LEU . 11.0 p -75.47 162.4 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.28 106.51 13.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.596 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 80' ' ' SER . 17.2 mt -98.17 140.94 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -128.23 117.67 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.25 120.12 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.112 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.51 132.66 44.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.696 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HE ' HG22 ' A' ' 91' ' ' VAL . 45.8 ttt180 -121.23 138.08 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.404 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.1 p -143.6 109.58 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 149' ' ' PRO . . . 75.57 -125.52 8.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.55 18.28 22.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.397 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.5 m -118.81 138.96 52.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 ' HE ' ' A' ' 86' ' ' ARG . 1.3 t -127.54 121.41 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.812 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.7 m -104.22 124.73 49.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.194 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.76 125.51 48.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.75 119.65 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.353 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.549 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . -175.5 -171.56 39.56 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -131.46 145.11 51.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.576 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.45 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 3.8 m-85 -134.5 155.87 79.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.14 -28.37 48.59 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.774 2.316 . . . . 0.0 112.483 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.09 169.45 20.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -24.82 50.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.683 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.24 89.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.814 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.67 78.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -59.74 -38.91 83.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.16 -37.76 62.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 106' ' ' LEU . 2.5 tt -72.02 -44.82 62.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 110.427 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 107' ' ' MET . 0.0 OUTLIER -57.49 -26.76 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.455 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.9 m -66.5 -32.12 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.72 -18.47 63.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 110' ' ' LEU . 3.3 pp -125.49 3.74 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.637 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' MET . 32.5 t-20 -54.82 -42.27 71.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.639 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.66 -16.87 70.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.52 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 0.0 110.461 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 114' ' ' LEU . 2.3 tt -45.52 105.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -154.8 160.53 30.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 118' ' ' VAL . 52.0 Cg_exo -47.46 155.59 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 112.426 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.04 -25.45 0.31 Allowed Glycine 0 N--CA 1.461 0.316 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 116' ' ' PRO . 12.7 t -93.22 140.04 17.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.173 -0.604 . . . . 0.0 110.635 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.55 130.29 54.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.605 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.2 t -134.22 119.82 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.7 pt -125.24 125.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -104.23 104.24 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.171 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -109.93 63.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.846 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.7 125.36 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.579 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -90.63 146.42 24.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.78 121.06 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 130' ' ' VAL . 1.2 t0 -136.76 132.19 18.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.439 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.97 60.41 7.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.35 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 130' ' ' VAL . 7.4 p -174.2 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 127' ' ' ASP . 26.3 m -52.03 142.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -99.55 158.03 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.154 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.45 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 13.8 t -120.46 155.02 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.76 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 183' ' ' TRP . 55.6 tp -81.61 127.87 33.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.01 139.22 52.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -130.36 24.03 5.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' PHE . 68.9 m -30.41 -39.95 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.393 0.616 . . . . 0.0 110.962 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.7 m -152.59 61.51 0.81 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.436 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.16 -7.62 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.427 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -56.29 -43.47 99.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.513 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.0 Cg_exo -58.37 -41.43 65.96 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.31 -49.07 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.076 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' N ' ' A' ' 146' ' ' VAL . 2.4 m-85 -65.01 -37.12 86.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 1.3 p -58.27 -37.89 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.417 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.73 53.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.692 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 p -101.65 -2.06 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.2 t -65.62 -40.01 37.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 56.4 Cg_endo -82.65 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.712 2.274 . . . . 0.0 112.256 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 165' ' ' THR . 5.2 mt -128.99 104.01 18.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 88' ' ' GLY . 59.6 Cg_endo -78.24 21.1 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.205 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 12.3 t70 -152.63 64.18 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.478 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.647 ' C ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -130.01 139.67 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.659 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 130.5 6.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -119.11 129.96 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.586 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 131.26 51.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.585 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.25 134.59 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.388 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 158' ' ' ASP . 69.8 mt-10 -141.95 95.82 2.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 8.3 mtt180 53.84 -90.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' GLU . 5.0 p30 -117.97 9.06 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.884 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 m -110.06 129.11 55.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.693 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 t -119.9 131.77 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.357 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.756 HG22 ' HB ' ' A' ' 189' ' ' VAL . 1.3 p -130.95 116.86 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.656 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 163' ' ' THR . 3.6 tt -112.0 118.7 36.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.436 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.559 ' N ' HD23 ' A' ' 162' ' ' LEU . 4.8 p -128.59 149.2 50.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.789 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.55 -168.04 28.57 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.492 ' O ' HG21 ' A' ' 148' ' ' ILE . 20.8 p -108.03 135.7 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.685 0.279 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.47 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -98.36 159.08 31.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.358 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 197' ' ' GLN . 46.4 Cg_endo -73.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.732 2.288 . . . . 0.0 112.142 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.38 166.4 16.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -41.45 94.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.44 -41.49 98.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.687 ' O ' HG23 ' A' ' 175' ' ' VAL . 2.0 m170 -63.94 -37.81 88.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.44 -43.25 97.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 173' ' ' ASP . 1.9 t70 -66.73 -36.85 83.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.7 -32.83 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 171' ' ' HIS . 73.4 t -65.5 -51.83 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.727 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 177' ' ' ARG . 8.3 ptpt -66.35 -39.26 89.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 176' ' ' LYS . 7.8 ttm-85 -56.17 -51.03 69.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.39 -31.74 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.661 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.41 99.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 40.7 p -67.4 -37.59 83.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.474 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -27.06 64.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.8 m -96.02 -52.62 3.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.989 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.1 m-90 -116.71 99.09 52.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.264 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 58.2 Cg_endo -80.19 17.09 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.508 2.139 . . . . 0.0 111.349 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.3 OUTLIER -30.86 -29.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.718 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 78.52 -29.21 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.594 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 185' ' ' ASP . 23.5 mttt -105.2 76.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.546 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.92 125.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.756 ' HB ' HG22 ' A' ' 161' ' ' THR . 21.9 t -98.25 124.27 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -98.31 123.53 42.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.19 45.69 1.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.16 126.64 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.396 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.3 p -84.71 56.5 3.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 53.45 26.31 30.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.596 ' O ' ' O ' ' A' ' 167' ' ' PRO . 27.5 mt-30 -113.27 157.04 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 110.527 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 197' ' ' GLN . . . 169.46 64.83 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.73 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.56 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 18.2 Cg_exo -50.8 -42.05 52.63 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.325 2.017 . . . . 0.0 111.989 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 72.8 Cg_endo -91.2 3.27 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.983 2.455 . . . . 0.0 112.548 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.49 72.69 0.43 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.516 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 17.1 Cg_exo -57.1 -42.58 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.774 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 54.0 Cg_exo -47.69 -12.97 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.42 2.08 . . . . 0.0 112.395 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' PRO . . . -89.38 -82.44 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.579 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.0 m -143.56 -54.54 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.6 171.79 42.33 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.14 -95.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.81 2.34 . . . . 0.0 112.316 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.92 71.16 0.88 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.807 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.98 112.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 213' ' ' SER . 15.7 m-20 62.18 72.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -40.48 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.243 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -50.51 51.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.058 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.4 m -70.73 -45.02 65.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.957 0.408 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.7 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.246 -0.284 . . . . 0.0 111.715 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.596 ' O ' HG12 ' A' ' 218' ' ' VAL . 1.2 tp -69.56 -41.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.563 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 21.0 t30 -70.33 -36.85 74.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.57 -30.11 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.2 -34.64 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.752 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 221' ' ' GLY . 0.8 OUTLIER -109.08 -15.89 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.752 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 56.03 4.13 0.68 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -165.98 -172.88 33.86 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.11 147.68 79.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.579 2.186 . . . . 0.0 111.982 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.0 mt -85.3 145.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 223' ' ' ILE . . . 176.59 -174.51 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.97 154.22 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -46.87 122.26 6.64 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -107.22 24.0 13.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.23 -15.97 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.514 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 143.56 68.1 0.02 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.9 62.52 1.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.752 0.31 . . . . 0.0 110.536 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 233' ' ' ILE . 0.5 OUTLIER -84.81 100.84 11.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.625 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp 56.01 -1.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 231' ' ' SER . 89.3 mt -133.59 82.03 52.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.936 0.398 . . . . 0.0 110.613 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 235' ' ' ALA . 50.1 Cg_exo -51.04 152.32 10.58 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.745 2.297 . . . . 0.0 112.027 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -28.18 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.668 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -128.21 163.61 24.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.719 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.82 -30.51 2.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 239' ' ' ILE . 10.1 pt-20 -62.2 -37.11 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.724 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 240' ' ' LEU . 4.2 tt -63.69 -37.43 79.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.437 ' HB3' HH21 ' A' ' 288' ' ' ARG . 2.2 mp -59.91 -43.25 94.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.722 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.04 -38.49 70.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.361 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -45.42 94.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.133 0.492 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 247' ' ' LEU . 3.6 t -68.36 -35.17 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.599 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -55.82 -47.18 77.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.903 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.08 -50.6 72.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.786 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -68.91 -32.09 71.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.916 0.389 . . . . 0.0 110.668 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.792 HD13 HG12 ' A' ' 243' ' ' VAL . 1.4 tp -55.07 -33.65 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.398 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -63.27 -37.69 88.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.894 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.45 -2.23 17.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -74.4 -46.59 5.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.941 -178.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 253' ' ' ALA . 31.5 Cg_exo -53.2 -13.75 3.46 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.986 2.458 . . . . 0.0 112.374 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 253' ' ' ALA . 0.6 OUTLIER -37.08 -23.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -107.19 -149.07 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.847 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 0.2 OUTLIER -103.77 138.23 40.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.03 132.12 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.95 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.0 m -123.48 124.37 42.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.067 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.99 114.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.57 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.85 128.88 56.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.6 148.83 19.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -139.65 130.79 26.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 110.379 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.7 p -124.99 -155.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.479 ' OD1' ' OD1' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -143.85 158.02 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.564 ' O ' ' OG1' ' A' ' 264' ' ' THR . 1.1 t-20 172.43 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 265' ' ' GLY . 10.6 p 66.74 -90.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.908 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 264' ' ' THR . . . 26.7 -103.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.983 ' OG ' ' CD1' ' A' ' 269' ' ' ILE . 88.9 p -142.25 166.41 24.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.54 -20.38 64.6 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . 0.658 ' C ' HD12 ' A' ' 269' ' ' ILE . . . -79.66 7.12 56.02 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.983 ' CD1' ' OG ' ' A' ' 266' ' ' SER . 3.1 mp -141.4 -35.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 0.0 110.888 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -68.8 -46.8 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.782 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 299' ' ' GLY . 0.6 OUTLIER -76.07 -47.05 3.71 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.625 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 39.8 Cg_exo -53.9 -32.62 68.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.259 1.973 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 28.2 tp -68.2 -48.36 65.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.477 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -32.92 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.17 -41.84 60.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -64.88 -37.38 87.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' CZ ' ' A' ' 319' ' ' ARG . 38.8 mtt-85 -61.38 -41.87 97.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.352 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.96 -28.84 67.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.174 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 277' ' ' ARG . 10.9 pt -70.87 -44.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.86 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.428 ' N ' HG13 ' A' ' 280' ' ' ILE . 71.0 t -58.6 -48.49 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.67 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -55.83 -39.11 70.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -38.78 92.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -42.0 83.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.636 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.55 -37.22 77.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.372 . . . . 0.0 110.012 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.4 t -62.35 -36.28 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.079 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.16 -20.1 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ARG . . . . . 0.599 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -81.42 -2.67 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.794 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.23 20.09 13.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.6 134.6 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.942 ' HB3' ' NE2' ' A' ' 294' ' ' HIS . . . -87.8 104.54 16.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.1 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.604 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.4 OUTLIER -79.29 -16.72 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 0.0 110.648 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.942 ' NE2' ' HB3' ' A' ' 291' ' ' ALA . 0.9 OUTLIER -133.74 35.02 3.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.738 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.96 136.79 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.668 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -137.29 143.59 42.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.1 124.46 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.01 119.05 60.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 271' ' ' ILE . . . -95.68 120.89 6.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 300' ' ' LEU . 4.0 mm? -99.0 111.45 23.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.328 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 302' ' ' SER . . . -78.42 120.44 5.39 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 301' ' ' GLY . 45.7 t 37.72 98.16 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.995 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.72 -38.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.964 0.411 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -133.67 70.23 75.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.127 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.81 131.51 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 0.0 112.196 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.445 HG21 HH12 ' A' ' 320' ' ' ARG . 8.4 mm -122.47 -57.19 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -116.84 156.67 26.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 309' ' ' ASN . 13.1 p -61.71 -136.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.786 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.53 ' N ' ' OG ' ' A' ' 308' ' ' SER . 25.4 p30 -173.15 34.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -92.78 -15.6 26.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 162.26 32.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.571 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -50.51 -33.1 37.25 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.446 2.098 . . . . 0.0 112.102 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.78 -40.11 91.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.04 -46.99 93.46 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 315' ' ' ARG . 37.7 mtm105 -65.61 -38.57 89.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.94 89.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.674 ' O ' ' NH1' ' A' ' 320' ' ' ARG . 41.1 mttm -71.02 -29.73 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.469 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -77.01 -16.13 59.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.541 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.578 ' CZ ' ' NH1' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -83.85 99.76 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.566 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 317' ' ' LYS . 0.0 OUTLIER -134.53 140.76 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.386 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.64 156.07 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 223' ' ' ILE . 40.6 tt0 -142.6 142.85 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 223' ' ' ILE . 35.1 mt -107.48 113.7 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.535 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.1 m -112.27 121.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 326' ' ' ASN . 0.7 OUTLIER -109.87 135.14 49.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.507 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASN . . . . . 0.563 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.633 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.786 0.327 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 154.94 40.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.08 159.74 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.758 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -88.94 168.39 12.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.36 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.79 107.93 11.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.03 136.07 54.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 121.05 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.609 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.0 pp -130.76 125.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.03 132.56 50.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -124.22 126.51 46.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.4 p -135.12 122.77 22.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.78 2.94 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.47 27.66 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -119.8 134.56 55.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.59 115.25 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.488 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.43 ' C ' HD12 ' A' ' 93' ' ' LEU . 72.2 p -109.77 116.27 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 92' ' ' THR . 9.1 mp -112.32 121.27 44.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.25 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 129.36 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.23 -152.54 20.15 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.57 154.3 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.39 144.74 44.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.5 -19.2 37.68 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.629 2.219 . . . . 0.0 111.873 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.65 -157.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.438 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.02 -26.45 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.389 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.26 98.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.353 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.35 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -58.45 -36.92 74.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.49 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.08 75.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.363 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.89 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.312 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.67 -39.98 93.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.439 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mmt -56.38 -37.16 69.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.478 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -65.98 -42.7 89.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.291 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.444 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -70.69 -22.87 62.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.44 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.03 -44.2 20.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.541 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -45.73 -37.47 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.7 -44.16 40.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' A' ' 114' ' ' LEU . 1.2 tp -43.53 -73.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 161.17 -156.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.698 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.628 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . 175.83 -48.89 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.573 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 118' ' ' VAL . 86.3 Cg_exo -40.03 -129.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.547 2.831 . . . . 0.0 113.834 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.37 -2.36 0.03 OUTLIER Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.9 t -95.72 134.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 122.353 -0.498 . . . . 0.0 110.362 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.89 129.38 35.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.532 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 t -129.33 116.7 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.24 140.04 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.259 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -126.36 96.65 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -99.33 61.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.949 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.63 128.71 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.58 146.59 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.3 t -99.6 119.2 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.63 125.07 20.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.289 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.17 42.88 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.368 2.045 . . . . 0.0 112.16 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.82 -35.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.57 167.34 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.07 159.29 34.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -143.94 155.8 44.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.705 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.11 135.8 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.37 139.46 57.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.576 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 17.4 m-85 -102.73 38.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.81 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -66.6 -58.68 4.66 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.615 0.721 . . . . 0.0 110.988 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 m -109.31 15.51 23.06 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.002 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.576 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -96.87 -23.26 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.797 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.8 OUTLIER -55.74 -46.26 99.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 23.2 Cg_exo -59.98 -29.59 89.69 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.805 2.337 . . . . 0.0 111.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 182' ' ' THR . 25.0 t -68.55 -44.96 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.5 m-85 -62.59 -32.4 73.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -65.59 -36.17 82.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.714 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.28 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -97.77 0.71 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.7 t -65.68 -38.78 27.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 72.4 Cg_endo -85.02 20.44 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.692 2.261 . . . . 0.0 112.336 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.57 116.62 22.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.676 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.36 178.61 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.14 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 54.38 20.29 2.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -82.69 139.51 33.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.772 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.08 153.24 24.89 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER -140.6 127.92 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.797 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.559 ' N ' HD23 ' A' ' 153' ' ' LEU . 0.4 OUTLIER -115.63 123.25 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.29 136.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.43 79.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.474 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 54.87 -115.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.732 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 158' ' ' ASP . 16.2 t70 -82.98 18.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -125.25 124.63 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.55 117.91 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.137 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -128.29 127.53 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.869 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.16 124.96 48.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.166 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.55 151.71 46.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.48 164.01 24.48 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 123.82 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.48 106.44 40.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.85 -62.52 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.338 2.026 . . . . 0.0 112.046 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.16 121.53 27.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.59 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.9 p -61.67 -30.6 70.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.437 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.99 -38.6 79.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.48 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -41.94 96.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -64.57 -39.95 94.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.62 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.81 -46.9 71.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.64 86.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.24 -37.8 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -58.34 -44.29 88.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.457 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.44 -37.16 82.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.55 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -63.86 -41.27 97.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.375 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 76.3 p -63.81 -40.87 97.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.903 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.7 t -71.37 -29.97 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.154 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 141' ' ' VAL . 22.8 m -50.71 -63.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.468 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CD1' HG22 ' A' ' 182' ' ' THR . 68.6 m95 -144.05 79.27 13.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.58 -33.56 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.921 2.414 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -75.82 55.87 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 158' ' ' ASP . 23.3 tpp -176.7 166.12 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.603 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 186' ' ' MET . 5.5 mtpm? -86.76 126.24 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.47 137.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.671 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.84 118.66 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -94.38 108.81 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.42 71.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.164 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.58 128.63 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.798 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -111.82 145.73 38.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.295 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 194' ' ' VAL . 20.0 m -88.38 129.4 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.59 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.747 -179.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.792 ' HA ' HD12 ' A' ' 211' ' ' LEU . 39.2 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.864 0.364 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -72.12 137.81 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 209' ' ' ALA . 16.0 m-20 37.81 19.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 208' ' ' CYS . 0.7 OUTLIER -56.3 -30.81 63.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.523 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.596 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 0.3 OUTLIER -54.28 -40.89 68.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -69.47 -42.05 75.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.404 0.621 . . . . 0.0 110.989 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.77 -34.69 64.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.079 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.572 HD11 HG13 ' A' ' 243' ' ' VAL . 2.8 tt -59.03 -37.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.527 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.16 -32.69 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.213 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.18 -45.7 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.664 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 246' ' ' LYS . 13.0 t -60.46 -38.85 79.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.532 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 220' ' ' GLY . 20.2 p -78.82 -31.44 45.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 219' ' ' THR . . . 19.57 52.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 219' ' ' THR . . . -153.88 166.32 31.89 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.74 138.93 39.05 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.89 2.394 . . . . 0.0 112.071 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.691 -179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.798 0.332 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.62 -32.86 73.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -58.91 -36.96 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.809 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 240' ' ' LEU . 0.7 OUTLIER -58.47 -46.15 87.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.409 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -63.29 -35.58 80.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -66.26 -45.25 81.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.499 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.572 HG13 HD11 ' A' ' 215' ' ' ILE . 57.9 t -62.79 -39.88 86.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -56.3 -41.91 76.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.35 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 218' ' ' VAL . 20.0 mtmt -69.83 -32.41 70.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -64.45 -31.07 72.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.828 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.25 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.401 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -106.01 3.78 28.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.247 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.689 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.7 m -75.41 -27.59 0.7 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.6 Cg_exo -53.58 -14.21 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.466 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 251' ' ' PRO . 40.2 t0 -39.88 -23.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -115.41 -148.82 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.76 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.464 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 12.5 ttm180 -109.61 139.39 44.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.9 t -118.83 132.15 69.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.894 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 95.5 m -123.4 125.77 45.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -113.81 120.25 63.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.874 0.369 . . . . 0.0 110.493 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.49 149.51 27.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -124.87 123.79 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 261' ' ' THR . 74.4 m-85 -100.6 133.93 44.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -165.7 165.19 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 -158.85 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 2.7 t-20 -176.34 129.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 264' ' ' THR . 35.9 m -150.6 -15.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.527 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.676 ' ND2' ' NH1' ' A' ' 315' ' ' ARG . 11.3 m120 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 0.7 OUTLIER -57.43 -51.82 78.89 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 12.4 Cg_endo -59.87 -41.91 49.89 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.947 1.765 . . . . 0.0 112.508 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.474 ' C ' HH22 ' A' ' 319' ' ' ARG . 5.4 tp -68.8 -37.97 79.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.522 ' N ' HH22 ' A' ' 319' ' ' ARG . 1.4 p -64.86 -40.18 94.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.9 -51.99 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.7 -34.59 78.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -60.51 -41.77 95.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.47 91.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -57.26 -40.21 77.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.596 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 11.1 mm -61.05 -40.68 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.589 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.45 -45.99 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.93 -43.14 99.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.49 -39.4 87.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.13 -52.09 31.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.65 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 285' ' ' LEU . 57.2 mt -59.6 -45.46 91.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.543 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 282' ' ' ALA . 59.4 t -58.95 -36.36 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.194 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.8 -25.13 68.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -84.16 -2.43 56.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.296 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.47 12.6 26.4 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 90.4 t -77.34 118.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 110.467 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.72 109.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -78.79 1.81 71.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.41 -15.84 59.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.409 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.41 5.98 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 292' ' ' GLY . 10.4 tt -91.07 133.83 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -130.0 135.98 48.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.41 134.05 51.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 122.13 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.71 106.67 3.39 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.789 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.0 OUTLIER -103.49 89.39 3.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.658 ' O ' ' OG ' ' A' ' 302' ' ' SER . . . -91.5 167.82 31.49 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.658 ' OG ' ' O ' ' A' ' 301' ' ' GLY . 89.7 p 69.64 -43.71 0.53 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.312 0.577 . . . . 0.0 110.963 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 304' ' ' ASN . 27.4 m -64.37 166.32 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.468 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 303' ' ' VAL . 10.3 m120 30.18 60.91 0.94 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.526 ' O ' ' C ' ' A' ' 306' ' ' ILE . 37.5 Cg_endo -69.72 67.16 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.784 2.323 . . . . 0.0 112.272 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 305' ' ' PRO . 6.4 mm -30.92 -66.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.391 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.7 160.4 22.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.33 160.27 30.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -100.81 108.55 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.206 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -163.84 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.59 161.32 28.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.69 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -50.23 -33.04 34.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.523 2.149 . . . . 0.0 112.08 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -68.51 -31.87 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.748 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.64 97.63 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.676 ' NH1' ' ND2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -63.44 -45.8 89.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.779 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -62.78 -40.43 97.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.74 HD22 ' N ' ' A' ' 319' ' ' ARG . 0.4 OUTLIER -83.79 -25.11 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.906 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.74 ' N ' HD22 ' A' ' 318' ' ' ASN . 0.7 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -137.22 157.77 45.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 111.048 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.9 t -144.87 152.58 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.73 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.97 142.95 29.17 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.507 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.1 mt -119.03 120.67 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.13 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 256' ' ' THR . 2.7 m -127.76 131.52 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.4 p -120.37 136.1 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.478 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.551 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 1.8 m-20 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.535 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.99 0.424 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 131' ' ' ARG . 24.2 p -129.3 138.27 51.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.24 159.29 15.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.6 p -97.18 159.67 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.745 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.45 115.77 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.637 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.96 144.09 49.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.81 125.94 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -133.43 115.49 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.347 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 m -137.26 127.37 26.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.519 ' NH2' HD21 ' A' ' 110' ' ' LEU . 7.9 mtt85 -114.91 126.46 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.302 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 p -134.23 116.71 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 150' ' ' ASP . . . 71.73 -137.14 25.29 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -95.22 15.68 18.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 110.497 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -121.61 125.76 47.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.8 m -107.36 118.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.38 127.72 45.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 94' ' ' ILE . 14.0 tp -133.15 120.41 21.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.284 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -134.13 129.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.614 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.5 -156.21 23.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 154.1 41.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 20.9 m-85 -138.67 146.59 51.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.535 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 24.9 Cg_endo -64.48 -25.47 63.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.676 2.251 . . . . 0.0 112.144 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 98' ' ' PRO . 35.5 m-20 -155.76 119.82 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.611 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -45.23 -21.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.43 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ASP . . . -60.41 -36.82 79.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.64 81.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -36.88 85.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.14 -38.52 79.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.351 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.37 90.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.28 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.54 -43.22 85.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -26.42 61.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -60.56 -42.81 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.799 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.09 67.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.469 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.7 mt -79.74 -21.15 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.61 -30.38 8.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.56 61.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.9 tt -88.04 -47.53 8.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.835 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 mt -21.2 116.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.157 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -142.98 -178.27 0.77 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.35 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 71.7 Cg_endo -89.01 153.58 5.8 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.127 2.552 . . . . 0.0 112.594 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.86 -10.04 21.06 Favored Glycine 0 C--O 1.24 0.483 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 115' ' ' ALA . 3.2 m -92.86 130.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.01 -0.7 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.476 HD22 ' N ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -92.26 130.47 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.524 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.476 ' N ' HD22 ' A' ' 119' ' ' ASN . 0.8 OUTLIER -102.3 129.06 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.425 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.0 mm -130.16 110.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.31 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 78.78 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.059 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -85.94 75.98 9.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 93' ' ' LEU . 3.9 mt -104.9 130.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.736 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.01 146.47 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.054 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 126' ' ' VAL . 2.3 p -99.76 111.74 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.813 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.621 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -137.54 102.94 8.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.351 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.71 26.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.391 2.061 . . . . 0.0 112.183 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.621 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.3 t -124.46 -4.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.902 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 171.41 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.735 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 78' ' ' SER . 6.2 mmt-85 -117.82 159.27 23.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.678 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -125.22 155.23 40.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.704 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.4 tp -86.91 134.98 33.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.61 132.41 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.734 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -117.68 27.31 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.302 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.1 m -32.65 -47.2 0.16 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.171 0.51 . . . . 0.0 110.978 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -100.22 -91.49 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.802 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . 69.99 -43.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.694 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.616 ' O ' HG23 ' A' ' 143' ' ' THR . 2.8 mm-40 -51.75 -58.86 9.52 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.958 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 20.6 Cg_endo -64.28 -35.13 52.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.514 2.143 . . . . 0.0 112.143 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 182' ' ' THR . 20.9 t -69.92 -48.27 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.84 -42.8 94.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 139' ' ' GLU . 63.0 p -65.97 -33.98 77.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.72 -22.03 59.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 p -111.99 5.54 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -63.86 -42.68 72.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.245 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 26.3 Cg_exo -57.92 -10.98 8.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.592 2.195 . . . . 0.0 111.756 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 147' ' ' PRO . 11.6 mm -125.03 89.7 52.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.63 16.36 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.666 2.244 . . . . 0.0 112.059 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 6.3 m-20 -132.4 61.66 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.616 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 2.7 p90 -125.55 143.17 51.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.54 142.2 15.61 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.6 tp -141.93 127.22 18.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -125.16 128.8 48.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.024 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.28 127.48 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.132 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 157' ' ' ARG . 2.2 tt0 -110.45 176.16 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.12 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 156' ' ' GLU . 25.6 mtt180 -32.26 -43.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.633 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 30.55 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 m -135.82 130.38 33.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.632 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.49 127.2 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 m -131.14 127.22 37.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.029 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -117.19 121.31 40.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.722 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.9 m -122.76 147.15 46.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.522 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.856 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 153.97 158.47 8.64 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.6 p -96.47 135.3 38.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.05 142.22 26.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.62 -39.19 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.687 2.258 . . . . 0.0 112.272 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.5 t -123.61 137.66 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.638 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -33.17 75.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -59.01 -48.56 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -58.35 -40.84 83.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.353 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.409 ' HZ1' ' HZ3' ' A' ' 176' ' ' LYS . 8.5 tttm -62.89 -36.18 82.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.6 t70 -63.93 -38.64 91.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.64 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.38 71.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.93 -51.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 177' ' ' ARG . 1.5 ptpt -63.52 -36.73 84.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.799 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.481 ' N ' ' HG3' ' A' ' 176' ' ' LYS . 9.3 ttm180 -59.76 -53.99 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.723 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.576 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -66.8 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.98 77.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.693 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -38.59 91.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.716 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 p -70.88 -36.32 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.2 OUTLIER -66.48 -68.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.845 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.826 ' CE2' HD21 ' A' ' 133' ' ' LEU . 8.5 m-90 -114.8 90.44 22.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 186' ' ' MET . 72.4 Cg_endo -83.53 22.52 0.91 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 123.017 2.478 . . . . 0.0 111.671 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 186' ' ' MET . 54.2 m-20 -36.56 -20.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.671 ' N ' ' O ' ' A' ' 184' ' ' PRO . 5.4 tpt 91.1 -39.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.564 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.12 53.53 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.44 119.08 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -108.93 129.68 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -104.41 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -125.13 59.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.291 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 164' ' ' GLY . 21.6 mt -113.39 129.16 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -121.99 139.63 53.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.232 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -88.28 129.42 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.485 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 250' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -65.32 134.37 53.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.822 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.0 OUTLIER 39.03 16.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.784 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -56.25 -30.85 62.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.077 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -38.2 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.402 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -65.73 -42.48 90.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.521 0.677 . . . . 0.0 110.984 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 211' ' ' LEU . . . -74.05 -34.83 64.21 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.37 -39.12 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.91 -38.52 82.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.29 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -58.6 -34.9 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 221' ' ' GLY . 3.5 t -105.54 -30.38 9.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.95 -37.93 2.66 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.42 ' H ' HG23 ' A' ' 219' ' ' THR . . . -169.21 -170.04 33.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 143.06 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.794 2.329 . . . . 0.0 111.976 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 1.09 ' H ' HD12 ' A' ' 223' ' ' ILE . 3.1 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.64 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.78 0.324 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.44 -39.52 88.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 58.8 mt -68.89 -36.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 240' ' ' LEU . 2.8 mm? -59.73 -32.74 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.595 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -56.1 -43.08 77.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -45.92 79.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.6 -45.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -57.11 -45.25 83.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.35 -50.64 70.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -31.7 71.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.115 0.483 . . . . 0.0 109.757 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -55.07 -30.19 59.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.49 11.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -104.36 -2.92 24.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.469 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.6 m -74.85 -27.17 0.7 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 51.4 Cg_exo -51.91 -13.83 2.02 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.728 1.618 . . . . 0.0 111.857 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.36 -14.65 63.11 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -126.9 -166.29 1.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -113.43 138.7 49.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 255' ' ' VAL . 11.6 p -119.36 133.13 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.944 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.2 m -117.34 118.85 33.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.051 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.568 HG12 HG23 ' A' ' 323' ' ' ILE . 65.6 mt -101.62 120.2 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -100.21 134.93 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.97 125.63 8.26 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -109.18 112.51 24.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.451 ' CG2' ' OD1' ' A' ' 270' ' ' ASN . 8.8 t -116.67 -158.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.251 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.432 ' N ' ' OG1' ' A' ' 261' ' ' THR . 1.0 OUTLIER -122.81 -151.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -119.7 28.46 8.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 265' ' ' GLY . 3.3 m -58.68 -68.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.524 0.639 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' CG2' ' A' ' 261' ' ' THR . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.714 0.292 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.566 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.2 mm -59.96 -51.94 77.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.4 Cg_endo -61.67 -33.25 86.64 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.111 1.874 . . . . 0.0 112.106 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.31 -42.61 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.423 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 p -74.33 -37.8 63.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.635 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.13 -35.8 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 41.7 mtt-85 -63.05 -47.11 84.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.91 70.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.393 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -55.82 -39.1 70.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.469 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 280' ' ' ILE . 1.7 mp -66.8 -43.62 89.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.328 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.73 -38.19 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -60.39 -41.21 93.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.644 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.96 -37.25 86.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.514 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -52.33 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 290' ' ' VAL . 4.5 mp -60.49 -48.94 79.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.7 t -56.36 -39.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.187 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.7 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.196 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.432 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -83.83 0.4 47.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.865 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.7 12.05 42.01 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 285' ' ' LEU . 21.2 t -81.45 133.93 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.563 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.74 102.8 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.93 1.71 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -133.4 6.99 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.2 mt -96.57 133.84 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.327 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.53 147.04 50.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 128.31 40.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.84 140.23 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.722 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -105.38 112.44 3.99 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 299' ' ' GLY . 11.4 mt -46.27 -96.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 302' ' ' SER . . . 132.05 82.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 301' ' ' GLY . 47.0 t 30.21 68.76 0.09 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.017 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.67 -82.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.704 0.288 . . . . 0.0 110.263 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 306' ' ' ILE . 0.7 OUTLIER -178.45 -51.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 32.1 Cg_exo -57.34 16.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.58 2.187 . . . . 0.0 112.346 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.641 ' H ' ' C ' ' A' ' 304' ' ' ASN . 14.4 pt -77.34 178.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.309 . . . . 0.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.74 171.91 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.726 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 14.5 m -81.18 152.88 27.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.41 31.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.86 -35.13 69.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.631 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.63 154.38 79.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.01 -34.2 97.17 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.89 2.393 . . . . 0.0 111.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.433 ' CG ' ' N ' ' A' ' 314' ' ' GLY . 7.8 pt-20 -65.24 -36.66 84.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.287 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 313' ' ' GLU . . . -59.82 -39.23 95.13 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.528 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -65.57 -44.64 86.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.42 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.426 ' HA ' ' NH2' ' A' ' 319' ' ' ARG . . . -55.45 -40.33 71.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.384 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -65.52 -29.95 70.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.546 ' C ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -76.23 -16.1 59.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.517 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.426 ' NH2' ' HA ' ' A' ' 316' ' ' ALA . 52.9 mtm180 -94.6 95.73 8.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -132.11 146.63 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.261 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.26 147.92 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.88 136.82 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.582 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.568 HG23 HG12 ' A' ' 257' ' ' ILE . 3.7 mt -130.19 117.9 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.62 131.64 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 250' ' ' CYS . 2.3 p -109.69 135.36 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.555 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.549 ' O ' ' OD1' ' A' ' 326' ' ' ASN . 19.2 t-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.612 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.979 0.418 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.655 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -163.81 144.68 8.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 78' ' ' SER . 5.8 mt -129.28 159.34 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.795 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.7 p -86.71 167.36 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 123.98 21.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.97 118.04 15.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.272 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 p -127.83 129.25 46.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 153' ' ' LEU . 1.4 pt -134.53 132.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.472 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -124.81 126.85 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.524 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 151' ' ' PHE . 28.5 ttm180 -113.4 131.2 56.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 90' ' ' THR . 41.2 t -142.8 112.5 6.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.12 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 27.08 106.04 0.0 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.14 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.7 1.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -106.99 124.91 50.31 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.476 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.86 125.64 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 78.2 m -123.12 118.59 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.5 tt -119.77 127.25 52.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.9 mt -135.32 128.19 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.475 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.56 -161.15 33.38 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.76 146.04 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.587 ' CD2' ' OG ' ' A' ' 132' ' ' SER . 11.4 m-85 -125.32 156.01 70.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.356 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 -20.76 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.779 2.319 . . . . 0.0 112.945 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 18.2 t0 -156.45 157.75 36.06 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.222 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -76.25 -26.99 56.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.062 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.06 79.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.08 86.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.203 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -57.07 -36.7 70.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.59 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.59 -40.42 68.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.98 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -41.34 76.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.301 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 39.3 mtp -58.58 -33.4 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.457 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -35.17 76.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.48 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.8 mt -78.36 -20.61 50.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -46.83 -23.02 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.93 -22.43 55.31 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 14.6 tp -98.28 -44.58 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.77 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -24.38 101.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -140.51 156.29 69.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 118' ' ' VAL . 17.8 Cg_endo -61.91 -79.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.884 2.389 . . . . 0.0 112.217 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -43.9 -10.35 0.01 OUTLIER Glycine 0 N--CA 1.46 0.246 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 116' ' ' PRO . 38.4 t -102.37 120.8 52.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 O-C-N 122.238 -0.566 . . . . 0.0 110.623 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.35 118.7 31.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -118.73 125.95 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.435 ' C ' ' OD1' ' A' ' 122' ' ' ASP . 13.5 pt -123.71 138.22 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.125 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -126.78 90.94 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.296 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.55 68.81 9.69 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.69 119.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.871 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -91.48 145.99 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.02 112.27 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.875 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.74 125.35 22.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.15 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.409 ' C ' HG23 ' A' ' 129' ' ' VAL . 55.9 Cg_endo -73.49 49.27 1.73 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.298 1.999 . . . . 0.0 112.171 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.409 HG23 ' C ' ' A' ' 128' ' ' PRO . 78.4 t -154.1 -35.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.23 153.6 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -110.08 159.54 17.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.587 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 1.4 m -120.78 150.55 40.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 183' ' ' TRP . 29.8 tp -83.24 129.82 35.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.419 ' N ' HD12 ' A' ' 133' ' ' LEU . 19.7 m-20 -53.3 147.35 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.8 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -125.21 11.75 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.151 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.4 p -39.63 -25.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -140.63 31.05 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.809 -179.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.83 24.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.3 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -51.59 -58.95 9.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.971 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 17.9 Cg_endo -63.39 -31.63 72.51 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.396 2.064 . . . . 0.0 112.042 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.6 t -64.75 -47.74 87.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 m-85 -63.75 -37.47 87.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 12.4 p -68.08 -33.15 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.0 -27.41 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -100.54 0.45 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.002 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.729 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -70.76 -36.16 5.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 16.4 Cg_exo -64.04 18.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.945 2.43 . . . . 0.0 112.208 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.55 ' C ' ' H ' ' A' ' 150' ' ' ASP . 60.2 mt -139.73 86.65 13.57 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.19 2.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.836 2.357 . . . . 0.0 112.008 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.2 p-10 -130.26 70.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.453 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.416 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 2.3 t80 -127.71 140.66 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.87 133.67 7.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.615 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -123.48 131.65 53.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 0.0 110.714 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 124.76 45.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.374 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.9 124.34 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -136.03 93.79 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.504 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 3.5 mtp180 58.79 -93.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.42 15.38 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -114.15 125.27 53.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.19 117.21 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.648 ' CG2' HD22 ' A' ' 191' ' ' ASN . 9.0 m -134.32 135.78 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.41 124.25 46.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.507 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.55 149.12 45.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 154.7 160.07 9.64 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.532 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 95.9 m -91.28 139.27 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.87 108.48 42.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.12 -27.28 1.78 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.416 2.077 . . . . 0.0 112.147 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -130.05 131.81 45.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -34.35 77.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -36.04 75.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.439 ' HD1' ' HA ' ' A' ' 171' ' ' HIS . 2.2 m-70 -63.67 -35.94 82.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -46.22 91.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.38 -44.43 95.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.38 86.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.75 -41.19 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.314 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 -52.13 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.115 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -57.17 -40.47 77.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -65.65 -36.43 83.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.21 69.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.3 m -60.58 -41.0 93.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -67.73 -29.16 68.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 2.6 m -68.38 -66.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.491 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.566 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.3 m-90 -118.42 67.24 6.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.693 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.67 1.93 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.627 2.218 . . . . 0.0 111.829 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.77 60.71 0.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.54 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 ttt -171.84 -163.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 104.98 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.93 127.75 57.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.488 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.565 ' HB ' HG23 ' A' ' 161' ' ' THR . 59.6 t -126.49 121.14 58.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 190' ' ' ASN . 0.9 OUTLIER -97.58 116.95 30.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.742 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.648 HD22 ' CG2' ' A' ' 161' ' ' THR . 12.4 m-80 -117.29 48.53 1.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.219 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.15 125.78 52.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.12 142.96 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.3 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.73 107.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.412 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 179.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.689 ' SG ' ' O ' ' A' ' 246' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.702 0.287 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . 53.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 2.7 m-20 33.46 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -56.24 -46.05 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.123 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.458 ' C ' ' CD ' ' A' ' 212' ' ' GLN . 10.2 tp60 -72.73 -50.38 25.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.249 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -71.17 -44.42 65.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.601 0.36 . . . . 0.0 110.948 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 210' ' ' ASP . . . -71.33 -45.27 63.38 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.028 -0.42 . . . . 0.0 111.943 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 211' ' ' LEU . 1.7 tp -69.48 -36.62 72.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.942 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 216' ' ' ASN . 0.7 OUTLIER -69.92 -43.96 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.662 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.81 95.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.703 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 214' ' ' ALA . 54.7 t -62.8 -50.15 80.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 221' ' ' GLY . 57.4 p -69.29 -22.22 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 74.5 -40.18 1.1 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -168.56 174.76 43.27 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.35 141.68 94.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.834 2.356 . . . . 0.0 111.986 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.631 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.564 ' O ' ' OD1' ' A' ' 241' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.915 0.388 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.61 -46.04 73.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 239' ' ' ILE . 24.5 mt -59.49 -38.06 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 77.6 mt -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 237' ' ' TYR . 11.1 m120 -55.82 -49.03 74.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.903 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -65.03 -45.78 84.03 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.724 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 218' ' ' VAL . 89.7 t -64.04 -48.42 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.31 82.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -50.71 70.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.689 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 6.0 mtpm? -69.18 -33.41 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.981 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.9 OUTLIER -54.81 -31.29 58.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.594 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -62.5 -16.88 58.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.22 22.27 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.34 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 57.8 m -74.98 -28.63 0.81 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.3 Cg_exo -53.63 -14.23 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.327 2.018 . . . . 0.0 112.646 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -52.36 -10.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.635 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -128.98 -157.87 0.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.217 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -100.23 139.1 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 50.7 t -119.41 132.95 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.112 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.536 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.2 m -121.23 119.43 32.26 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 257' ' ' ILE . 36.4 mt -106.17 121.02 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.79 0.328 . . . . 0.0 110.786 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.68 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -109.45 125.1 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -112.4 166.21 12.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 261' ' ' THR . 1.2 t80 -172.99 109.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.744 HG23 ' N ' ' A' ' 262' ' ' ASP . 1.3 t -105.08 -162.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.714 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 261' ' ' THR . 12.6 p-10 -89.75 174.69 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 265' ' ' GLY . 2.4 m-20 -96.6 -86.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 54.2 m 61.09 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.458 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.567 0.222 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.7 mm -68.26 -52.49 21.7 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.8 Cg_endo -61.7 -35.59 79.28 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.085 1.856 . . . . 0.0 112.292 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.0 mm? -68.26 -47.25 68.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.5 p -73.3 -35.19 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.54 -38.49 71.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.32 -43.79 98.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.658 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.402 ' CD ' ' HE ' ' A' ' 319' ' ' ARG . 13.6 ttp85 -60.15 -39.76 87.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.608 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.34 -31.21 70.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -73.57 -37.5 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.81 -46.52 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 282' ' ' ALA . 28.1 m -63.69 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.15 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -63.58 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.123 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -30.83 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -46.69 51.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.712 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 290' ' ' VAL . 9.7 mt -59.91 -49.25 78.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.15 -36.21 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.76 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 -2.33 58.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.419 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.4 2.67 38.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 285' ' ' LEU . 22.0 t -68.74 131.91 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.349 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.77 97.66 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.596 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -77.46 12.86 12.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.14 -16.29 38.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -121.31 27.68 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.328 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 295' ' ' ILE . 35.4 mt -117.75 124.85 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.3 135.5 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 124.44 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.99 116.47 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.152 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.8 105.37 2.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.679 ' O ' ' N ' ' A' ' 302' ' ' SER . 27.5 mt -74.29 0.07 15.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 110.42 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.5 -72.18 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 300' ' ' LEU . 89.4 p -174.73 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 120.352 0.12 . . . . 0.0 110.955 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 304' ' ' ASN . 66.2 t -41.89 -84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.63 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 0.1 OUTLIER -86.38 -39.58 0.56 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.14 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 60.4 Cg_endo -82.53 143.64 12.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.667 2.245 . . . . 0.0 112.465 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.24 137.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.92 163.04 30.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 158.72 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -122.07 49.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -106.78 -40.06 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.852 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.91 157.99 67.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -50.04 -30.11 23.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.609 2.206 . . . . 0.0 112.056 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.09 -40.54 89.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.452 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -67.99 -44.13 79.39 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.429 ' HA ' HD22 ' A' ' 318' ' ' ASN . 27.1 mtt-85 -66.08 -46.15 78.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.76 80.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.316 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -72.7 -24.38 60.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 260' ' ' TYR . 65.5 m-20 -72.8 -24.27 60.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 277' ' ' ARG . 12.7 ttt-85 -91.72 101.68 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.23 139.52 39.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.759 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.32 155.11 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.04 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 323' ' ' ILE . 2.7 tp10 -145.09 143.17 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 111.018 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.402 ' N ' ' HG3' ' A' ' 322' ' ' GLU . 17.8 mt -125.89 112.7 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.5 m -122.03 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.169 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -115.51 135.05 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.635 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 41.5 t30 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.703 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.836 0.35 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 p -92.08 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.113 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 157' ' ' ARG . 2.5 mt -121.35 159.65 25.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.2 m -81.31 178.91 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.245 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.7 pp -83.1 132.71 35.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.662 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.632 HD23 HD11 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -131.95 138.33 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.7 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -124.09 123.08 39.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.717 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -129.41 115.72 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.394 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -136.5 130.36 32.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 149' ' ' PRO . 42.1 mtt85 -112.22 140.15 47.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.8 p -142.89 114.82 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.623 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 56.66 -161.09 7.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.72 7.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 110.49 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 88' ' ' GLY . 99.7 m -107.58 130.93 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.35 116.93 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.3 m -103.25 121.38 42.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.582 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -123.05 127.62 49.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 123' ' ' GLN . 1.7 mt -139.31 123.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.386 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . 178.36 -161.39 28.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -137.33 156.36 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.624 0.249 . . . . 0.0 110.447 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -133.28 150.88 76.5 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.569 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.6 -19.66 31.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.772 2.315 . . . . 0.0 112.132 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.8 173.36 10.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -82.05 -34.8 29.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.89 85.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.9 78.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -36.75 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.717 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -37.5 64.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.536 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -60.56 -38.07 83.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.28 -43.98 69.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.016 0.436 . . . . 0.0 110.3 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.0 mtp -58.0 -26.31 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.531 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -43.97 96.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.79 -21.95 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.415 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.8 mt -99.64 -1.43 38.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -47.79 -34.39 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 -32.13 29.98 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.38 -34.91 69.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.317 . . . . 0.0 110.595 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mt -39.28 116.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.506 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -159.14 155.15 23.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.354 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.672 ' O ' ' N ' ' A' ' 118' ' ' VAL . 26.7 Cg_endo -65.11 -83.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.753 2.302 . . . . 0.0 112.108 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -41.86 -11.71 0.01 OUTLIER Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.672 ' N ' ' O ' ' A' ' 116' ' ' PRO . 27.8 t -92.38 137.51 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 122.416 -0.461 . . . . 0.0 110.743 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -100.44 134.9 42.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.236 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.46 114.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.998 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -124.74 122.59 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.792 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 121' ' ' ILE . 49.5 m-20 -133.56 86.85 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.007 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 93' ' ' LEU . 11.6 mm100 -83.84 55.39 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.033 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.1 128.44 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.47 143.29 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.32 112.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.5 134.6 19.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.69 33.06 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.18 -51.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' ASP . 35.3 m -56.14 150.03 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.632 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -104.03 159.04 16.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.406 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.08 151.16 41.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 183' ' ' TRP . 11.4 tp -80.99 133.12 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.656 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.68 133.42 56.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 105' ' ' ALA . 26.5 p90 -102.35 -22.87 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.584 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.2 m -34.17 -61.8 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.516 0.674 . . . . 0.0 110.988 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.18 20.76 9.8 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.747 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.763 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -124.4 -9.78 7.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -56.86 -43.85 99.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.803 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.2 Cg_exo -55.05 -36.49 92.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.39 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.478 HG23 ' OG1' ' A' ' 182' ' ' THR . 43.4 t -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.9 m-85 -62.39 -42.72 99.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.807 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -71.34 -36.04 71.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.664 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.06 -20.42 61.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.562 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -116.34 12.08 15.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -68.83 -43.28 27.16 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 12.2 Cg_exo -66.21 6.5 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.643 2.228 . . . . 0.0 111.901 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mm -111.91 99.99 47.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.722 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 86' ' ' ARG . 65.4 Cg_endo -79.83 -5.57 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.615 2.21 . . . . 0.0 112.187 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -117.52 40.49 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.517 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 4.0 t80 -127.65 137.87 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.631 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -142.94 160.46 27.5 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.49 138.55 24.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.756 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -106.15 128.65 54.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.2 t -112.81 138.55 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 158' ' ' ASP . 21.8 tt0 -150.39 102.83 3.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.754 ' O ' HD12 ' A' ' 79' ' ' LEU . 15.7 mtt180 49.83 -91.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 156' ' ' GLU . 4.4 p30 -121.57 33.98 5.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.92 130.75 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.338 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.4 129.88 62.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.696 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.02 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.67 105.29 12.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 p -118.04 149.72 40.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.29 175.32 14.38 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 66.7 p -100.17 119.27 38.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.48 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -87.09 145.79 38.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.52 -60.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.759 2.306 . . . . 0.0 111.845 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 t -124.47 153.87 41.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -30.89 71.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.872 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.26 -43.46 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -58.45 -37.08 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.013 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -69.09 -39.03 79.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.001 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -59.28 -47.78 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.877 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.68 77.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.09 -39.12 65.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -64.32 -44.31 91.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -64.95 -44.44 89.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.586 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -31.92 72.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.83 71.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 -47.76 83.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.7 t -70.72 -27.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.556 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 183' ' ' TRP . 0.9 OUTLIER -66.38 -60.92 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.625 ' CD1' HD21 ' A' ' 133' ' ' LEU . 21.7 m95 -120.67 85.14 38.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.139 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.67 ' O ' ' N ' ' A' ' 186' ' ' MET . 17.6 Cg_exo -62.35 20.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.88 2.387 . . . . 0.0 111.73 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 183' ' ' TRP . 0.8 OUTLIER -35.9 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.67 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.5 ttm 78.08 -8.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -120.05 80.98 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.19 136.71 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.1 t -126.97 121.72 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.861 ' H ' HD22 ' A' ' 190' ' ' ASN . 0.1 OUTLIER -87.73 125.99 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.57 40.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.466 . . . . 0.0 110.427 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.48 126.43 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -126.91 148.51 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 194' ' ' VAL . 2.3 p -97.03 110.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.716 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 195' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.427 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 31.1 t . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.905 0.383 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 210' ' ' ASP . . . -38.65 160.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.761 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 0.0 OUTLIER 33.12 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.154 0.502 . . . . 0.0 110.15 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -56.76 -42.94 80.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.065 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 216' ' ' ASN . 12.7 pt20 -71.96 -49.74 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.191 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 72.7 m -71.08 -48.69 51.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -62.51 -44.84 95.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.426 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 211' ' ' LEU . 3.6 tp -69.36 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.6 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 220' ' ' GLY . 3.1 m120 -67.8 -39.77 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.422 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.33 70.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.273 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' ALA . 74.3 t -58.46 -47.03 89.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.189 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 221' ' ' GLY . 68.1 p -87.83 -21.5 25.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.584 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.32 -37.57 0.21 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -160.48 179.75 35.78 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.6 154.22 9.46 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.763 2.308 . . . . 0.0 112.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.742 0.306 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -66.21 -37.72 86.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.04 -43.42 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 240' ' ' LEU . 10.4 tt -58.64 -32.35 68.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.374 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -44.73 94.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -63.67 -41.29 98.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.87 -40.91 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.51 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.518 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.91 -45.91 85.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -56.11 -50.81 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.67 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 0.4 OUTLIER -65.01 -35.54 81.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.702 HD21 HD13 ' A' ' 285' ' ' LEU . 9.0 tp -55.29 -30.2 59.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.368 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 249' ' ' ALA . 8.5 ptmt -63.63 -36.13 82.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.407 ' N ' ' HG2' ' A' ' 248' ' ' LYS . . . -107.49 3.24 24.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.714 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 85.7 m -74.63 -28.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 41.1 Cg_exo -55.12 -14.37 8.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.539 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 251' ' ' PRO . 9.0 t70 -40.89 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -119.99 -153.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.082 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 2.7 ttp180 -106.83 138.06 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.94 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.1 131.72 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -124.13 124.28 42.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 77.9 mt -113.01 117.44 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 110.715 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.42 131.99 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.383 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -108.07 133.19 11.52 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 318' ' ' ASN . 11.8 m-85 -100.49 107.82 19.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.56 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -143.84 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.282 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 262' ' ' ASP . 36.2 t0 -145.92 -99.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.497 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 0.2 OUTLIER -177.96 44.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.606 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.0 m -45.97 -58.74 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.465 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.439 0.162 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 272' ' ' PRO . 0.4 OUTLIER -73.46 -48.33 7.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.163 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 28.0 Cg_exo -53.53 -39.51 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.993 1.795 . . . . 0.0 111.669 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.21 -44.7 75.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.22 77.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.48 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.551 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.85 -45.18 90.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.439 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.621 ' O ' HG23 ' A' ' 281' ' ' VAL . 0.3 OUTLIER -60.14 -44.51 94.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.335 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -68.19 -45.74 72.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.367 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.27 -45.99 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.529 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 277' ' ' ARG . 57.3 t -61.39 -46.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.28 88.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.39 -32.97 69.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.546 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.6 -48.19 27.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.702 HD13 HD21 ' A' ' 247' ' ' LEU . 46.8 mt -59.45 -44.69 92.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.313 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 65.3 t -59.34 -37.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.291 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.32 -20.7 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.518 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.94 0.15 56.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.27 18.13 20.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 247' ' ' LEU . 98.2 t -86.1 132.79 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.602 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.98 104.45 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.63 16.74 7.58 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.0 OUTLIER -96.4 -12.2 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.703 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.652 ' N ' ' ND1' ' A' ' 294' ' ' HIS . 0.2 OUTLIER -119.45 23.38 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.633 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 4.9 mt -117.19 134.13 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.39 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.119 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.94 129.16 49.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.867 0.365 . . . . 0.0 110.992 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 12.1 t -133.26 116.69 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 301' ' ' GLY . . . -89.15 105.59 3.21 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 302' ' ' SER . 26.0 mt -56.64 77.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 299' ' ' GLY . . . -47.49 80.6 0.0 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.634 ' N ' ' O ' ' A' ' 300' ' ' LEU . 70.3 m 73.91 -52.89 0.69 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.292 0.567 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 300' ' ' LEU . 2.8 m -27.99 130.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 304' ' ' ASN . 0.1 OUTLIER 58.19 56.82 6.65 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 110.338 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 41.8 Cg_endo -71.69 176.78 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.905 2.403 . . . . 0.0 112.369 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 20.9 mt -132.52 -72.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.28 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.449 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 310' ' ' ALA . 5.3 p -68.02 171.05 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -76.18 24.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -44.29 -52.88 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.365 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.41 161.93 56.27 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -50.37 -41.06 52.57 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.255 1.97 . . . . 0.0 111.738 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.84 -42.26 98.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.04 -47.53 59.1 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.568 ' CZ ' ' NH2' ' A' ' 319' ' ' ARG . 58.2 ttt180 -60.16 -46.26 90.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.339 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.22 78.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.382 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -31.42 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.65 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -79.95 -25.13 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.549 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' A' ' 315' ' ' ARG . 1.5 mtt85 -80.38 82.21 6.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.317 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.3 ttm180 -129.03 141.97 51.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.33 161.12 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.033 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.24 127.9 16.18 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.086 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.47 110.33 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.37 135.65 60.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.3 p -115.76 135.62 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.225 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.618 ' O ' HD13 ' A' ' 211' ' ' LEU . 2.0 t30 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.663 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.679 0.276 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.86 121.42 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 5.1 mp -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 p -50.64 134.95 23.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -47.56 124.11 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.61 125.57 38.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.356 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -101.91 131.54 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.892 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.489 HG23 ' CD2' ' A' ' 93' ' ' LEU . 79.8 mt -133.85 120.0 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 92' ' ' THR . 15.5 t -133.34 140.05 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.502 ' CG ' HG12 ' A' ' 91' ' ' VAL . 1.5 ttt180 -125.22 150.01 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' THR . 8.9 t -145.23 95.09 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 46.72 -130.45 12.1 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 118' ' ' VAL . 2.1 m120 -69.65 4.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 87' ' ' SER . 30.9 m -115.98 126.05 53.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.535 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 91' ' ' VAL . 22.7 m -117.48 117.57 55.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.407 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.571 HG22 ' CD1' ' A' ' 94' ' ' ILE . 7.8 m -106.6 126.07 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.825 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 84' ' ' ILE . 6.9 mt -129.88 121.19 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.486 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.571 ' CD1' HG22 ' A' ' 92' ' ' THR . 2.4 mp -133.86 141.49 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.631 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.07 -157.28 27.72 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -130.98 156.8 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 0.0 110.563 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -141.42 153.35 65.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.3 -29.73 80.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.925 2.417 . . . . 0.0 112.455 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.56 176.1 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.648 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -74.85 -16.03 60.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.524 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.42 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.202 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.41 77.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.129 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 122' ' ' ASP . 2.6 tttp -63.81 -36.45 83.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.375 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.31 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.72 79.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.14 -41.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.603 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.7 mmt -58.35 -39.44 79.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -38.6 89.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.39 -16.12 62.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.86 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -100.77 -13.95 18.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -52.17 -25.6 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -10.81 81.51 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.3 tt -111.13 -17.25 13.27 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.261 -0.553 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.74 95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . -151.73 140.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' C ' ' H ' ' A' ' 118' ' ' VAL . 81.8 Cg_exo -41.17 173.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.6 2.2 . . . . 0.0 112.276 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.0 -14.64 0.18 Allowed Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 113' ' ' LEU . 48.8 t -101.72 139.39 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 122.218 -0.578 . . . . 0.0 110.646 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -108.06 123.55 48.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.619 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.19 114.43 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.463 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 92' ' ' THR . 0.8 OUTLIER -130.34 139.6 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 103' ' ' LYS . 7.7 p-10 -154.43 110.43 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -95.21 90.16 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.67 129.09 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.009 0.433 . . . . 0.0 111.132 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 148.94 22.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.566 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.02 117.95 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.228 0.537 . . . . 0.0 110.987 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.611 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -112.66 141.26 25.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.083 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 127' ' ' ASP . 91.1 Cg_exo -29.3 -62.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.06 2.507 . . . . 0.0 112.856 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 p -164.09 47.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.267 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 127' ' ' ASP . 1.5 m -50.4 -169.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -108.86 158.81 17.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -148.97 155.86 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.04 136.16 37.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.04 129.24 39.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 136' ' ' SER . 0.0 OUTLIER -105.45 -8.32 18.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.579 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.8 t -21.51 -47.74 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.403 0.621 . . . . 0.0 111.002 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.4 t -133.42 65.64 1.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.284 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -123.56 -15.5 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.5 tt0 -48.11 -49.32 61.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.7 Cg_exo -57.97 -30.94 91.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.728 2.285 . . . . 0.0 112.105 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.503 ' O ' ' OG ' ' A' ' 145' ' ' SER . 18.3 t -67.07 -42.98 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.9 m-85 -62.35 -41.7 98.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.245 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 21.3 p -60.88 -37.69 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.081 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.61 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.797 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 141' ' ' VAL . 0.7 OUTLIER -106.44 11.24 31.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 142' ' ' PHE . 3.5 t -88.23 -32.24 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 60.3 Cg_endo -85.84 9.6 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.862 2.374 . . . . 0.0 112.357 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 148' ' ' ILE . 8.8 mt -126.63 98.56 31.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 173.71 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.6 2.2 . . . . 0.0 112.058 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 52.88 54.19 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.69 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.651 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -127.08 145.8 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.36 149.03 16.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 162' ' ' LEU . 17.3 tp -139.02 126.48 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.502 ' N ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -126.08 126.7 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.852 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 154' ' ' LYS . 88.8 t -114.82 122.83 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.14 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 158' ' ' ASP . 4.8 tt0 -110.98 163.42 13.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -25.52 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.782 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 156' ' ' GLU . 1.4 p-10 -156.14 29.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.536 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 125.97 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.534 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.54 121.65 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 189' ' ' VAL . 24.4 m -130.38 136.96 49.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.592 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -119.19 109.22 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 147.99 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.542 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.81 -169.28 36.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.2 m -107.37 137.44 45.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.737 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -124.62 109.65 28.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.43 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.31 -16.11 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.435 2.09 . . . . 0.0 112.417 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.21 129.37 35.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.03 -41.71 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.647 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -35.75 76.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.582 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.644 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.3 m170 -63.06 -42.18 99.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -66.84 -39.4 87.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.98 -46.1 90.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.863 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.24 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 171' ' ' HIS . 17.9 t -70.59 -37.59 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.804 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -62.38 -49.32 75.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.797 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.89 -39.42 94.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.17 96.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.09 68.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.4 m -58.16 -39.57 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.412 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.8 p -65.85 -27.05 67.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.335 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.476 ' HB ' ' CD2' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.86 -44.07 28.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.476 ' CD2' ' HB ' ' A' ' 182' ' ' THR . 2.3 m-90 -138.21 67.26 46.85 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.627 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.27 -10.75 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.814 2.343 . . . . 0.0 111.973 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.71 58.47 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.433 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -176.57 -170.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.533 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -107.21 110.75 22.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 183' ' ' TRP . 39.7 mt -116.41 131.41 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 161' ' ' THR . 17.0 m -131.02 121.4 49.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.57 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.497 ' C ' HD22 ' A' ' 191' ' ' ASN . 2.6 m-20 -89.56 110.17 21.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 191' ' ' ASN . 2.1 m120 -104.1 55.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.662 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.41 115.85 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.385 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.545 ' CD ' ' O ' ' A' ' 193' ' ' GLU . 2.9 pp20? -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.683 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 166' ' ' ALA . 3.0 m -93.53 134.99 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.313 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.479 ' SG ' ' HD3' ' A' ' 251' ' ' PRO . 1.9 t . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.686 0.279 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -135.82 -147.89 0.28 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.256 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -70.01 50.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.151 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 211' ' ' LEU . 0.1 OUTLIER -66.66 -31.52 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 0.0 OUTLIER -54.19 -31.62 53.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 72.8 m -65.94 -48.55 70.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.706 0.765 . . . . 0.0 110.996 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -75.26 -34.55 61.39 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.848 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.718 HG21 HG11 ' A' ' 325' ' ' VAL . 0.3 OUTLIER -58.37 -39.5 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.404 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 2.2 m-20 -53.63 -34.42 58.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.083 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.88 62.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.53 -43.38 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 221' ' ' GLY . 6.3 p -93.67 -31.56 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.463 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.96 -35.33 0.1 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -174.56 -173.15 40.26 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.66 154.07 32.98 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.735 2.29 . . . . 0.0 111.895 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.806 0.336 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.47 -32.92 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.292 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.0 OUTLIER -66.46 -40.94 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.52 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.468 ' O ' ' NE ' ' A' ' 288' ' ' ARG . 12.5 mt -58.56 -47.28 84.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.344 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.515 ' OD1' ' C ' ' A' ' 241' ' ' ASN . 8.7 t-20 -63.52 -33.19 75.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.296 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.75 84.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.513 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 285' ' ' LEU . 48.3 t -62.06 -42.55 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 247' ' ' LEU . . . -56.43 -41.59 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 109.897 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.58 -40.14 74.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.4 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 28.9 ttmt -69.6 -31.29 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.453 HD11 HG23 ' A' ' 290' ' ' VAL . 0.1 OUTLIER -53.71 -33.04 54.24 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.3 OUTLIER -62.0 -12.11 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.496 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -69.04 11.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.879 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.563 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -37.63 -48.8 2.68 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.23 -178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.479 ' HD3' ' SG ' ' A' ' 208' ' ' CYS . 31.3 Cg_exo -56.29 -18.64 24.97 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.904 1.736 . . . . 0.0 111.596 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 254' ' ' ARG . 14.0 m-20 -156.74 39.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.668 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -62.65 62.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.711 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 252' ' ' ASP . 1.6 mtm180 -111.52 134.91 52.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.05 139.5 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.926 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.9 m -122.54 127.05 49.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 295' ' ' ILE . 74.1 mt -102.1 123.19 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 111.254 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.41 120.1 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.15 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -100.55 139.57 14.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.36 100.41 6.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.425 ' CG2' ' OD1' ' A' ' 263' ' ' ASN . 1.3 m -141.48 128.25 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.547 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.51 ' CG ' ' N ' ' A' ' 263' ' ' ASN . 22.4 t70 -68.54 -116.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 10.9 m120 65.15 41.09 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.565 ' O ' ' OD1' ' A' ' 270' ' ' ASN . 10.5 m -31.92 -74.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.648 ' ND2' ' N ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.573 0.225 . . . . 0.0 111.329 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.1 mm -72.67 -51.97 6.58 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.705 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.4 Cg_endo -62.0 -30.22 82.82 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.934 1.756 . . . . 0.0 112.115 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 273' ' ' LEU . 0.3 OUTLIER -64.4 -48.76 74.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.179 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 12.0 p -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.54 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.91 64.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 272' ' ' PRO . 6.9 tt0 -61.12 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.517 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -33.12 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.59 -33.99 76.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -43.31 84.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.3 -37.2 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.3 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.48 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.312 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.48 80.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -41.73 84.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.335 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -70.69 -42.34 70.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 243' ' ' VAL . 1.7 mm? -59.76 -49.19 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.93 -34.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.5 67.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.298 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 240' ' ' LEU . 3.1 tpt85 -80.77 -1.24 42.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.0 0.429 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.63 3.51 43.31 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.453 HG23 HD11 ' A' ' 247' ' ' LEU . 95.5 t -67.3 128.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.467 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -79.99 107.85 13.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.745 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -55.96 -4.25 0.68 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -68.52 -10.6 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -134.97 52.64 2.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 292' ' ' GLY . 17.6 tt -133.04 139.3 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.27 142.33 43.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.2 p -122.62 142.15 50.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.887 0.375 . . . . 0.0 110.955 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.39 116.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.282 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.3 107.45 3.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 300' ' ' LEU . 10.2 mp -97.65 62.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.449 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -34.94 -102.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -112.49 99.86 8.3 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 122.99 -0.124 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.717 HG12 ' N ' ' A' ' 304' ' ' ASN . 54.4 t -119.59 -95.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.717 ' N ' HG12 ' A' ' 303' ' ' VAL . 0.4 OUTLIER -89.16 -52.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.649 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 68.4 Cg_endo -80.72 153.33 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.772 2.315 . . . . 0.0 112.309 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.8 tt -167.62 137.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.416 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.21 137.66 47.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 309' ' ' ASN . 13.3 t -74.18 79.95 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 309' ' ' ASN . 0.0 OUTLIER -32.23 116.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.394 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -174.87 -50.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.482 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 164.38 15.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.39 -43.01 46.29 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.868 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -45.86 92.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.13 97.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -60.8 -40.92 94.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.48 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.21 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -68.05 -37.47 81.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 318' ' ' ASN . 1.1 t30 -72.08 -6.55 43.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.28 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -160.0 89.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.318 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -134.43 149.09 50.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.012 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.3 t -123.83 145.25 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.837 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.94 129.8 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.43 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.69 109.87 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 178.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 135.86 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.718 HG11 HG21 ' A' ' 215' ' ' ILE . 2.4 p -107.93 135.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 20.3 t30 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.645 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' C ' ' OG ' ' A' ' 78' ' ' SER . 3.7 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.818 0.342 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -168.93 121.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.68 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 132' ' ' SER . 1.9 mm? -110.46 151.79 27.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.466 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.95 151.84 18.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.445 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -66.07 129.49 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -131.49 130.77 42.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -109.68 121.17 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.95 118.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.606 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 t -130.52 132.45 45.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.456 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.48 HH11 HG22 ' A' ' 91' ' ' VAL . 25.4 ttm-85 -112.86 143.71 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 p -140.57 120.68 13.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.315 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 48.68 -135.77 19.4 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.48 17.08 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.824 0.345 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -109.97 139.06 45.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.688 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 HH11 ' A' ' 86' ' ' ARG . 89.6 t -112.95 114.13 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.458 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 116.45 32.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 93' ' ' LEU . 1.2 mm? -109.8 122.26 47.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.356 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.28 124.73 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.7 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.25 -135.83 4.48 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -154.36 156.91 37.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.749 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.92 153.99 80.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.497 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.2 -26.96 41.83 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.24 . . . . 0.0 112.011 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 4.3 p-10 -168.07 158.38 10.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.344 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.76 74.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.328 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.66 77.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -42.98 73.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.04 -40.61 73.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.29 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.54 -46.02 60.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.4 mtm -59.74 -33.14 71.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 2.9 m -62.01 -40.54 96.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.99 -29.51 66.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.79 -0.65 57.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.466 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.667 ' ND2' ' N ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -52.47 -22.66 5.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.667 ' N ' ' ND2' ' A' ' 111' ' ' ASN . . . -83.48 -10.07 82.44 Favored Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -97.4 -51.25 4.23 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.447 -0.443 . . . . 0.0 110.546 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -35.23 106.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -149.38 173.55 4.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 25.2 Cg_exo -57.76 164.81 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.632 2.221 . . . . 0.0 112.288 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.38 13.41 2.69 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -102.36 138.66 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.209 -0.583 . . . . 0.0 110.754 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.4 137.95 45.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.273 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.98 122.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.96 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.44 128.04 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.918 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.13 81.78 1.94 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -92.12 48.43 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.253 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -105.4 130.54 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -93.37 146.54 23.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.783 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.8 111.58 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 129' ' ' VAL . 31.6 m-20 -125.44 103.9 28.62 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -52.36 69.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.494 2.13 . . . . 0.0 112.293 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.677 ' O ' ' NE ' ' A' ' 131' ' ' ARG . 3.4 p -179.27 -30.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.742 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.02 164.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.677 ' NE ' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -122.45 159.17 28.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.478 ' C ' HD11 ' A' ' 79' ' ' LEU . 10.2 t -133.86 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -81.76 135.65 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.64 137.44 43.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -105.94 6.83 31.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.057 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t -45.72 132.71 8.54 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m 45.47 38.21 3.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 135' ' ' PHE . . . -101.6 -10.95 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -53.18 -47.32 96.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.367 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 32.0 Cg_exo -58.26 -36.55 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.782 2.321 . . . . 0.0 111.654 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.39 -44.4 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.49 -38.62 91.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.314 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 35.6 p -62.69 -37.24 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.44 -21.08 56.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.03 10.84 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -77.71 -43.58 2.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.493 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 28.1 Cg_exo -57.56 -9.6 5.58 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.512 2.142 . . . . 0.0 111.534 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 171' ' ' HIS . 1.3 mm -108.57 93.46 11.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.321 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.8 7.99 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.628 2.219 . . . . 0.0 112.311 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.38 50.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.38 141.57 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.23 123.07 4.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -118.51 135.28 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 130.22 49.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.19 133.86 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.044 0.449 . . . . 0.0 111.266 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -140.79 78.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 159' ' ' THR . 7.4 ttp180 70.11 -137.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.989 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -75.97 25.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.47 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ARG . 3.6 m -127.8 139.97 52.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.55 134.82 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.284 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 189' ' ' VAL . 11.2 m -127.35 136.88 52.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.913 HD12 ' N ' ' A' ' 162' ' ' LEU . 2.2 mp -106.64 125.23 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.951 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -137.93 146.89 43.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.09 163.18 10.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.2 p -87.03 126.75 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.749 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -99.84 146.86 32.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.2 -23.76 24.08 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.784 2.323 . . . . 0.0 111.901 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.86 137.93 21.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -36.33 83.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.86 -35.3 79.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.574 ' CE1' HD11 ' A' ' 148' ' ' ILE . 1.7 m-70 -57.47 -43.7 84.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.894 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -36.17 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.683 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.87 -40.18 87.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.37 99.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.45 -37.04 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -61.83 -48.62 79.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -55.8 -48.27 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.488 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.39 87.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.29 -41.3 96.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.664 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.0 -38.88 90.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 m -71.04 -37.47 72.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.37 -22.11 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.823 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' ALA . 7.9 m0 -141.69 88.36 9.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.664 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 186' ' ' MET . 71.5 Cg_endo -82.96 15.73 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.073 2.515 . . . . 0.0 112.291 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.9 OUTLIER -31.58 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 184' ' ' PRO . 9.3 ttt 80.47 -23.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -103.24 68.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.85 134.43 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 161' ' ' THR . 94.1 t -115.4 130.18 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.65 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 3.3 p-10 -97.02 119.12 34.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.96 50.49 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 192' ' ' ILE . 1.6 pp -101.59 129.56 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -98.7 139.41 34.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.356 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 194' ' ' VAL . 6.8 m -109.52 119.91 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 195' ' ' THR . 3.0 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.319 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 52.8 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.656 0.265 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.627 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -68.45 147.2 52.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.177 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 35.78 27.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 109.815 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 209' ' ' ALA . 56.9 tp -56.28 -31.7 63.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 213' ' ' SER . 14.3 pt20 -54.65 -44.76 73.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.79 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 74.1 m -69.78 -40.44 76.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.172 0.51 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -68.83 -37.15 78.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.514 ' CD1' HG22 ' A' ' 243' ' ' VAL . 3.5 mm -59.6 -36.53 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.709 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 220' ' ' GLY . 0.7 OUTLIER -57.3 -42.0 80.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.804 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.13 -41.45 63.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.698 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 214' ' ' ALA . 85.4 t -59.96 -45.12 95.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.706 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 221' ' ' GLY . 75.0 p -94.52 -23.24 17.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 65.95 -2.46 3.8 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -171.15 -172.82 37.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.97 151.47 62.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.732 2.288 . . . . 0.0 112.048 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.572 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -58.86 -34.66 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.899 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.77 -46.37 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.05 -34.37 73.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.626 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 -45.32 80.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -61.06 -43.74 98.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.333 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 215' ' ' ILE . 51.0 t -68.18 -39.38 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.453 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.728 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -64.81 -46.6 81.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -60.53 -50.77 72.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -60.47 -31.66 70.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.482 HD13 HD22 ' A' ' 285' ' ' LEU . 0.9 OUTLIER -62.67 -32.92 74.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.252 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.65 -18.59 64.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.92 -2.05 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 0.0 110.73 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.687 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.4 m -74.97 -28.72 0.82 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 43.6 Cg_exo -53.6 -16.04 7.34 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.148 1.899 . . . . 0.0 112.405 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -62.4 -9.43 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.553 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -136.07 -157.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.878 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -108.79 138.2 45.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.08 133.31 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.007 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.801 HG22 ' ND2' ' A' ' 258' ' ' ASN . 95.2 m -120.75 116.13 24.64 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.0 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 295' ' ' ILE . 53.3 mt -100.96 112.54 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.768 0.318 . . . . 0.0 110.557 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.801 ' ND2' HG22 ' A' ' 256' ' ' THR . 2.3 m-80 -112.6 122.65 48.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -122.85 133.98 9.36 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.649 ' HB2' HG11 ' A' ' 303' ' ' VAL . 29.6 p90 -130.52 154.67 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.799 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 262' ' ' ASP . 30.8 p -117.42 -118.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.603 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 303' ' ' VAL . 14.6 p-10 -134.58 -99.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.264 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.599 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 1.7 p30 -174.82 -123.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.943 ' O ' HD12 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -55.85 -49.96 89.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.657 ' HD3' HG23 ' A' ' 271' ' ' ILE . 21.8 Cg_endo -62.69 -39.93 40.26 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.594 1.529 . . . . 0.0 111.883 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.62 -34.08 77.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -40.0 94.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.763 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.62 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -65.9 -34.62 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.554 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -60.26 -45.67 92.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.67 76.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.46 -44.46 87.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.98 -36.96 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.298 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.87 -41.93 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -62.97 -39.66 95.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.95 -41.6 87.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.04 -44.28 85.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.729 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 247' ' ' LEU . 89.7 mt -59.72 -41.37 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.5 t -60.06 -36.31 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.167 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.24 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.772 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.728 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -86.6 -1.85 58.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 18.15 11.79 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.552 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 74.6 t -87.2 124.06 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 110.433 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -70.12 98.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.68 16.5 0.4 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 291' ' ' ALA . 25.3 t0 -93.21 -13.36 28.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.775 0.321 . . . . 0.0 110.518 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -132.48 24.72 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.815 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 295' ' ' ILE . 16.1 tt -116.36 125.34 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.468 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.86 48.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.552 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p -124.05 138.48 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.387 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.11 122.13 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.528 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -98.12 107.73 3.5 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.0 OUTLIER -38.96 -61.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.723 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.64 ' HA2' HD13 ' A' ' 271' ' ' ILE . . . 96.15 106.57 2.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.0 p 40.24 90.01 0.01 OUTLIER 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.971 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 260' ' ' TYR . 0.7 OUTLIER -107.24 160.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 303' ' ' VAL . 0.6 OUTLIER -40.33 152.76 0.22 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.402 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.2 114.64 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.746 2.297 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 16.2 mt -103.03 -42.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.73 168.88 11.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.506 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.45 90.41 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.483 ' CG ' ' O ' ' A' ' 309' ' ' ASN . 3.7 t30 -65.73 -1.06 2.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.68 -11.1 1.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.99 158.44 69.71 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.62 -36.59 81.52 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.85 2.366 . . . . 0.0 111.918 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -64.62 -31.45 72.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.406 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.99 99.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.683 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 6.7 ttm180 -60.8 -37.77 83.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.403 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.09 -36.23 82.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.55 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -36.88 64.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.806 HD22 ' N ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -74.99 -25.12 58.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.785 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.806 ' N ' HD22 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -95.57 84.41 3.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.611 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 260' ' ' TYR . 12.6 mtm180 -122.87 154.52 38.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.1 t -129.36 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.091 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.483 ' C ' HD13 ' A' ' 323' ' ' ILE . 2.8 tt0 -128.44 127.17 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -102.69 111.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.148 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 256' ' ' THR . 4.4 m -118.1 121.03 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.437 HG21 ' SG ' ' A' ' 208' ' ' CYS . 0.2 OUTLIER -105.63 135.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.553 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 3.7 t-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.858 0.361 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -130.34 126.04 36.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 27.3 mt -103.76 139.65 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.751 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -81.13 153.3 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.516 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 82' ' ' LEU . 1.3 tt -53.65 121.26 7.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -125.35 118.49 26.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.5 t -101.85 117.2 34.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.32 116.25 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -134.05 128.31 34.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.461 HH21 ' HA ' ' A' ' 149' ' ' PRO . 11.2 mtp85 -110.69 130.78 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.585 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.4 ' HG ' ' HB ' ' A' ' 90' ' ' THR . 19.9 p -130.01 115.94 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 42.3 -131.32 4.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.832 ' O ' HG23 ' A' ' 118' ' ' VAL . 22.2 m-20 -86.4 21.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.678 0.275 . . . . 0.0 110.606 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 87' ' ' SER . 75.6 m -122.07 125.73 46.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.397 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.59 132.9 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.5 m -119.31 116.56 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.382 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.93 123.35 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 123' ' ' GLN . 2.0 mt -142.08 124.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.291 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.57 -143.78 8.47 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.449 ' OD2' HG11 ' A' ' 130' ' ' VAL . 26.1 p30 -154.34 153.06 31.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 124' ' ' ILE . 33.9 p90 -137.26 150.43 68.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.83 -20.49 22.46 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.738 2.292 . . . . 0.0 112.242 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -165.87 145.75 6.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' C ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -53.75 -10.63 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' ASP . . . -60.86 -40.16 91.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.5 77.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -68.37 -37.05 80.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.86 81.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.54 77.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 106' ' ' LEU . 1.5 tt -72.19 -43.02 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -39.87 80.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -61.2 -28.36 69.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.32 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.741 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.5 mt -86.63 -17.42 33.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -45.88 -35.43 4.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.632 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.73 -17.19 66.36 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 114' ' ' LEU . 5.6 tp -95.77 -33.51 12.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.67 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 113' ' ' LEU . 1.7 tt -33.71 104.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.575 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -131.72 135.45 26.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -43.6 162.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.213 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.8 13.88 41.74 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' ASN . 8.7 p -102.54 130.14 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 121.903 -0.763 . . . . 0.0 110.761 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.81 126.08 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 120' ' ' VAL . 9.0 p -118.56 127.31 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.91 134.05 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.164 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -120.74 91.62 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.996 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.44 ' HB2' HG23 ' A' ' 94' ' ' ILE . 4.5 mm-40 -94.05 50.31 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.966 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 97' ' ' PHE . 1.3 pt -105.33 130.22 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -93.38 146.1 23.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.299 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 126' ' ' VAL . 13.7 p -100.02 120.06 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -137.45 129.87 16.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.368 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.48 41.91 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.377 2.051 . . . . 0.0 112.17 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.6 t -147.45 -35.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.449 HG11 ' OD2' ' A' ' 96' ' ' ASP . 34.0 m -67.21 164.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -115.56 158.61 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.246 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -126.12 155.94 40.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.699 HD21 ' CE2' ' A' ' 183' ' ' TRP . 37.1 tp -78.73 130.62 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.197 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.7 OUTLIER -64.18 134.53 55.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.857 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' O ' ' C ' ' A' ' 136' ' ' SER . 83.0 m-85 -120.54 6.55 10.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.22 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.558 ' C ' ' O ' ' A' ' 135' ' ' PHE . 90.0 p -24.08 -65.86 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.462 0.649 . . . . 0.0 110.985 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.41 47.69 1.97 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.845 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.58 -7.85 39.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.506 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.4 tt0 -48.49 -49.01 66.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.0 Cg_exo -55.36 -42.24 70.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.848 2.365 . . . . 0.0 112.14 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.74 -45.98 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.89 -41.63 95.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.55 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 21.8 p -65.73 -40.07 91.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.54 -18.66 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.444 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -105.55 2.58 28.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.651 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -64.54 -41.08 55.69 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 46.0 Cg_exo -53.25 -7.88 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.632 2.221 . . . . 0.0 111.719 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 150' ' ' ASP . 29.1 mt -122.77 101.53 39.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.415 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HA ' HH21 ' A' ' 86' ' ' ARG . 47.6 Cg_endo -75.66 19.26 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.187 1.925 . . . . 0.0 111.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 148' ' ' ILE . 22.4 m-20 -145.9 80.56 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.54 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.64 139.63 53.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.231 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.32 123.2 5.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.19 127.08 52.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 110.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.4 126.43 44.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.4 t -119.82 128.48 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -140.71 84.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.283 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 159' ' ' THR . 2.8 mtt180 60.77 -141.4 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.444 ' C ' ' OD2' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -68.81 27.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.413 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.602 ' H ' ' C ' ' A' ' 157' ' ' ARG . 1.8 m -139.15 129.72 25.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -131.94 135.12 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.21 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.937 ' C ' HD13 ' A' ' 162' ' ' LEU . 66.0 m -131.53 130.99 43.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.946 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.056 ' H ' HD22 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -113.25 123.86 51.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.379 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 149.4 49.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 148.97 158.58 8.12 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.71 136.7 37.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.08 140.61 27.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.517 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.02 -30.57 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.506 2.137 . . . . 0.0 111.947 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 t -122.39 128.0 50.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.03 72.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.642 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 171' ' ' HIS . 3.9 pt-20 -59.36 -35.86 74.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.726 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.4 m-70 -63.19 -37.95 89.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -64.15 -38.56 91.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.89 -47.07 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 171' ' ' HIS . 47.3 t -71.28 -41.37 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.958 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -58.05 -51.31 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -45.54 94.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.23 75.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.991 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.2 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.179 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 m -67.44 -36.36 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.226 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.1 t -71.02 -43.01 68.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.1 m -72.88 -44.4 61.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.568 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.699 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.0 m0 -126.12 77.05 71.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 186' ' ' MET . 15.4 Cg_exo -65.34 12.3 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.016 2.478 . . . . 0.0 112.424 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 186' ' ' MET . 21.1 t0 -31.3 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.829 0.347 . . . . 0.0 110.551 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 4.6 tpt 86.99 -28.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -93.1 63.75 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -101.9 121.26 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.785 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.601 ' O ' HD22 ' A' ' 162' ' ' LEU . 2.6 t -100.58 125.28 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.173 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.433 ' OD1' ' C ' ' A' ' 190' ' ' ASN . 47.2 t-20 -91.93 124.13 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.82 44.56 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.193 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.04 133.19 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.641 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -102.72 149.15 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.435 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.8 m -108.79 108.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.787 -179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -78.42 -164.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.872 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -91.43 56.32 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.725 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.57 ' CB ' ' O ' ' A' ' 245' ' ' ASP . 4.0 mm? -58.19 -30.33 66.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.622 ' CD ' ' N ' ' A' ' 213' ' ' SER . 2.9 pp0? -53.2 -34.81 58.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.611 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.622 ' N ' ' CD ' ' A' ' 212' ' ' GLN . 89.9 p -65.61 -35.5 80.99 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.928 0.871 . . . . 0.0 110.974 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.13 -32.51 63.2 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.371 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.16 -35.94 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.414 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.1 t30 -53.89 -44.08 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.669 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.46 -28.83 61.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.608 ' CG1' HH11 ' A' ' 242' ' ' ARG . 65.8 t -58.04 -49.64 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.386 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.574 ' C ' ' H ' ' A' ' 221' ' ' GLY . 12.8 p -103.58 -11.4 17.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.13 -35.75 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -173.66 178.7 45.46 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 153.63 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.728 2.286 . . . . 0.0 112.009 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 238' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.709 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 3.8 pt-20 -61.14 -38.71 87.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.457 HG23 HH21 ' A' ' 242' ' ' ARG . 0.8 OUTLIER -71.81 -42.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.941 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 243' ' ' VAL . 0.9 OUTLIER -65.27 -47.54 76.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.667 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -31.71 71.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.319 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.608 HH11 ' CG1' ' A' ' 218' ' ' VAL . 2.4 ttp-105 -60.92 -45.69 93.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.433 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 240' ' ' LEU . 10.8 m -63.73 -36.26 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.29 81.44 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.995 0.426 . . . . 0.0 109.859 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 211' ' ' LEU . 33.8 m-20 -56.07 -48.85 75.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 3.1 pttt -62.38 -30.47 71.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.806 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.851 ' O ' HD23 ' A' ' 247' ' ' LEU . 5.3 tt -53.13 -32.91 49.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -61.13 -11.35 8.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -68.07 10.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.638 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.568 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -38.52 -48.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.928 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.0 Cg_exo -54.23 -13.73 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.98 1.786 . . . . 0.0 111.353 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' ARG . 23.0 t0 -160.42 30.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.604 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -55.89 67.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.675 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' ASP . 2.6 ttt180 -116.17 135.01 54.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.94 135.86 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.923 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -122.45 120.0 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.045 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.89 127.51 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.95 122.16 41.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.276 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.69 145.44 16.88 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -134.24 149.48 50.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.645 0.259 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.591 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -162.61 -173.06 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.558 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.543 ' OD1' ' OD1' ' A' ' 270' ' ' ASN . 2.4 p30 -92.28 -164.36 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.64 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 265' ' ' GLY . 0.9 OUTLIER -125.14 -116.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.486 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 265' ' ' GLY . 0.2 OUTLIER 68.52 -29.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.528 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.543 ' OD1' ' OD1' ' A' ' 262' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.4 mm -54.79 -52.22 72.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.3 Cg_endo -61.26 -35.83 82.81 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.853 1.702 . . . . 0.0 111.876 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.6 mm? -68.5 -46.55 69.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 23.6 p -65.65 -39.76 91.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.575 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.96 95.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.441 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.98 -36.48 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 277' ' ' ARG . 4.1 mtt85 -63.24 -35.17 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.448 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.25 69.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.034 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -73.97 -47.97 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.61 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 281' ' ' VAL . 1.7 tp -60.39 -44.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.137 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.529 ' N ' ' CG2' ' A' ' 280' ' ' ILE . 27.6 m -61.28 -40.85 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -59.3 -39.0 81.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.01 -47.04 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.717 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -57.01 -39.92 75.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 290' ' ' VAL . 1.0 OUTLIER -60.84 -42.53 97.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.58 -36.25 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.64 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.003 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.64 ' O ' ' CD1' ' A' ' 247' ' ' LEU . 2.2 tpm_? -82.53 -2.79 54.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.798 0.333 . . . . 0.0 110.304 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.484 ' C ' HD11 ' A' ' 247' ' ' LEU . . . 105.97 10.63 29.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 285' ' ' LEU . 35.0 t -79.24 128.67 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.78 96.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.637 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -48.78 -8.28 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 291' ' ' ALA . 72.8 m-20 -75.93 -6.42 50.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.556 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -124.92 26.17 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 292' ' ' GLY . 61.9 mt -116.6 131.99 67.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.63 52.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 127.21 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 110.864 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.8 140.83 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.326 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.2 117.88 3.11 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.1 OUTLIER -119.23 59.84 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.524 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.515 ' HA2' ' H ' ' A' ' 261' ' ' THR . . . -77.99 -96.12 0.23 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 301' ' ' GLY . 90.1 p -36.87 -29.47 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.214 0.53 . . . . 0.0 110.955 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 301' ' ' GLY . 66.1 t -61.53 -47.41 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 301' ' ' GLY . 0.4 OUTLIER -139.73 86.42 13.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.645 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.79 163.48 9.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.952 2.435 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 74.3 mt -136.68 -22.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.321 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 308' ' ' SER . . . -119.9 151.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.437 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 307' ' ' ALA . 0.6 OUTLIER -50.29 -165.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.634 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.85 50.56 0.54 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.618 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.19 -2.86 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.523 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 p -146.62 148.63 34.28 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.374 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.45 -31.11 76.61 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.681 2.254 . . . . 0.0 111.918 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.03 -33.86 76.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.129 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.36 -44.98 97.35 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -65.27 -43.97 89.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.17 94.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.82 -32.61 74.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.235 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 261' ' ' THR . 0.7 OUTLIER -76.48 -25.43 54.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.426 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 319' ' ' ARG . 2.8 ttm180 -70.36 78.23 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.282 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -122.4 150.19 42.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.07 149.16 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.68 131.97 53.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.077 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.98 110.3 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.28 120.21 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 325' ' ' VAL . 11.8 p -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.54 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 77' ' ' LEU . 19.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.022 0.439 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 p 178.38 111.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -84.77 147.61 26.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -79.62 159.86 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.51 119.35 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.714 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.11 131.3 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.34 120.73 30.64 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.047 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.1 tt -123.15 122.64 65.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.062 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.59 127.51 35.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.621 ' HG2' HG13 ' A' ' 91' ' ' VAL . 55.9 mtt180 -114.21 141.26 47.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.218 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 126.39 16.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.66 -125.41 29.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.09 19.44 15.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.756 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.4 m -125.3 135.1 52.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.621 HG13 ' HG2' ' A' ' 86' ' ' ARG . 17.1 t -115.14 122.22 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 120.89 43.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -124.33 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.272 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -142.19 129.04 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.777 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.69 -152.1 21.18 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -154.39 154.37 33.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.417 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -125.96 158.95 64.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.845 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.16 -24.71 27.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.322 . . . . 0.0 112.025 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -157.91 -173.59 4.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -88.71 -19.61 25.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.515 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.78 75.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.538 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.04 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -61.89 -37.67 85.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.622 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.07 67.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 135' ' ' PHE . . . -65.96 -40.64 91.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt -62.5 -43.85 97.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.84 -42.89 85.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -62.76 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 mt -103.0 -12.79 17.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.734 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -51.91 -42.47 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.617 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.99 -13.71 57.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -98.01 -26.46 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.603 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -161.65 163.79 19.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.488 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 58.2 Cg_endo -76.15 166.64 27.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.842 2.361 . . . . 0.0 112.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.96 1.71 3.14 Favored Glycine 0 N--CA 1.461 0.325 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 116' ' ' PRO . 54.9 t -99.81 135.11 36.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 O-C-N 122.278 -0.543 . . . . 0.0 110.818 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.86 128.63 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.288 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.34 134.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.022 0.439 . . . . 0.0 111.282 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 121' ' ' ILE . 2.2 mm -123.79 125.31 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.755 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.501 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 13.3 p-10 -136.15 83.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.505 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.464 ' CA ' HE21 ' A' ' 123' ' ' GLN . 0.6 OUTLIER -97.42 72.22 2.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.717 HG21 ' CE2' ' A' ' 97' ' ' PHE . 12.3 mt -105.53 130.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.93 146.2 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 126' ' ' VAL . 7.7 p -100.3 116.07 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.6 m-20 -133.6 103.14 12.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.695 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.3 Cg_exo -61.57 56.73 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.468 2.112 . . . . 0.0 112.405 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 128' ' ' PRO . 56.0 t -162.68 -39.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.814 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.35 -178.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -123.87 159.58 29.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.315 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 m -134.65 155.5 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 183' ' ' TRP . 16.1 tp -80.08 113.17 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.276 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.6 136.35 57.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.56 ' O ' ' C ' ' A' ' 136' ' ' SER . 7.7 m-85 -92.0 2.05 56.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.38 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 135' ' ' PHE . 94.4 p -24.51 -80.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.656 0.741 . . . . 0.0 110.988 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.7 20.55 16.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.761 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.47 -11.09 24.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER -55.6 -45.85 99.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.696 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 31.8 Cg_exo -54.69 -38.95 91.19 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.007 2.471 . . . . 0.0 112.508 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.423 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 40.6 t -59.79 -47.61 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -63.26 -39.35 94.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 11.4 p -62.81 -34.68 77.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.79 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.62 66.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -104.46 11.26 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.707 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -73.71 -34.67 2.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 37.4 Cg_exo -54.17 -28.75 53.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.615 2.21 . . . . 0.0 112.263 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.4 tp -118.68 109.33 40.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.47 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 86' ' ' ARG . 57.3 Cg_endo -76.7 17.34 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.09 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.512 ' H ' HG13 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -114.14 53.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.544 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.59 144.86 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -125.9 134.8 8.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -127.95 127.99 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 110.83 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.16 131.41 56.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.63 131.32 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.75 77.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 67.2 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.14 -18.17 8.76 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.36 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -104.23 131.39 51.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.913 0.387 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.15 135.48 63.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.2 m -109.19 129.82 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.85 117.98 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 m -130.21 153.2 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 140.55 155.07 6.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.5 p -81.25 141.91 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 192' ' ' ILE . . . -109.73 138.4 20.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.492 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.42 -39.53 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.482 2.121 . . . . 0.0 111.961 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.03 130.59 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.448 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 172' ' ' LYS . 47.1 m -54.85 -33.12 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.77 -35.52 77.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.5 t60 -58.5 -48.04 82.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.961 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 169' ' ' SER . 21.2 pttt -67.24 -35.2 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.857 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.49 -43.25 83.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.486 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -70.41 -35.89 73.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 171' ' ' HIS . 20.3 t -66.73 -43.65 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -62.32 -47.93 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -60.17 -51.43 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.643 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.64 72.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.37 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 185' ' ' ASP . 4.5 m -64.57 -48.86 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.3 m -72.22 -26.62 62.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 183' ' ' TRP . 2.4 m -70.33 -72.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.086 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 185' ' ' ASP . 28.0 m95 -131.36 -67.65 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 186' ' ' MET . 11.4 Cg_endo -56.54 32.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.858 2.372 . . . . 0.0 113.361 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 183' ' ' TRP . 2.3 t0 -63.39 9.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.427 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.586 ' H ' ' C ' ' A' ' 184' ' ' PRO . 6.5 mtt -116.95 -89.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.903 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -108.92 115.89 30.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.942 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -125.68 147.55 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.724 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.27 124.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -98.9 128.39 45.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -144.2 42.66 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 164' ' ' GLY . 5.3 mt -114.55 133.3 61.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.66 141.83 50.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 194' ' ' VAL . 27.1 m -96.6 117.84 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.604 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.574 -179.892 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.589 ' O ' HD23 ' A' ' 211' ' ' LEU . 43.3 t . . . . . 0 C--O 1.23 0.061 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.586 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -25.62 146.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 24.0 m-20 44.04 64.09 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 208' ' ' CYS . 0.0 OUTLIER -56.01 -43.33 77.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.25 -51.34 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.331 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.1 m -71.0 -45.15 64.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -61.51 -44.28 97.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.23 -0.294 . . . . 0.0 111.573 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 2.5 tp -69.55 -39.25 78.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -70.11 -42.92 72.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.711 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.3 -49.53 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 t -59.22 -46.09 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 215' ' ' ILE . 30.6 p -84.93 -29.29 25.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.748 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 74.72 -48.0 1.89 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -151.55 151.55 23.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.692 ' C ' HG22 ' A' ' 223' ' ' ILE . 40.3 Cg_endo -70.38 140.23 39.87 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.749 2.299 . . . . 0.0 112.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.692 HG22 ' C ' ' A' ' 222' ' ' PRO . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 237' ' ' TYR . 25.1 t80 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.776 0.322 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -46.19 75.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 49.7 mt -67.71 -38.69 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -36.74 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.439 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.04 96.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.334 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -61.32 -45.35 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.33 -38.97 81.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.483 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.653 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.11 -45.94 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -51.06 70.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.529 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.681 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 8.0 mttt -66.1 -32.83 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.611 HD23 HG21 ' A' ' 290' ' ' VAL . 3.3 tp -54.56 -30.85 55.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.488 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 0.8 OUTLIER -63.81 -36.98 85.68 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.576 ' O ' ' OD1' ' A' ' 252' ' ' ASP . . . -101.57 5.27 41.65 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.972 0.415 . . . . 0.0 111.351 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.716 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.9 m -74.84 -27.51 0.73 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 52.1 Cg_exo -54.21 -15.66 8.4 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.372 2.048 . . . . 0.0 112.891 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -42.1 -18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 326' ' ' ASN . . . -125.65 -154.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.624 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.499 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 1.2 mtm180 -110.27 136.0 50.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 295' ' ' ILE . 0.6 OUTLIER -119.15 132.81 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.955 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.3 m -122.74 122.29 38.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.04 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.1 mt -102.23 116.71 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -101.77 130.21 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.363 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.59 127.74 7.02 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 318' ' ' ASN . 43.1 m-85 -106.57 136.58 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.405 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -128.47 -161.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.656 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 262' ' ' ASP . 2.5 p30 -132.83 125.47 30.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.2 p30 -42.92 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.9 m 51.06 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 271' ' ' ILE . 23.7 p-10 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.631 0.253 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.9 mm -57.59 -51.62 80.37 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.917 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 9.4 Cg_endo -57.36 -31.96 92.53 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.906 1.737 . . . . 0.0 112.083 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.58 -40.32 80.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.433 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.9 p -69.82 -37.78 76.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.73 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.85 -40.42 92.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.577 ' O ' HG22 ' A' ' 281' ' ' VAL . 6.4 mtt-85 -60.0 -44.28 94.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' ALA . . . -67.72 -32.6 73.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.416 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -70.92 -46.27 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.29 -46.28 95.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 277' ' ' ARG . 33.2 m -72.46 -38.75 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.391 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -43.06 79.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.38 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -72.43 -34.91 68.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 281' ' ' VAL . 5.2 mp -60.05 -48.27 82.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 282' ' ' ALA . 12.0 t -63.44 -36.17 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.298 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.37 -20.17 65.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.653 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -90.25 -2.14 58.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.629 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 19.94 9.69 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.465 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.611 HG21 HD23 ' A' ' 247' ' ' LEU . 64.9 t -87.74 129.65 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.405 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -74.53 101.04 4.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.943 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.02 9.53 0.97 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.7 OUTLIER -83.27 -12.32 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 110.651 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -134.67 11.66 3.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.981 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.541 ' HA ' HG13 ' A' ' 255' ' ' VAL . 14.1 tt -88.33 133.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -138.66 135.52 34.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 128.26 48.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.1 116.71 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.58 114.72 4.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.35 54.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -54.49 -92.65 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.47 ' C ' ' CG2' ' A' ' 303' ' ' VAL . 89.8 p -79.8 69.08 6.06 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 122.939 -0.154 . . . . 0.0 110.955 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 304' ' ' ASN . 0.2 OUTLIER -154.93 163.97 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.531 ' O ' ' O ' ' A' ' 303' ' ' VAL . 2.4 m-80 33.29 96.2 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.424 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.52 162.98 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.625 2.217 . . . . 0.0 112.298 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 306' ' ' ILE . 24.1 mt -153.5 -79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.308 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -125.1 155.58 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.518 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.07 141.12 58.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.598 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 4.7 p-10 -98.77 41.14 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.55 -36.21 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.683 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.79 153.75 37.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.718 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -36.1 98.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.803 2.336 . . . . 0.0 112.02 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -66.29 -32.15 73.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.15 87.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -62.59 -45.74 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.5 80.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.97 -30.32 68.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.4 t-20 -74.95 -23.03 58.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -87.45 87.91 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.562 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.33 145.55 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.638 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.67 148.54 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.325 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.15 130.65 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.18 113.33 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.536 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 255' ' ' VAL . 2.2 t -114.74 135.54 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 326' ' ' ASN . 1.5 p -115.8 135.56 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 253' ' ' ALA . 7.6 t-20 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.6 tp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.003 0.43 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -156.12 111.82 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.597 HD13 HD12 ' A' ' 133' ' ' LEU . 17.0 mt -115.28 155.1 27.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -84.98 140.97 30.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -53.41 125.85 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.44 ' H ' ' HB ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -127.31 122.89 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.021 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -102.69 122.55 44.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.07 123.23 60.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -135.03 124.81 25.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD2' ' CE2' ' A' ' 151' ' ' PHE . 20.1 ttm180 -116.15 120.23 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.496 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.07 123.38 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.46 -138.73 43.2 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.64 18.22 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.24 46.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.572 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.2 122.44 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.6 m -113.62 116.82 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -120.91 130.37 53.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.729 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.696 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.5 mt -142.86 131.49 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.82 -156.63 26.18 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.62 151.09 47.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -135.63 156.61 77.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.95 -22.29 19.92 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.777 2.318 . . . . 0.0 112.075 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.38 152.21 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 -27.0 68.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.43 94.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.94 79.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -60.04 -36.01 76.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.454 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.55 -37.17 57.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.64 87.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.26 -40.94 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.2 mtm -61.38 -31.85 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 m -61.28 -33.17 73.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.632 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB1' ' CG ' ' A' ' 142' ' ' PHE . . . -70.58 -26.86 63.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.36 -16.14 33.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -50.98 -28.92 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.56 -9.89 82.58 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -100.16 -42.7 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.703 ' C ' HD23 ' A' ' 114' ' ' LEU . 6.7 tt -32.55 113.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.575 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -156.75 158.32 31.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.485 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 14.2 Cg_endo -59.47 149.88 78.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.852 2.368 . . . . 0.0 112.297 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 -12.98 8.31 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 126.63 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 O-C-N 122.278 -0.542 . . . . 0.0 110.534 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.04 137.89 37.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.99 118.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.16 136.69 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.61 105.48 10.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.987 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -98.35 64.82 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.058 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.25 128.59 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.692 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.62 146.17 24.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.949 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.91 113.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -136.89 128.68 16.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.134 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.36 38.32 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.383 2.055 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.85 -34.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 127' ' ' ASP . 27.2 m -65.92 167.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 80' ' ' SER . 0.1 OUTLIER -121.08 160.26 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.3 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -119.87 156.06 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.671 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 79' ' ' LEU . 20.0 tp -78.59 126.39 30.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.487 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -58.47 150.03 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -140.42 74.11 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.533 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.9 p -95.34 7.34 46.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 182' ' ' THR . 2.1 p -176.59 31.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.77 40.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 7.7 mt-10 -49.16 -58.9 7.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 15.9 Cg_endo -61.13 -28.13 85.07 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.446 2.097 . . . . 0.0 111.961 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.08 -43.11 89.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 m-85 -64.09 -40.72 96.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.351 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 p -63.29 -35.26 79.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.85 -28.96 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -93.72 -9.55 37.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.518 ' N ' ' HD2' ' A' ' 147' ' ' PRO . 1.1 t -53.24 -48.67 91.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.531 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 56.3 Cg_endo -75.21 1.5 7.77 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.186 1.924 . . . . 0.0 111.666 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 171' ' ' HIS . 5.5 mm -118.66 85.55 27.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.81 22.15 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.844 2.363 . . . . 0.0 112.354 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -141.27 55.66 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.751 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.639 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 1.7 p90 -123.71 143.7 50.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 163' ' ' THR . . . -126.81 145.04 15.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.9 129.39 36.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 110.779 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.6 53.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.2 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 82' ' ' LEU . 57.2 t -117.92 134.7 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.659 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -145.61 77.68 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.656 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 62.14 -96.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.21 33.58 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.64 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 m -136.47 133.56 36.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.519 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.41 134.24 66.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.354 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.579 HG23 ' HB ' ' A' ' 189' ' ' VAL . 82.2 m -132.35 128.26 37.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.699 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -111.75 118.96 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 152' ' ' GLY . 87.8 m -128.22 147.49 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.675 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 150.38 166.41 13.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 193' ' ' GLU . 0.6 OUTLIER -100.02 142.0 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.73 149.4 46.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.11 -40.63 1.63 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.743 2.296 . . . . 0.0 111.69 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 146.68 52.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.236 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -36.97 85.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.457 ' HB3' HD11 ' A' ' 148' ' ' ILE . 1.8 m170 -63.4 -48.16 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.798 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -66.58 -33.7 76.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.577 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.5 -44.34 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.8 90.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.61 -40.94 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -62.55 -52.01 65.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.057 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -62.12 -39.66 93.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.858 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.16 97.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.9 -40.0 94.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.588 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.4 m -67.81 -40.08 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.4 p -68.63 -39.22 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.533 HG23 ' OG ' ' A' ' 137' ' ' SER . 55.8 m -83.53 -38.43 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.577 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 179' ' ' ALA . 4.7 m-90 -127.18 73.13 77.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.686 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 61.2 Cg_endo -77.87 28.0 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.857 2.371 . . . . 0.0 111.923 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 187' ' ' LYS . 1.2 t70 -41.58 -12.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.679 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 74.78 -26.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 185' ' ' ASP . 18.2 mttm -95.6 61.42 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 162' ' ' LEU . 3.9 mp -97.1 136.04 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 161' ' ' THR . 42.4 t -110.79 129.68 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -88.52 107.76 19.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.441 ' CB ' ' OG1' ' A' ' 163' ' ' THR . 4.7 m-80 -122.23 52.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.8 mt -86.33 133.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.599 ' O ' HG22 ' A' ' 165' ' ' THR . 17.5 mt-10 -120.12 124.79 46.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.913 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.4 m -105.25 109.86 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.128 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.807 179.333 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . 0.563 ' O ' ' O ' ' A' ' 209' ' ' ALA . 9.4 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.627 0.251 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -48.88 -111.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.347 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -81.95 18.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.305 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 215' ' ' ILE . 6.7 mp -56.55 -29.93 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -50.62 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.701 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -62.72 -39.92 95.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 110.975 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.22 68.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.448 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LEU . 6.2 mt -58.95 -37.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 220' ' ' GLY . 9.3 t-20 -54.78 -41.67 70.81 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.28 -31.28 62.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.517 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.32 -41.4 81.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -106.43 -27.53 10.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 78.47 -14.7 11.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.17 173.25 43.6 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.91 148.46 57.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.793 2.328 . . . . 0.0 112.128 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 23.2 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.88 0.372 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.02 -34.58 78.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 239' ' ' ILE . 7.7 mm -59.55 -45.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.745 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -31.96 68.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -42.97 76.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.13 -45.68 93.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.974 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 247' ' ' LEU . 54.8 t -69.26 -38.0 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.186 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.749 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -62.53 -45.76 91.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -50.38 72.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -65.49 -32.08 73.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.9 HD13 HD22 ' A' ' 285' ' ' LEU . 0.4 OUTLIER -63.44 -32.27 73.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -63.83 -26.13 68.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.791 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.5 1.95 47.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.023 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.678 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.2 m -74.69 -28.57 0.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.2 Cg_exo -53.43 -14.15 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.854 1.703 . . . . 0.0 111.819 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -2.66 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -141.02 -159.0 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.545 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -103.44 139.99 38.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.203 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.52 133.01 67.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.622 ' HB ' HG23 ' A' ' 324' ' ' VAL . 93.7 m -123.02 111.96 17.22 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.055 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.35 121.46 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -101.09 126.02 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.55 134.79 11.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -120.39 116.7 26.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 111.042 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.497 ' C ' ' OD1' ' A' ' 318' ' ' ASN . 2.9 t -134.74 159.28 41.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.667 ' N ' ' OD1' ' A' ' 318' ' ' ASN . 39.9 p-10 -113.24 97.33 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.6 t-20 38.36 -94.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.1 m 62.14 -69.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.651 ' N ' HG22 ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.71 0.291 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 3.1 mm -63.04 -51.36 71.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.754 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.3 Cg_endo -61.72 -39.84 50.17 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.055 1.837 . . . . 0.0 112.004 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.76 -43.98 91.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -38.0 67.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.76 71.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.402 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -60.97 -38.72 86.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -68.09 -39.05 82.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.55 68.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.177 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -45.6 76.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.357 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.23 -40.99 85.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.373 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.25 -39.38 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.86 94.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.492 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.72 -42.04 83.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -49.72 76.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.391 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.9 HD22 HD13 ' A' ' 247' ' ' LEU . 39.5 mt -59.51 -48.0 83.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.287 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.66 -38.07 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.09 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.749 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.63 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.496 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.2 12.99 24.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.18 130.89 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.36 9.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.439 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -75.47 11.02 10.17 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.1 OUTLIER -89.37 -16.71 30.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -113.83 2.34 15.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.87 124.79 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.69 154.12 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.38 132.83 38.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.73 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.9 t -125.62 116.48 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -83.26 105.34 2.69 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.6 mm? -31.28 -61.47 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.63 49.62 63.39 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 303' ' ' VAL . 94.3 p -99.58 -23.98 14.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.58 0.228 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 302' ' ' SER . 1.3 m 51.68 124.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.157 0.504 . . . . 0.0 110.512 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 305' ' ' PRO . 0.1 OUTLIER 60.2 53.25 3.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.621 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 304' ' ' ASN . 67.6 Cg_endo -77.61 -101.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.838 2.358 . . . . 0.0 112.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.6 mm -81.27 -38.59 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -115.79 160.75 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.44 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 p -102.83 16.15 27.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.769 HD21 ' CZ ' ' A' ' 315' ' ' ARG . 2.3 t30 44.63 53.81 6.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.615 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -127.25 -5.0 6.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.447 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.56 148.88 63.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.53 -31.81 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.674 2.249 . . . . 0.0 111.936 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.24 -33.39 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 318' ' ' ASN . . . -66.76 -44.38 89.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.769 ' CZ ' HD21 ' A' ' 309' ' ' ASN . 1.8 mtt-85 -62.06 -44.94 95.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 110.444 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.05 -45.53 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -34.69 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.667 ' OD1' ' N ' ' A' ' 262' ' ' ASP . 2.4 t30 -63.11 -25.4 68.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.733 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -79.68 98.97 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -133.79 146.86 51.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.85 144.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.321 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.43 148.52 46.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 323' ' ' ILE . 4.5 mp -123.58 129.64 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 256' ' ' THR . 0.6 OUTLIER -130.73 123.56 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.681 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.535 HG11 ' SG ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -107.33 134.6 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.305 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.568 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.641 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.17 117.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 69.6 mt -99.34 152.54 19.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 82' ' ' LEU . 11.0 p -75.47 162.4 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.28 106.51 13.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.596 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 80' ' ' SER . 17.2 mt -98.17 140.94 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -128.23 117.67 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.25 120.12 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.112 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.51 132.66 44.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.696 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HE ' HG22 ' A' ' 91' ' ' VAL . 45.8 ttt180 -121.23 138.08 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.404 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.1 p -143.6 109.58 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 149' ' ' PRO . . . 75.57 -125.52 8.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.55 18.28 22.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.397 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.5 m -118.81 138.96 52.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 ' HE ' ' A' ' 86' ' ' ARG . 1.3 t -127.54 121.41 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.812 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.7 m -104.22 124.73 49.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.194 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.76 125.51 48.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.75 119.65 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.353 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.549 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . -175.5 -171.56 39.56 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.549 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -131.46 145.11 51.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.576 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.45 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 3.8 m-85 -134.5 155.87 79.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.14 -28.37 48.59 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.774 2.316 . . . . 0.0 112.483 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.09 169.45 20.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -24.82 50.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.683 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.24 89.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.814 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.67 78.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -59.74 -38.91 83.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.16 -37.76 62.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 106' ' ' LEU . 2.5 tt -72.02 -44.82 62.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 110.427 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.498 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER -57.49 -26.76 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.455 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.9 m -66.5 -32.12 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.72 -18.47 63.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 110' ' ' LEU . 3.3 pp -125.49 3.74 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.637 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' MET . 32.5 t-20 -54.82 -42.27 71.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.639 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.66 -16.87 70.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.52 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 0.0 110.461 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 114' ' ' LEU . 2.3 tt -45.52 105.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -154.8 160.53 30.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 118' ' ' VAL . 52.0 Cg_exo -47.46 155.59 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 112.426 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.04 -25.45 0.31 Allowed Glycine 0 N--CA 1.461 0.316 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 116' ' ' PRO . 12.7 t -93.22 140.04 17.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.173 -0.604 . . . . 0.0 110.635 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.55 130.29 54.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.605 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.2 t -134.22 119.82 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.7 pt -125.24 125.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -104.23 104.24 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.171 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -109.93 63.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.846 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.7 125.36 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.579 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -90.63 146.42 24.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.78 121.06 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 130' ' ' VAL . 1.2 t0 -136.76 132.19 18.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.439 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.97 60.41 7.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.35 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 130' ' ' VAL . 7.4 p -174.2 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 127' ' ' ASP . 26.3 m -52.03 142.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -99.55 158.03 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.154 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.45 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 13.8 t -120.46 155.02 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.76 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 183' ' ' TRP . 55.6 tp -81.61 127.87 33.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.01 139.22 52.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -130.36 24.03 5.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' PHE . 68.9 m -30.41 -39.95 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.393 0.616 . . . . 0.0 110.962 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.7 m -152.59 61.51 0.81 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.436 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.16 -7.62 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.427 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -56.29 -43.47 99.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.513 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.0 Cg_exo -58.37 -41.43 65.96 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.31 -49.07 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.076 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' N ' ' A' ' 146' ' ' VAL . 2.4 m-85 -65.01 -37.12 86.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 1.3 p -58.27 -37.89 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.417 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.73 53.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.692 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 p -101.65 -2.06 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.2 t -65.62 -40.01 37.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 56.4 Cg_endo -82.65 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.712 2.274 . . . . 0.0 112.256 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 165' ' ' THR . 5.2 mt -128.99 104.01 18.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 88' ' ' GLY . 59.6 Cg_endo -78.24 21.1 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.205 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 12.3 t70 -152.63 64.18 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.478 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.647 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -130.01 139.67 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.659 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 130.5 6.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -119.11 129.96 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.586 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 131.26 51.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.585 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.25 134.59 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.388 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 158' ' ' ASP . 69.8 mt-10 -141.95 95.82 2.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 8.3 mtt180 53.84 -90.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' GLU . 5.0 p30 -117.97 9.06 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.884 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 m -110.06 129.11 55.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.693 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 t -119.9 131.77 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.357 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.756 HG22 ' HB ' ' A' ' 189' ' ' VAL . 1.3 p -130.95 116.86 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.656 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 163' ' ' THR . 3.6 tt -112.0 118.7 36.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.436 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.559 ' N ' HD23 ' A' ' 162' ' ' LEU . 4.8 p -128.59 149.2 50.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.789 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.55 -168.04 28.57 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.492 ' O ' HG21 ' A' ' 148' ' ' ILE . 20.8 p -108.03 135.7 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.685 0.279 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.47 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -98.36 159.08 31.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.358 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' ' 166' ' ' ALA . 46.4 Cg_endo -73.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.732 2.288 . . . . 0.0 112.142 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.38 166.4 16.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -41.45 94.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.44 -41.49 98.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.687 ' O ' HG23 ' A' ' 175' ' ' VAL . 2.0 m170 -63.94 -37.81 88.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.44 -43.25 97.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.9 t70 -66.73 -36.85 83.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.7 -32.83 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 171' ' ' HIS . 73.4 t -65.5 -51.83 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.727 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 177' ' ' ARG . 8.3 ptpt -66.35 -39.26 89.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 176' ' ' LYS . 7.8 ttm-85 -56.17 -51.03 69.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.39 -31.74 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.661 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.41 99.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 40.7 p -67.4 -37.59 83.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.474 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -27.06 64.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.8 m -96.02 -52.62 3.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.989 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.1 m-90 -116.71 99.09 52.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.264 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 58.2 Cg_endo -80.19 17.09 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.508 2.139 . . . . 0.0 111.349 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.3 OUTLIER -30.86 -29.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.718 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 78.52 -29.21 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.594 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 185' ' ' ASP . 23.5 mttt -105.2 76.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.546 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.92 125.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.756 ' HB ' HG22 ' A' ' 161' ' ' THR . 21.9 t -98.25 124.27 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -98.31 123.53 42.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.19 45.69 1.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.16 126.64 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.396 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.98 112.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 213' ' ' SER . 15.7 m-20 62.18 72.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -40.48 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.243 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -50.51 51.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.058 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.4 m -70.73 -45.02 65.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.957 0.408 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.7 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.246 -0.284 . . . . 0.0 111.715 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.596 ' O ' HG12 ' A' ' 218' ' ' VAL . 1.2 tp -69.56 -41.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.563 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 21.0 t30 -70.33 -36.85 74.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.57 -30.11 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.2 -34.64 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.752 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 221' ' ' GLY . 0.8 OUTLIER -109.08 -15.89 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.752 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 56.03 4.13 0.68 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -165.98 -172.88 33.86 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.11 147.68 79.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.579 2.186 . . . . 0.0 111.982 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.0 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 239' ' ' ILE . 10.1 pt-20 -62.2 -37.11 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.724 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 240' ' ' LEU . 4.2 tt -63.69 -37.43 79.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.437 ' HB3' HH21 ' A' ' 288' ' ' ARG . 2.2 mp -59.91 -43.25 94.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.722 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -38.49 70.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -45.42 94.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.133 0.492 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 247' ' ' LEU . 3.6 t -68.36 -35.17 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.599 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -55.82 -47.18 77.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.903 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.08 -50.6 72.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.786 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -68.91 -32.09 71.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.916 0.389 . . . . 0.0 110.668 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.792 HD13 HG12 ' A' ' 243' ' ' VAL . 1.4 tp -55.07 -33.65 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.398 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -63.27 -37.69 88.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.894 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.45 -2.23 17.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -74.4 -46.59 5.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.941 -178.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 253' ' ' ALA . 31.5 Cg_exo -53.2 -13.75 3.46 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.986 2.458 . . . . 0.0 112.374 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 253' ' ' ALA . 0.6 OUTLIER -37.08 -23.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -107.19 -149.07 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.847 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 0.2 OUTLIER -103.77 138.23 40.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.03 132.12 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.95 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.0 m -123.48 124.37 42.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.067 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.99 114.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.57 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.85 128.88 56.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.6 148.83 19.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -139.65 130.79 26.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 110.379 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.7 p -124.99 -155.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.479 ' OD1' ' OD1' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -143.85 158.02 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.564 ' O ' ' OG1' ' A' ' 264' ' ' THR . 0.3 OUTLIER 172.43 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 265' ' ' GLY . 10.6 p 66.74 -90.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.908 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 264' ' ' THR . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 299' ' ' GLY . 0.6 OUTLIER -76.07 -47.05 3.71 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.625 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 39.8 Cg_exo -53.9 -32.62 68.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.259 1.973 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 28.2 tp -68.2 -48.36 65.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.477 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -32.92 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.17 -41.84 60.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -64.88 -37.38 87.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' CZ ' ' A' ' 319' ' ' ARG . 38.8 mtt-85 -61.38 -41.87 97.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.352 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.96 -28.84 67.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.174 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 277' ' ' ARG . 10.9 pt -70.87 -44.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.86 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.428 ' N ' HG13 ' A' ' 280' ' ' ILE . 71.0 t -58.6 -48.49 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.67 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -55.83 -39.11 70.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -38.78 92.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -42.0 83.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.636 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.55 -37.22 77.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.372 . . . . 0.0 110.012 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.4 t -62.35 -36.28 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.079 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.16 -20.1 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ARG . . . . . 0.599 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -81.42 -2.67 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.794 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.23 20.09 13.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.6 134.6 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.942 ' HB3' ' NE2' ' A' ' 294' ' ' HIS . . . -87.8 104.54 16.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.1 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.604 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.4 OUTLIER -79.29 -16.72 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 0.0 110.648 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.942 ' NE2' ' HB3' ' A' ' 291' ' ' ALA . 0.9 OUTLIER -133.74 35.02 3.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.738 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.96 136.79 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.668 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -137.29 143.59 42.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.1 124.46 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.01 119.05 60.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 271' ' ' ILE . . . -95.68 120.89 6.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 300' ' ' LEU . 4.0 mm? -99.0 111.45 23.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.328 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 302' ' ' SER . . . -78.42 120.44 5.39 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 301' ' ' GLY . 45.7 t 37.72 98.16 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.995 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.72 -38.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.964 0.411 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -133.67 70.23 75.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.127 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.81 131.51 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 0.0 112.196 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.445 HG21 HH12 ' A' ' 320' ' ' ARG . 8.4 mm -122.47 -57.19 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -116.84 156.67 26.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 309' ' ' ASN . 13.1 p -61.71 -136.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.786 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.636 ' C ' HD22 ' A' ' 309' ' ' ASN . 0.4 OUTLIER -173.15 34.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -92.78 -15.6 26.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 162.26 32.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.571 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -50.51 -33.1 37.25 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.446 2.098 . . . . 0.0 112.102 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.78 -40.11 91.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.04 -46.99 93.46 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 315' ' ' ARG . 37.7 mtm105 -65.61 -38.57 89.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.94 89.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.674 ' O ' ' NH1' ' A' ' 320' ' ' ARG . 41.1 mttm -71.02 -29.73 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.469 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -77.01 -16.13 59.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.541 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.578 ' CZ ' ' NH1' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -83.85 99.76 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.566 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 317' ' ' LYS . 0.0 OUTLIER -134.53 140.76 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.386 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.64 156.07 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 223' ' ' ILE . 40.6 tt0 -142.6 142.85 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 223' ' ' ILE . 35.1 mt -107.48 113.7 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.535 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.1 m -112.27 121.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 326' ' ' ASN . 0.7 OUTLIER -109.87 135.14 49.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.507 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . 0.563 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 5.9 m-20 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.783 0.325 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.35 179.48 9.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.27 -20.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.71 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 154.94 40.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.486 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.08 159.74 27.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.758 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -88.94 168.39 12.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.36 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.79 107.93 11.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.03 136.07 54.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.461 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 121.05 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.609 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 84' ' ' ILE . 2.0 pp -130.76 125.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.03 132.56 50.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.578 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -124.22 126.51 46.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.4 p -135.12 122.77 22.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.78 2.94 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.47 27.66 9.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 0.0 110.491 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -119.8 134.56 55.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.59 115.25 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.488 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.43 ' C ' HD12 ' A' ' 93' ' ' LEU . 72.2 p -109.77 116.27 31.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 92' ' ' THR . 9.1 mp -112.32 121.27 44.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.25 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.21 129.36 22.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.23 -152.54 20.15 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.57 154.3 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -123.39 144.74 44.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.389 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.5 -19.2 37.68 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.629 2.219 . . . . 0.0 111.873 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.65 -157.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.438 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -97.02 -26.45 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.389 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.26 98.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.353 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.02 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.35 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -58.45 -36.92 74.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.49 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.08 75.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.363 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.89 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.312 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.67 -39.98 93.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.439 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mmt -56.38 -37.16 69.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.478 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.7 m -65.98 -42.7 89.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.291 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.444 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -70.69 -22.87 62.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.44 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.03 -44.2 20.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.541 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -45.73 -37.47 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.36 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.7 -44.16 40.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' A' ' 114' ' ' LEU . 1.2 tp -43.53 -73.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.335 0.588 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 161.17 -156.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.698 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.628 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . 175.83 -48.89 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.573 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 118' ' ' VAL . 86.3 Cg_exo -40.03 -129.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.547 2.831 . . . . 0.0 113.834 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.37 -2.36 0.03 OUTLIER Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 116' ' ' PRO . 19.9 t -95.72 134.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 O-C-N 122.353 -0.498 . . . . 0.0 110.362 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.89 129.38 35.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.532 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 t -129.33 116.7 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.24 140.04 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.259 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -126.36 96.65 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -99.33 61.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.949 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.63 128.71 59.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -91.58 146.59 23.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.3 t -99.6 119.2 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.63 125.07 20.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.289 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.17 42.88 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.368 2.045 . . . . 0.0 112.16 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.82 -35.98 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.57 167.34 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.07 159.29 34.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.102 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -143.94 155.8 44.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.705 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.11 135.8 36.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.315 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.37 139.46 57.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.492 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.576 ' HA ' ' HB3' ' A' ' 138' ' ' ALA . 17.4 m-85 -102.73 38.5 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.81 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.4 t -66.6 -58.68 4.66 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.615 0.721 . . . . 0.0 110.988 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.9 m -109.31 15.51 23.06 Favored 'General case' 0 N--CA 1.457 -0.079 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.002 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.576 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -96.87 -23.26 16.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.797 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.8 OUTLIER -55.74 -46.26 99.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 23.2 Cg_exo -59.98 -29.59 89.69 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.805 2.337 . . . . 0.0 111.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.748 HG21 ' OG1' ' A' ' 182' ' ' THR . 25.0 t -68.55 -44.96 82.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.671 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.5 m-85 -62.59 -32.4 73.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.686 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -65.59 -36.17 82.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.714 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.28 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -97.77 0.71 47.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.64 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.7 t -65.68 -38.78 27.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 72.4 Cg_endo -85.02 20.44 1.24 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.692 2.261 . . . . 0.0 112.336 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.57 116.62 22.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.676 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.36 178.61 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.14 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 54.38 20.29 2.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.803 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -82.69 139.51 33.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.772 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.08 153.24 24.89 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER -140.6 127.92 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.797 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.559 ' N ' HD23 ' A' ' 153' ' ' LEU . 0.4 OUTLIER -115.63 123.25 47.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.359 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.29 136.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.43 79.54 1.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.474 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 54.87 -115.16 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.732 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 158' ' ' ASP . 16.2 t70 -82.98 18.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.7 m -125.25 124.63 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.55 117.91 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.137 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -128.29 127.53 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.869 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.16 124.96 48.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.166 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.55 151.71 46.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.48 164.01 24.48 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.84 123.82 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.725 0.298 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.48 106.44 40.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 197' ' ' GLN . 32.1 Cg_exo -53.85 -62.52 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.338 2.026 . . . . 0.0 112.046 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.16 121.53 27.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.59 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.9 p -61.67 -30.6 70.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.437 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -58.99 -38.6 79.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.48 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -41.94 96.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -64.57 -39.95 94.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.62 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.81 -46.9 71.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.64 86.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.24 -37.8 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.736 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -58.34 -44.29 88.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.457 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.44 -37.16 82.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.55 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -63.86 -41.27 97.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.375 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 76.3 p -63.81 -40.87 97.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.903 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.7 t -71.37 -29.97 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.154 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.748 ' OG1' HG21 ' A' ' 141' ' ' VAL . 22.8 m -50.71 -63.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.468 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CD1' HG22 ' A' ' 182' ' ' THR . 68.6 m95 -144.05 79.27 13.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.58 -33.56 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.921 2.414 . . . . 0.0 112.363 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -75.82 55.87 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.566 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 158' ' ' ASP . 23.3 tpp -176.7 166.12 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.603 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 186' ' ' MET . 5.5 mtpm? -86.76 126.24 34.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.47 137.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.671 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.84 118.66 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -94.38 108.81 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 -179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.42 71.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.164 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.58 128.63 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.798 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -111.82 145.73 38.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.295 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 194' ' ' VAL . 20.0 m -88.38 129.4 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.59 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.5 t -75.49 18.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.747 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 194' ' ' VAL . . . 112.02 -2.75 27.08 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 167' ' ' PRO . 2.1 tp60 -113.49 147.54 37.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . . . -175.91 -55.09 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.721 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 198' ' ' ALA . 86.4 Cg_exo -41.79 130.66 4.1 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.671 2.247 . . . . 0.0 112.064 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -43.05 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.466 2.111 . . . . 0.0 112.165 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -116.03 178.16 17.36 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -46.19 102.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.043 2.495 . . . . 0.0 112.538 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -58.33 102.08 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.514 2.142 . . . . 0.0 111.887 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -179.99 29.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.607 ' O ' ' N ' ' A' ' 207' ' ' PRO . 4.0 m 50.75 70.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.479 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 205' ' ' SER . . . -15.38 81.18 0.0 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.607 ' N ' ' O ' ' A' ' 205' ' ' SER . 72.4 Cg_endo -82.6 -169.28 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.012 2.475 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.792 ' HA ' HD12 ' A' ' 211' ' ' LEU . 39.2 t -76.56 33.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.402 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -72.12 137.81 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 209' ' ' ALA . 16.0 m-20 37.81 19.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.172 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 208' ' ' CYS . 0.7 OUTLIER -56.3 -30.81 63.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.523 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.596 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 0.3 OUTLIER -54.28 -40.89 68.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -69.47 -42.05 75.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.404 0.621 . . . . 0.0 110.989 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -73.77 -34.69 64.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.079 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.572 HD11 HG13 ' A' ' 243' ' ' VAL . 2.8 tt -59.03 -37.12 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.527 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -54.16 -32.69 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.213 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.18 -45.7 46.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.664 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 246' ' ' LYS . 13.0 t -60.46 -38.85 79.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.532 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.575 ' O ' ' C ' ' A' ' 220' ' ' GLY . 20.2 p -78.82 -31.44 45.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 219' ' ' THR . . . 19.57 52.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 219' ' ' THR . . . -153.88 166.32 31.89 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.74 138.93 39.05 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.89 2.394 . . . . 0.0 112.071 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.7 tp -160.25 -24.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.691 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -173.08 129.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 79.6 t80 53.32 77.98 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.554 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -126.94 123.79 4.78 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.06 48.47 1.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.479 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.522 ' O ' ' C ' ' A' ' 229' ' ' GLY . 7.7 p30 -100.01 111.6 23.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.53 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 228' ' ' ASP . . . -28.58 -68.04 0.08 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -168.51 76.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.19 109.41 19.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.614 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 32.1 mt 60.99 128.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 3.1 mp -134.05 70.38 74.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.387 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.16 135.01 11.91 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.968 2.446 . . . . 0.0 112.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -115.06 58.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.417 ' C ' ' CD1' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -120.21 177.84 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.658 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 236' ' ' ASP . 45.9 m-85 -143.18 -3.66 0.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.428 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.62 -32.86 73.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.494 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -58.91 -36.96 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.809 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 240' ' ' LEU . 0.7 OUTLIER -58.47 -46.15 87.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.409 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -63.29 -35.58 80.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -66.26 -45.25 81.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.499 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.572 HG13 HD11 ' A' ' 215' ' ' ILE . 57.9 t -62.79 -39.88 86.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -56.3 -41.91 76.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.34 -50.51 73.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.35 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 218' ' ' VAL . 20.0 mtmt -69.83 -32.41 70.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.595 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.479 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -64.45 -31.07 72.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.828 -179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.05 -26.25 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.401 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -106.01 3.78 28.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.247 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.689 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.7 m -75.41 -27.59 0.7 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.6 Cg_exo -53.58 -14.21 4.75 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.466 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 251' ' ' PRO . 40.2 t0 -39.88 -23.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -115.41 -148.82 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.76 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.464 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 12.5 ttm180 -109.61 139.39 44.68 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.9 t -118.83 132.15 69.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.894 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 95.5 m -123.4 125.77 45.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.1 mt -113.81 120.25 63.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.874 0.369 . . . . 0.0 110.493 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.49 149.51 27.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -124.87 123.79 5.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.461 ' O ' HG23 ' A' ' 261' ' ' THR . 74.4 m-85 -100.6 133.93 44.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.905 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -165.7 165.19 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.362 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 -158.85 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.4 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 302' ' ' SER . 2.7 t-20 -176.34 129.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 264' ' ' THR . 35.9 m -150.6 -15.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.527 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 266' ' ' SER . . . 82.04 105.44 0.4 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 265' ' ' GLY . 14.2 t 80.38 -67.44 0.13 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.574 0.702 . . . . 0.0 110.963 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -64.35 -30.09 71.14 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.429 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -96.73 -50.7 1.77 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 269' ' ' ILE . 2.2 tt 38.51 17.78 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.353 0.597 . . . . 0.0 110.843 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.676 ' ND2' ' NH1' ' A' ' 315' ' ' ARG . 11.3 m120 -69.82 -34.45 73.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.912 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.552 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 0.7 OUTLIER -57.43 -51.82 78.89 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 12.4 Cg_endo -59.87 -41.91 49.89 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.947 1.765 . . . . 0.0 112.508 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.474 ' C ' HH22 ' A' ' 319' ' ' ARG . 5.4 tp -68.8 -37.97 79.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.522 ' N ' HH22 ' A' ' 319' ' ' ARG . 1.4 p -64.86 -40.18 94.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.9 -51.99 48.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.7 -34.59 78.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.531 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -60.51 -41.77 95.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.47 91.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.742 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -57.26 -40.21 77.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.596 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 11.1 mm -61.05 -40.68 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.589 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.45 -45.99 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.739 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -61.93 -43.14 99.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.49 -39.4 87.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -69.13 -52.09 31.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.65 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 285' ' ' LEU . 57.2 mt -59.6 -45.46 91.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.543 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 282' ' ' ALA . 59.4 t -58.95 -36.36 61.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.194 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.8 -25.13 68.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -84.16 -2.43 56.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.296 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 105.47 12.6 26.4 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 90.4 t -77.34 118.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 110.467 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -61.72 109.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -78.79 1.81 71.6 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.41 -15.84 59.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.409 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.41 5.98 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 292' ' ' GLY . 10.4 tt -91.07 133.83 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 0.0 110.859 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -130.0 135.98 48.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.271 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.41 134.05 51.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.914 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 122.13 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -96.71 106.67 3.39 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.789 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.0 OUTLIER -103.49 89.39 3.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.658 ' O ' ' OG ' ' A' ' 302' ' ' SER . . . -91.5 167.82 31.49 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.658 ' OG ' ' O ' ' A' ' 301' ' ' GLY . 89.7 p 69.64 -43.71 0.53 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.312 0.577 . . . . 0.0 110.963 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 304' ' ' ASN . 27.4 m -64.37 166.32 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.468 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 303' ' ' VAL . 10.3 m120 30.18 60.91 0.94 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.526 ' O ' ' C ' ' A' ' 306' ' ' ILE . 37.5 Cg_endo -69.72 67.16 1.73 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.784 2.323 . . . . 0.0 112.272 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 305' ' ' PRO . 6.4 mm -30.92 -66.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.391 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -119.7 160.4 22.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.33 160.27 30.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -100.81 108.55 20.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.206 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -163.84 -40.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.59 161.32 28.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.69 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -50.23 -33.04 34.82 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.523 2.149 . . . . 0.0 112.08 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -68.51 -31.87 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.748 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.73 -44.64 97.63 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.676 ' NH1' ' ND2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -63.44 -45.8 89.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.779 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.791 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -62.78 -40.43 97.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.74 HD22 ' N ' ' A' ' 319' ' ' ARG . 0.4 OUTLIER -83.79 -25.11 30.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.906 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.74 ' N ' HD22 ' A' ' 318' ' ' ASN . 0.7 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.342 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.506 ' NE ' ' O ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -137.22 157.77 45.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 111.048 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 15.9 t -144.87 152.58 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.73 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -145.97 142.95 29.17 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.507 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 16.1 mt -119.03 120.67 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.13 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 256' ' ' THR . 2.7 m -127.76 131.52 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.4 p -120.37 136.1 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.478 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.551 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 1.8 m-20 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.535 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 0.0 110.478 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.73 67.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -45.53 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.328 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 131' ' ' ARG . 24.2 p -129.3 138.27 51.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.24 159.29 15.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.483 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.6 p -97.18 159.67 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.745 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.45 115.77 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.637 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.96 144.09 49.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.81 125.94 43.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.669 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -133.43 115.49 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.347 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 m -137.26 127.37 26.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.986 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.519 ' NH2' HD21 ' A' ' 110' ' ' LEU . 7.9 mtt85 -114.91 126.46 54.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.302 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 p -134.23 116.71 15.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.54 ' H ' ' CG ' ' A' ' 150' ' ' ASP . . . 71.73 -137.14 25.29 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -95.22 15.68 18.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.842 0.353 . . . . 0.0 110.497 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.2 m -121.61 125.76 47.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.8 m -107.36 118.28 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.38 127.72 45.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.611 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 94' ' ' ILE . 14.0 tp -133.15 120.41 21.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.284 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -134.13 129.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.614 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 173.5 -156.21 23.74 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 154.1 41.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 20.9 m-85 -138.67 146.59 51.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.428 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.535 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 24.9 Cg_endo -64.48 -25.47 63.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.676 2.251 . . . . 0.0 112.144 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 98' ' ' PRO . 35.5 m-20 -155.76 119.82 4.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.611 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -45.23 -21.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.43 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ASP . . . -60.41 -36.82 79.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.64 81.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -36.88 85.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.14 -38.52 79.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.351 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.37 90.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.28 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.54 -43.22 85.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -26.42 61.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -60.56 -42.81 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.799 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.09 67.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.469 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD21 ' NH2' ' A' ' 86' ' ' ARG . 3.7 mt -79.74 -21.15 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.61 -30.38 8.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.694 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.56 61.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.9 tt -88.04 -47.53 8.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.835 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 mt -21.2 116.52 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.157 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -142.98 -178.27 0.77 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.35 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 71.7 Cg_endo -89.01 153.58 5.8 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.127 2.552 . . . . 0.0 112.594 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.86 -10.04 21.06 Favored Glycine 0 C--O 1.24 0.483 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 115' ' ' ALA . 3.2 m -92.86 130.28 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.01 -0.7 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.476 HD22 ' N ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -92.26 130.47 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.524 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.476 ' N ' HD22 ' A' ' 119' ' ' ASN . 0.8 OUTLIER -102.3 129.06 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.425 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.0 mm -130.16 110.12 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.31 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.0 78.78 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.059 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -85.94 75.98 9.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 93' ' ' LEU . 3.9 mt -104.9 130.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.736 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.01 146.47 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.054 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 126' ' ' VAL . 2.3 p -99.76 111.74 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.813 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.621 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -137.54 102.94 8.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.351 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -59.71 26.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.391 2.061 . . . . 0.0 112.183 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.621 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.3 t -124.46 -4.63 6.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.902 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 171.41 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.948 0.404 . . . . 0.0 110.735 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 78' ' ' SER . 6.2 mmt-85 -117.82 159.27 23.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.678 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -125.22 155.23 40.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.704 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.826 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.4 tp -86.91 134.98 33.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.61 132.41 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.734 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -117.68 27.31 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.302 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.477 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.1 m -32.65 -47.2 0.16 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.171 0.51 . . . . 0.0 110.978 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -100.22 -91.49 0.3 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.802 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 137' ' ' SER . . . 69.99 -43.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.694 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.616 ' O ' HG23 ' A' ' 143' ' ' THR . 2.8 mm-40 -51.75 -58.86 9.52 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.958 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 20.6 Cg_endo -64.28 -35.13 52.95 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.514 2.143 . . . . 0.0 112.143 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 182' ' ' THR . 20.9 t -69.92 -48.27 64.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.84 -42.8 94.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.754 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 139' ' ' GLU . 63.0 p -65.97 -33.98 77.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.72 -22.03 59.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 p -111.99 5.54 18.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -63.86 -42.68 72.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.245 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 26.3 Cg_exo -57.92 -10.98 8.67 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.592 2.195 . . . . 0.0 111.756 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 147' ' ' PRO . 11.6 mm -125.03 89.7 52.23 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.63 16.36 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.666 2.244 . . . . 0.0 112.059 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 6.3 m-20 -132.4 61.66 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.616 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 2.7 p90 -125.55 143.17 51.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.479 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.54 142.2 15.61 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.6 tp -141.93 127.22 18.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -125.16 128.8 48.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.024 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.28 127.48 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 111.132 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 157' ' ' ARG . 2.2 tt0 -110.45 176.16 5.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.12 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 156' ' ' GLU . 25.6 mtt180 -32.26 -43.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.633 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 30.55 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.909 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.5 m -135.82 130.38 33.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.632 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.7 p -117.49 127.2 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 m -131.14 127.22 37.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.423 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.029 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -117.19 121.31 40.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.722 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.9 m -122.76 147.15 46.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.522 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.856 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 153.97 158.47 8.64 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.6 p -96.47 135.3 38.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.05 142.22 26.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.402 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.62 -39.19 3.72 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.687 2.258 . . . . 0.0 112.272 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 44.5 t -123.61 137.66 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.638 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -33.17 75.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -59.01 -48.56 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -58.35 -40.84 83.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.353 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.409 ' HZ1' ' HZ3' ' A' ' 176' ' ' LYS . 8.5 tttm -62.89 -36.18 82.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.6 t70 -63.93 -38.64 91.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.64 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.32 -37.38 71.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.93 -51.3 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.002 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 177' ' ' ARG . 1.5 ptpt -63.52 -36.73 84.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.799 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.481 ' N ' ' HG3' ' A' ' 176' ' ' LYS . 9.3 ttm180 -59.76 -53.99 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.723 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.576 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -66.8 -33.05 74.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.3 -39.98 77.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.693 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -38.59 91.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.716 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 p -70.88 -36.32 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.2 OUTLIER -66.48 -68.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.845 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.826 ' CE2' HD21 ' A' ' 133' ' ' LEU . 8.5 m-90 -114.8 90.44 22.37 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.094 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 186' ' ' MET . 72.4 Cg_endo -83.53 22.52 0.91 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 123.017 2.478 . . . . 0.0 111.671 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 186' ' ' MET . 54.2 m-20 -36.56 -20.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.671 ' N ' ' O ' ' A' ' 184' ' ' PRO . 5.4 tpt 91.1 -39.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.564 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.12 53.53 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.44 119.08 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.541 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -108.93 129.68 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.47 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -104.41 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -125.13 59.14 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.291 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 164' ' ' GLY . 21.6 mt -113.39 129.16 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -121.99 139.63 53.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.232 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -88.28 129.42 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.788 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.8 p -76.85 45.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.485 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.31 35.42 65.49 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 140.69 47.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.754 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.592 ' HB2' ' HA ' ' A' ' 205' ' ' SER . . . 56.73 88.27 0.13 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 201' ' ' GLY . 39.3 Cg_exo -52.5 148.58 26.29 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.689 2.259 . . . . 0.0 111.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -39.11 83.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.783 2.322 . . . . 0.0 112.111 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 156.45 -89.35 0.12 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -39.45 98.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.842 2.361 . . . . 0.0 112.123 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.64 52.69 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 123.112 2.541 . . . . 0.0 112.26 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.635 ' O ' ' CB ' ' A' ' 205' ' ' SER . . . -132.84 -27.61 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.972 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 204' ' ' ALA . 0.9 OUTLIER 90.44 120.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -114.91 93.85 0.65 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.619 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.19 -91.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.801 2.334 . . . . 0.0 111.838 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 250' ' ' CYS . 0.0 OUTLIER -118.14 17.07 14.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 211' ' ' LEU . . . -65.32 134.37 53.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.822 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' A' ' 210' ' ' ASP . 0.0 OUTLIER 39.03 16.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.784 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -56.25 -30.85 62.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.077 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -38.2 66.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.402 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -65.73 -42.48 90.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.521 0.677 . . . . 0.0 110.984 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 211' ' ' LEU . . . -74.05 -34.83 64.21 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.272 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 9.9 mt -59.37 -39.12 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.91 -38.52 82.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.29 63.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 13.5 t -58.6 -34.9 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.354 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 221' ' ' GLY . 3.5 t -105.54 -30.38 9.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.95 -37.93 2.66 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.42 ' H ' HG23 ' A' ' 219' ' ' THR . . . -169.21 -170.04 33.3 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 143.06 30.5 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.794 2.329 . . . . 0.0 111.976 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 1.09 ' H ' HD12 ' A' ' 223' ' ' ILE . 3.1 mp -59.34 104.22 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.64 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -140.16 -52.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.509 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 17.6 p90 -174.71 117.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -88.75 143.02 17.41 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.612 ' CG ' ' H ' ' A' ' 228' ' ' ASP . 25.6 p-10 -127.36 -124.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.749 0.309 . . . . 0.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.612 ' H ' ' CG ' ' A' ' 227' ' ' ASN . 1.1 m-20 79.68 112.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.558 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 99.64 -58.79 0.8 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -146.4 -142.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 0.0 110.639 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 232' ' ' LEU . 32.7 t -149.15 -25.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 231' ' ' SER . 5.4 mt -31.31 119.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 233' ' ' ILE . 3.2 mm 39.46 83.87 0.19 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 235' ' ' ALA . 52.6 Cg_exo -50.63 -178.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.803 2.336 . . . . 0.0 111.941 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 234' ' ' PRO . . . 70.06 150.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.623 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 235' ' ' ALA . 1.3 m-20 -148.15 178.14 8.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.539 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -125.67 -16.25 5.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.566 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.44 -39.52 88.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.301 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 58.8 mt -68.89 -36.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.389 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 240' ' ' LEU . 2.8 mm? -59.73 -32.74 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.595 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -56.1 -43.08 77.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -45.92 79.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.8 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.6 t -68.6 -45.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.41 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -57.11 -45.25 83.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.838 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.35 -50.64 70.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -31.7 71.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.115 0.483 . . . . 0.0 109.757 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -55.07 -30.19 59.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.49 11.28 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.734 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 251' ' ' PRO . . . -104.36 -2.92 24.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.078 0.466 . . . . 0.0 110.469 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.6 m -74.85 -27.17 0.7 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 51.4 Cg_exo -51.91 -13.83 2.02 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.728 1.618 . . . . 0.0 111.857 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.36 -14.65 63.11 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -126.9 -166.29 1.57 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -113.43 138.7 49.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 255' ' ' VAL . 11.6 p -119.36 133.13 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.944 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.2 m -117.34 118.85 33.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.051 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.568 HG12 HG23 ' A' ' 323' ' ' ILE . 65.6 mt -101.62 120.2 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.854 0.359 . . . . 0.0 110.629 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -100.21 134.93 42.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.582 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -105.97 125.63 8.26 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -109.18 112.51 24.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 110.752 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.451 ' CG2' ' OD1' ' A' ' 270' ' ' ASN . 8.8 t -116.67 -158.49 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.251 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.432 ' N ' ' OG1' ' A' ' 261' ' ' THR . 1.0 OUTLIER -122.81 -151.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -119.7 28.46 8.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 265' ' ' GLY . 3.3 m -58.68 -68.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 264' ' ' THR . . . -91.65 147.96 19.03 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 270' ' ' ASN . 47.0 t -44.07 161.72 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.649 0.261 . . . . 0.0 110.945 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.15 -36.46 63.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.87 0.366 . . . . 0.0 110.417 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -68.94 -5.99 49.82 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.63 -24.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.639 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.451 ' OD1' ' CG2' ' A' ' 261' ' ' THR . 0.6 OUTLIER -68.3 -44.25 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.566 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.2 mm -59.96 -51.94 77.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.4 Cg_endo -61.67 -33.25 86.64 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.111 1.874 . . . . 0.0 112.106 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 tp -68.31 -42.61 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.423 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 p -74.33 -37.8 63.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.555 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.88 -34.72 69.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.635 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.13 -35.8 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 41.7 mtt-85 -63.05 -47.11 84.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.91 70.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.393 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -55.82 -39.1 70.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.469 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 280' ' ' ILE . 1.7 mp -66.8 -43.62 89.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.328 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.73 -38.19 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -60.39 -41.21 93.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.644 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.96 -37.25 86.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.514 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -52.33 57.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 290' ' ' VAL . 4.5 mp -60.49 -48.94 79.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 282' ' ' ALA . 91.7 t -56.36 -39.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.187 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -66.7 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.196 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.432 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -83.83 0.4 47.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.865 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 99.7 12.05 42.01 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 285' ' ' LEU . 21.2 t -81.45 133.93 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.563 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -71.74 102.8 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -66.22 1.51 4.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.93 1.71 48.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.602 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -133.4 6.99 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.2 mt -96.57 133.84 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.327 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.53 147.04 50.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.674 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 128.31 40.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.422 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.84 140.23 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.722 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -105.38 112.44 3.99 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 299' ' ' GLY . 11.4 mt -46.27 -96.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.616 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 302' ' ' SER . . . 132.05 82.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 301' ' ' GLY . 47.0 t 30.21 68.76 0.09 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.017 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.67 -82.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.704 0.288 . . . . 0.0 110.263 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 306' ' ' ILE . 0.7 OUTLIER -178.45 -51.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.918 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 32.1 Cg_exo -57.34 16.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.58 2.187 . . . . 0.0 112.346 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.641 ' H ' ' C ' ' A' ' 304' ' ' ASN . 14.4 pt -77.34 178.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.309 . . . . 0.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.74 171.91 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.726 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 14.5 m -81.18 152.88 27.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.41 31.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.86 -35.13 69.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.631 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.63 154.38 79.65 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.01 -34.2 97.17 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.89 2.393 . . . . 0.0 111.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.433 ' CG ' ' N ' ' A' ' 314' ' ' GLY . 7.8 pt-20 -65.24 -36.66 84.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.287 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 313' ' ' GLU . . . -59.82 -39.23 95.13 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.528 ' O ' ' OD1' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -65.57 -44.64 86.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.42 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.426 ' HA ' ' NH2' ' A' ' 319' ' ' ARG . . . -55.45 -40.33 71.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.384 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -65.52 -29.95 70.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.546 ' C ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -76.23 -16.1 59.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.517 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.426 ' NH2' ' HA ' ' A' ' 316' ' ' ALA . 52.9 mtm180 -94.6 95.73 8.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -132.11 146.63 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.261 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 73.4 t -131.26 147.92 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.68 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.88 136.82 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.582 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.568 HG23 HG12 ' A' ' 257' ' ' ILE . 3.7 mt -130.19 117.9 41.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.62 131.64 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 250' ' ' CYS . 2.3 p -109.69 135.36 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.555 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.549 ' O ' ' OD1' ' A' ' 326' ' ' ASN . 19.2 t-20 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.612 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.724 0.297 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -166.83 83.2 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.629 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -8.01 14.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.343 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.655 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -163.81 144.68 8.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 78' ' ' SER . 5.8 mt -129.28 159.34 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.795 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.7 p -86.71 167.36 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 123.98 21.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.97 118.04 15.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.272 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 p -127.83 129.25 46.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 153' ' ' LEU . 1.4 pt -134.53 132.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.472 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -124.81 126.85 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.524 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 151' ' ' PHE . 28.5 ttm180 -113.4 131.2 56.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.641 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 90' ' ' THR . 41.2 t -142.8 112.5 6.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.12 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 27.08 106.04 0.0 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.14 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 48.7 1.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.619 ' H ' ' C ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -106.99 124.91 50.31 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.476 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.86 125.64 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.559 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 78.2 m -123.12 118.59 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.391 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.5 tt -119.77 127.25 52.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.766 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.9 mt -135.32 128.19 48.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.475 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.56 -161.15 33.38 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.76 146.04 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 110.579 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.587 ' CD2' ' OG ' ' A' ' 132' ' ' SER . 11.4 m-85 -125.32 156.01 70.67 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.356 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.5 -20.76 15.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.779 2.319 . . . . 0.0 112.945 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 100' ' ' GLU . 18.2 t0 -156.45 157.75 36.06 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.222 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -76.25 -26.99 56.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.062 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.06 79.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.55 -37.08 86.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.203 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -57.07 -36.7 70.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.59 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.59 -40.42 68.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.98 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -41.34 76.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.301 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 39.3 mtp -58.58 -33.4 69.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.457 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -35.17 76.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.48 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.8 mt -78.36 -20.61 50.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -46.83 -23.02 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.93 -22.43 55.31 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' LEU . 14.6 tp -98.28 -44.58 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.77 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -24.38 101.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -140.51 156.29 69.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.621 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 118' ' ' VAL . 17.8 Cg_endo -61.91 -79.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.884 2.389 . . . . 0.0 112.217 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -43.9 -10.35 0.01 OUTLIER Glycine 0 N--CA 1.46 0.246 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 116' ' ' PRO . 38.4 t -102.37 120.8 52.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 O-C-N 122.238 -0.566 . . . . 0.0 110.623 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.35 118.7 31.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -118.73 125.95 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.435 ' C ' ' OD1' ' A' ' 122' ' ' ASP . 13.5 pt -123.71 138.22 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.125 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -126.78 90.94 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.296 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.55 68.81 9.69 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.69 119.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.871 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -91.48 145.99 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.02 112.27 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.925 0.393 . . . . 0.0 110.875 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.74 125.35 22.19 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.15 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.409 ' C ' HG23 ' A' ' 129' ' ' VAL . 55.9 Cg_endo -73.49 49.27 1.73 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.298 1.999 . . . . 0.0 112.171 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.409 HG23 ' C ' ' A' ' 128' ' ' PRO . 78.4 t -154.1 -35.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.23 153.6 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -110.08 159.54 17.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.344 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.587 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 1.4 m -120.78 150.55 40.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 183' ' ' TRP . 29.8 tp -83.24 129.82 35.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.419 ' N ' HD12 ' A' ' 133' ' ' LEU . 19.7 m-20 -53.3 147.35 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.8 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -125.21 11.75 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.151 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 97.4 p -39.63 -25.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -140.63 31.05 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.809 -179.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.83 24.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.3 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 0.4 OUTLIER -51.59 -58.95 9.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.971 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 17.9 Cg_endo -63.39 -31.63 72.51 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.396 2.064 . . . . 0.0 112.042 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.6 t -64.75 -47.74 87.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.581 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 m-85 -63.75 -37.47 87.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 12.4 p -68.08 -33.15 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.0 -27.41 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -100.54 0.45 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.002 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.729 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -70.76 -36.16 5.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.729 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 16.4 Cg_exo -64.04 18.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.945 2.43 . . . . 0.0 112.208 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.55 ' C ' ' H ' ' A' ' 150' ' ' ASP . 60.2 mt -139.73 86.65 13.57 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.19 2.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.836 2.357 . . . . 0.0 112.008 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.2 p-10 -130.26 70.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.453 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.416 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 2.3 t80 -127.71 140.66 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.697 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.87 133.67 7.16 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.615 ' HB2' HD11 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -123.48 131.65 53.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.796 0.331 . . . . 0.0 110.714 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.45 124.76 45.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.374 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.9 124.34 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.514 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -136.03 93.79 2.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.504 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 3.5 mtp180 58.79 -93.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.42 15.38 16.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.842 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.1 m -114.15 125.27 53.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 t -132.19 117.21 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.556 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.648 ' CG2' HD22 ' A' ' 191' ' ' ASN . 9.0 m -134.32 135.78 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.41 124.25 46.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.507 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.55 149.12 45.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 154.7 160.07 9.64 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.532 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 95.9 m -91.28 139.27 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.87 108.48 42.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.12 -27.28 1.78 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.416 2.077 . . . . 0.0 112.147 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -130.05 131.81 45.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -34.35 77.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -36.04 75.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.809 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.439 ' HD1' ' HA ' ' A' ' 171' ' ' HIS . 2.2 m-70 -63.67 -35.94 82.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.618 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -46.22 91.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.38 -44.43 95.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.89 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.38 86.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.75 -41.19 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.314 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -58.72 -52.13 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.115 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.0 ttt85 -57.17 -40.47 77.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -65.65 -36.43 83.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.52 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.21 69.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.501 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 16.3 m -60.58 -41.0 93.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.466 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.5 t -67.73 -29.16 68.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 2.6 m -68.38 -66.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.491 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.566 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.3 m-90 -118.42 67.24 6.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.693 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.67 1.93 3.94 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.627 2.218 . . . . 0.0 111.829 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.77 60.71 0.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.54 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.3 ttt -171.84 -163.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.514 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 104.98 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 43.9 mt -103.93 127.75 57.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.488 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.565 ' HB ' HG23 ' A' ' 161' ' ' THR . 59.6 t -126.49 121.14 58.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.428 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 190' ' ' ASN . 0.9 OUTLIER -97.58 116.95 30.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.742 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.648 HD22 ' CG2' ' A' ' 161' ' ' THR . 12.4 m-80 -117.29 48.53 1.32 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.219 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 12.5 mt -99.15 125.78 52.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.12 142.96 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.3 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.73 107.01 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.964 0.412 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 p -119.38 -7.51 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -110.44 -18.03 8.87 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 198' ' ' ALA . 0.8 OUTLIER -76.92 131.76 38.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . . . 164.23 -51.75 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.078 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 198' ' ' ALA . 16.6 Cg_exo -54.06 -43.14 60.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.456 2.104 . . . . 0.0 112.512 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' A' ' 198' ' ' ALA . 86.6 Cg_endo -87.02 -91.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.671 2.247 . . . . 0.0 112.29 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 125.94 -68.04 0.52 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -50.58 154.27 6.68 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.813 2.342 . . . . 0.0 112.065 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.13 73.41 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.735 2.29 . . . . 0.0 112.088 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 205' ' ' SER . . . -176.77 101.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 204' ' ' ALA . 1.0 OUTLIER -35.77 131.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.441 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 207' ' ' PRO . . . -147.4 106.77 0.37 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 209' ' ' ALA . 51.6 Cg_exo -50.62 -139.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.689 ' SG ' ' O ' ' A' ' 246' ' ' LYS . 1.3 m -38.02 -21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.622 ' N ' ' O ' ' A' ' 207' ' ' PRO . . . 53.79 125.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 2.7 m-20 33.46 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.757 HD23 ' N ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -56.24 -46.05 79.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.123 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.458 ' C ' ' CD ' ' A' ' 212' ' ' GLN . 10.2 tp60 -72.73 -50.38 25.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.821 0.343 . . . . 0.0 111.249 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -71.17 -44.42 65.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.601 0.36 . . . . 0.0 110.948 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 210' ' ' ASP . . . -71.33 -45.27 63.38 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.028 -0.42 . . . . 0.0 111.943 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 211' ' ' LEU . 1.7 tp -69.48 -36.62 72.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.942 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 216' ' ' ASN . 0.7 OUTLIER -69.92 -43.96 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.662 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.81 95.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.703 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 214' ' ' ALA . 54.7 t -62.8 -50.15 80.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 221' ' ' GLY . 57.4 p -69.29 -22.22 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.585 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 74.5 -40.18 1.1 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -168.56 174.76 43.27 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.35 141.68 94.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.834 2.356 . . . . 0.0 111.986 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 27.3 mt -65.16 108.19 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.631 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -178.1 66.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -108.79 97.23 6.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.475 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -78.8 -83.01 0.64 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -178.24 4.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 110.711 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -59.94 -151.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.609 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 147.1 -106.22 0.35 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.539 ' O ' ' C ' ' A' ' 231' ' ' SER . . . -112.64 -40.17 4.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.31 . . . . 0.0 110.587 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 230' ' ' ALA . 0.1 OUTLIER -27.7 106.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.596 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 230' ' ' ALA . 5.9 mp -65.0 124.95 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.613 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 234' ' ' PRO . 20.6 mt 42.59 79.93 0.31 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.532 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 233' ' ' ILE . 52.7 Cg_exo -48.33 -172.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.866 2.377 . . . . 0.0 112.11 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 46.81 93.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' GLU . 14.0 t0 -178.73 90.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.701 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.564 ' O ' ' OD1' ' A' ' 241' ' ' ASN . 0.2 OUTLIER -68.19 19.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.324 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' ASP . 2.2 mt-10 -67.61 -46.04 73.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.809 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 239' ' ' ILE . 24.5 mt -59.49 -38.06 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 77.6 mt -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 237' ' ' TYR . 11.1 m120 -55.82 -49.03 74.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.903 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -65.03 -45.78 84.03 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.724 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.427 HG22 HG11 ' A' ' 218' ' ' VAL . 89.7 t -64.04 -48.42 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.31 82.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -50.71 70.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.689 ' O ' ' SG ' ' A' ' 208' ' ' CYS . 6.0 mtpm? -69.18 -33.41 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.981 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.476 ' O ' ' HD3' ' A' ' 251' ' ' PRO . 0.9 OUTLIER -54.81 -31.29 58.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.594 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -62.5 -16.88 58.08 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.22 22.27 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.34 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.691 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 57.8 m -74.98 -28.63 0.81 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.3 Cg_exo -53.63 -14.23 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.327 2.018 . . . . 0.0 112.646 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -52.36 -10.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.635 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -128.98 -157.87 0.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.217 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -100.23 139.1 36.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 50.7 t -119.41 132.95 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.112 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.536 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.2 m -121.23 119.43 32.26 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 257' ' ' ILE . 36.4 mt -106.17 121.02 58.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.79 0.328 . . . . 0.0 110.786 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.68 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -109.45 125.1 52.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.498 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -112.4 166.21 12.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 261' ' ' THR . 1.2 t80 -172.99 109.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.744 HG23 ' N ' ' A' ' 262' ' ' ASP . 1.3 t -105.08 -162.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.714 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 261' ' ' THR . 12.6 p-10 -89.75 174.69 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.605 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 265' ' ' GLY . 2.4 m-20 -96.6 -86.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.493 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 54.2 m 61.09 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.458 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -63.52 -125.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 89.6 p -129.34 170.92 13.04 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 120.732 0.301 . . . . 0.0 110.998 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -59.74 -19.8 52.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.611 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -76.88 -35.17 40.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 2.9 mm -90.51 -21.87 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.834 0.35 . . . . 0.0 110.375 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -68.64 -33.12 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.46 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.555 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.7 mm -68.26 -52.49 21.7 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 19.8 Cg_endo -61.7 -35.59 79.28 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.085 1.856 . . . . 0.0 112.292 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.0 mm? -68.26 -47.25 68.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.5 p -73.3 -35.19 66.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.809 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.54 -38.49 71.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.32 -43.79 98.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.658 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.402 ' CD ' ' HE ' ' A' ' 319' ' ' ARG . 13.6 ttp85 -60.15 -39.76 87.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.608 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.34 -31.21 70.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -73.57 -37.5 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.792 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.81 -46.52 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 282' ' ' ALA . 28.1 m -63.69 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.15 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -63.58 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.123 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -30.83 65.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.295 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -46.69 51.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.712 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 290' ' ' VAL . 9.7 mt -59.91 -49.25 78.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.15 -36.21 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.76 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.28 -2.33 58.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.419 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.4 2.67 38.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 285' ' ' LEU . 22.0 t -68.74 131.91 33.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.83 0.348 . . . . 0.0 110.349 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.77 97.66 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.596 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -77.46 12.86 12.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.14 -16.29 38.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 0.0 110.615 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -121.31 27.68 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.328 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 295' ' ' ILE . 35.4 mt -117.75 124.85 73.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.3 135.5 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 124.44 48.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.734 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.99 116.47 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.152 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.8 105.37 2.94 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.679 ' O ' ' N ' ' A' ' 302' ' ' SER . 27.5 mt -74.29 0.07 15.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.781 0.324 . . . . 0.0 110.42 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.5 -72.18 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 300' ' ' LEU . 89.4 p -174.73 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 120.352 0.12 . . . . 0.0 110.955 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 304' ' ' ASN . 66.2 t -41.89 -84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.816 0.341 . . . . 0.0 110.62 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.63 ' N ' ' CD ' ' A' ' 305' ' ' PRO . 0.1 OUTLIER -86.38 -39.58 0.56 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.14 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 60.4 Cg_endo -82.53 143.64 12.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.667 2.245 . . . . 0.0 112.465 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.24 137.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.92 163.04 30.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 158.72 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.635 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 0.1 OUTLIER -122.07 49.95 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -106.78 -40.06 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.852 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.91 157.99 67.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -50.04 -30.11 23.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.609 2.206 . . . . 0.0 112.056 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.09 -40.54 89.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.452 ' O ' ' ND2' ' A' ' 318' ' ' ASN . . . -67.99 -44.13 79.39 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.429 ' HA ' HD22 ' A' ' 318' ' ' ASN . 27.1 mtt-85 -66.08 -46.15 78.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.267 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.76 80.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.316 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -72.7 -24.38 60.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.567 ' O ' ' O ' ' A' ' 260' ' ' TYR . 65.5 m-20 -72.8 -24.27 60.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.704 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 277' ' ' ARG . 12.7 ttt-85 -91.72 101.68 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.23 139.52 39.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.759 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.32 155.11 31.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.04 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 323' ' ' ILE . 2.7 tp10 -145.09 143.17 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.43 . . . . 0.0 111.018 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.402 ' N ' ' HG3' ' A' ' 322' ' ' GLU . 17.8 mt -125.89 112.7 31.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.054 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.5 m -122.03 130.94 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.169 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 253' ' ' ALA . 0.2 OUTLIER -115.51 135.05 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.635 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 41.5 t30 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.703 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.49 59.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.457 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.2 -15.4 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 p -92.08 114.89 27.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.113 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 157' ' ' ARG . 2.5 mt -121.35 159.65 25.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.2 m -81.31 178.91 8.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.245 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.834 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.7 pp -83.1 132.71 35.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.662 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.632 HD23 HD11 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -131.95 138.33 48.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.7 ' O ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -124.09 123.08 39.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.717 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 83' ' ' SER . 0.9 OUTLIER -129.41 115.72 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.394 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -136.5 130.36 32.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' C ' ' O ' ' A' ' 149' ' ' PRO . 42.1 mtt85 -112.22 140.15 47.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.8 p -142.89 114.82 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.623 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 56.66 -161.09 7.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.72 7.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 110.49 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 88' ' ' GLY . 99.7 m -107.58 130.93 54.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.35 116.93 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.3 m -103.25 121.38 42.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.582 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -123.05 127.62 49.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 123' ' ' GLN . 1.7 mt -139.31 123.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.386 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.517 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . 178.36 -161.39 28.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -137.33 156.36 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.624 0.249 . . . . 0.0 110.447 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -133.28 150.88 76.5 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.369 . . . . 0.0 110.569 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.6 -19.66 31.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.772 2.315 . . . . 0.0 112.132 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.8 173.36 10.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.569 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -82.05 -34.8 29.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.705 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.89 85.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.9 78.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -36.75 67.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.717 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -37.5 64.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.536 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -60.56 -38.07 83.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.462 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.28 -43.98 69.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.016 0.436 . . . . 0.0 110.3 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.0 mtp -58.0 -26.31 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.531 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -43.97 96.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.79 -21.95 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.415 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.8 mt -99.64 -1.43 38.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -47.79 -34.39 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 -32.13 29.98 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.38 -34.91 69.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.765 0.317 . . . . 0.0 110.595 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mt -39.28 116.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.506 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -159.14 155.15 23.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.354 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.672 ' O ' ' N ' ' A' ' 118' ' ' VAL . 26.7 Cg_endo -65.11 -83.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.753 2.302 . . . . 0.0 112.108 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -41.86 -11.71 0.01 OUTLIER Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.672 ' N ' ' O ' ' A' ' 116' ' ' PRO . 27.8 t -92.38 137.51 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 122.416 -0.461 . . . . 0.0 110.743 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -100.44 134.9 42.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.236 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.46 114.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.998 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -124.74 122.59 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.792 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 121' ' ' ILE . 49.5 m-20 -133.56 86.85 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.007 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 93' ' ' LEU . 11.6 mm100 -83.84 55.39 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.033 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.1 128.44 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.47 143.29 26.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.59 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.32 112.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.5 134.6 19.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.69 33.06 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.18 -51.38 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 96' ' ' ASP . 35.3 m -56.14 150.03 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.632 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -104.03 159.04 16.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.406 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.08 151.16 41.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 183' ' ' TRP . 11.4 tp -80.99 133.12 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.656 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.68 133.42 56.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 105' ' ' ALA . 26.5 p90 -102.35 -22.87 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.584 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 135' ' ' PHE . 75.2 m -34.17 -61.8 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.516 0.674 . . . . 0.0 110.988 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.18 20.76 9.8 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.747 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.763 ' HB3' ' HA ' ' A' ' 135' ' ' PHE . . . -124.4 -9.78 7.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.3 OUTLIER -56.86 -43.85 99.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.803 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.2 Cg_exo -55.05 -36.49 92.9 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.39 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.478 HG23 ' OG1' ' A' ' 182' ' ' THR . 43.4 t -69.31 -43.96 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.9 m-85 -62.39 -42.72 99.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.807 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -71.34 -36.04 71.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.664 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.06 -20.42 61.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.562 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.5 p -116.34 12.08 15.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.609 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.0 OUTLIER -68.83 -43.28 27.16 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.422 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 12.2 Cg_exo -66.21 6.5 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.643 2.228 . . . . 0.0 111.901 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mm -111.91 99.99 47.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.722 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 86' ' ' ARG . 65.4 Cg_endo -79.83 -5.57 13.93 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.615 2.21 . . . . 0.0 112.187 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.416 ' OD1' HG22 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -117.52 40.49 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.517 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 4.0 t80 -127.65 137.87 52.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.631 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -142.94 160.46 27.5 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.49 138.55 24.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.756 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -106.15 128.65 54.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.438 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.2 t -112.81 138.55 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 158' ' ' ASP . 21.8 tt0 -150.39 102.83 3.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.754 ' O ' HD12 ' A' ' 79' ' ' LEU . 15.7 mtt180 49.83 -91.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 156' ' ' GLU . 4.4 p30 -121.57 33.98 5.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.92 130.75 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.338 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.4 129.88 62.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.696 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.36 146.02 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.67 105.29 12.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.668 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 p -118.04 149.72 40.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.29 175.32 14.38 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 66.7 p -100.17 119.27 38.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 110.48 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -87.09 145.79 38.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 197' ' ' GLN . 51.4 Cg_endo -72.52 -60.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.759 2.306 . . . . 0.0 111.845 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.5 t -124.47 153.87 41.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -30.89 71.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.872 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.26 -43.46 97.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.039 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -58.45 -37.08 74.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.013 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -69.09 -39.03 79.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.001 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -59.28 -47.78 84.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.877 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.68 77.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.661 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.09 -39.12 65.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -64.32 -44.31 91.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.818 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -64.95 -44.44 89.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.586 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -31.92 72.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.822 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.83 71.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.67 -47.76 83.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.7 t -70.72 -27.4 63.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.556 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 183' ' ' TRP . 0.9 OUTLIER -66.38 -60.92 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.625 ' CD1' HD21 ' A' ' 133' ' ' LEU . 21.7 m95 -120.67 85.14 38.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 111.139 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.67 ' O ' ' N ' ' A' ' 186' ' ' MET . 17.6 Cg_exo -62.35 20.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.88 2.387 . . . . 0.0 111.73 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 183' ' ' TRP . 0.8 OUTLIER -35.9 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.69 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.67 ' N ' ' O ' ' A' ' 184' ' ' PRO . 4.5 ttm 78.08 -8.47 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -120.05 80.98 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.19 136.71 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 73.1 t -126.97 121.72 58.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.468 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.861 ' H ' HD22 ' A' ' 190' ' ' ASN . 0.1 OUTLIER -87.73 125.99 34.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.57 40.44 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.466 . . . . 0.0 110.427 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.48 126.43 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -126.91 148.51 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.513 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 194' ' ' VAL . 2.3 p -97.03 110.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.716 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 195' ' ' THR . 0.0 OUTLIER -74.63 62.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.427 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . 47.43 32.68 7.61 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.576 ' O ' ' O ' ' A' ' 167' ' ' PRO . 18.4 mt-30 -113.58 156.67 23.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.694 ' HB1' ' O ' ' A' ' 201' ' ' GLY . . . -179.94 65.03 0.14 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.298 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.519 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 21.1 Cg_exo -56.15 -42.7 63.6 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.643 2.229 . . . . 0.0 112.723 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 73.1 Cg_endo -81.8 -33.99 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.373 2.049 . . . . 0.0 112.105 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.694 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -126.57 81.31 0.35 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.522 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 21.3 Cg_exo -56.32 -42.66 63.6 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.644 2.229 . . . . 0.0 112.694 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 56.7 Cg_exo -47.23 -18.61 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.204 1.936 . . . . 0.0 112.008 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.73 -56.06 4.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.55 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.82 -83.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.385 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 196' ' ' GLY . . . 83.13 151.75 11.05 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.98 -67.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.742 2.295 . . . . 0.0 112.067 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 31.1 t -110.29 35.74 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.368 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.498 ' O ' ' C ' ' A' ' 210' ' ' ASP . . . -38.65 160.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.761 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 214' ' ' ALA . 0.0 OUTLIER 33.12 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.154 0.502 . . . . 0.0 110.15 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -56.76 -42.94 80.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.065 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' A' ' 216' ' ' ASN . 12.7 pt20 -71.96 -49.74 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.191 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 72.7 m -71.08 -48.69 51.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.972 0.415 . . . . 0.0 110.952 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.808 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -62.51 -44.84 95.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.426 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 211' ' ' LEU . 3.6 tp -69.36 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.6 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 220' ' ' GLY . 3.1 m120 -67.8 -39.77 83.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.422 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.33 70.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.273 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 214' ' ' ALA . 74.3 t -58.46 -47.03 89.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.189 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 221' ' ' GLY . 68.1 p -87.83 -21.5 25.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.584 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.32 -37.57 0.21 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -160.48 179.75 35.78 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.6 154.22 9.46 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.763 2.308 . . . . 0.0 112.062 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 225' ' ' PHE . 41.2 mt -103.41 113.38 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . -96.41 15.17 22.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.651 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.485 ' H ' HG22 ' A' ' 223' ' ' ILE . 0.9 OUTLIER 34.16 85.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.523 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.409 ' C ' ' OD1' ' A' ' 227' ' ' ASN . . . -108.67 134.51 12.28 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 226' ' ' GLY . 0.4 OUTLIER -165.93 55.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.548 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -121.96 68.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -137.38 71.74 0.46 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 61.64 152.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.781 0.325 . . . . 0.0 110.477 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.97 -178.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.6 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.51 -5.31 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 16.6 pt -126.35 61.07 40.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.91 41.3 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.831 2.354 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 47.96 -147.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.772 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 236' ' ' ASP . 0.5 OUTLIER 64.77 46.65 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.56 -17.86 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.497 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -66.21 -37.72 86.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.04 -43.42 92.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 240' ' ' LEU . 10.4 tt -58.64 -32.35 68.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.374 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.25 -44.73 94.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -63.67 -41.29 98.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.87 -40.91 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.51 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.518 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.91 -45.91 85.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -56.11 -50.81 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.262 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.67 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 0.4 OUTLIER -65.01 -35.54 81.5 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.702 HD21 HD13 ' A' ' 285' ' ' LEU . 9.0 tp -55.29 -30.2 59.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.368 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 249' ' ' ALA . 8.5 ptmt -63.63 -36.13 82.8 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.407 ' N ' ' HG2' ' A' ' 248' ' ' LYS . . . -107.49 3.24 24.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.587 -0.445 . . . . 0.0 112.105 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.714 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 85.7 m -74.63 -28.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.714 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 41.1 Cg_exo -55.12 -14.37 8.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.701 2.268 . . . . 0.0 112.539 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 251' ' ' PRO . 9.0 t70 -40.89 -17.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -119.99 -153.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.082 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 2.7 ttp180 -106.83 138.06 43.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.94 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.1 131.72 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.057 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -124.13 124.28 42.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.076 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 77.9 mt -113.01 117.44 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 110.715 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' A' ' 258' ' ' ASN . 0.0 OUTLIER -107.42 131.99 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.383 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -108.07 133.19 11.52 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.578 ' O ' ' O ' ' A' ' 318' ' ' ASN . 11.8 m-85 -100.49 107.82 19.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.56 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -143.84 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.282 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 262' ' ' ASP . 36.2 t0 -145.92 -99.72 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.497 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 0.2 OUTLIER -177.96 44.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.606 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 21.0 m -45.97 -58.74 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.465 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -146.6 -92.62 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 95.0 p -125.01 179.87 4.85 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 120.976 0.417 . . . . 0.0 110.977 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 269' ' ' ILE . 2.6 mt-10 -59.18 -31.19 68.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.538 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -64.76 6.66 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.513 ' H ' ' C ' ' A' ' 267' ' ' GLU . 0.4 OUTLIER -143.56 -36.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.625 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -68.59 -46.47 69.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.436 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 272' ' ' PRO . 0.4 OUTLIER -73.46 -48.33 7.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.163 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 28.0 Cg_exo -53.53 -39.51 82.21 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.993 1.795 . . . . 0.0 111.669 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.21 -44.7 75.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.22 77.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.48 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.551 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.85 -45.18 90.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.439 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.621 ' O ' HG23 ' A' ' 281' ' ' VAL . 0.3 OUTLIER -60.14 -44.51 94.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.335 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -68.19 -45.74 72.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.367 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.27 -45.99 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.529 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 277' ' ' ARG . 57.3 t -61.39 -46.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.368 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.28 88.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.39 -32.97 69.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.546 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.6 -48.19 27.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.702 HD13 HD21 ' A' ' 247' ' ' LEU . 46.8 mt -59.45 -44.69 92.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.313 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 65.3 t -59.34 -37.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.291 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.32 -20.7 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.457 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.518 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.94 0.15 56.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 101.27 18.13 20.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 247' ' ' LEU . 98.2 t -86.1 132.79 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 110.602 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.98 104.45 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -78.63 16.74 7.58 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.0 OUTLIER -96.4 -12.2 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.703 0.287 . . . . 0.0 110.703 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.652 ' N ' ' ND1' ' A' ' 294' ' ' HIS . 0.2 OUTLIER -119.45 23.38 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.633 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 4.9 mt -117.19 134.13 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -119.39 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.119 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.94 129.16 49.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.867 0.365 . . . . 0.0 110.992 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 12.1 t -133.26 116.69 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 301' ' ' GLY . . . -89.15 105.59 3.21 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 302' ' ' SER . 26.0 mt -56.64 77.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.339 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 299' ' ' GLY . . . -47.49 80.6 0.0 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.634 ' N ' ' O ' ' A' ' 300' ' ' LEU . 70.3 m 73.91 -52.89 0.69 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.292 0.567 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 300' ' ' LEU . 2.8 m -27.99 130.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 304' ' ' ASN . 0.1 OUTLIER 58.19 56.82 6.65 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 110.338 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 41.8 Cg_endo -71.69 176.78 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.905 2.403 . . . . 0.0 112.369 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 20.9 mt -132.52 -72.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.51 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.28 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.449 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 310' ' ' ALA . 5.3 p -68.02 171.05 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -76.18 24.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 308' ' ' SER . . . -44.29 -52.88 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.365 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.41 161.93 56.27 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.394 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -50.37 -41.06 52.57 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.255 1.97 . . . . 0.0 111.738 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.84 -42.26 98.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.04 -47.53 59.1 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.568 ' CZ ' ' NH2' ' A' ' 319' ' ' ARG . 58.2 ttt180 -60.16 -46.26 90.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.844 0.354 . . . . 0.0 110.339 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.22 78.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.382 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -31.42 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.65 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.0 OUTLIER -79.95 -25.13 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.549 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' A' ' 315' ' ' ARG . 1.5 mtt85 -80.38 82.21 6.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.317 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.3 ttm180 -129.03 141.97 51.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.33 161.12 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.033 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.24 127.9 16.18 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.086 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.47 110.33 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.37 135.65 60.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 326' ' ' ASN . 2.3 p -115.76 135.62 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.225 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.618 ' O ' HD13 ' A' ' 211' ' ' LEU . 2.0 t30 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.663 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.779 0.323 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.648 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -137.01 161.83 34.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.555 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.3 mm? -87.46 -4.18 59.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.86 121.42 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 76' ' ' ALA . 5.1 mp -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 p -50.64 134.95 23.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -47.56 124.11 6.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.61 125.57 38.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.356 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 t -101.91 131.54 48.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.892 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.489 HG23 ' CD2' ' A' ' 93' ' ' LEU . 79.8 mt -133.85 120.0 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 92' ' ' THR . 15.5 t -133.34 140.05 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.502 ' CG ' HG12 ' A' ' 91' ' ' VAL . 1.5 ttt180 -125.22 150.01 47.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' THR . 8.9 t -145.23 95.09 2.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 46.72 -130.45 12.1 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 118' ' ' VAL . 2.1 m120 -69.65 4.43 1.91 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.626 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 87' ' ' SER . 30.9 m -115.98 126.05 53.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.535 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 91' ' ' VAL . 22.7 m -117.48 117.57 55.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.407 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.571 HG22 ' CD1' ' A' ' 94' ' ' ILE . 7.8 m -106.6 126.07 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.825 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 84' ' ' ILE . 6.9 mt -129.88 121.19 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.486 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.571 ' CD1' HG22 ' A' ' 92' ' ' THR . 2.4 mp -133.86 141.49 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.631 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.07 -157.28 27.72 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -130.98 156.8 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.762 0.315 . . . . 0.0 110.563 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -141.42 153.35 65.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.3 -29.73 80.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.925 2.417 . . . . 0.0 112.455 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.56 176.1 3.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 0.0 110.648 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -74.85 -16.03 60.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.524 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.27 -42.42 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.202 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.41 77.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.129 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 122' ' ' ASP . 2.6 tttp -63.81 -36.45 83.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.375 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.31 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.72 79.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.14 -41.51 90.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.603 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.7 mmt -58.35 -39.44 79.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -38.6 89.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.39 -16.12 62.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.86 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -100.77 -13.95 18.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -52.17 -25.6 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.38 -10.81 81.51 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.3 tt -111.13 -17.25 13.27 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 122.261 -0.553 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -57.74 95.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 116' ' ' PRO . . . -151.73 140.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' C ' ' H ' ' A' ' 118' ' ' VAL . 81.8 Cg_exo -41.17 173.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.6 2.2 . . . . 0.0 112.276 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.0 -14.64 0.18 Allowed Glycine 0 C--O 1.238 0.347 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.59 HG11 HD21 ' A' ' 113' ' ' LEU . 48.8 t -101.72 139.39 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 O-C-N 122.218 -0.578 . . . . 0.0 110.646 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -108.06 123.55 48.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.619 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.19 114.43 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.463 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 92' ' ' THR . 0.8 OUTLIER -130.34 139.6 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.305 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 103' ' ' LYS . 7.7 p-10 -154.43 110.43 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -95.21 90.16 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 15.0 mt -105.67 129.09 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.009 0.433 . . . . 0.0 111.132 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 148.94 22.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.566 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.02 117.95 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.228 0.537 . . . . 0.0 110.987 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.611 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -112.66 141.26 25.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.083 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 127' ' ' ASP . 91.1 Cg_exo -29.3 -62.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.06 2.507 . . . . 0.0 112.856 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.75 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 p -164.09 47.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.267 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG13 ' HB3' ' A' ' 127' ' ' ASP . 1.5 m -50.4 -169.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -108.86 158.81 17.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -148.97 155.86 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -79.04 136.16 37.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.04 129.24 39.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 136' ' ' SER . 0.0 OUTLIER -105.45 -8.32 18.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.601 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.579 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.8 t -21.51 -47.74 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.403 0.621 . . . . 0.0 111.002 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.4 t -133.42 65.64 1.58 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.284 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -123.56 -15.5 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.5 tt0 -48.11 -49.32 61.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.7 Cg_exo -57.97 -30.94 91.52 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.728 2.285 . . . . 0.0 112.105 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.503 ' O ' ' OG ' ' A' ' 145' ' ' SER . 18.3 t -67.07 -42.98 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.9 m-85 -62.35 -41.7 98.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.245 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 21.3 p -60.88 -37.69 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.081 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.61 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.797 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 141' ' ' VAL . 0.7 OUTLIER -106.44 11.24 31.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 142' ' ' PHE . 3.5 t -88.23 -32.24 0.4 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 60.3 Cg_endo -85.84 9.6 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.862 2.374 . . . . 0.0 112.357 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 148' ' ' ILE . 8.8 mt -126.63 98.56 31.34 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 173.71 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.6 2.2 . . . . 0.0 112.058 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 52.88 54.19 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.69 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.651 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -127.08 145.8 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.36 149.03 16.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 162' ' ' LEU . 17.3 tp -139.02 126.48 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.502 ' N ' HD12 ' A' ' 153' ' ' LEU . 0.1 OUTLIER -126.08 126.7 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 110.852 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 154' ' ' LYS . 88.8 t -114.82 122.83 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.14 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 158' ' ' ASP . 4.8 tt0 -110.98 163.42 13.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.695 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 156' ' ' GLU . 1.0 OUTLIER -25.52 -43.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.782 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 156' ' ' GLU . 1.4 p-10 -156.14 29.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.536 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 125.97 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.534 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.54 121.65 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.667 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.731 HG23 HG23 ' A' ' 189' ' ' VAL . 24.4 m -130.38 136.96 49.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.592 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.532 ' CD2' HD13 ' A' ' 153' ' ' LEU . 1.0 OUTLIER -119.19 109.22 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.612 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 147.99 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.542 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.81 -169.28 36.45 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 89.2 m -107.37 137.44 45.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.737 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -124.62 109.65 28.34 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.43 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.31 -16.11 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.435 2.09 . . . . 0.0 112.417 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.21 129.37 35.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.03 -41.71 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.647 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.29 -35.75 76.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.582 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.644 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.3 m170 -63.06 -42.18 99.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -66.84 -39.4 87.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -61.98 -46.1 90.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.863 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.04 -43.24 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 171' ' ' HIS . 17.9 t -70.59 -37.59 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.804 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -62.38 -49.32 75.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.797 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -63.89 -39.42 94.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.17 96.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.9 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.09 68.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.597 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 17.4 m -58.16 -39.57 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.412 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.8 p -65.85 -27.05 67.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.335 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.476 ' HB ' ' CD2' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.86 -44.07 28.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.561 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.476 ' CD2' ' HB ' ' A' ' 182' ' ' THR . 2.3 m-90 -138.21 67.26 46.85 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.627 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.27 -10.75 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.814 2.343 . . . . 0.0 111.973 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.71 58.47 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.588 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.433 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -176.57 -170.31 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.533 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -107.21 110.75 22.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.465 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 183' ' ' TRP . 39.7 mt -116.41 131.41 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.731 HG23 HG23 ' A' ' 161' ' ' THR . 17.0 m -131.02 121.4 49.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.57 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.497 ' C ' HD22 ' A' ' 191' ' ' ASN . 2.6 m-20 -89.56 110.17 21.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.613 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 191' ' ' ASN . 2.1 m120 -104.1 55.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.662 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.41 115.85 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.385 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.545 ' CD ' ' O ' ' A' ' 193' ' ' GLU . 2.9 pp20? -103.33 140.9 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.683 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 166' ' ' ALA . 3.0 m -93.53 134.99 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.313 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.4 -26.53 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -104.7 -5.93 41.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.584 ' NE2' HG11 ' A' ' 194' ' ' VAL . 5.0 tt0 -63.81 156.21 28.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.917 0.389 . . . . 0.0 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.741 ' H ' ' CD ' ' A' ' 199' ' ' PRO . . . -151.58 -46.6 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.253 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.741 ' CD ' ' H ' ' A' ' 198' ' ' ALA . 6.4 Cg_endo -84.47 110.07 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.267 2.644 . . . . 0.0 111.735 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.28 106.36 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.608 2.205 . . . . 0.0 112.399 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 122.76 -82.66 0.35 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -38.47 148.34 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.104 2.536 . . . . 0.0 112.311 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 204' ' ' ALA . 61.3 Cg_endo -75.52 172.74 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.816 2.344 . . . . 0.0 112.12 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.577 ' O ' ' O ' ' A' ' 203' ' ' PRO . . . 50.47 163.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.6 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.5 m -162.63 -74.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -152.39 57.93 0.42 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.06 33.78 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.794 2.329 . . . . 0.0 112.28 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.479 ' SG ' ' HD3' ' A' ' 251' ' ' PRO . 1.9 t 50.4 87.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -135.82 -147.89 0.28 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.958 0.408 . . . . 0.0 111.256 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -70.01 50.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.151 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 211' ' ' LEU . 0.1 OUTLIER -66.66 -31.52 72.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 0.0 OUTLIER -54.19 -31.62 53.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.971 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 72.8 m -65.94 -48.55 70.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.706 0.765 . . . . 0.0 110.996 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -75.26 -34.55 61.39 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.848 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.718 HG21 HG11 ' A' ' 325' ' ' VAL . 0.3 OUTLIER -58.37 -39.5 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.404 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 2.2 m-20 -53.63 -34.42 58.46 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.083 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.88 62.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 219' ' ' THR . 0.3 OUTLIER -58.53 -43.38 86.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 221' ' ' GLY . 6.3 p -93.67 -31.56 14.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.463 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.96 -35.33 0.1 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -174.56 -173.15 40.26 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.66 154.07 32.98 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.735 2.29 . . . . 0.0 111.895 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.1 tt -115.74 145.05 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.527 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . -157.18 112.72 2.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.601 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.527 ' C ' ' O ' ' A' ' 224' ' ' ALA . 64.5 t80 28.0 -104.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.551 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.539 ' O ' ' OD1' ' A' ' 228' ' ' ASP . . . -107.25 -147.77 14.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 226' ' ' GLY . 14.2 t-20 37.02 89.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.812 0.339 . . . . 0.0 110.598 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 226' ' ' GLY . 1.6 m-20 -142.94 -109.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -170.98 -168.64 32.98 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . 60.03 177.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.804 0.335 . . . . 0.0 110.519 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.38 22.97 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.83 163.18 27.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.409 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 pt -119.1 73.73 13.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.842 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.2 133.44 13.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.938 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -138.31 -100.33 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.56 59.62 1.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.783 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.2 t80 179.61 -36.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.48 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.47 -32.92 72.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.292 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 243' ' ' VAL . 1.0 OUTLIER -66.46 -40.94 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.52 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.468 ' O ' ' NE ' ' A' ' 288' ' ' ARG . 12.5 mt -58.56 -47.28 84.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.344 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.515 ' OD1' ' C ' ' A' ' 241' ' ' ASN . 8.7 t-20 -63.52 -33.19 75.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.296 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.75 84.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.513 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 285' ' ' LEU . 48.3 t -62.06 -42.55 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 247' ' ' LEU . . . -56.43 -41.59 76.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 109.897 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.58 -40.14 74.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.4 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 28.9 ttmt -69.6 -31.29 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.441 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.453 HD11 HG23 ' A' ' 290' ' ' VAL . 0.1 OUTLIER -53.71 -33.04 54.24 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.3 OUTLIER -62.0 -12.11 16.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.334 0.588 . . . . 0.0 109.496 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.668 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -69.04 11.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.879 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.563 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -37.63 -48.8 2.68 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.23 -178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.479 ' HD3' ' SG ' ' A' ' 208' ' ' CYS . 31.3 Cg_exo -56.29 -18.64 24.97 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.904 1.736 . . . . 0.0 111.596 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 254' ' ' ARG . 14.0 m-20 -156.74 39.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.668 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -62.65 62.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.711 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 252' ' ' ASP . 1.6 mtm180 -111.52 134.91 52.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.05 139.5 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.926 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.9 m -122.54 127.05 49.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.048 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 295' ' ' ILE . 74.1 mt -102.1 123.19 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.892 0.377 . . . . 0.0 111.254 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.41 120.1 35.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.15 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -100.55 139.57 14.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -126.36 100.41 6.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.381 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.425 ' CG2' ' OD1' ' A' ' 263' ' ' ASN . 1.3 m -141.48 128.25 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.547 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.51 ' CG ' ' N ' ' A' ' 263' ' ' ASN . 22.4 t70 -68.54 -116.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.416 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 262' ' ' ASP . 10.9 m120 65.15 41.09 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.565 ' O ' ' OD1' ' A' ' 270' ' ' ASN . 10.5 m -31.92 -74.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.708 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 264' ' ' THR . . . 27.12 -92.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.561 ' O ' ' ND2' ' A' ' 270' ' ' ASN . 48.1 t -142.83 137.74 29.85 Favored 'General case' 0 CA--C 1.511 -0.535 0 O-C-N 122.967 -0.137 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 267' ' ' GLU . 1.9 pm0 -58.44 -30.42 66.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.348 . . . . 0.0 110.434 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -61.08 6.8 0.13 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.564 ' H ' ' C ' ' A' ' 267' ' ' GLU . 0.5 OUTLIER -140.71 -42.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.675 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.648 ' ND2' ' N ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -68.35 -34.0 75.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.329 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.55 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.1 mm -72.67 -51.97 6.58 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.705 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.4 Cg_endo -62.0 -30.22 82.82 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.934 1.756 . . . . 0.0 112.115 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 273' ' ' LEU . 0.3 OUTLIER -64.4 -48.76 74.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.368 . . . . 0.0 110.179 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 12.0 p -74.48 -36.18 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.54 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.91 64.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 272' ' ' PRO . 6.9 tt0 -61.12 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.517 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -33.12 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.259 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.59 -33.99 76.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -43.31 84.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.3 -37.2 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.3 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.48 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.312 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.35 -38.48 80.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -41.73 84.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.335 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -70.69 -42.34 70.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.379 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 243' ' ' VAL . 1.7 mm? -59.76 -49.19 78.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.158 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.93 -34.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.5 67.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.298 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 240' ' ' LEU . 3.1 tpt85 -80.77 -1.24 42.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.0 0.429 . . . . 0.0 109.917 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 104.63 3.51 43.31 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.453 HG23 HD11 ' A' ' 247' ' ' LEU . 95.5 t -67.3 128.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.467 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -79.99 107.85 13.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.745 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.667 ' O ' HG22 ' A' ' 295' ' ' ILE . . . -55.96 -4.25 0.68 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 291' ' ' ALA . 5.5 m-20 -68.52 -10.6 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.478 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -134.97 52.64 2.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.594 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 292' ' ' GLY . 17.6 tt -133.04 139.3 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.716 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -136.27 142.33 43.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.129 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 2.2 p -122.62 142.15 50.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.887 0.375 . . . . 0.0 110.955 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.39 116.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.282 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.3 107.45 3.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 300' ' ' LEU . 10.2 mp -97.65 62.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.449 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 300' ' ' LEU . . . -34.94 -102.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 45.4 t -112.49 99.86 8.3 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 122.99 -0.124 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.717 HG12 ' N ' ' A' ' 304' ' ' ASN . 54.4 t -119.59 -95.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.717 ' N ' HG12 ' A' ' 303' ' ' VAL . 0.4 OUTLIER -89.16 -52.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.649 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 304' ' ' ASN . 68.4 Cg_endo -80.72 153.33 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.772 2.315 . . . . 0.0 112.309 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 6.8 tt -167.62 137.35 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.416 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -132.21 137.66 47.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 309' ' ' ASN . 13.3 t -74.18 79.95 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.555 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 309' ' ' ASN . 0.0 OUTLIER -32.23 116.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.394 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -174.87 -50.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.482 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.7 164.38 15.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.227 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.39 -43.01 46.29 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.868 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -45.86 92.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.222 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.13 97.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -60.8 -40.92 94.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 110.178 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.48 72.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.21 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -68.05 -37.47 81.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.247 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 318' ' ' ASN . 1.1 t30 -72.08 -6.55 43.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.28 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -160.0 89.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.318 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -134.43 149.09 50.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.012 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 18.3 t -123.83 145.25 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.837 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.94 129.8 42.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.43 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -117.69 109.87 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.532 178.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 135.86 55.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.718 HG11 HG21 ' A' ' 215' ' ' ILE . 2.4 p -107.93 135.09 47.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 20.3 t30 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.645 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 76' ' ' ALA . 12.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.846 0.355 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 53.81 106.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.477 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' C ' ' OG ' ' A' ' 78' ' ' SER . 3.7 mt -108.27 -29.53 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -168.93 121.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.68 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 132' ' ' SER . 1.9 mm? -110.46 151.79 27.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.466 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.95 151.84 18.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.445 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -66.07 129.49 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.67 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -131.49 130.77 42.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -109.68 121.17 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -128.95 118.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.606 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 t -130.52 132.45 45.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.456 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.48 HH11 HG22 ' A' ' 91' ' ' VAL . 25.4 ttm-85 -112.86 143.71 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 p -140.57 120.68 13.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.315 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 48.68 -135.77 19.4 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.48 17.08 5.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.824 0.345 . . . . 0.0 110.478 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -109.97 139.06 45.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.688 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 HH11 ' A' ' 86' ' ' ARG . 89.6 t -112.95 114.13 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.458 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 116.45 32.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 93' ' ' LEU . 1.2 mm? -109.8 122.26 47.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.356 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.28 124.73 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.7 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 158.25 -135.83 4.48 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -154.36 156.91 37.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 110.749 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -133.92 153.99 80.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.497 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.2 -26.96 41.83 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.661 2.24 . . . . 0.0 112.011 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 4.3 p-10 -168.07 158.38 10.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.344 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.25 -21.3 62.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.76 74.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.328 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.66 77.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.454 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -42.98 73.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.548 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.497 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.04 -40.61 73.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.621 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.29 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.54 -46.02 60.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.4 mtm -59.74 -33.14 71.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 2.9 m -62.01 -40.54 96.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.99 -29.51 66.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.79 -0.65 57.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.466 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.667 ' ND2' ' N ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -52.47 -22.66 5.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.667 ' N ' ' ND2' ' A' ' 111' ' ' ASN . . . -83.48 -10.07 82.44 Favored Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.672 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -97.4 -51.25 4.23 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.447 -0.443 . . . . 0.0 110.546 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -35.23 106.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -149.38 173.55 4.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 25.2 Cg_exo -57.76 164.81 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.632 2.221 . . . . 0.0 112.288 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 53.38 13.41 2.69 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -102.36 138.66 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.209 -0.583 . . . . 0.0 110.754 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.4 137.95 45.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.273 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.98 122.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.96 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.44 128.04 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.918 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.13 81.78 1.94 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -92.12 48.43 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.253 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -105.4 130.54 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -93.37 146.54 23.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.783 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.8 111.58 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 129' ' ' VAL . 31.6 m-20 -125.44 103.9 28.62 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.571 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -52.36 69.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.494 2.13 . . . . 0.0 112.293 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.677 ' O ' ' NE ' ' A' ' 131' ' ' ARG . 3.4 p -179.27 -30.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.742 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.02 164.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.677 ' NE ' ' O ' ' A' ' 129' ' ' VAL . 0.0 OUTLIER -122.45 159.17 28.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.588 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.478 ' C ' HD11 ' A' ' 79' ' ' LEU . 10.2 t -133.86 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.3 OUTLIER -81.76 135.65 35.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.64 137.44 43.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -105.94 6.83 31.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.057 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t -45.72 132.71 8.54 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m 45.47 38.21 3.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.77 0.319 . . . . 0.0 110.68 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 135' ' ' PHE . . . -101.6 -10.95 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -53.18 -47.32 96.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.367 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 32.0 Cg_exo -58.26 -36.55 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.782 2.321 . . . . 0.0 111.654 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.1 t -64.39 -44.4 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.49 -38.62 91.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.314 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 35.6 p -62.69 -37.24 85.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.721 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -76.44 -21.08 56.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.005 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.03 10.84 22.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -77.71 -43.58 2.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.493 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 28.1 Cg_exo -57.56 -9.6 5.58 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.512 2.142 . . . . 0.0 111.534 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 171' ' ' HIS . 1.3 mm -108.57 93.46 11.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.321 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.8 7.99 3.98 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.628 2.219 . . . . 0.0 112.311 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -124.38 50.73 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.38 141.57 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.23 123.07 4.46 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -118.51 135.28 54.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 130.22 49.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.19 133.86 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.044 0.449 . . . . 0.0 111.266 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -140.79 78.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.636 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 159' ' ' THR . 7.4 ttp180 70.11 -137.35 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.989 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -75.97 25.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.47 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ARG . 3.6 m -127.8 139.97 52.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.55 134.82 63.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.284 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 189' ' ' VAL . 11.2 m -127.35 136.88 52.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.963 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.913 HD12 ' N ' ' A' ' 162' ' ' LEU . 2.2 mp -106.64 125.23 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.951 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -137.93 146.89 43.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.09 163.18 10.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.2 p -87.03 126.75 34.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.749 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.523 ' O ' ' OE1' ' A' ' 197' ' ' GLN . . . -99.84 146.86 32.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.675 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 43.6 Cg_endo -71.2 -23.76 24.08 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.784 2.323 . . . . 0.0 111.901 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 204' ' ' ALA . 0.2 OUTLIER -148.86 137.93 21.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -36.33 83.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -62.86 -35.3 79.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.574 ' CE1' HD11 ' A' ' 148' ' ' ILE . 1.7 m-70 -57.47 -43.7 84.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.894 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -36.17 76.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.683 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.87 -40.18 87.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.37 99.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.45 -37.04 77.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.892 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -61.83 -48.62 79.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.808 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -55.8 -48.27 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.488 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.39 87.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.29 -41.3 96.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.664 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.0 -38.88 90.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 m -71.04 -37.47 72.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.37 -22.11 21.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.823 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.604 ' N ' ' O ' ' A' ' 179' ' ' ALA . 7.9 m0 -141.69 88.36 9.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.902 0.382 . . . . 0.0 110.664 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 186' ' ' MET . 71.5 Cg_endo -82.96 15.73 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 123.073 2.515 . . . . 0.0 112.291 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.9 OUTLIER -31.58 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.5 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 184' ' ' PRO . 9.3 ttt 80.47 -23.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.761 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -103.24 68.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.85 134.43 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 161' ' ' THR . 94.1 t -115.4 130.18 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.65 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 3.3 p-10 -97.02 119.12 34.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -131.96 50.49 2.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 192' ' ' ILE . 1.6 pp -101.59 129.56 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -98.7 139.41 34.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.356 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 194' ' ' VAL . 6.8 m -109.52 119.91 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 195' ' ' THR . 3.0 t -98.71 65.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.319 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.94 31.09 54.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.675 ' NE2' ' O ' ' A' ' 167' ' ' PRO . 1.0 OUTLIER -68.84 156.24 38.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -108.67 99.59 34.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.721 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.533 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 21.3 Cg_exo -56.0 -42.54 65.62 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.36 2.04 . . . . 0.0 112.446 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 74.1 Cg_endo -81.02 50.61 3.63 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.229 1.953 . . . . 0.0 111.859 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.05 98.27 0.18 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 21.0 Cg_exo -55.36 -42.8 64.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.374 2.049 . . . . 0.0 112.405 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 71.5 Cg_endo -83.03 -1.63 10.49 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.452 2.101 . . . . 0.0 112.2 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 203' ' ' PRO . . . 70.53 179.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.698 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.2 t -99.73 -55.97 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.538 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 114.6 179.91 18.65 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.829 ' HB2' ' HB1' ' A' ' 249' ' ' ALA . 75.5 Cg_endo -81.37 139.57 11.64 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 123.18 2.587 . . . . 0.0 112.703 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 208' ' ' CYS . 52.8 t 39.38 13.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.978 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 207' ' ' PRO . . . -68.45 147.2 52.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.177 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.488 ' C ' ' O ' ' A' ' 209' ' ' ALA . 0.0 OUTLIER 35.78 27.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 109.815 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 209' ' ' ALA . 56.9 tp -56.28 -31.7 63.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.948 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 213' ' ' SER . 14.3 pt20 -54.65 -44.76 73.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.79 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 212' ' ' GLN . 74.1 m -69.78 -40.44 76.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.172 0.51 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 218' ' ' VAL . . . -68.83 -37.15 78.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.514 ' CD1' HG22 ' A' ' 243' ' ' VAL . 3.5 mm -59.6 -36.53 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.709 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 220' ' ' GLY . 0.7 OUTLIER -57.3 -42.0 80.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.804 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.13 -41.45 63.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.698 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 214' ' ' ALA . 85.4 t -59.96 -45.12 95.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.706 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 221' ' ' GLY . 75.0 p -94.52 -23.24 17.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.779 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 65.95 -2.46 3.8 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -171.15 -172.82 37.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.97 151.47 62.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.732 2.288 . . . . 0.0 112.048 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.4 mt -89.16 118.67 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.572 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -168.39 78.92 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.6 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.3 t80 61.92 121.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -134.23 -115.62 1.58 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.75 88.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -94.98 115.34 27.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -94.73 133.29 11.5 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.82 -67.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.668 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.5 m -133.59 -86.1 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.572 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.38 54.22 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 233' ' ' ILE . 18.3 tt -177.09 75.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.615 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.03 93.51 1.1 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.971 2.447 . . . . 0.0 112.158 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -141.07 97.05 3.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.547 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.51 91.91 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -113.73 9.25 17.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.249 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -58.86 -34.66 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.899 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.77 -46.37 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 9.9 tp -70.05 -34.37 73.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.626 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.23 -45.32 80.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.632 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -61.06 -43.74 98.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.333 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 215' ' ' ILE . 51.0 t -68.18 -39.38 81.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.453 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.728 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -64.81 -46.6 81.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -60.53 -50.77 72.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -60.47 -31.66 70.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.482 HD13 HD22 ' A' ' 285' ' ' LEU . 0.9 OUTLIER -62.67 -32.92 74.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.252 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -63.65 -18.59 64.11 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.829 ' HB1' ' HB2' ' A' ' 207' ' ' PRO . . . -98.92 -2.05 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.006 0.431 . . . . 0.0 110.73 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.687 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.4 m -74.97 -28.72 0.82 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 43.6 Cg_exo -53.6 -16.04 7.34 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.148 1.899 . . . . 0.0 112.405 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' C ' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -62.4 -9.43 8.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.553 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -136.07 -157.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.878 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -108.79 138.2 45.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.08 133.31 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.007 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.801 HG22 ' ND2' ' A' ' 258' ' ' ASN . 95.2 m -120.75 116.13 24.64 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.0 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 295' ' ' ILE . 53.3 mt -100.96 112.54 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.768 0.318 . . . . 0.0 110.557 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.801 ' ND2' HG22 ' A' ' 256' ' ' THR . 2.3 m-80 -112.6 122.65 48.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -122.85 133.98 9.36 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.649 ' HB2' HG11 ' A' ' 303' ' ' VAL . 29.6 p90 -130.52 154.67 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 110.799 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 262' ' ' ASP . 30.8 p -117.42 -118.62 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.603 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 303' ' ' VAL . 14.6 p-10 -134.58 -99.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.264 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.599 ' H ' ' CG ' ' A' ' 262' ' ' ASP . 1.7 p30 -174.82 -123.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' A' ' 266' ' ' SER . . . 78.85 128.74 0.56 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' A' ' 265' ' ' GLY . 14.1 t 82.61 -77.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.623 0.725 . . . . 0.0 110.99 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.54 -28.95 67.55 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.238 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -99.23 -35.93 4.58 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 269' ' ' ILE . 3.1 tt 34.87 23.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.346 0.593 . . . . 0.0 110.439 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.679 ' N ' ' O ' ' A' ' 268' ' ' GLY . 11.6 t-20 -69.85 -36.54 75.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.259 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.943 ' O ' HD12 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -55.85 -49.96 89.9 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.657 ' HD3' HG23 ' A' ' 271' ' ' ILE . 21.8 Cg_endo -62.69 -39.93 40.26 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.594 1.529 . . . . 0.0 111.883 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.62 -34.08 77.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -40.0 94.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.763 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.62 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -65.9 -34.62 78.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.554 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -60.26 -45.67 92.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.67 76.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.61 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.46 -44.46 87.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.98 -36.96 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.298 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.87 -41.93 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.66 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -62.97 -39.66 95.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.95 -41.6 87.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -66.04 -44.28 85.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.913 0.387 . . . . 0.0 110.729 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.482 HD22 HD13 ' A' ' 247' ' ' LEU . 89.7 mt -59.72 -41.37 90.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 282' ' ' ALA . 89.5 t -60.06 -36.31 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.167 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.24 65.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.772 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.728 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -86.6 -1.85 58.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.53 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 18.15 11.79 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.552 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 74.6 t -87.2 124.06 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 110.433 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -70.12 98.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.68 16.5 0.4 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.58 ' H ' ' C ' ' A' ' 291' ' ' ALA . 25.3 t0 -93.21 -13.36 28.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.775 0.321 . . . . 0.0 110.518 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -132.48 24.72 4.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.815 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 295' ' ' ILE . 16.1 tt -116.36 125.34 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.468 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.86 48.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.552 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p -124.05 138.48 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.387 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 22.0 t -136.11 122.13 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.528 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -98.12 107.73 3.5 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.0 OUTLIER -38.96 -61.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.723 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.64 ' HA2' HD13 ' A' ' 271' ' ' ILE . . . 96.15 106.57 2.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 91.0 p 40.24 90.01 0.01 OUTLIER 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.971 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 260' ' ' TYR . 0.7 OUTLIER -107.24 160.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.545 ' N ' ' CG2' ' A' ' 303' ' ' VAL . 0.6 OUTLIER -40.33 152.76 0.22 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.402 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.2 114.64 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.746 2.297 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 16.2 mt -103.03 -42.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -121.73 168.88 11.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.506 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.45 90.41 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.483 ' CG ' ' O ' ' A' ' 309' ' ' ASN . 3.7 t30 -65.73 -1.06 2.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.523 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -57.68 -11.1 1.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.515 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.99 158.44 69.71 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.62 -36.59 81.52 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.85 2.366 . . . . 0.0 111.918 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -64.62 -31.45 72.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.406 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.99 99.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.683 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 6.7 ttm180 -60.8 -37.77 83.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.95 0.405 . . . . 0.0 110.403 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -63.09 -36.23 82.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.55 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -36.88 64.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.658 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.806 HD22 ' N ' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -74.99 -25.12 58.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.785 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.806 ' N ' HD22 ' A' ' 318' ' ' ASN . 0.0 OUTLIER -95.57 84.41 3.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.611 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 260' ' ' TYR . 12.6 mtm180 -122.87 154.52 38.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 7.1 t -129.36 147.79 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.091 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.483 ' C ' HD13 ' A' ' 323' ' ' ILE . 2.8 tt0 -128.44 127.17 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.95 0.405 . . . . 0.0 110.9 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.598 ' N ' HD13 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -102.69 111.38 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.148 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 256' ' ' THR . 4.4 m -118.1 121.03 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.79 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.437 HG21 ' SG ' ' A' ' 208' ' ' CYS . 0.2 OUTLIER -105.63 135.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.553 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 3.7 t-20 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.74 0.305 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.36 135.54 35.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.31 -88.13 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.579 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -130.34 126.04 36.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 27.3 mt -103.76 139.65 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.751 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -81.13 153.3 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.516 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 82' ' ' LEU . 1.3 tt -53.65 121.26 7.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.655 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -125.35 118.49 26.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.5 t -101.85 117.2 34.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.352 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.32 116.25 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.573 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -134.05 128.31 34.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.461 HH21 ' HA ' ' A' ' 149' ' ' PRO . 11.2 mtp85 -110.69 130.78 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.585 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.4 ' HG ' ' HB ' ' A' ' 90' ' ' THR . 19.9 p -130.01 115.94 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 42.3 -131.32 4.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.832 ' O ' HG23 ' A' ' 118' ' ' VAL . 22.2 m-20 -86.4 21.91 1.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.678 0.275 . . . . 0.0 110.606 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 87' ' ' SER . 75.6 m -122.07 125.73 46.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.397 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.59 132.9 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.5 m -119.31 116.56 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.382 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.93 123.35 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.621 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 123' ' ' GLN . 2.0 mt -142.08 124.61 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.291 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.57 -143.78 8.47 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.449 ' OD2' HG11 ' A' ' 130' ' ' VAL . 26.1 p30 -154.34 153.06 31.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 124' ' ' ILE . 33.9 p90 -137.26 150.43 68.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.83 -20.49 22.46 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.738 2.292 . . . . 0.0 112.242 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -165.87 145.75 6.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.688 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' C ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -53.75 -10.63 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' ASP . . . -60.86 -40.16 91.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.88 -34.5 77.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -68.37 -37.05 80.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.11 -47.86 81.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.54 77.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.706 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 106' ' ' LEU . 1.5 tt -72.19 -43.02 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -39.87 80.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -61.2 -28.36 69.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.94 -31.32 69.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.741 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.5 mt -86.63 -17.42 33.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.574 ' C ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -45.88 -35.43 4.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.632 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.73 -17.19 66.36 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 114' ' ' LEU . 5.6 tp -95.77 -33.51 12.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.67 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 113' ' ' LEU . 1.7 tt -33.71 104.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.575 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -131.72 135.45 26.81 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.449 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -43.6 162.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.213 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.8 13.88 41.74 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 89' ' ' ASN . 8.7 p -102.54 130.14 52.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 O-C-N 121.903 -0.763 . . . . 0.0 110.761 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.81 126.08 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 120' ' ' VAL . 9.0 p -118.56 127.31 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.794 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.91 134.05 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.164 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -120.74 91.62 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.996 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.44 ' HB2' HG23 ' A' ' 94' ' ' ILE . 4.5 mm-40 -94.05 50.31 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.966 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 97' ' ' PHE . 1.3 pt -105.33 130.22 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.587 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -93.38 146.1 23.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.299 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 126' ' ' VAL . 13.7 p -100.02 120.06 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.848 0.356 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -137.45 129.87 16.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.368 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.48 41.91 0.84 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.377 2.051 . . . . 0.0 112.17 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 24.6 t -147.45 -35.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.449 HG11 ' OD2' ' A' ' 96' ' ' ASP . 34.0 m -67.21 164.11 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -115.56 158.61 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.246 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -126.12 155.94 40.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.87 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.699 HD21 ' CE2' ' A' ' 183' ' ' TRP . 37.1 tp -78.73 130.62 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.197 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.7 OUTLIER -64.18 134.53 55.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.857 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.558 ' O ' ' C ' ' A' ' 136' ' ' SER . 83.0 m-85 -120.54 6.55 10.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.22 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.558 ' C ' ' O ' ' A' ' 135' ' ' PHE . 90.0 p -24.08 -65.86 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.462 0.649 . . . . 0.0 110.985 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.41 47.69 1.97 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.845 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.58 -7.85 39.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.506 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.4 tt0 -48.49 -49.01 66.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 33.0 Cg_exo -55.36 -42.24 70.21 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.848 2.365 . . . . 0.0 112.14 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.74 -45.98 93.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -64.89 -41.63 95.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.55 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 140' ' ' PRO . 21.8 p -65.73 -40.07 91.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.54 -18.66 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.444 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 t -105.55 2.58 28.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.651 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -64.54 -41.08 55.69 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.381 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 46.0 Cg_exo -53.25 -7.88 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.632 2.221 . . . . 0.0 111.719 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 150' ' ' ASP . 29.1 mt -122.77 101.53 39.46 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.415 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HA ' HH21 ' A' ' 86' ' ' ARG . 47.6 Cg_endo -75.66 19.26 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.187 1.925 . . . . 0.0 111.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 148' ' ' ILE . 22.4 m-20 -145.9 80.56 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.54 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.64 139.63 53.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.231 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.32 123.2 5.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.19 127.08 52.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 110.474 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.4 126.43 44.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.4 t -119.82 128.48 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -140.71 84.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.283 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 159' ' ' THR . 2.8 mtt180 60.77 -141.4 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.444 ' C ' ' OD2' ' A' ' 185' ' ' ASP . 0.0 OUTLIER -68.81 27.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.413 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.602 ' H ' ' C ' ' A' ' 157' ' ' ARG . 1.8 m -139.15 129.72 25.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -131.94 135.12 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.21 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.937 ' C ' HD13 ' A' ' 162' ' ' LEU . 66.0 m -131.53 130.99 43.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.946 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.056 ' H ' HD22 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -113.25 123.86 51.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.379 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 149.4 49.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.516 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 148.97 158.58 8.12 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.71 136.7 37.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.592 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.08 140.61 27.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.517 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.02 -30.57 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.506 2.137 . . . . 0.0 111.947 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 t -122.39 128.0 50.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.563 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.421 ' HB2' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -64.8 -31.03 72.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.642 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 171' ' ' HIS . 3.9 pt-20 -59.36 -35.86 74.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.726 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.747 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.4 m-70 -63.19 -37.95 89.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -64.15 -38.56 91.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.89 -47.07 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.966 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 171' ' ' HIS . 47.3 t -71.28 -41.37 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.958 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -58.05 -51.31 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.46 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -45.54 94.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.134 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.23 -33.23 75.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.991 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.2 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.179 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.8 m -67.44 -36.36 81.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.226 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.1 t -71.02 -43.01 68.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.595 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.1 m -72.88 -44.4 61.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.568 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.699 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.0 m0 -126.12 77.05 71.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 186' ' ' MET . 15.4 Cg_exo -65.34 12.3 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.016 2.478 . . . . 0.0 112.424 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 186' ' ' MET . 21.1 t0 -31.3 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.829 0.347 . . . . 0.0 110.551 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.583 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 4.6 tpt 86.99 -28.4 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -93.1 63.75 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 162' ' ' LEU . 0.7 OUTLIER -101.9 121.26 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.785 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.601 ' O ' HD22 ' A' ' 162' ' ' LEU . 2.6 t -100.58 125.28 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.173 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.433 ' OD1' ' C ' ' A' ' 190' ' ' ASN . 47.2 t-20 -91.93 124.13 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.743 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.82 44.56 2.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.193 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.04 133.19 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.641 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -102.72 149.15 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.435 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.8 m -108.79 108.36 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.3 p -109.01 -37.67 5.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.787 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -121.62 -1.96 10.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' A' ' 169' ' ' SER . 0.1 OUTLIER -54.81 146.09 18.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.383 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -144.22 167.23 15.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 74.9 Cg_exo -42.54 163.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.917 2.411 . . . . 0.0 112.002 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -43.23 88.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.697 2.265 . . . . 0.0 112.059 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -150.15 109.2 0.42 Allowed Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.554 ' C ' ' H ' ' A' ' 204' ' ' ALA . 17.6 Cg_exo -52.05 -42.39 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.082 1.854 . . . . 0.0 112.466 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 24.2 Cg_exo -60.42 9.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.027 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 202' ' ' PRO . . . -103.35 50.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.802 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 32.8 p -118.58 21.66 12.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.405 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 208' ' ' CYS . . . 56.67 54.91 32.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 206' ' ' GLY . 50.3 Cg_exo -46.72 -6.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.556 2.171 . . . . 0.0 111.864 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.561 ' H ' ' C ' ' A' ' 206' ' ' GLY . 1.2 m 45.76 44.41 10.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.039 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -78.42 -164.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.872 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -91.43 56.32 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.725 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.57 ' CB ' ' O ' ' A' ' 245' ' ' ASP . 4.0 mm? -58.19 -30.33 66.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.622 ' CD ' ' N ' ' A' ' 213' ' ' SER . 2.9 pp0? -53.2 -34.81 58.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.611 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.622 ' N ' ' CD ' ' A' ' 212' ' ' GLN . 89.9 p -65.61 -35.5 80.99 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.928 0.871 . . . . 0.0 110.974 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.13 -32.51 63.2 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.371 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.16 -35.94 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.414 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.1 t30 -53.89 -44.08 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.669 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.46 -28.83 61.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.491 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.608 ' CG1' HH11 ' A' ' 242' ' ' ARG . 65.8 t -58.04 -49.64 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.386 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.574 ' C ' ' H ' ' A' ' 221' ' ' GLY . 12.8 p -103.58 -11.4 17.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 67.13 -35.75 0.19 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -173.66 178.7 45.46 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 153.63 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.728 2.286 . . . . 0.0 112.009 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 224' ' ' ALA . 1.1 mt -140.43 -141.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 226' ' ' GLY . . . 177.31 104.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.518 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 225' ' ' PHE . 18.4 t80 -56.96 74.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.519 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 224' ' ' ALA . . . -170.75 -60.28 0.04 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.69 -68.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 110.678 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -168.37 -142.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 230' ' ' ALA . . . 88.36 -177.58 45.7 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 229' ' ' GLY . . . 39.4 78.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 5.9 t -112.39 -54.33 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.378 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.4 tp -100.64 28.44 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 233' ' ' ILE . 3.6 mp -136.25 63.3 48.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.583 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 235' ' ' ALA . 48.8 Cg_endo -72.46 92.39 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.789 2.326 . . . . 0.0 111.972 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 234' ' ' PRO . . . 171.0 125.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.548 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 109.96 21.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.709 ' CD1' ' N ' ' A' ' 238' ' ' GLU . 0.4 OUTLIER -173.76 -29.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.816 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.709 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 3.8 pt-20 -61.14 -38.71 87.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.457 HG23 HH21 ' A' ' 242' ' ' ARG . 0.8 OUTLIER -71.81 -42.06 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.941 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 243' ' ' VAL . 0.9 OUTLIER -65.27 -47.54 76.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 110.667 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -68.01 -31.71 71.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.319 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.608 HH11 ' CG1' ' A' ' 218' ' ' VAL . 2.4 ttp-105 -60.92 -45.69 93.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.433 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 240' ' ' LEU . 10.8 m -63.73 -36.26 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.29 81.44 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.995 0.426 . . . . 0.0 109.859 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 211' ' ' LEU . 33.8 m-20 -56.07 -48.85 75.3 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 249' ' ' ALA . 3.1 pttt -62.38 -30.47 71.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.806 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.851 ' O ' HD23 ' A' ' 247' ' ' LEU . 5.3 tt -53.13 -32.91 49.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -61.13 -11.35 8.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 253' ' ' ALA . . . -68.07 10.6 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.638 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.568 ' H ' ' C ' ' A' ' 248' ' ' LYS . 0.0 OUTLIER -38.52 -48.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.928 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 47.0 Cg_exo -54.23 -13.73 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.98 1.786 . . . . 0.0 111.353 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' ARG . 23.0 t0 -160.42 30.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.604 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 249' ' ' ALA . . . -55.89 67.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.675 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' ASP . 2.6 ttt180 -116.17 135.01 54.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.94 135.86 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.923 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.1 m -122.45 120.0 32.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.045 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.89 127.51 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.879 0.371 . . . . 0.0 110.999 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.95 122.16 41.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.276 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -109.69 145.44 16.88 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -134.24 149.48 50.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.645 0.259 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.591 ' O ' ' ND2' ' A' ' 318' ' ' ASN . 0.0 OUTLIER -162.61 -173.06 3.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.558 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.543 ' OD1' ' OD1' ' A' ' 270' ' ' ASN . 2.4 p30 -92.28 -164.36 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.64 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 265' ' ' GLY . 0.9 OUTLIER -125.14 -116.7 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.486 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 265' ' ' GLY . 0.2 OUTLIER 68.52 -29.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.528 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 267' ' ' GLU . . . 56.84 150.56 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.2 t 58.49 -71.28 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.588 0.709 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 265' ' ' GLY . 2.1 tt0 -55.99 -37.25 68.85 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.102 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 270' ' ' ASN . . . -93.73 -47.38 2.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 269' ' ' ILE . 3.0 tt 34.67 24.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.337 0.589 . . . . 0.0 110.561 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 268' ' ' GLY . 0.8 OUTLIER -69.57 -30.92 68.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.918 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.4 mm -54.79 -52.22 72.3 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 13.3 Cg_endo -61.26 -35.83 82.81 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.853 1.702 . . . . 0.0 111.876 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 273' ' ' LEU . 3.6 mm? -68.5 -46.55 69.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 23.6 p -65.65 -39.76 91.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.575 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.96 95.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.441 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -63.98 -36.48 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 277' ' ' ARG . 4.1 mtt85 -63.24 -35.17 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.448 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.25 69.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.034 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -73.97 -47.97 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.61 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 281' ' ' VAL . 1.7 tp -60.39 -44.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.137 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.529 ' N ' ' CG2' ' A' ' 280' ' ' ILE . 27.6 m -61.28 -40.85 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.765 0.317 . . . . 0.0 110.749 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 281' ' ' VAL . . . -59.3 -39.0 81.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.01 -47.04 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.717 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -57.01 -39.92 75.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.725 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 290' ' ' VAL . 1.0 OUTLIER -60.84 -42.53 97.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.562 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.58 -36.25 76.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -64.76 -24.64 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.003 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.64 ' O ' ' CD1' ' A' ' 247' ' ' LEU . 2.2 tpm_? -82.53 -2.79 54.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.798 0.333 . . . . 0.0 110.304 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.484 ' C ' HD11 ' A' ' 247' ' ' LEU . . . 105.97 10.63 29.87 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 285' ' ' LEU . 35.0 t -79.24 128.67 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.47 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -71.78 96.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.637 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 295' ' ' ILE . . . -48.78 -8.28 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 291' ' ' ALA . 72.8 m-20 -75.93 -6.42 50.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.556 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -124.92 26.17 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 292' ' ' GLY . 61.9 mt -116.6 131.99 67.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.63 52.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.83 127.21 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 0.0 110.864 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.8 140.83 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.326 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.2 117.88 3.11 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 300' ' ' LEU . 0.1 OUTLIER -119.23 59.84 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.524 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.515 ' HA2' ' H ' ' A' ' 261' ' ' THR . . . -77.99 -96.12 0.23 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 301' ' ' GLY . 90.1 p -36.87 -29.47 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.214 0.53 . . . . 0.0 110.955 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 301' ' ' GLY . 66.1 t -61.53 -47.41 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.625 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 301' ' ' GLY . 0.4 OUTLIER -139.73 86.42 13.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.645 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.79 163.48 9.15 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.952 2.435 . . . . 0.0 112.079 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 74.3 mt -136.68 -22.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.321 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 308' ' ' SER . . . -119.9 151.94 38.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.437 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 307' ' ' ALA . 0.6 OUTLIER -50.29 -165.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.634 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.85 50.56 0.54 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.618 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.19 -2.86 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.523 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.7 p -146.62 148.63 34.28 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.374 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.45 -31.11 76.61 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.681 2.254 . . . . 0.0 111.918 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -64.03 -33.86 76.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.129 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.36 -44.98 97.35 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -65.27 -43.97 89.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -65.22 -41.17 94.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.82 -32.61 74.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.235 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 261' ' ' THR . 0.7 OUTLIER -76.48 -25.43 54.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.426 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 319' ' ' ARG . 2.8 ttm180 -70.36 78.23 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.282 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -122.4 150.19 42.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 11.9 t -130.07 149.16 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.015 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.68 131.97 53.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.077 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 mt -131.98 110.3 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.28 120.21 52.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 325' ' ' VAL . 11.8 p -108.55 129.85 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.537 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 326' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.54 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.638 ' O ' ' N ' ' A' ' 77' ' ' LEU . 1.1 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.788 0.327 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -44.55 -9.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.516 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 75' ' ' SER . 19.6 tp -178.53 -57.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.641 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 p 178.38 111.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -84.77 147.61 26.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -79.62 159.86 26.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.509 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -64.51 119.35 10.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.714 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.11 131.3 49.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.34 120.73 30.64 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.047 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.1 tt -123.15 122.64 65.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.062 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.59 127.51 35.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.885 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.621 ' HG2' HG13 ' A' ' 91' ' ' VAL . 55.9 mtt180 -114.21 141.26 47.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.218 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 126.39 16.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.66 -125.41 29.49 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.09 19.44 15.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.303 . . . . 0.0 110.756 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.4 m -125.3 135.1 52.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.514 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.621 HG13 ' HG2' ' A' ' 86' ' ' ARG . 17.1 t -115.14 122.22 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.407 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 120.89 43.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -124.33 131.9 53.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.272 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -142.19 129.04 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.777 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.69 -152.1 21.18 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -154.39 154.37 33.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 110.417 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE2' HG21 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -125.96 158.95 64.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.845 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.16 -24.71 27.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.782 2.322 . . . . 0.0 112.025 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -157.91 -173.59 4.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -88.71 -19.61 25.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.515 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.78 75.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.538 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.04 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.648 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -61.89 -37.67 85.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.622 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.07 67.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 135' ' ' PHE . . . -65.96 -40.64 91.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.494 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt -62.5 -43.85 97.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.664 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.9 mmm -57.84 -42.89 85.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.751 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -62.76 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.76 -15.18 63.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.8 mt -103.0 -12.79 17.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.734 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -51.91 -42.47 62.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.617 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.99 -13.71 57.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -98.01 -26.46 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.603 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -161.65 163.79 19.07 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.488 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 58.2 Cg_endo -76.15 166.64 27.43 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.842 2.361 . . . . 0.0 112.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 61.96 1.71 3.14 Favored Glycine 0 N--CA 1.461 0.325 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 116' ' ' PRO . 54.9 t -99.81 135.11 36.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 O-C-N 122.278 -0.543 . . . . 0.0 110.818 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -106.86 128.63 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.288 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 p -112.34 134.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.022 0.439 . . . . 0.0 111.282 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 121' ' ' ILE . 2.2 mm -123.79 125.31 70.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.755 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.501 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 13.3 p-10 -136.15 83.12 1.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.505 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.464 ' CA ' HE21 ' A' ' 123' ' ' GLN . 0.6 OUTLIER -97.42 72.22 2.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.717 HG21 ' CE2' ' A' ' 97' ' ' PHE . 12.3 mt -105.53 130.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.93 146.2 23.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.444 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 126' ' ' VAL . 7.7 p -100.3 116.07 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.684 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.6 m-20 -133.6 103.14 12.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.695 ' O ' HG23 ' A' ' 129' ' ' VAL . 17.3 Cg_exo -61.57 56.73 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.468 2.112 . . . . 0.0 112.405 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 128' ' ' PRO . 56.0 t -162.68 -39.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.814 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.35 -178.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.064 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -123.87 159.58 29.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.315 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 m -134.65 155.5 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 183' ' ' TRP . 16.1 tp -80.08 113.17 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.276 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.6 136.35 57.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.56 ' O ' ' C ' ' A' ' 136' ' ' SER . 7.7 m-85 -92.0 2.05 56.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.38 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 135' ' ' PHE . 94.4 p -24.51 -80.65 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.656 0.741 . . . . 0.0 110.988 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.7 20.55 16.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.761 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.47 -11.09 24.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER -55.6 -45.85 99.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.696 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 31.8 Cg_exo -54.69 -38.95 91.19 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.007 2.471 . . . . 0.0 112.508 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.423 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 40.6 t -59.79 -47.61 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -63.26 -39.35 94.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 11.4 p -62.81 -34.68 77.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.79 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.17 -28.62 66.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -104.46 11.26 34.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.707 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -73.71 -34.67 2.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.889 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 37.4 Cg_exo -54.17 -28.75 53.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.615 2.21 . . . . 0.0 112.263 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 148' ' ' ILE . 1.4 tp -118.68 109.33 40.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.47 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 86' ' ' ARG . 57.3 Cg_endo -76.7 17.34 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.307 2.005 . . . . 0.0 112.09 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.512 ' H ' HG13 ' A' ' 148' ' ' ILE . 1.0 OUTLIER -114.14 53.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.544 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.59 144.86 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -125.9 134.8 8.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -127.95 127.99 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.933 0.397 . . . . 0.0 110.83 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.16 131.41 56.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.63 131.32 72.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.75 77.47 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 67.2 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.14 -18.17 8.76 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.36 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.4 t -104.23 131.39 51.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.913 0.387 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.15 135.48 63.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.2 m -109.19 129.82 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mp -115.85 117.98 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.384 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 21.7 m -130.21 153.2 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 192' ' ' ILE . . . 140.55 155.07 6.4 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.5 p -81.25 141.91 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 192' ' ' ILE . . . -109.73 138.4 20.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.492 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 197' ' ' GLN . 44.3 Cg_endo -71.42 -39.53 3.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.482 2.121 . . . . 0.0 111.961 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.03 130.59 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.448 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 172' ' ' LYS . 47.1 m -54.85 -33.12 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -68.77 -35.52 77.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.668 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.5 t60 -58.5 -48.04 82.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.961 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 169' ' ' SER . 21.2 pttt -67.24 -35.2 79.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.857 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -57.49 -43.25 83.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.486 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -70.41 -35.89 73.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.688 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 171' ' ' HIS . 20.3 t -66.73 -43.65 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -62.32 -47.93 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -60.17 -51.43 69.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.643 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.64 72.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.37 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.072 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 185' ' ' ASP . 4.5 m -64.57 -48.86 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.864 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.3 m -72.22 -26.62 62.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.56 HG22 ' N ' ' A' ' 183' ' ' TRP . 2.4 m -70.33 -72.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.086 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.628 ' O ' ' N ' ' A' ' 185' ' ' ASP . 28.0 m95 -131.36 -67.65 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 186' ' ' MET . 11.4 Cg_endo -56.54 32.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.858 2.372 . . . . 0.0 113.361 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 183' ' ' TRP . 2.3 t0 -63.39 9.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.427 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.586 ' H ' ' C ' ' A' ' 184' ' ' PRO . 6.5 mtt -116.95 -89.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.903 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -108.92 115.89 30.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.776 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.942 ' H ' HD12 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -125.68 147.55 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.724 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.27 124.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.318 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -98.9 128.39 45.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -144.2 42.66 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.192 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 164' ' ' GLY . 5.3 mt -114.55 133.3 61.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.687 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -130.66 141.83 50.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.323 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 194' ' ' VAL . 27.1 m -96.6 117.84 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.604 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -77.58 42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.574 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.92 26.05 73.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 167' ' ' PRO . 4.8 mt-30 -86.77 128.24 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.524 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.431 ' HB2' ' N ' ' A' ' 206' ' ' GLY . . . 41.56 73.66 0.86 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 20.9 Cg_exo -55.99 -42.58 65.3 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.697 2.265 . . . . 0.0 112.541 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 65.6 Cg_exo -47.59 -69.99 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.259 1.973 . . . . 0.0 112.013 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 137.26 -73.0 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 204' ' ' ALA . 54.0 Cg_exo -41.96 -52.75 3.84 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.874 2.383 . . . . 0.0 112.899 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 202' ' ' PRO . 8.9 Cg_exo -34.23 -25.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.485 2.123 . . . . 0.0 112.154 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 202' ' ' PRO . . . 67.56 -15.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.667 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 203' ' ' PRO . 16.0 t -177.03 137.22 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.466 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 198' ' ' ALA . . . -130.41 74.81 0.43 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.604 ' C ' ' H ' ' A' ' 209' ' ' ALA . 72.4 Cg_endo -85.03 -162.11 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 123.11 2.54 . . . . 0.0 111.85 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.589 ' O ' HD23 ' A' ' 211' ' ' LEU . 43.3 t -67.59 15.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.034 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 207' ' ' PRO . . . -25.62 146.19 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.376 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.579 ' O ' ' CB ' ' A' ' 214' ' ' ALA . 24.0 m-20 44.04 64.09 1.4 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 208' ' ' CYS . 0.0 OUTLIER -56.01 -43.33 77.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.659 -179.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -72.25 -51.34 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.331 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.1 m -71.0 -45.15 64.49 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.87 0.367 . . . . 0.0 110.957 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 210' ' ' ASP . . . -61.51 -44.28 97.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.23 -0.294 . . . . 0.0 111.573 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 216' ' ' ASN . 2.5 tp -69.55 -39.25 78.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -70.11 -42.92 72.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.711 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -69.3 -49.53 55.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 t -59.22 -46.09 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 215' ' ' ILE . 30.6 p -84.93 -29.29 25.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.748 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 74.72 -48.0 1.89 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -151.55 151.55 23.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.692 ' C ' HG22 ' A' ' 223' ' ' ILE . 40.3 Cg_endo -70.38 140.23 39.87 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.749 2.299 . . . . 0.0 112.234 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.692 HG22 ' C ' ' A' ' 222' ' ' PRO . 1.0 OUTLIER 163.93 -47.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 225' ' ' PHE . . . 55.07 -120.19 1.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 224' ' ' ALA . 0.6 OUTLIER -36.48 132.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.667 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 102.63 178.0 27.07 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 227' ' ' ASN . 4.6 p-10 -105.22 154.1 20.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.777 0.322 . . . . 0.0 110.554 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.1 -32.77 69.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 146.67 -62.56 0.45 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 231' ' ' SER . . . -93.82 -154.17 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.712 0.291 . . . . 0.0 110.518 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.547 ' O ' ' O ' ' A' ' 230' ' ' ALA . 9.2 p 51.51 116.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.626 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.16 94.2 9.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.61 116.6 33.23 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.547 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 235' ' ' ALA . 59.9 Cg_endo -76.93 113.47 3.64 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.331 2.021 . . . . 0.0 112.085 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 234' ' ' PRO . . . 71.51 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.551 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.96 81.15 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 237' ' ' TYR . 25.1 t80 -129.25 -13.39 4.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.622 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -46.19 75.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 49.7 mt -67.71 -38.69 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -36.74 74.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.439 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -42.04 96.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.334 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -61.32 -45.35 94.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.439 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.33 -38.97 81.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.483 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.653 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -57.11 -45.94 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -51.06 70.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.799 0.333 . . . . 0.0 110.529 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.681 ' O ' ' SG ' ' A' ' 250' ' ' CYS . 8.0 mttt -66.1 -32.83 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.611 HD23 HG21 ' A' ' 290' ' ' VAL . 3.3 tp -54.56 -30.85 55.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.488 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 249' ' ' ALA . 0.8 OUTLIER -63.81 -36.98 85.68 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.576 ' O ' ' OD1' ' A' ' 252' ' ' ASP . . . -101.57 5.27 41.65 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.972 0.415 . . . . 0.0 111.351 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.716 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 91.9 m -74.84 -27.51 0.73 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 52.1 Cg_exo -54.21 -15.66 8.4 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.372 2.048 . . . . 0.0 112.891 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.581 ' N ' ' OD1' ' A' ' 252' ' ' ASP . 0.4 OUTLIER -42.1 -18.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 326' ' ' ASN . . . -125.65 -154.41 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.624 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.499 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 1.2 mtm180 -110.27 136.0 50.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.541 HG13 ' HA ' ' A' ' 295' ' ' ILE . 0.6 OUTLIER -119.15 132.81 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.955 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 95.3 m -122.74 122.29 38.38 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.04 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 17.1 mt -102.23 116.71 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -101.77 130.21 48.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.363 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -121.59 127.74 7.02 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 318' ' ' ASN . 43.1 m-85 -106.57 136.58 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.405 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.479 ' O ' ' CG ' ' A' ' 318' ' ' ASN . 0.2 OUTLIER -128.47 -161.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.656 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 262' ' ' ASP . 2.5 p30 -132.83 125.47 30.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.535 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.2 p30 -42.92 -80.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.057 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.9 m 51.06 -76.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 263' ' ' ASN . . . -73.05 -132.78 0.18 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 59.6 m -117.13 168.84 9.93 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -64.95 -31.31 72.48 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.95 5.5 84.48 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 41.9 mt -122.41 -45.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.778 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 271' ' ' ILE . 23.7 p-10 -68.18 -46.25 71.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.136 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 1.9 mm -57.59 -51.62 80.37 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.917 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 9.4 Cg_endo -57.36 -31.96 92.53 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.906 1.737 . . . . 0.0 112.083 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.58 -40.32 80.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.433 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.9 p -69.82 -37.78 76.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.469 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.73 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.85 -40.42 92.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.577 ' O ' HG22 ' A' ' 281' ' ' VAL . 6.4 mtt-85 -60.0 -44.28 94.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.446 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' ALA . . . -67.72 -32.6 73.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.416 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -70.92 -46.27 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.585 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.29 -46.28 95.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 277' ' ' ARG . 33.2 m -72.46 -38.75 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.391 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -56.48 -43.06 79.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.38 -37.59 87.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.365 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -72.43 -34.91 68.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 281' ' ' VAL . 5.2 mp -60.05 -48.27 82.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 282' ' ' ALA . 12.0 t -63.44 -36.17 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.298 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -63.37 -20.17 65.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.653 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -90.25 -2.14 58.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.629 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.07 19.94 9.69 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.465 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.611 HG21 HD23 ' A' ' 247' ' ' LEU . 64.9 t -87.74 129.65 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.405 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 293' ' ' ASP . . . -74.53 101.04 4.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.943 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -67.02 9.53 0.97 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.7 OUTLIER -83.27 -12.32 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.716 0.293 . . . . 0.0 110.651 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -134.67 11.66 3.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.981 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.541 ' HA ' HG13 ' A' ' 255' ' ' VAL . 14.1 tt -88.33 133.79 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -138.66 135.52 34.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 128.26 48.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.1 116.71 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -87.58 114.72 4.2 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.35 54.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -54.49 -92.65 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.47 ' C ' ' CG2' ' A' ' 303' ' ' VAL . 89.8 p -79.8 69.08 6.06 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 122.939 -0.154 . . . . 0.0 110.955 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 304' ' ' ASN . 0.2 OUTLIER -154.93 163.97 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.531 ' O ' ' O ' ' A' ' 303' ' ' VAL . 2.4 m-80 33.29 96.2 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.424 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -51.52 162.98 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.625 2.217 . . . . 0.0 112.298 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 306' ' ' ILE . 24.1 mt -153.5 -79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.308 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -125.1 155.58 39.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.518 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.07 141.12 58.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.598 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 309' ' ' ASN . 4.7 p-10 -98.77 41.14 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.55 -36.21 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.683 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.79 153.75 37.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.718 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.23 -36.1 98.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.803 2.336 . . . . 0.0 112.02 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -66.29 -32.15 73.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.15 87.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -62.59 -45.74 91.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.5 80.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.97 -30.32 68.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 260' ' ' TYR . 1.4 t-20 -74.95 -23.03 58.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.488 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -87.45 87.91 7.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.562 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.33 145.55 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.638 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.67 148.54 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.325 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.15 130.65 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.18 113.33 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.536 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 255' ' ' VAL . 2.2 t -114.74 135.54 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 326' ' ' ASN . 1.5 p -115.8 135.56 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.629 ' O ' ' CB ' ' A' ' 253' ' ' ALA . 7.6 t-20 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.94 20.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.563 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.6 tp -90.69 -57.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -156.12 111.82 3.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.325 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.597 HD13 HD12 ' A' ' 133' ' ' LEU . 17.0 mt -115.28 155.1 27.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -84.98 140.97 30.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -53.41 125.85 19.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.765 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.44 ' H ' ' HB ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -127.31 122.89 35.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.021 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -102.69 122.55 44.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.07 123.23 60.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -135.03 124.81 25.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD2' ' CE2' ' A' ' 151' ' ' PHE . 20.1 ttm180 -116.15 120.23 38.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.496 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.07 123.38 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.719 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.46 -138.73 43.2 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.64 18.22 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.24 46.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.572 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 t -112.2 122.44 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.6 m -113.62 116.82 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.399 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 94' ' ' ILE . 1.0 OUTLIER -120.91 130.37 53.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.729 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.696 ' N ' HD23 ' A' ' 93' ' ' LEU . 3.5 mt -142.86 131.49 20.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.575 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.82 -156.63 26.18 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.62 151.09 47.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -135.63 156.61 77.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.558 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.95 -22.29 19.92 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.777 2.318 . . . . 0.0 112.075 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.38 152.21 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.499 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.72 -27.0 68.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.43 94.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.94 79.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -60.04 -36.01 76.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.454 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.55 -37.17 57.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.64 87.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.26 -40.94 67.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.571 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.2 mtm -61.38 -31.85 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 m -61.28 -33.17 73.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.632 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB1' ' CG ' ' A' ' 142' ' ' PHE . . . -70.58 -26.86 63.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.36 -16.14 33.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -50.98 -28.92 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.56 -9.89 82.58 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' O ' ' C ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -100.16 -42.7 6.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.703 ' C ' HD23 ' A' ' 114' ' ' LEU . 6.7 tt -32.55 113.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.575 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -156.75 158.32 31.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.485 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 14.2 Cg_endo -59.47 149.88 78.95 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.852 2.368 . . . . 0.0 112.297 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 -12.98 8.31 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -95.99 126.63 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 O-C-N 122.278 -0.542 . . . . 0.0 110.534 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.04 137.89 37.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.5 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -138.99 118.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.16 136.69 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.61 105.48 10.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.987 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -98.35 64.82 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.058 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.6 mt -105.25 128.59 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.692 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.62 146.17 24.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.949 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.91 113.99 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.82 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -136.89 128.68 16.86 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.134 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.36 38.32 0.54 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.383 2.055 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.85 -34.6 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 127' ' ' ASP . 27.2 m -65.92 167.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.837 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 80' ' ' SER . 0.1 OUTLIER -121.08 160.26 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.3 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -119.87 156.06 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.671 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.597 HD12 HD13 ' A' ' 79' ' ' LEU . 20.0 tp -78.59 126.39 30.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.487 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -58.47 150.03 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.885 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -140.42 74.11 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.533 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.9 p -95.34 7.34 46.5 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.533 ' OG ' HG23 ' A' ' 182' ' ' THR . 2.1 p -176.59 31.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.77 40.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.438 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 140' ' ' PRO . 7.7 mt-10 -49.16 -58.9 7.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.815 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 15.9 Cg_endo -61.13 -28.13 85.07 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.446 2.097 . . . . 0.0 111.961 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.08 -43.11 89.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' CG ' ' HB1' ' A' ' 109' ' ' ALA . 12.9 m-85 -64.09 -40.72 96.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.351 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 p -63.29 -35.26 79.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.85 -28.96 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -93.72 -9.55 37.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.374 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.518 ' N ' ' HD2' ' A' ' 147' ' ' PRO . 1.1 t -53.24 -48.67 91.51 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.531 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 56.3 Cg_endo -75.21 1.5 7.77 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.186 1.924 . . . . 0.0 111.666 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 171' ' ' HIS . 5.5 mm -118.66 85.55 27.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.208 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.81 22.15 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.844 2.363 . . . . 0.0 112.354 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -141.27 55.66 1.54 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.751 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.639 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 1.7 p90 -123.71 143.7 50.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 163' ' ' THR . . . -126.81 145.04 15.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.9 129.39 36.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 110.779 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.86 135.6 53.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.2 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 82' ' ' LEU . 57.2 t -117.92 134.7 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.659 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -145.61 77.68 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.656 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 62.14 -96.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.21 33.58 4.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.64 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.6 m -136.47 133.56 36.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.519 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.41 134.24 66.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.354 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.579 HG23 ' HB ' ' A' ' 189' ' ' VAL . 82.2 m -132.35 128.26 37.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.699 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -111.75 118.96 37.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 152' ' ' GLY . 87.8 m -128.22 147.49 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.675 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 150.38 166.41 13.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 193' ' ' GLU . 0.6 OUTLIER -100.02 142.0 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.73 149.4 46.36 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.11 -40.63 1.63 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.743 2.296 . . . . 0.0 111.69 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 146.68 52.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.236 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.25 -36.97 85.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.457 ' HB3' HD11 ' A' ' 148' ' ' ILE . 1.8 m170 -63.4 -48.16 79.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.798 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -66.58 -33.7 76.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.577 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -53.5 -44.34 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.8 90.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.577 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.61 -40.94 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -62.55 -52.01 65.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.057 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.3 ttm-85 -62.12 -39.66 93.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.858 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.16 97.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 110.556 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 183' ' ' TRP . . . -64.9 -40.0 94.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.588 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.4 m -67.81 -40.08 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.4 p -68.63 -39.22 80.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.597 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.533 HG23 ' OG ' ' A' ' 137' ' ' SER . 55.8 m -83.53 -38.43 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.577 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 179' ' ' ALA . 4.7 m-90 -127.18 73.13 77.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.686 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 61.2 Cg_endo -77.87 28.0 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.857 2.371 . . . . 0.0 111.923 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 187' ' ' LYS . 1.2 t70 -41.58 -12.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.679 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 74.78 -26.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.481 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 185' ' ' ASP . 18.2 mttm -95.6 61.42 2.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.403 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 162' ' ' LEU . 3.9 mp -97.1 136.04 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.579 ' HB ' HG23 ' A' ' 161' ' ' THR . 42.4 t -110.79 129.68 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -88.52 107.76 19.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.441 ' CB ' ' OG1' ' A' ' 163' ' ' THR . 4.7 m-80 -122.23 52.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.8 mt -86.33 133.11 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.599 ' O ' HG22 ' A' ' 165' ' ' THR . 17.5 mt-10 -120.12 124.79 46.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.913 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.4 m -105.25 109.86 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.128 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.8 t -115.56 -24.5 8.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.807 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -151.38 16.34 0.87 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -65.04 156.39 31.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.921 0.391 . . . . 0.0 110.815 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.2 106.67 52.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.405 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.517 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 23.8 Cg_exo -54.67 -42.53 67.52 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.154 1.903 . . . . 0.0 112.428 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 58.2 Cg_exo -48.92 -69.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 111.893 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.449 ' H ' ' HD2' ' A' ' 203' ' ' PRO . . . 134.33 -57.52 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.541 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 38.0 Cg_exo -49.88 -40.84 48.6 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.7 2.266 . . . . 0.0 113.001 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.615 ' O ' ' HB2' ' A' ' 204' ' ' ALA . 21.3 Cg_exo -62.73 -175.64 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.196 1.93 . . . . 0.0 112.02 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 203' ' ' PRO . . . 166.77 128.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 204' ' ' ALA . 0.7 OUTLIER 75.34 64.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -119.74 70.86 0.34 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.432 ' O ' HD22 ' A' ' 211' ' ' LEU . 60.7 Cg_endo -76.9 -91.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.932 2.422 . . . . 0.0 112.19 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . 0.563 ' O ' ' O ' ' A' ' 209' ' ' ALA . 9.4 m -124.94 35.3 4.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.568 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 208' ' ' CYS . . . -48.88 -111.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.347 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -81.95 18.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.305 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 215' ' ' ILE . 6.7 mp -56.55 -29.93 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -50.62 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.701 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 74.3 m -62.72 -39.92 95.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.465 0.65 . . . . 0.0 110.975 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -72.13 -34.22 68.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.448 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LEU . 6.2 mt -58.95 -37.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.376 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 220' ' ' GLY . 9.3 t-20 -54.78 -41.67 70.81 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -74.28 -31.28 62.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.517 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.32 -41.4 81.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -106.43 -27.53 10.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.542 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 216' ' ' ASN . . . 78.47 -14.7 11.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.17 173.25 43.6 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.91 148.46 57.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.793 2.328 . . . . 0.0 112.128 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 23.2 mt -54.27 96.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.606 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.406 ' HB2' ' HG3' ' A' ' 320' ' ' ARG . . . -155.29 62.43 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.697 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.59 125.74 40.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -101.17 30.75 9.7 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -115.71 132.71 56.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 0.0 110.635 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.25 70.78 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.65 6.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -144.94 -83.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 0.0 110.362 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.97 171.82 8.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 233' ' ' ILE . 2.1 mm? -46.84 162.63 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.416 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 232' ' ' LEU . 5.2 mt 33.93 77.41 0.37 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.436 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.83 -66.92 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.841 2.361 . . . . 0.0 112.333 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . 43.07 72.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.463 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 236' ' ' ASP . 0.0 OUTLIER 72.64 -140.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.547 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -131.47 90.69 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.411 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.02 -34.58 78.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.842 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 239' ' ' ILE . 7.7 mm -59.55 -45.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.745 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -31.96 68.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -42.97 76.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.13 -45.68 93.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.974 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 247' ' ' LEU . 54.8 t -69.26 -38.0 76.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.186 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.749 ' HB1' ' HG2' ' A' ' 288' ' ' ARG . . . -62.53 -45.76 91.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 -50.38 72.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -65.49 -32.08 73.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.9 HD13 HD22 ' A' ' 285' ' ' LEU . 0.4 OUTLIER -63.44 -32.27 73.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -63.83 -26.13 68.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.791 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -98.5 1.95 47.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.023 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.678 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 1.2 m -74.69 -28.57 0.84 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 250' ' ' CYS . 46.2 Cg_exo -53.43 -14.15 4.34 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.854 1.703 . . . . 0.0 111.819 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -2.66 3.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB1' ' C ' ' A' ' 326' ' ' ASN . . . -141.02 -159.0 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.101 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.545 ' H ' ' HB3' ' A' ' 326' ' ' ASN . 0.0 OUTLIER -103.44 139.99 38.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.203 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.52 133.01 67.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.817 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.622 ' HB ' HG23 ' A' ' 324' ' ' VAL . 93.7 m -123.02 111.96 17.22 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.055 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.35 121.46 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -101.09 126.02 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -98.55 134.79 11.83 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -120.39 116.7 26.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 111.042 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.497 ' C ' ' OD1' ' A' ' 318' ' ' ASN . 2.9 t -134.74 159.28 41.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.113 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.667 ' N ' ' OD1' ' A' ' 318' ' ' ASN . 39.9 p-10 -113.24 97.33 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 265' ' ' GLY . 1.6 t-20 38.36 -94.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.651 HG22 ' N ' ' A' ' 265' ' ' GLY . 1.1 m 62.14 -69.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.651 ' N ' HG22 ' A' ' 264' ' ' THR . . . -90.33 -161.15 37.19 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.859 ' OG ' HG13 ' A' ' 269' ' ' ILE . 88.7 p -89.49 162.79 15.53 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 120.79 0.329 . . . . 0.0 110.974 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -64.62 -17.08 63.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.735 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.69 -20.31 22.28 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.859 HG13 ' OG ' ' A' ' 266' ' ' SER . 5.1 mt -111.97 4.4 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -44.02 76.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.001 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 272' ' ' PRO . 3.1 mm -63.04 -51.36 71.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.754 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 271' ' ' ILE . 18.3 Cg_endo -61.72 -39.84 50.17 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.055 1.837 . . . . 0.0 112.004 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.76 -43.98 91.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.47 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -38.0 67.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.76 71.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.402 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -60.97 -38.72 86.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 33.6 mtt180 -68.09 -39.05 82.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.095 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.61 -29.55 68.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.177 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -45.6 76.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.357 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -60.23 -40.99 85.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.373 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.25 -39.38 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.86 94.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.492 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.72 -42.04 83.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.444 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.2 -49.72 76.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.391 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.9 HD22 HD13 ' A' ' 247' ' ' LEU . 39.5 mt -59.51 -48.0 83.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.287 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.66 -38.07 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -62.56 -23.09 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.479 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.749 ' HG2' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -87.63 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.496 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 106.2 12.99 24.19 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.18 130.89 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -72.44 113.36 9.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.439 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -75.47 11.02 10.17 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 293' ' ' ASP . 0.1 OUTLIER -89.37 -16.71 30.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.904 0.383 . . . . 0.0 110.482 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -113.83 2.34 15.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.87 124.79 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.698 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -123.69 154.12 39.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.298 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.38 132.83 38.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.73 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.9 t -125.62 116.48 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.263 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 300' ' ' LEU . . . -83.26 105.34 2.69 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 299' ' ' GLY . 1.6 mm? -31.28 -61.47 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 64.63 49.62 63.39 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.603 ' O ' ' O ' ' A' ' 303' ' ' VAL . 94.3 p -99.58 -23.98 14.9 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.58 0.228 . . . . 0.0 110.95 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.603 ' O ' ' O ' ' A' ' 302' ' ' SER . 1.3 m 51.68 124.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.157 0.504 . . . . 0.0 110.512 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.489 ' N ' ' HD3' ' A' ' 305' ' ' PRO . 0.1 OUTLIER 60.2 53.25 3.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.621 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 304' ' ' ASN . 67.6 Cg_endo -77.61 -101.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.838 2.358 . . . . 0.0 112.046 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . . . . . . . . . 4.6 mm -81.27 -38.59 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -115.79 160.75 19.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.44 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 p -102.83 16.15 27.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.769 HD21 ' CZ ' ' A' ' 315' ' ' ARG . 2.3 t30 44.63 53.81 6.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.615 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -127.25 -5.0 6.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.447 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.56 148.88 63.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.432 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.53 -31.81 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.674 2.249 . . . . 0.0 111.936 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.24 -33.39 65.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.209 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 318' ' ' ASN . . . -66.76 -44.38 89.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.769 ' CZ ' HD21 ' A' ' 309' ' ' ASN . 1.8 mtt-85 -62.06 -44.94 95.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 0.0 110.444 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -62.05 -45.53 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -34.69 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.597 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.667 ' OD1' ' N ' ' A' ' 262' ' ' ASP . 2.4 t30 -63.11 -25.4 68.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.733 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -79.68 98.97 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 224' ' ' ALA . 10.0 ttp180 -133.79 146.86 51.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.0 t -144.85 144.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.321 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.43 148.52 46.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 323' ' ' ILE . 4.5 mp -123.58 129.64 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 256' ' ' THR . 0.6 OUTLIER -130.73 123.56 54.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.681 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.535 HG11 ' SG ' ' A' ' 250' ' ' CYS . 0.1 OUTLIER -107.33 134.6 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.305 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.568 ' C ' ' HB1' ' A' ' 253' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.641 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.748 0.308 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.98 17.51 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.601 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.23 -42.16 84.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.806 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.17 117.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 157' ' ' ARG . 69.6 mt -99.34 152.54 19.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.402 ' OG ' HD21 ' A' ' 82' ' ' LEU . 11.0 p -75.47 162.4 28.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.618 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.28 106.51 13.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.596 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' OG ' ' A' ' 80' ' ' SER . 17.2 mt -98.17 140.94 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -128.23 117.67 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.25 120.12 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.112 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.51 132.66 44.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.696 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HE ' HG22 ' A' ' 91' ' ' VAL . 45.8 ttt180 -121.23 138.08 54.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.404 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.1 p -143.6 109.58 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.364 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 149' ' ' PRO . . . 75.57 -125.52 8.06 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.55 18.28 22.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.938 0.399 . . . . 0.0 110.397 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.5 m -118.81 138.96 52.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 ' HE ' ' A' ' 86' ' ' ARG . 1.3 t -127.54 121.41 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.812 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.7 m -104.22 124.73 49.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.194 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.76 125.51 48.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.963 0.411 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.75 119.65 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.353 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.549 ' C ' ' OD1' ' A' ' 96' ' ' ASP . . . -175.5 -171.56 39.56 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' OD1' ' C ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -131.46 145.11 51.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.798 0.332 . . . . 0.0 110.576 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.45 ' CE2' ' OG ' ' A' ' 132' ' ' SER . 3.8 m-85 -134.5 155.87 79.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.14 -28.37 48.59 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.774 2.316 . . . . 0.0 112.483 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.09 169.45 20.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -24.82 50.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.683 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.24 89.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.814 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.67 78.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -59.74 -38.91 83.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.16 -37.76 62.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.992 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 106' ' ' LEU . 2.5 tt -72.02 -44.82 62.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.032 0.444 . . . . 0.0 110.427 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.498 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER -57.49 -26.76 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.455 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.9 m -66.5 -32.12 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.72 -18.47 63.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 110' ' ' LEU . 3.3 pp -125.49 3.74 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.637 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 107' ' ' MET . 32.5 t-20 -54.82 -42.27 71.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.639 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.66 -16.87 70.42 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.52 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 0.0 110.461 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 114' ' ' LEU . 2.3 tt -45.52 105.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.621 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -154.8 160.53 30.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.567 ' C ' ' H ' ' A' ' 118' ' ' VAL . 52.0 Cg_exo -47.46 155.59 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 112.426 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.04 -25.45 0.31 Allowed Glycine 0 N--CA 1.461 0.316 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 116' ' ' PRO . 12.7 t -93.22 140.04 17.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.173 -0.604 . . . . 0.0 110.635 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.55 130.29 54.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.605 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.2 t -134.22 119.82 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.508 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.7 pt -125.24 125.13 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -104.23 104.24 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.171 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -109.93 63.93 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.846 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.2 mt -103.7 125.36 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.579 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -90.63 146.42 24.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.219 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.78 121.06 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.561 ' HB3' HG13 ' A' ' 130' ' ' VAL . 1.2 t0 -136.76 132.19 18.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.439 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.97 60.41 7.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.35 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 130' ' ' VAL . 7.4 p -174.2 -41.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.909 0.385 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 127' ' ' ASP . 26.3 m -52.03 142.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 131' ' ' ARG . 0.5 OUTLIER -99.55 158.03 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.154 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.45 ' OG ' ' CE2' ' A' ' 97' ' ' PHE . 13.8 t -120.46 155.02 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.76 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 183' ' ' TRP . 55.6 tp -81.61 127.87 33.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.01 139.22 52.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.258 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -130.36 24.03 5.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.923 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 135' ' ' PHE . 68.9 m -30.41 -39.95 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.393 0.616 . . . . 0.0 110.962 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . 1.7 m -152.59 61.51 0.81 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.436 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.16 -7.62 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.427 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -56.29 -43.47 99.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.513 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 26.0 Cg_exo -58.37 -41.43 65.96 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.1 t -66.31 -49.07 78.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.076 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' N ' ' A' ' 146' ' ' VAL . 2.4 m-85 -65.01 -37.12 86.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.816 0.341 . . . . 0.0 110.673 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 140' ' ' PRO . 1.3 p -58.27 -37.89 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.417 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.73 53.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.692 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 p -101.65 -2.06 31.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.645 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.2 t -65.62 -40.01 37.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 56.4 Cg_endo -82.65 29.64 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.712 2.274 . . . . 0.0 112.256 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 165' ' ' THR . 5.2 mt -128.99 104.01 18.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.284 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 88' ' ' GLY . 59.6 Cg_endo -78.24 21.1 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.205 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 12.3 t70 -152.63 64.18 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.478 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.647 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -130.01 139.67 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.659 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 130.5 6.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -119.11 129.96 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.586 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 131.26 51.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.585 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.25 134.59 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.388 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 158' ' ' ASP . 69.8 mt-10 -141.95 95.82 2.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.621 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.493 ' HA ' ' H ' ' A' ' 79' ' ' LEU . 8.3 mtt180 53.84 -90.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' GLU . 5.0 p30 -117.97 9.06 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.884 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 m -110.06 129.11 55.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.693 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.9 t -119.9 131.77 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.357 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.756 HG22 ' HB ' ' A' ' 189' ' ' VAL . 1.3 p -130.95 116.86 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.656 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 163' ' ' THR . 3.6 tt -112.0 118.7 36.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.436 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.559 ' N ' HD23 ' A' ' 162' ' ' LEU . 4.8 p -128.59 149.2 50.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.789 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 147.55 -168.04 28.57 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.492 ' O ' HG21 ' A' ' 148' ' ' ILE . 20.8 p -108.03 135.7 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.685 0.279 . . . . 0.0 110.731 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.47 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -98.36 159.08 31.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.358 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.596 ' O ' ' O ' ' A' ' 197' ' ' GLN . 46.4 Cg_endo -73.78 -67.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.732 2.288 . . . . 0.0 112.142 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.38 166.4 16.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.15 -41.45 94.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -63.44 -41.49 98.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.687 ' O ' HG23 ' A' ' 175' ' ' VAL . 2.0 m170 -63.94 -37.81 88.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.44 -43.25 97.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 173' ' ' ASP . 1.9 t70 -66.73 -36.85 83.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.7 -32.83 68.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 171' ' ' HIS . 73.4 t -65.5 -51.83 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.727 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 177' ' ' ARG . 8.3 ptpt -66.35 -39.26 89.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 176' ' ' LYS . 7.8 ttm-85 -56.17 -51.03 69.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.569 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.39 -31.74 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.661 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.41 99.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 40.7 p -67.4 -37.59 83.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.474 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -27.06 64.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.8 m -96.02 -52.62 3.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.989 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.489 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.1 m-90 -116.71 99.09 52.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.264 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 186' ' ' MET . 58.2 Cg_endo -80.19 17.09 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.508 2.139 . . . . 0.0 111.349 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 184' ' ' PRO . 0.3 OUTLIER -30.86 -29.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.718 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.673 ' N ' ' O ' ' A' ' 184' ' ' PRO . 0.0 OUTLIER 78.52 -29.21 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.594 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 185' ' ' ASP . 23.5 mttt -105.2 76.86 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.546 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.92 125.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.756 ' HB ' HG22 ' A' ' 161' ' ' THR . 21.9 t -98.25 124.27 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.344 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -98.31 123.53 42.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.19 45.69 1.24 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.16 126.64 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.396 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.3 p -84.71 56.5 3.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 53.45 26.31 30.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.596 ' O ' ' O ' ' A' ' 167' ' ' PRO . 6.7 mt-30 -113.27 157.04 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 110.527 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 197' ' ' GLN . . . 169.46 64.83 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.73 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.56 ' N ' ' CD ' ' A' ' 200' ' ' PRO . 18.2 Cg_exo -50.8 -42.05 52.63 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.325 2.017 . . . . 0.0 111.989 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 199' ' ' PRO . 72.8 Cg_endo -91.2 3.27 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.983 2.455 . . . . 0.0 112.548 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.49 72.69 0.43 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.516 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 17.1 Cg_exo -57.1 -42.58 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.6 2.2 . . . . 0.0 112.774 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 54.0 Cg_exo -47.69 -12.97 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.42 2.08 . . . . 0.0 112.395 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 202' ' ' PRO . . . -89.38 -82.44 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.579 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.0 m -143.56 -54.54 0.38 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 79.6 171.79 42.33 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.14 -95.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.81 2.34 . . . . 0.0 112.316 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.92 71.16 0.88 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.807 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -53.98 112.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 213' ' ' SER . 15.7 m-20 62.18 72.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -40.48 74.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.243 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -50.51 51.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.058 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 210' ' ' ASP . 74.4 m -70.73 -45.02 65.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.957 0.408 . . . . 0.0 110.976 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.7 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.246 -0.284 . . . . 0.0 111.715 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.596 ' O ' HG12 ' A' ' 218' ' ' VAL . 1.2 tp -69.56 -41.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.563 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.489 ' N ' ' CG2' ' A' ' 215' ' ' ILE . 21.0 t30 -70.33 -36.85 74.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -73.57 -30.11 62.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.165 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 215' ' ' ILE . 0.3 OUTLIER -58.2 -34.64 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.752 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 221' ' ' GLY . 0.8 OUTLIER -109.08 -15.89 14.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.752 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 56.03 4.13 0.68 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 219' ' ' THR . . . -165.98 -172.88 33.86 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.11 147.68 79.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.579 2.186 . . . . 0.0 111.982 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 322' ' ' GLU . 21.0 mt -85.3 145.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 223' ' ' ILE . . . 176.59 -174.51 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -99.97 154.22 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -46.87 122.26 6.64 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -107.22 24.0 13.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.23 -15.97 13.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.514 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . 143.56 68.1 0.02 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.9 62.52 1.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.752 0.31 . . . . 0.0 110.536 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 233' ' ' ILE . 0.5 OUTLIER -84.81 100.84 11.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.625 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 mp 56.01 -1.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.643 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 231' ' ' SER . 89.3 mt -133.59 82.03 52.39 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.936 0.398 . . . . 0.0 110.613 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 235' ' ' ALA . 50.1 Cg_exo -51.04 152.32 10.58 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.745 2.297 . . . . 0.0 112.027 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -28.18 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.668 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -128.21 163.61 24.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.719 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.82 -30.51 2.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.526 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 239' ' ' ILE . 10.1 pt-20 -62.2 -37.11 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.724 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 240' ' ' LEU . 4.2 tt -63.69 -37.43 79.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.787 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.437 ' HB3' HH21 ' A' ' 288' ' ' ARG . 2.2 mp -59.91 -43.25 94.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.722 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -38.49 70.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.361 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -45.42 94.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.133 0.492 . . . . 0.0 109.852 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 247' ' ' LEU . 3.6 t -68.36 -35.17 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.2 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.599 ' HB1' ' HG3' ' A' ' 288' ' ' ARG . . . -55.82 -47.18 77.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.903 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -58.08 -50.6 72.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.786 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -68.91 -32.09 71.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.916 0.389 . . . . 0.0 110.668 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.792 HD13 HG12 ' A' ' 243' ' ' VAL . 1.4 tp -55.07 -33.65 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.398 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -63.27 -37.69 88.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.894 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -109.45 -2.23 17.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -74.4 -46.59 5.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.941 -178.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 253' ' ' ALA . 31.5 Cg_exo -53.2 -13.75 3.46 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.986 2.458 . . . . 0.0 112.374 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 253' ' ' ALA . 0.6 OUTLIER -37.08 -23.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 251' ' ' PRO . . . -107.19 -149.07 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.847 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.546 ' H ' ' HB2' ' A' ' 326' ' ' ASN . 0.2 OUTLIER -103.77 138.23 40.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.03 132.12 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.95 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 324' ' ' VAL . 95.0 m -123.48 124.37 42.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.067 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.99 114.01 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.837 0.351 . . . . 0.0 110.57 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.85 128.88 56.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -132.6 148.83 19.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -139.65 130.79 26.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 110.379 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.7 p -124.99 -155.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.651 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.479 ' OD1' ' OD1' ' A' ' 318' ' ' ASN . 0.1 OUTLIER -143.85 158.02 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.482 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.564 ' O ' ' OG1' ' A' ' 264' ' ' THR . 0.3 OUTLIER 172.43 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.883 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 265' ' ' GLY . 10.6 p 66.74 -90.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.908 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 264' ' ' THR . . . 26.7 -103.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.983 ' OG ' ' CD1' ' A' ' 269' ' ' ILE . 88.9 p -142.25 166.41 24.76 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.808 0.337 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.54 -20.38 64.6 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.495 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . 0.658 ' C ' HD12 ' A' ' 269' ' ' ILE . . . -79.66 7.12 56.02 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.983 ' CD1' ' OG ' ' A' ' 266' ' ' SER . 3.1 mp -141.4 -35.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.838 0.351 . . . . 0.0 110.888 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -68.8 -46.8 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.782 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.617 ' CD1' ' O ' ' A' ' 299' ' ' GLY . 0.6 OUTLIER -76.07 -47.05 3.71 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.625 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 271' ' ' ILE . 39.8 Cg_exo -53.9 -32.62 68.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.259 1.973 . . . . 0.0 112.294 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 28.2 tp -68.2 -48.36 65.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.825 0.345 . . . . 0.0 110.477 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.59 -32.92 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -74.17 -41.84 60.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.448 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -64.88 -37.38 87.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' CZ ' ' A' ' 319' ' ' ARG . 38.8 mtt-85 -61.38 -41.87 97.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.352 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.96 -28.84 67.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.174 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -47.19 73.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.877 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 277' ' ' ARG . 10.9 pt -70.87 -44.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.86 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.428 ' N ' HG13 ' A' ' 280' ' ' ILE . 71.0 t -58.6 -48.49 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.67 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 286' ' ' VAL . . . -55.83 -39.11 70.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.15 -38.78 92.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -42.0 83.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.636 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.55 -37.22 77.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.88 0.372 . . . . 0.0 110.012 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 282' ' ' ALA . 95.4 t -62.35 -36.28 73.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.079 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -68.16 -20.1 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . 0.599 ' HG3' ' HB1' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -81.42 -2.67 50.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.794 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 102.23 20.09 13.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.6 134.6 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.942 ' HB3' ' NE2' ' A' ' 294' ' ' HIS . . . -87.8 104.54 16.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.1 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.604 ' H ' ' C ' ' A' ' 291' ' ' ALA . 0.4 OUTLIER -79.29 -16.72 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 0.0 110.648 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.942 ' NE2' ' HB3' ' A' ' 291' ' ' ALA . 0.9 OUTLIER -133.74 35.02 3.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.738 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.96 136.79 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.668 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -137.29 143.59 42.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.533 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.1 124.46 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.01 119.05 60.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 271' ' ' ILE . . . -95.68 120.89 6.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 300' ' ' LEU . 4.0 mm? -99.0 111.45 23.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.328 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 302' ' ' SER . . . -78.42 120.44 5.39 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 301' ' ' GLY . 45.7 t 37.72 98.16 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.995 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.72 -38.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.964 0.411 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -133.67 70.23 75.88 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.127 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.81 131.51 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.915 2.41 . . . . 0.0 112.196 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.445 HG21 HH12 ' A' ' 320' ' ' ARG . 8.4 mm -122.47 -57.19 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -116.84 156.67 26.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 309' ' ' ASN . 13.1 p -61.71 -136.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.786 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.636 ' C ' HD22 ' A' ' 309' ' ' ASN . 0.4 OUTLIER -173.15 34.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.626 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -92.78 -15.6 26.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.779 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 162.26 32.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.571 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -50.51 -33.1 37.25 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.446 2.098 . . . . 0.0 112.102 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.78 -40.11 91.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -61.04 -46.99 93.46 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 315' ' ' ARG . 37.7 mtm105 -65.61 -38.57 89.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.94 89.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.674 ' O ' ' NH1' ' A' ' 320' ' ' ARG . 41.1 mttm -71.02 -29.73 65.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.469 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 260' ' ' TYR . 0.1 OUTLIER -77.01 -16.13 59.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.541 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.578 ' CZ ' ' NH1' ' A' ' 277' ' ' ARG . 0.8 OUTLIER -83.85 99.76 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.566 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.674 ' NH1' ' O ' ' A' ' 317' ' ' LYS . 0.0 OUTLIER -134.53 140.76 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.386 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.64 156.07 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.52 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.509 ' HA ' HD12 ' A' ' 223' ' ' ILE . 40.6 tt0 -142.6 142.85 32.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 223' ' ' ILE . 35.1 mt -107.48 113.7 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.535 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 256' ' ' THR . 2.1 m -112.27 121.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 326' ' ' ASN . 0.7 OUTLIER -109.87 135.14 49.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.507 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . 0.563 ' C ' ' CB ' ' A' ' 253' ' ' ALA . 5.9 m-20 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 stop_ save_